Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AARD	"C8orf85, LOC441376"	ENSG00000205002	"Alanine and arginine rich domain containing protein"	Q4LEZ3	8	116938207-116944487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.5;urinary bladder: 7.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 27.6;Breast glandular cells: 26.0;Breast myoepithelial cells: 29.0;granulocytes: 14.5;Late spermatids: 18.4;Proximal tubular cells: 14.9;Spermatocytes: 57.4"	"Cancer enriched"	"Detected in many"	8	"breast cancer: 27.0"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.7;JURKAT: 7.2;SK-BR-3: 11.8;U-2 OS: 5.5;U-266/84: 4.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"midbrain: 4.4"	HPA068290			Approved	"Lipid droplets"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Lipid droplets"		"HPA068290: "	"unprognostic (5.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.28e-8)"	"unprognostic (3.42e-2)"	"unprognostic (4.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.29e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.20e-1)"	"unprognostic (2.23e-6)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.77e-2)"	"unprognostic (5.27e-4)"	0.6	0.9	0.5	0.4	0.8	0.2	4.3	0.4	0.9	0.3	0.9	5.9	0.1	0.8	0.2	2.4	0.1	0.2	0.0	0.6	0.6	1.0	0.0	2.5	0.8	1.2	1.0	0.0	0.0	0.0	0.0	0.4	0.9	0.6	0.5	0.1	2.0	0.1	0.1	1.5	1.0	1.0	0.8	0.1	6.8	22.5	0.7	0.0	0.1	0.0	0.4	7.7	0.2	1.3	0.0	0.0	0.5	0.0	0.0	0.0	0.2	1.8	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.5	0.0	0.2	0.1	2.4	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.0	7.2	0.0	2.4	0.1	0.5	0.9	0.1	1.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	1.9	0.3	0.0	11.8	0.1	0.2	0.5	0.0	0.0	0.1	5.5	0.2	0.0	1.6	4.5	0.0	3.0	0.0	0.3	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.3	0.1	0.2	0.6	0.0	0.5	0.8	0.4	0.9	0.6	0.6	1.2	1.0	0.9	0.8	0.7	1.3	0.2	12.8	27.6	0.0	0.1	0.8	0.6	0.2	0.0	0.4	26.0	29.0	0.9	0.0	5.0	7.3	0.0	0.2	0.8	0.1	1.9	0.1	9.3	0.1	1.7	0.9	0.0	0.0	0.8	0.0	0.9	1.4	0.0	0.0	14.5	0.1	0.0	0.1	0.0	1.7	2.1	0.0	0.0	0.0	0.3	18.4	4.1	0.5	0.0	0.0	0.1	0.1	4.1	0.0	0.2	0.1	0.0	0.7	0.0	0.6	0.0	14.9	0.7	0.2	0.0	0.5	1.1	57.4	7.3	0.0	0.6	0.3	0.8	2.0	0.0	0.4
AC004080.3		ENSG00000257184	"HOXA10-HOXA9 readthrough"		7	27163535-27180013	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BJ: 1.3"					"Region enriched"	"Detected in single"	165	"spinal cord: 16.4"							NA	NA					"Cluster 10: BJ & FHDF - ECM organization"							"unprognostic (4.27e-1)"									"unprognostic (4.63e-1)"		"unprognostic (4.49e-1)"				0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	1.3	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835755-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 314.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 365.2;Endometrial stromal cells: 235.3;Endothelial cells: 275.9;Extravillous trophoblasts: 240.8;Fibroblasts: 243.9;Sertoli cells: 210.4;Smooth muscle cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"gdT-cell: 4.5;NK-cell: 6.6"	"Group enriched"	"Detected in many"	56	"NK-cells: 6.6;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 382.0;BJ: 451.4;hTEC/SVTERT24-B: 250.0;hTERT-HME1: 248.2;LHCN-M2: 295.3;RPTEC TERT1: 343.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 35.6"	"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4100000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	234.6	46.4	22.2	71.3	24.9	1.4	94.1	20.8	28.9	87.4	22.3	54.6	8.7	97.1	9.0	82.6	161.2	111.8	95.9	21.5	23.5	76.0	39.0	79.7	10.1	24.8	25.5	314.4	29.4	18.5	25.5	245.1	25.2	88.2	59.3	15.6	19.2	13.9	48.9	21.9	44.6	162.6	25.3	13.9	56.0	8.2	26.4	12.2	50.1	40.3	5.4	143.1	50.6	30.5	0.1	0.0	6.8	0.1	382.0	104.9	21.8	451.4	199.6	90.4	61.1	0.0	0.0	0.0	29.5	120.1	2.0	9.2	4.6	23.6	150.0	0.4	120.3	0.0	29.7	0.1	85.6	15.5	0.0	103.0	0.3	250.0	248.2	15.1	35.4	3.7	7.3	0.0	295.3	0.0	1.7	0.3	21.9	0.0	14.5	0.0	151.6	0.6	343.9	25.1	0.2	32.7	21.4	0.0	2.2	16.0	0.2	3.8	34.9	99.6	4.3	156.0	63.1	0.5	0.0	0.0	80.8	0.5	29.7	0.0	0.0	0.0	4.5	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.0	6.6	0.0	0.0	0.0	0.8	22.2	24.9	20.8	28.9	21.5	23.5	24.8	25.5	25.2	25.3	26.4	30.5	365.2	6.4	22.4	2.9	0.5	121.2	32.5	10.4	53.5	0.6	13.9	54.9	179.5	12.8	9.6	57.0	0.0	71.1	13.1	0.2	1.9	47.4	1.4	86.5	235.3	275.9	0.0	0.4	3.2	22.3	240.8	243.9	11.7	148.2	2.5	0.3	157.8	2.2	16.5	0.0	3.3	0.2	2.0	5.0	38.5	4.4	109.0	5.8	53.4	7.5	0.6	52.2	20.6	2.0	19.9	20.6	0.0	41.8	3.6	26.3	0.0	6.3	3.3	3.3	210.4	91.0	452.4	0.4	1.0	22.8	41.6	54.9	10.1	8.8	0.0	16.8
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449090	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;heart muscle: 105.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 75.5;Inhibitory neurons: 44.0;Oligodendrocytes: 89.7;Paneth cells: 59.6;Peritubular cells: 73.7;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 15.5;RPMI-8226: 2.7;RPTEC TERT1: 5.2"	"Region enriched"	"Detected in all"	5	"basal ganglia: 388.0"	"Region enriched"	"Detected in all"	6	"basal ganglia: 155.9"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	18.9	3.3	25.5	4.9	97.7	0.0	10.6	13.9	43.9	9.8	0.0	35.1	5.2	14.7	5.7	18.8	12.7	10.0	105.2	25.8	15.9	12.8	3.3	4.1	2.3	20.5	18.3	13.2	7.5	0.8	14.3	6.1	17.4	19.8	5.6	4.5	4.0	21.5	2.7	2.6	13.0	18.2	10.8	6.5	21.2	8.2	34.4	1.3	1.9	5.8	3.0	23.2	7.8	30.1	0.0	0.6	1.3	0.1	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.3	0.2	2.3	0.5	0.6	0.0	0.0	0.1	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	15.5	0.0	0.0	0.8	0.0	0.1	0.0	0.3	2.7	5.2	0.5	1.8	1.6	0.0	0.5	0.1	1.7	0.0	0.1	0.0	0.1	1.2	0.1	0.2	0.1	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.5	97.7	13.9	43.9	25.8	15.9	20.5	18.3	17.4	10.8	34.4	30.1	0.3	0.0	0.0	8.1	0.1	0.3	0.1	0.2	0.0	21.8	0.4	5.8	75.5	8.6	0.0	7.3	0.0	1.4	0.0	2.6	0.0	15.9	0.9	1.5	7.1	1.8	0.0	0.0	34.0	6.9	4.0	5.2	0.0	4.0	0.0	4.6	3.9	0.1	0.3	0.0	44.0	0.3	0.0	0.0	0.3	3.0	20.5	0.1	0.0	6.5	1.0	1.0	0.0	19.1	89.7	0.4	59.6	73.7	0.0	0.1	0.3	0.8	0.0	2.2	65.7	0.6	21.4	0.8	6.3	0.2	0.9	12.4	0.2	1.0	2.0	0.1
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442357	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 40.6;brain: 101.4;lymphoid tissue: 54.1"	"Group enriched"	"Detected in some"	6	"B-cells: 5.8;monocytes: 10.9;Plasma cells: 11.8;T-cells: 3.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"basal ganglia: 101.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.3;Karpas-707: 52.8;RPMI-8226: 41.1;SK-BR-3: 74.0;U-266/70: 52.8;U-266/84: 74.4;U-698: 55.0"	"Region enriched"	"Detected in many"	9	"basal ganglia: 399.8"	"Region enriched"	"Detected in many"	50	"basal ganglia: 142.2"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported				NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"	3.4	5.4	12.3	13.5	101.4	40.6	2.5	10.8	19.2	4.0	8.0	4.1	6.6	2.9	1.6	2.0	3.7	3.0	13.5	11.6	10.0	17.5	14.5	14.6	20.5	10.2	10.4	3.9	2.3	0.2	6.7	1.8	10.4	5.5	1.0	2.1	3.2	1.7	2.5	1.6	7.0	0.9	9.9	15.2	4.0	3.1	19.9	54.1	4.3	1.4	10.4	5.3	3.4	9.7	0.5	0.9	1.0	0.3	0.4	0.3	1.0	0.7	23.2	1.3	2.4	4.5	0.3	39.3	2.6	0.7	2.4	1.0	2.4	0.0	0.0	4.7	6.6	0.7	0.2	5.6	0.4	0.8	18.7	0.2	0.2	7.2	0.0	0.5	8.2	5.8	0.3	52.8	0.0	0.7	14.0	4.2	1.6	5.0	0.1	0.6	1.7	41.1	0.1	0.3	3.9	21.6	1.1	74.0	0.3	1.1	0.8	3.7	0.5	2.2	3.7	0.5	0.4	52.8	74.4	55.0	11.5	13.6	0.3	9.6	2.1	11.6	20.0	6.5	46.9	21.9	37.4	39.2	2.6	38.3	51.5	42.4	32.6	6.3	23.1	2.9	54.0	27.1	12.3	101.4	10.8	19.2	11.6	10.0	10.2	10.4	10.4	9.9	19.9	9.7	0.0	0.0	0.5	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.5	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 84.9;endometrium 1: 57.6"	"Cell type enriched"	"Detected in some"	5	"Endometrial stromal cells: 135.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 22.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 13.3;MCF7: 21.9;NTERA-2: 7.4;OE19: 8.6;SCLC-21H: 8.0;SH-SY5Y: 9.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"basal ganglia: 34.3"	HPA057688	Uncertain					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA057688: AB_2683503"	"unprognostic (1.44e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.12e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.48e-2)"	17.9	3.7	7.6	0.5	22.3	0.0	8.2	3.7	8.8	84.9	3.2	3.1	0.4	57.6	2.2	2.0	22.7	0.4	7.6	6.8	5.5	32.9	0.6	4.1	0.7	5.4	5.7	8.3	3.8	0.2	4.8	3.6	7.1	22.4	0.2	0.8	1.2	18.6	3.5	7.4	3.2	2.1	3.8	22.0	2.4	3.7	8.6	0.4	1.4	1.8	0.1	4.2	14.1	6.4	0.0	4.6	0.1	0.1	0.5	0.0	0.2	0.5	0.0	0.1	0.0	2.4	1.4	0.0	2.3	0.4	0.8	0.0	0.2	0.0	0.0	0.0	6.6	0.0	0.0	13.3	0.6	0.0	0.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.2	21.9	0.0	0.0	7.4	8.6	0.0	0.0	6.8	0.0	0.0	0.4	8.0	9.7	3.0	0.0	0.1	1.9	7.0	0.1	0.0	0.0	5.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	22.3	3.7	8.8	6.8	5.5	5.4	5.7	7.1	3.8	8.6	6.4	26.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.2	1.7	0.8	0.9	1.0	2.8	0.0	12.9	0.0	0.9	0.1	0.1	3.9	0.4	0.0	4.7	135.9	5.4	0.0	0.0	1.2	0.0	0.2	1.4	0.0	2.4	0.0	10.7	1.1	0.0	0.3	3.3	0.6	0.2	0.0	0.0	0.7	0.4	1.5	0.6	0.0	1.0	0.0	5.8	0.0	0.0	0.2	0.1	0.0	3.8	0.0	0.3	0.0	2.4	0.0	0.1	0.0	0.9	5.8	0.1	1.6	0.0	0.0	1.6	0.6	0.0	0.1	0.2
AGTR2	"AT2, MRX88"	ENSG00000180772	"Angiotensin II receptor type 2"	P50052	X	116170744-116174974	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 8.8;lung: 8.8;smooth muscle: 13.2"	"Cell type enriched"	"Detected in some"	15	"Alveolar cells type 2: 20.4"	"Group enriched"	"Detected in some"	12	"endometrial cancer: 3.0;lung cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"cerebellum: 2.0"							NA	NA				"Cluster 46: Fibroblasts - ECM organization"		"Cluster 11: Alveolar cells - Smell perception"							"unprognostic (2.13e-1)"				"unprognostic (1.71e-1)"			"unprognostic (3.22e-2)"				"unprognostic (4.37e-2)"			0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	5.0	0.0	0.1	0.0	8.8	0.8	0.0	2.6	0.1	1.7	0.0	0.0	0.6	0.0	8.8	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900671-73080442	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1500.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"classical monocyte: 87.3"	"Lineage enriched"	"Detected in many"	33	"monocytes: 87.3"	"Cell line enhanced"	"Detected in many"		"A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"midbrain: 378.3"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	109.4	182.4	51.3	28.4	71.9	31.8	64.3	125.1	72.4	121.8	35.7	218.2	549.7	139.3	583.4	41.3	184.3	175.4	53.7	64.6	62.1	335.4	1500.8	142.6	31.2	93.4	370.7	222.7	498.1	24.3	164.4	32.0	84.7	57.2	88.8	0.4	104.5	245.4	66.7	17.2	304.3	117.0	104.2	77.5	568.5	149.5	74.5	19.8	211.7	83.0	21.6	31.6	90.7	106.1	0.0	4019.8	0.4	0.0	22.4	0.2	1.4	139.6	0.0	0.1	0.1	136.2	0.0	0.1	50.5	0.0	0.3	2.6	0.0	0.2	0.1	0.4	0.1	232.1	0.6	1269.3	13.7	0.6	0.3	6.7	0.1	0.0	0.0	0.3	143.0	0.0	16.9	0.0	153.3	7.2	0.2	1.8	0.7	7.2	0.4	0.5	44.0	1.8	710.6	1.1	0.3	1.4	0.3	0.4	2.9	0.2	0.0	0.5	0.7	0.0	3.5	0.5	0.3	0.4	0.2	1.0	0.0	1.7	0.4	0.0	87.3	1.4	0.0	14.9	0.0	0.0	0.2	0.1	1.4	0.7	0.0	0.0	2.6	0.0	1.1	1.0	0.0	30.3	51.3	71.9	125.1	72.4	64.6	62.1	93.4	370.7	84.7	104.2	74.5	106.1	4.9	96.1	107.6	31.3	6.9	2.7	18.3	168.3	1.2	0.4	12.6	1.7	4.3	187.3	361.1	115.8	0.0	1.7	0.1	20.2	389.4	71.6	12.6	6.3	125.2	26.4	54.9	96.1	3.5	349.7	1.0	102.7	258.4	8.1	158.9	0.2	133.5	624.4	134.4	0.0	0.5	168.9	138.4	109.6	5.1	37.8	406.4	61.7	7.2	17.8	46.0	0.0	2.1	0.0	0.7	128.4	77.4	207.3	1.3	2.0	267.4	375.4	583.7	0.3	26.3	334.2	28.6	8.6	4.6	21.5	3.1	2.5	8.8	129.6	131.7	26.5
ALX4	"FPP, KIAA1788, PFM, PFM2"	ENSG00000052850	"ALX homeobox 4"	Q9H161	11	44260440-44310139	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 1.8;choroid plexus: 1.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 20.4;Fibroblasts: 4.3;Leydig cells: 4.7;Microglial cells: 6.5;Skeletal myocytes: 5.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.0;BJ: 3.4;HAP1: 4.7;HEK 293: 4.8;HEL: 6.8;K-562: 3.2;SiHa: 7.0"	"Region enriched"	"Detected in some"	8	"olfactory bulb: 9.0"	"Region enriched"	"Detected in single"	31	"olfactory bulb: 9.0"	HPA001903			Supported	Nucleoplasm		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA001903: AB_2666495"	"unprognostic (7.56e-5)"	"unprognostic (1.69e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.24e-3)"	"unprognostic (2.63e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.33e-4)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.34e-6)"	"unprognostic (3.62e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.03e-1)"	0.4	0.0	0.1	0.0	0.1	0.0	1.8	0.1	0.4	0.4	1.9	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	1.0	0.9	0.0	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.5	0.0	4.0	0.0	0.0	0.0	3.4	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	1.0	4.8	6.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.1	1.3	20.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.6	4.7	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AMHR2	"MISR2, MISRII"	ENSG00000135409	"Anti-Mullerian hormone receptor type 2"	Q16671	12	53423855-53431672	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 41.5;ovary: 33.1"	"Group enriched"	"Detected in some"	4	"granulocytes: 26.0;Granulosa cells: 36.1;Theca cells: 94.9"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HEL: 40.1;K-562: 22.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 9.4"	"HPA060228, HPA069636"			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Nucleoplasm, Cytosol"	"HPA060228: AB_2684227, HPA069636: AB_2686163"	"unprognostic (5.79e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.97e-1)"	0.6	41.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.5	0.0	0.3	0.0	0.9	0.4	0.0	0.0	0.2	33.1	12.5	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.2	0.1	0.1	0.0	0.0	5.7	0.7	9.1	0.5	0.0	0.0	1.8	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	40.1	0.0	0.8	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	3.5	2.6	0.0	0.1	1.5	0.0	4.2	0.1	2.1	0.1	2.7	0.0	0.1	26.0	36.1	11.4	0.3	0.1	0.0	0.0	0.0	0.0	1.2	0.0	2.5	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.3	0.0	0.0	0.3	0.8	94.9	0.1	0.0
ANGPTL7	"AngX, CDT6"	ENSG00000171819	"Angiopoietin like 7"	O43827	1	11189355-11195981	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Cardiomyocytes: 4.1;Enteroendocrine cells: 1.8;Fibroblasts: 6.9;Melanocytes: 3.6;Microglial cells: 1.9"	"Cancer enriched"	"Detected in some"	14	"melanoma: 18.4"	"Region enhanced"	"Detected in some"		"thalamus: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	65	"SCLC-21H: 41.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	13	"spinal cord: 62.2"						"Secreted in other tissues"	NA	NA		1100000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.23e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"		"unprognostic (4.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.49e-2)"	15.9	2.2	0.3	1.3	0.2	0.0	5.3	1.9	1.0	4.8	0.2	9.2	0.8	0.5	2.1	2.2	2.2	3.8	7.6	0.1	0.4	2.7	0.1	1.3	0.0	0.4	0.5	0.4	0.4	0.0	4.2	0.6	0.3	4.2	1.5	0.2	2.3	6.6	7.8	6.2	1.8	1.9	0.0	0.3	2.3	0.2	4.3	0.3	0.7	5.7	0.2	4.2	5.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.9	1.0	0.1	0.4	0.4	0.5	0.3	0.0	4.3	0.4	0.1	3.2	0.0	0.3	0.0	0.1	0.1	0.0	1.2	0.1	0.2	0.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.0	0.3	0.0	0.0	6.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	1.9	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.6	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
ANO3	"C11orf25, DYT23, GENX-3947, TMEM16C"	ENSG00000134343	"Anoctamin 3"	Q9BYT9	11	26188842-26663289	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"brain: 59.2;epididymis: 57.4"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 201.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 59.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;HDLM-2: 6.8;U-2 OS: 1.6;U-2197: 4.3"	"Region enhanced"	"Detected in all"		"basal ganglia: 158.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 180.1"	HPA041629	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041629: AB_10793969"	"unprognostic (7.01e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-4)"	"unprognostic (9.48e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.01e-1)"	3.0	0.8	4.3	0.1	59.2	0.0	0.5	0.0	11.8	0.5	0.0	0.2	0.1	0.1	57.4	0.0	0.2	1.8	0.3	7.7	0.0	1.0	1.1	0.4	0.0	1.1	0.1	0.1	0.3	0.1	0.3	0.0	1.9	0.0	0.1	0.4	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.4	0.0	1.9	0.3	0.1	1.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	0.4	0.0	1.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.3	0.0	0.4	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	59.2	0.0	11.8	7.7	0.0	1.1	0.1	1.9	0.0	0.3	1.7	1.0	0.0	2.0	3.3	0.0	0.0	0.0	0.1	0.0	1.7	0.2	0.0	0.9	0.0	0.2	0.0	14.6	0.2	0.0	0.0	0.0	0.1	12.0	0.5	0.0	0.4	0.0	0.0	201.9	0.0	0.3	0.5	0.0	0.3	0.0	0.0	1.8	0.7	0.0	8.4	4.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	38.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	2.3	0.0	0.0	4.7	3.8	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784895-89815401	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 2384.1;pancreas: 675.0"	"Cell type enriched"	"Detected in many"	14	"Proximal enterocytes: 6315.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebral cortex: 9.2;thalamus: 17.4"	"Immune cell enriched"	"Detected in many"	4	"neutrophil: 227.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 227.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 613.7;ASC TERT1: 764.2;BJ: 738.4;BJ hTERT+: 1135.6;fHDF/TERT166: 703.8;HMC-1: 660.3;HSkMC: 670.0;HUVEC TERT2: 874.8;TIME: 815.1;U-2197: 891.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 14.8"	"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		NA	NA		1200000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	55.4	7.0	1.6	36.6	1.6	103.4	55.9	1.3	9.2	41.4	3.4	266.8	2384.1	3.6	1.7	4.8	8.0	120.3	6.9	1.3	1.5	249.7	271.8	34.3	12.8	1.5	2.1	1.9	675.0	0.8	1.9	33.1	2.5	94.0	59.9	0.0	42.1	5.5	2.5	32.5	1970.6	29.7	1.3	25.9	8.0	2.0	17.4	7.1	8.2	3.8	4.7	16.8	15.0	1.2	0.1	45.6	0.0	0.5	613.7	764.2	6.2	738.4	1135.6	95.3	81.6	5.8	0.4	0.2	8.4	703.8	0.0	0.6	5.6	0.2	38.6	0.1	0.1	137.3	4.6	122.8	352.0	11.4	660.3	670.0	1.4	302.3	0.3	4.4	874.8	0.0	3.8	0.8	37.8	0.1	0.6	355.4	1.9	0.0	49.9	0.3	0.1	9.5	449.2	0.0	1.2	7.2	0.1	1.3	0.1	1.8	0.5	72.1	815.1	385.3	0.6	891.4	0.1	0.4	0.1	0.1	0.9	0.9	20.5	22.2	56.3	41.1	0.1	27.4	0.0	0.2	0.0	0.0	26.2	0.2	0.0	0.0	227.1	0.0	49.7	0.7	0.0	25.7	1.6	1.6	1.3	9.2	1.3	1.5	1.5	2.1	2.5	1.3	17.4	1.2	2.4	0.0	3.0	0.0	5.2	9.9	2.8	1.4	0.6	0.0	35.7	12.8	1.2	391.7	19.7	20.2	0.0	13.0	0.7	429.8	43.0	15.4	0.2	0.5	10.1	8.4	3.0	6.6	0.3	386.2	16.3	31.0	0.0	0.4	24.1	0.3	79.2	192.4	37.5	0.0	0.3	199.6	2.0	54.1	63.2	0.2	2.8	71.9	3.6	0.0	38.3	0.0	0.0	0.0	0.1	75.5	316.9	1.5	2.1	20.9	6315.2	435.0	3.3	0.0	26.3	0.8	8.1	0.3	0.5	0.2	5.8	6.4	3.7	187.8	290.9	1.4
ARHGAP10	"FLJ20896, FLJ41791, GRAF2"	ENSG00000071205	"Rho GTPase activating protein 10"	A1A4S6	4	147732063-148072776	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 137.6;Oligodendrocyte precursor cells: 124.7;Peritubular cells: 121.1;Rod photoreceptor cells: 132.9;Sertoli cells: 144.7;Smooth muscle cells: 107.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 16.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 80.2"	HPA039589			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA039589: "	"unprognostic (8.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.57e-2)"	"prognostic favorable (8.15e-5)"	"prognostic unfavorable (6.26e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.09e-2)"	35.0	11.4	4.6	7.0	6.3	3.3	22.6	2.0	7.1	35.1	9.8	47.0	4.9	16.9	9.8	35.7	35.1	13.0	38.7	6.0	2.6	9.7	7.9	15.1	5.8	3.1	4.7	33.4	9.2	16.0	6.2	10.7	3.5	26.0	8.0	14.4	11.1	20.0	38.6	22.2	16.6	13.3	3.6	9.8	26.3	11.8	5.5	11.3	16.9	33.1	6.7	44.2	30.8	4.1	21.0	8.3	4.4	9.2	33.2	45.1	46.0	28.3	23.5	17.9	13.8	21.6	11.8	0.0	4.7	24.4	15.0	10.1	16.4	23.4	21.5	11.4	10.9	7.2	6.2	0.7	51.2	7.1	8.0	23.4	17.9	22.3	19.0	22.7	22.0	6.0	1.0	38.3	32.3	25.5	4.5	0.0	4.1	13.9	4.0	8.1	12.7	24.5	12.3	19.0	10.7	5.1	7.4	29.6	7.9	19.0	3.7	0.6	21.9	16.8	12.9	10.3	13.8	14.2	1.8	0.1	25.5	0.9	15.1	0.0	1.7	16.7	5.3	0.1	10.5	0.0	4.1	6.2	3.0	0.0	1.2	6.0	0.2	5.3	0.1	0.1	5.4	2.4	4.6	6.3	2.0	7.1	6.0	2.6	3.1	4.7	3.5	3.6	5.5	4.1	18.5	3.2	4.1	5.5	1.5	14.4	7.9	7.0	16.5	7.1	13.0	15.4	64.8	5.7	3.5	1.8	43.8	29.0	11.1	0.2	0.0	5.8	13.6	16.3	83.5	11.8	0.0	1.3	63.3	16.0	48.2	45.6	11.2	31.8	1.3	21.7	4.2	13.0	20.9	3.3	26.7	0.4	0.0	6.2	33.7	10.2	137.6	24.2	5.4	46.9	58.4	8.2	8.2	124.7	2.1	14.0	0.1	121.1	3.2	4.5	0.8	15.0	1.3	132.9	144.7	22.7	107.3	4.7	13.3	15.7	10.2	12.7	16.0	9.1	1.1	3.1
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889875-38975454	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 34.8;Excitatory neurons: 15.2;Late spermatids: 26.8;Spermatocytes: 34.7;Spermatogonia: 35.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"eosinophil: 3.6"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 3.6"	"Group enriched"	"Detected in some"	4	"BEWO: 5.6;HeLa: 2.6;SiHa: 7.2"	"Region enriched"	"Detected in many"	32	"cerebellum: 280.4"	"Region enriched"	"Detected in all"	6	"cerebellum: 23.1"	"HPA034661, HPA041051"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Vesicles	"Nucleoplasm, Cytosol"	"HPA034661: AB_10669679, HPA041051: AB_2677274"	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.4	2.1	4.9	0.6	5.2	0.0	0.9	22.6	5.8	1.5	4.4	1.0	0.1	1.5	2.6	0.4	1.4	0.8	0.5	4.9	4.1	0.9	0.2	0.7	0.3	4.1	5.4	3.5	0.4	0.7	3.4	0.5	4.0	0.9	0.3	4.0	0.5	0.7	0.3	0.8	0.4	0.5	3.1	0.3	0.5	5.7	7.2	0.1	1.1	0.0	0.2	0.7	0.7	5.0	0.2	0.0	0.2	0.1	0.1	0.1	5.6	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.6	0.1	2.6	0.1	0.4	0.2	0.1	0.5	0.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.3	0.3	0.2	7.2	0.3	0.0	0.6	0.0	0.2	0.4	0.1	0.9	0.0	0.1	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.2	3.6	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	4.9	5.2	22.6	5.8	4.9	4.1	4.1	5.4	4.0	3.1	7.2	5.0	0.4	0.0	1.5	7.8	0.1	0.0	0.1	0.0	0.6	2.5	0.3	0.6	0.8	1.5	0.6	0.0	0.0	1.1	0.0	0.1	0.0	0.1	34.8	1.8	1.2	0.4	0.0	2.7	15.2	0.0	1.9	1.2	0.0	0.2	0.0	1.4	0.0	0.2	1.0	0.0	11.4	0.4	0.0	0.0	0.0	26.8	1.2	0.2	0.0	1.9	0.1	3.6	0.0	5.5	3.4	0.0	0.0	3.4	0.0	0.1	0.0	0.4	3.9	2.9	0.0	0.3	1.5	34.7	35.6	0.1	0.1	0.5	0.0	2.0	0.1	0.2
ARID3B	"BDP, DRIL2"	ENSG00000179361	"AT-rich interaction domain 3B"	Q8IVW6	15	74541206-74598131	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 24.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Early spermatids: 45.4;Glandular and luminal cells: 45.6;Late spermatids: 65.8;Rod photoreceptor cells: 50.8;Syncytiotrophoblasts: 64.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 10.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 87.8;SuSa: 95.4;U-266/70: 53.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 28.8"	HPA050320	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA050320: AB_2681085"	"unprognostic (2.97e-1)"	"unprognostic (5.91e-2)"	"unprognostic (6.41e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.20e-1)"	2.8	2.4	3.1	6.1	2.4	24.6	2.6	5.2	3.4	3.3	6.6	4.9	4.4	2.3	1.9	6.2	2.5	2.4	2.3	3.3	4.4	3.6	4.0	7.3	7.2	2.9	3.4	1.5	5.7	1.7	6.2	15.7	2.9	4.6	4.0	18.7	3.8	1.7	3.4	3.2	7.0	1.6	2.3	9.5	7.1	22.1	3.7	6.0	3.8	2.2	6.3	3.2	3.9	2.8	7.6	3.1	40.7	8.9	1.5	0.8	43.8	1.8	2.0	2.5	2.7	49.9	3.6	0.7	2.0	1.9	14.3	9.0	49.8	6.8	2.2	47.7	11.6	29.5	6.0	13.7	1.0	4.7	18.5	1.0	3.0	4.2	4.3	2.0	4.3	11.7	26.1	16.8	0.7	1.8	12.9	15.7	87.8	3.2	2.7	5.7	1.6	12.1	2.4	7.9	10.4	18.4	2.2	4.5	8.8	95.4	5.8	8.5	2.7	3.4	4.3	2.7	5.6	53.0	36.1	5.3	1.8	7.3	1.3	2.6	1.9	7.0	5.0	1.5	3.0	3.1	2.9	3.8	1.4	1.4	2.2	2.9	13.0	4.0	2.0	1.9	4.4	3.4	3.1	2.4	5.2	3.4	3.3	4.4	2.9	3.4	2.9	2.3	3.7	2.8	3.5	3.2	5.6	10.7	11.8	5.2	5.2	3.5	3.4	23.9	4.4	2.3	1.2	4.3	1.9	0.0	43.8	36.0	10.2	10.2	0.0	2.5	45.4	20.5	4.4	4.8	5.4	9.7	7.3	3.5	20.6	2.3	8.6	45.6	2.5	4.2	4.2	2.5	8.3	11.8	7.8	6.0	0.0	8.7	9.1	65.8	2.8	9.5	3.6	5.6	6.4	5.9	18.6	5.5	7.8	7.6	8.4	3.0	19.2	7.8	7.0	1.7	3.8	50.8	0.0	1.5	1.8	17.2	19.4	10.4	3.3	64.0	12.8	5.5	4.0	8.0
ASB4	ASB-4	ENSG00000005981	"Ankyrin repeat and SOCS box containing 4"	Q9Y574	7	95478444-95540233	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 47.1;skeletal muscle: 34.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.2;Cardiomyocytes: 3.2;Early spermatids: 2.3;Late spermatids: 2.0;Respiratory ciliated cells: 2.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.9;Hep G2: 7.9;SCLC-21H: 4.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 9.5;hypothalamus: 31.7"	"Region enriched"	"Detected in single"	10	"midbrain: 4.3"	HPA055240	Uncertain					NA	NA				"Cluster 39: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 33: Fibroblasts - ECM organization"			"HPA055240: AB_2682753"	"unprognostic (1.41e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.24e-1)"	"unprognostic (9.13e-7)"	"unprognostic (1.71e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.23e-2)"	0.1	47.1	1.8	0.2	2.3	0.6	0.4	2.3	2.1	0.1	1.5	0.1	0.3	0.1	0.2	0.3	0.3	0.2	1.9	1.8	2.4	0.2	1.5	0.6	0.3	2.5	3.8	0.2	0.7	0.0	8.4	2.1	2.6	0.2	0.1	1.3	0.6	0.2	34.2	0.3	0.4	0.1	1.8	0.3	0.6	0.3	2.2	0.2	0.3	10.5	0.1	0.0	0.0	2.8	0.2	4.9	0.2	1.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	7.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	4.7	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	2.3	2.3	2.1	1.8	2.4	2.5	3.8	2.6	1.8	2.2	2.8	0.1	0.0	0.5	7.2	0.0	0.1	0.1	0.5	0.0	0.0	0.4	0.1	3.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.4	1.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	2.0	0.6	0.0	0.0	1.0	0.0	0.0	1.0	1.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.7	0.1	0.9	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.1
AVPR2	"DIR, DIR3, V2R"	ENSG00000126895	"Arginine vasopressin receptor 2"	P30518	X	153902531-153907166	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes insipidus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.1"	"Group enriched"	"Detected in some"	4	"Adipocytes: 48.0;Collecting duct cells: 49.7;Endothelial cells: 17.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.9"	"Group enriched"	"Detected in some"	28	"intermediate monocyte: 3.6;non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	29	"monocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;SCLC-21H: 3.7;U-266/84: 3.7;U-698: 3.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 6.8"							NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (3.05e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.50e-4)"	"unprognostic (2.76e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.38e-1)"	"unprognostic (9.83e-2)"	5.2	0.2	0.1	0.2	0.0	0.8	3.1	3.9	0.1	1.0	0.5	0.8	0.6	0.9	0.1	0.6	1.6	1.0	5.1	0.1	0.0	8.1	0.0	1.3	1.0	0.3	0.5	0.2	0.6	0.7	0.1	0.2	0.4	0.7	0.2	0.0	0.7	0.6	3.1	1.5	0.8	0.8	0.1	0.3	0.7	0.2	0.1	0.4	0.9	4.0	0.3	0.8	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	3.2	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.1	1.2	0.6	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.8	1.0	0.1	0.0	0.0	1.4	0.6	1.4	0.0	0.0	3.7	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.6	3.7	3.6	0.0	0.9	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.1	0.0	3.9	0.1	0.1	0.0	0.3	0.5	0.4	0.1	0.1	0.2	48.0	3.2	1.3	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.5	0.4	1.5	0.0	0.0	49.7	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.6	0.8	0.0	0.0	0.1	1.3	0.0	0.1	0.5	0.0	0.1
BARHL2		ENSG00000143032	"BarH like homeobox 2"	Q9NY43	1	90711539-90717302	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 27.4"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 23.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	14	"cerebellum: 27.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;HEK 293: 3.7;HMC-1: 1.0"	"Region enriched"	"Detected in many"	5	"cerebellum: 12.9"	"Region enriched"	"Detected in some"	20	"cerebellum: 24.6"							NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"								"unprognostic (1.83e-1)"				"unprognostic (1.73e-1)"	"unprognostic (6.80e-2)"				"unprognostic (3.10e-1)"	"unprognostic (1.60e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	27.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.7	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	27.4	0.7	0.0	1.2	0.1	1.9	1.9	0.3	2.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BSPRY	FLJ20150	ENSG00000119411	"B-box and SPRY domain containing"	Q5W0U4	9	113349541-113371233	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 447.2"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 61.9;Ductal cells: 66.8;Exocrine glandular cells: 65.8;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in many"		"A-431: 41.8;CAPAN-2: 25.9;MCF7: 62.0;OE19: 70.9;RPMI-8226: 32.3;SK-BR-3: 29.9;T-47d: 30.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.8"	"HPA042889, HPA077485"	Approved		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	Cytosol	"HPA042889: AB_10795515, HPA077485: "	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.95e-2)"	"prognostic favorable (4.56e-14)"	"unprognostic (1.15e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.70e-1)"	0.3	3.1	3.7	2.6	11.3	5.9	14.6	5.9	4.2	6.5	1.2	12.0	8.8	1.1	10.9	30.1	4.4	4.4	1.5	2.5	3.0	14.4	0.8	5.6	0.8	2.1	4.8	0.0	41.7	447.2	8.3	1.7	1.7	5.0	11.0	6.9	81.6	4.5	0.0	26.3	7.0	0.7	1.7	0.5	24.7	2.8	5.9	1.8	30.3	0.1	3.1	3.0	7.6	2.5	41.8	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	8.6	25.9	0.0	0.4	0.0	0.0	3.6	0.4	0.0	0.0	4.6	3.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.3	0.0	0.0	62.0	0.7	0.0	1.0	70.9	0.0	0.9	0.0	32.3	4.0	8.8	13.7	0.0	0.0	29.9	0.0	1.7	30.3	4.3	0.0	0.0	0.0	0.1	0.0	9.7	13.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	3.7	11.3	5.9	4.2	2.5	3.0	2.1	4.8	1.7	1.7	5.9	2.5	0.3	6.4	6.9	0.0	2.5	1.0	2.0	4.4	0.0	1.8	61.9	31.2	2.8	17.2	9.5	27.6	6.2	9.2	9.9	20.8	39.2	66.8	0.5	11.3	1.6	0.9	20.4	15.6	1.0	65.8	1.1	0.7	21.4	17.3	3.8	1.5	0.0	0.8	1.4	0.0	3.2	19.1	12.2	0.3	0.3	0.6	0.0	0.5	10.6	0.0	1.0	0.8	3.1	0.5	0.2	48.6	14.5	0.0	2.5	13.8	13.5	21.2	9.7	12.1	0.0	0.0	1.7	0.6	4.3	26.4	14.2	6.7	1.3	0.1	24.9	17.7
BSX	BSX1	ENSG00000188909	"Brain specific homeobox"	Q3C1V8	11	122977570-122981834	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	48	"brain: 12.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"hypothalamus: 12.0;thalamus: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"hypothalamus: 4.5"	"Region enriched"	"Detected in single"	10	"hypothalamus: 3.4"	HPA015654	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"					"HPA015654: AB_1845470"																		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.0	0.0	0.8	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C17orf58		ENSG00000186665	"Chromosome 17 open reading frame 58"	Q2M2W7	17	67991099-67996469	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 35.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 55.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 37.3"	HPA023036	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA023036: AB_10601144"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.65e-3)"	"prognostic unfavorable (8.99e-4)"	"unprognostic (7.45e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.69e-2)"	"prognostic unfavorable (1.31e-10)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.01e-1)"	11.9	5.4	5.2	2.8	5.5	3.9	16.9	5.4	10.0	26.8	4.8	8.4	4.0	15.1	6.9	5.1	7.8	4.7	5.9	5.7	5.3	6.1	9.4	3.4	3.2	5.4	5.3	4.8	4.8	3.2	2.0	35.6	5.1	5.8	7.3	8.9	4.3	3.6	3.5	3.5	4.6	10.9	5.5	2.3	6.8	3.0	5.2	2.1	6.8	7.3	7.1	8.8	7.6	5.5	9.8	9.5	9.3	11.6	6.6	16.6	7.3	4.0	11.4	6.9	11.2	5.6	12.4	13.0	8.9	3.3	12.1	4.9	21.3	8.6	16.6	23.5	21.5	8.4	3.2	17.8	10.4	7.2	14.9	9.2	10.2	6.7	15.4	7.7	32.7	11.2	18.2	19.6	6.7	13.1	1.3	9.5	10.7	23.6	10.0	3.1	10.2	17.4	8.7	6.5	6.9	12.5	6.0	55.5	20.8	11.4	15.8	8.2	6.1	5.8	5.9	4.2	8.5	38.9	30.9	11.6	14.8	12.6	10.5	8.6	2.8	5.0	2.2	2.9	0.7	3.0	0.8	1.7	3.9	0.5	0.3	0.8	1.1	2.7	5.0	0.1	0.4	1.8	5.2	5.5	5.4	10.0	5.7	5.3	5.4	5.3	5.1	5.5	5.2	5.5	21.6	0.0	1.7	6.2	3.5	4.8	5.5	5.6	7.4	8.9	31.0	21.8	4.7	12.8	6.1	11.0	10.4	28.6	4.1	10.5	23.5	10.1	0.9	21.0	40.5	16.3	3.6	8.4	5.0	9.3	21.7	51.6	19.9	19.4	12.7	3.8	14.3	18.5	16.9	5.0	4.6	15.0	10.2	9.7	21.5	2.8	3.7	7.3	8.8	2.8	18.4	31.9	12.3	3.0	4.6	10.7	10.0	5.3	7.0	11.6	10.9	19.7	16.5	15.6	6.6	36.2	14.1	7.3	6.0	20.7	8.4	15.3	4.1	8.3	10.1	7.6
CA8	"CALS, CARP"	ENSG00000178538	"Carbonic anhydrase 8"	P35219	8	60185412-60281400	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.3;parathyroid gland: 40.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Enteroendocrine cells: 35.2;Gastric mucus-secreting cells: 40.2;Oligodendrocyte precursor cells: 129.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	24	"basophil: 76.2"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 76.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 10.1;JURKAT: 11.0;K-562: 20.3;NB-4: 12.3;OE19: 17.4"	"Region enriched"	"Detected in all"	38	"cerebellum: 1260.5"	"Region enriched"	"Detected in all"	9	"cerebellum: 86.3"	"HPA024748, CAB025545, CAB047309"	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB025545: , CAB047309: , HPA024748: AB_1846003"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.46e-3)"	"unprognostic (6.67e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.79e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.41e-1)"	1.6	0.9	5.2	0.3	5.8	0.5	4.6	18.3	5.6	4.3	2.0	1.3	1.0	1.9	10.2	0.2	1.5	0.3	4.3	4.4	5.3	5.3	0.0	0.9	0.4	4.7	4.9	0.2	1.9	40.1	8.5	6.2	5.0	1.5	2.0	2.3	3.7	0.2	1.2	0.3	1.0	0.5	3.1	0.8	4.4	4.1	5.1	1.3	0.3	2.3	0.3	0.6	0.3	4.0	0.0	2.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	10.1	4.5	0.0	0.0	3.6	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	11.0	20.3	0.2	0.0	0.0	3.3	12.3	0.2	17.4	0.0	0.0	0.0	0.2	0.4	0.8	5.1	0.0	0.0	1.1	0.0	2.0	4.5	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	76.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.1	5.2	5.8	18.3	5.6	4.4	5.3	4.7	4.9	5.0	3.1	5.1	4.0	22.0	0.0	4.8	92.7	1.6	1.0	0.4	4.1	0.0	8.2	15.6	10.3	4.7	0.0	5.7	3.7	0.0	8.3	10.9	2.0	3.9	8.1	9.9	9.8	2.4	16.7	35.2	13.5	4.7	6.0	0.3	4.0	40.2	26.2	0.0	1.1	0.0	0.0	9.9	0.0	25.6	25.0	6.1	1.9	1.1	4.9	1.5	1.1	7.2	18.7	0.0	2.6	1.0	129.7	0.4	1.6	3.5	1.5	14.0	2.1	0.3	0.0	1.2	1.0	0.0	0.8	2.3	3.8	5.5	0.2	0.4	1.4	0.7	3.1	3.3	1.5
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112451	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	86	"skeletal muscle: 254.9;tongue: 193.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Cone photoreceptor cells: 6.2;Late spermatids: 5.9;Skeletal myocytes: 6.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"BEWO: 1.1;HSkMC: 1.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.8"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 2.6"	"CAB009507, HPA048892, HPA056815"	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242"	"unprognostic (2.14e-2)"		"unprognostic (1.38e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.52e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.84e-1)"		"unprognostic (2.23e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-1)"	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.9	1.5	0.0	254.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	193.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.6	0.2	0.8	0.2	0.1	1.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	6.3	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CBLN1		ENSG00000102924	"Cerebellin 1 precursor"	P23435	16	49277917-49281838	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 114.2;testis: 31.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 100.9;Late spermatids: 291.0;Spermatocytes: 61.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.5"	"Region enriched"	"Detected in all"	4	"cerebellum: 114.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"NTERA-2: 40.0;SCLC-21H: 126.0"	"Region enriched"	"Detected in all"	9	"cerebellum: 613.4"	"Region enriched"	"Detected in many"	13	"cerebellum: 369.4"						"Secreted in brain"	NA	NA		6000000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (1.39e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.18e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.06e-2)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.60e-2)"	11.8	1.0	4.6	0.2	3.2	0.0	3.8	114.2	7.1	2.1	0.9	0.7	1.0	5.8	0.4	1.0	1.3	7.5	4.6	2.4	23.4	0.2	1.0	0.1	0.8	10.7	18.4	1.3	2.8	0.2	4.2	0.0	12.7	0.5	0.7	3.5	0.6	0.6	0.9	0.8	1.3	1.7	4.8	0.1	0.7	31.9	27.0	0.2	2.3	1.7	2.8	1.4	0.5	5.4	0.0	0.0	0.6	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	2.7	2.6	0.3	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	126.0	3.0	0.0	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	3.2	114.2	7.1	2.4	23.4	10.7	18.4	12.7	4.8	27.0	5.4	4.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.3	2.2	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	100.9	0.1	2.4	6.7	13.2	0.0	0.6	0.4	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.7	4.7	0.5	0.0	0.0	0.0	291.0	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.5	0.4	0.2	0.0	0.4	0.0	0.1	0.3	0.0	0.0	1.8	26.3	0.1	19.2	61.7	5.8	0.0	0.1	0.0	0.0	8.8	0.2	0.0
CBLN3		ENSG00000139899	"Cerebellin 3 precursor"	Q6UW01	14	24426545-24430954	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 93.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 3.0;Theca cells: 5.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	11	"cerebellum: 93.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.4;HDLM-2: 17.2;HSkMC: 23.3;Karpas-707: 18.3;U-266/70: 12.8"	"Region enriched"	"Detected in many"	25	"cerebellum: 429.5"	"Region enriched"	"Detected in many"	42	"cerebellum: 446.5"	HPA041266	Enhanced	Supported	Approved	Nucleoplasm	"Secreted in brain"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA041266: AB_10674430"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.39e-4)"	"unprognostic (5.39e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (6.20e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.02e-2)"	7.3	17.1	2.7	8.3	3.0	0.6	4.7	93.9	7.0	4.6	2.1	4.2	2.1	2.7	7.4	2.9	4.0	5.6	3.7	2.4	3.3	4.4	6.0	4.8	13.7	3.9	5.8	10.1	2.0	2.9	4.2	3.7	8.4	4.5	2.1	0.5	4.3	3.1	1.8	3.5	5.4	2.2	3.2	13.7	3.3	5.1	3.4	3.9	4.5	0.6	9.1	4.9	4.6	4.8	1.5	1.3	0.7	2.5	6.2	13.4	0.4	5.5	11.1	2.1	2.7	0.7	2.6	2.4	1.2	3.4	2.4	0.3	0.8	2.9	1.4	17.2	0.6	0.0	5.2	1.1	3.3	0.4	0.9	23.3	1.3	2.7	2.1	8.8	1.9	1.0	0.7	18.3	2.8	0.8	0.0	0.7	0.1	1.5	1.5	0.0	0.0	1.8	1.2	0.5	0.9	0.5	0.5	0.1	0.8	0.3	0.8	0.6	8.7	7.7	1.5	3.2	0.3	12.8	3.2	2.7	0.4	1.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.0	93.9	7.0	2.4	3.3	3.9	5.8	8.4	3.2	3.4	4.8	1.4	0.0	0.0	0.0	2.6	0.4	0.6	1.5	0.0	0.0	0.8	1.0	0.5	0.0	0.4	0.0	0.0	0.9	3.0	0.8	0.0	1.1	0.0	0.3	2.0	0.8	0.0	0.4	0.3	1.1	0.6	2.6	0.0	0.5	0.0	0.9	0.0	0.2	0.9	0.0	0.1	0.5	0.0	0.3	0.4	0.3	2.5	0.7	0.0	1.0	2.6	1.2	0.0	0.0	0.0	0.8	0.0	1.5	0.1	0.5	0.9	0.8	1.4	0.2	0.0	0.7	1.4	0.0	0.2	0.2	0.6	0.8	0.2	5.7	0.6	0.6
CCDC27	FLJ32825	ENSG00000162592	"Coiled-coil domain containing 27"	Q2M243	1	3746460-3771645	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 16.9"	"Group enriched"	"Detected in some"	63	"Early spermatids: 87.6;Late spermatids: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	HPA044395			Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA044395: AB_10962987"	"unprognostic (1.36e-1)"	"unprognostic (6.67e-3)"		"unprognostic (3.23e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.42e-1)"		"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.28e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	27.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 80.1;NK-cells: 142.2;Plasma cells: 93.2;Respiratory ciliated cells: 112.5;T-cells: 89.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 55.6;Karpas-707: 50.1;SCLC-21H: 53.6;U-266/70: 58.5;U-266/84: 76.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 37.0"	HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	4.5	1.4	5.9	19.4	23.9	31.2	6.9	3.2	7.1	4.0	2.5	9.4	13.3	3.1	1.6	12.5	12.2	6.2	4.0	3.6	3.9	6.8	3.6	9.7	33.9	5.6	6.7	1.0	8.3	5.3	5.2	2.4	4.6	9.4	7.0	1.0	10.1	3.9	2.3	7.0	11.7	2.3	4.3	21.7	12.4	8.0	7.8	20.4	2.5	2.7	20.4	8.1	7.6	3.2	8.5	6.9	7.5	9.5	0.0	0.0	34.9	0.0	0.0	0.0	0.0	6.8	13.4	45.1	6.1	0.0	0.4	0.4	11.3	6.4	0.0	28.8	4.7	10.0	4.8	9.9	0.7	23.0	8.4	0.0	11.4	0.0	0.0	0.7	8.6	55.6	11.2	50.1	0.1	24.9	24.2	29.6	7.1	6.2	11.5	19.5	0.2	14.2	2.6	10.2	53.6	11.6	4.6	16.9	4.6	5.6	10.2	20.7	2.6	0.0	0.2	0.1	0.1	58.5	76.2	22.8	0.0	20.1	0.1	7.8	3.3	1.3	9.4	1.9	8.8	2.5	6.0	9.2	1.8	2.1	3.8	5.8	2.3	4.0	3.0	2.0	10.7	4.1	5.9	23.9	3.2	7.1	3.6	3.9	5.6	6.7	4.6	4.3	7.8	3.2	26.6	3.2	28.8	7.8	54.1	9.3	15.9	19.0	27.9	0.0	15.3	7.6	19.8	10.0	22.1	14.7	0.0	3.6	80.1	29.6	0.0	4.4	9.6	62.6	1.4	17.3	23.9	20.6	7.1	5.9	2.2	4.2	20.4	12.1	2.5	1.3	20.3	1.6	6.3	0.0	2.5	15.3	22.4	21.0	12.4	18.7	4.1	18.9	1.8	9.4	20.1	8.0	142.2	8.0	5.2	7.8	18.2	3.0	93.2	16.8	13.1	13.2	112.5	0.1	0.0	2.9	4.4	4.7	17.4	31.2	9.5	1.8	89.2	3.3	19.4	19.8
CCL24	"Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24"	ENSG00000106178	"C-C motif chemokine ligand 24"	O00175	7	75810825-75823356	"Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 71.4;lymphoid tissue: 71.8"	"Cell type enhanced"	"Detected in single"		"Macrophages: 1.1"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 67.6;pancreatic cancer: 17.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.6;OE19: 2.3;U-2 OS: 4.8"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	4	"spinal cord: 9.9"						"Secreted to blood"	NA	NA	276000		"Cluster 11: Basophils - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	2.8	0.4	0.4	16.0	0.3	0.8	1.0	1.1	0.6	0.7	0.4	27.4	23.0	0.5	1.2	2.4	0.3	2.0	0.7	0.5	0.2	0.5	5.0	14.2	14.0	0.4	0.3	0.4	0.4	0.5	0.1	0.2	0.4	0.4	71.4	0.5	0.8	0.6	0.5	0.9	63.5	2.3	0.2	71.8	3.5	1.3	0.5	1.6	0.5	0.7	3.2	12.2	0.6	1.2	0.1	0.4	0.3	0.3	0.2	0.6	0.3	0.0	0.1	0.1	0.0	0.1	4.6	0.4	1.4	0.0	0.2	0.3	0.2	0.1	0.2	0.1	0.4	0.1	0.4	0.1	0.0	0.1	1.3	0.9	0.3	0.1	0.1	0.2	0.1	0.2	0.4	0.4	0.0	0.0	0.2	0.6	0.1	2.3	0.2	0.3	1.6	0.2	0.1	0.3	0.3	0.2	0.1	0.2	0.0	0.2	0.4	1.2	0.1	0.4	4.8	0.4	0.4	0.3	0.1	0.1	0.5	0.2	0.1	0.7	0.2	0.1	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.5	0.3	0.0	0.2	0.1	0.0	0.4	0.3	1.1	0.6	0.5	0.2	0.4	0.3	0.4	0.2	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CCL26	"eotaxin-3, IMAC, MIP-4a, MIP-4alpha, SCYA26, TSC-1"	ENSG00000006606	"C-C motif chemokine ligand 26"	Q9Y258	7	75769533-75789896	"Human disease related genes, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 20.4;pituitary gland: 16.4"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 7.1;Intestinal goblet cells: 7.7;Leydig cells: 16.8;Sertoli cells: 13.1;Smooth muscle cells: 20.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 11.2;hTEC/SVTERT24-B: 14.8;PC-3: 51.1;U-2 OS: 13.7"					"Region enriched"	"Detected in single"	16	"spinal cord: 1.7"						"Secreted to blood"	NA	NA	117000		"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.71e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.05e-11)"	"unprognostic (2.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.73e-1)"	"unprognostic (6.29e-3)"	2.7	3.1	1.5	0.6	1.7	0.0	1.9	1.6	3.7	3.1	10.1	0.8	0.3	1.2	1.9	1.8	2.7	1.4	3.9	1.5	1.5	1.7	0.4	1.9	3.4	1.7	1.5	20.4	0.4	3.2	16.4	0.4	1.6	1.0	7.2	2.5	0.7	0.3	0.4	1.9	1.0	1.4	1.7	0.4	0.9	1.2	1.9	0.3	0.6	0.1	0.2	3.6	4.3	1.5	0.2	11.2	0.0	0.0	1.3	1.7	0.0	0.6	5.2	4.3	7.3	0.3	3.2	0.0	7.2	3.5	0.3	2.1	0.0	0.0	5.8	0.0	0.5	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.6	14.8	0.1	2.3	0.0	0.0	5.2	0.0	2.2	0.7	0.0	0.0	8.4	0.5	51.1	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.6	0.1	0.0	2.2	0.0	0.0	0.3	8.2	13.7	4.2	2.7	0.0	0.0	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.7	1.6	3.7	1.5	1.5	1.7	1.5	1.6	1.7	1.9	1.5	0.5	0.0	0.0	0.0	0.0	1.1	3.5	1.8	0.0	0.5	0.1	0.1	0.4	0.0	0.7	0.0	4.2	0.0	0.0	2.3	0.0	0.0	0.5	0.1	1.1	0.6	0.0	0.0	0.1	0.0	0.0	7.1	0.5	0.1	0.0	0.1	1.1	0.0	0.0	0.0	0.1	7.7	0.0	3.2	1.4	0.9	16.8	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	4.9	0.0	0.6	0.1	0.0	0.2	2.2	13.1	0.9	20.2	0.1	0.4	0.6	1.8	0.0	0.2	2.5	1.6	2.6
CCN3	"IGFBP9, NOV"	ENSG00000136999	"Cellular communication network factor 3"	P48745	8	119416446-119424434	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	44	"adrenal gland: 1105.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.2;Endothelial cells: 2.7;Fibroblasts: 9.8;Smooth muscle cells: 4.6"	"Cancer enriched"	"Detected in all"	4	"melanoma: 62.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	116	"eosinophil: 64.8;neutrophil: 30.8"	"Lineage enriched"	"Detected in single"	157	"granulocytes: 64.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.0;hTERT-RPE1: 38.1;U-2197: 128.2"	"Group enriched"	"Detected in all"	6	"amygdala: 129.2;basal ganglia: 51.5;cerebral cortex: 99.5;hippocampal formation: 152.5;white matter: 85.0"	"Region enriched"	"Detected in all"	6	"spinal cord: 114.6"	"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	23.7	1105.4	7.6	3.6	11.5	1.7	8.1	6.7	12.2	11.2	5.9	6.9	3.9	8.6	6.3	5.5	9.0	6.3	18.1	16.2	9.7	6.9	1.1	6.8	2.2	5.6	6.5	3.1	6.8	9.4	21.8	0.6	4.9	22.8	7.0	1.2	2.7	20.0	4.7	13.8	4.4	8.4	8.7	1.5	4.9	3.6	6.3	1.0	25.3	7.2	1.9	4.4	8.0	6.2	0.1	3.1	1.7	0.0	11.1	2.9	0.1	16.9	125.0	14.9	8.6	0.0	0.3	0.0	12.9	21.2	11.6	10.5	0.6	0.0	5.1	0.0	0.3	0.0	9.1	0.0	0.4	0.0	0.0	0.6	0.1	5.7	0.6	38.1	0.4	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.2	1.2	24.9	0.1	0.0	0.0	15.8	0.1	3.9	0.1	6.3	0.1	24.2	0.0	0.0	0.0	0.0	10.6	15.8	128.2	3.5	0.0	0.0	0.0	16.7	5.4	12.5	0.0	0.3	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.1	7.6	11.5	6.7	12.2	16.2	9.7	5.6	6.5	4.9	8.7	6.3	6.2	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CDCA7L	"JPO2, R1, RAM2"	ENSG00000164649	"Cell division cycle associated 7 like"	Q96GN5	7	21900899-21945903	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 51.0;Spermatogonia: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 101.0;naive B-cell: 124.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"olfactory bulb: 10.1"	"HPA027169, HPA074623"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		No	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA027169: AB_1856058, HPA074623: "	"unprognostic (5.13e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (4.36e-6)"	"unprognostic (4.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.87e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-3)"	5.9	1.4	3.9	15.0	9.1	51.7	15.7	5.7	5.2	8.7	17.8	17.0	10.7	13.8	5.5	11.2	11.5	8.1	25.3	3.9	3.5	2.8	4.8	14.0	37.1	6.9	4.8	21.8	13.0	1.8	1.1	4.7	3.8	7.3	19.0	5.1	9.0	7.6	6.2	18.5	13.6	11.9	5.0	13.3	17.8	18.5	7.8	49.0	29.8	3.4	31.8	6.3	8.1	9.8	84.5	27.6	26.0	0.6	14.5	17.9	0.0	65.9	58.2	51.8	73.5	11.3	75.4	173.6	21.8	59.3	102.4	51.1	41.4	69.4	103.6	0.3	28.6	42.3	83.8	7.4	21.1	111.1	0.4	35.2	12.7	40.0	116.9	54.9	104.8	133.5	58.3	0.1	41.4	34.5	146.1	46.1	153.2	17.4	36.2	141.0	94.0	119.8	15.4	14.8	96.9	79.7	30.3	19.9	29.9	34.4	45.6	54.6	43.0	57.1	68.5	101.3	83.8	90.6	63.6	223.0	55.7	154.6	54.5	1.1	2.3	43.2	2.2	3.8	0.3	101.0	6.4	3.2	14.9	124.5	30.9	12.8	3.8	3.4	4.9	75.9	9.9	12.2	3.9	9.1	5.7	5.2	3.9	3.5	6.9	4.8	3.8	5.0	7.8	9.8	1.0	19.2	31.5	7.5	51.0	27.1	23.7	6.9	17.1	1.5	12.5	20.7	38.7	11.5	19.0	0.0	2.1	0.5	30.7	8.4	3.9	8.9	7.3	5.4	2.7	4.8	10.7	21.9	0.5	6.2	0.3	13.4	18.3	5.3	8.8	14.9	1.4	4.0	10.8	13.5	1.0	26.1	8.2	15.2	3.5	5.2	4.1	7.0	8.8	1.9	1.6	2.4	1.0	15.1	8.7	3.9	7.4	2.6	20.2	14.2	1.5	0.1	4.2	2.7	13.1	6.8	12.4	4.6	63.5	9.6	7.7	0.3	5.4	8.3	23.0	6.2
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171748-89195492	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 24.4;skeletal muscle: 57.0"	"Cell type enriched"	"Detected in some"	13	"Skeletal myocytes: 76.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	15	"cerebellum: 24.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 145.8"	"Region enriched"	"Detected in many"	7	"cerebellum: 15.7"	"Region enriched"	"Detected in some"	17	"cerebellum: 18.7"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		NA	NA		870000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.0	0.2	0.1	0.0	0.2	0.0	0.0	24.4	0.8	1.3	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	1.3	0.4	0.0	0.1	0.8	0.2	1.4	0.0	0.1	0.7	1.6	0.4	0.0	0.0	0.9	0.0	57.0	0.1	0.0	0.0	0.3	1.2	0.2	0.6	0.1	0.0	0.0	5.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.7	0.0	0.1	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	31.5	0.1	0.0	0.1	0.0	0.2	0.3	0.0	145.8	0.3	0.0	0.0	0.8	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	24.4	0.8	0.0	0.1	0.1	0.8	1.6	0.3	0.1	0.6	0.2	0.0	2.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	1.0	0.1	1.2	0.0	0.1	0.0	0.3	0.7	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.2	1.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.0	76.1	0.4	1.5	5.5	0.0	0.0	0.1	0.2	0.8	0.1	0.1
CEP76	"C18orf9, FLJ12542, HsT1705"	ENSG00000101624	"Centrosomal protein 76"	Q8TAP6	18	12661833-12702777	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 209.7;Late spermatids: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 60.5"	"Region enriched"	"Detected in all"	9	"cerebellum: 55.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 16.3"	HPA039395	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA039395: AB_10673357"	"unprognostic (3.39e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.31e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.00e-4)"	"unprognostic (7.88e-3)"	"unprognostic (2.45e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.70e-2)"	"unprognostic (8.21e-2)"	3.0	3.4	2.5	2.6	2.5	6.2	3.8	7.7	3.3	3.4	2.6	2.9	2.7	3.3	5.1	5.3	2.7	2.6	2.7	2.3	2.5	3.1	4.8	2.7	3.8	2.3	2.4	3.2	2.3	2.5	2.2	3.4	2.5	2.8	3.9	4.5	2.9	2.8	3.2	4.0	3.1	3.3	2.3	2.5	2.8	8.2	2.6	7.9	3.7	3.5	4.7	3.2	2.8	2.6	7.3	7.2	12.1	5.9	7.1	3.8	11.7	8.4	9.4	16.1	12.5	16.6	8.5	9.7	7.3	5.5	9.4	5.6	12.1	5.3	13.7	6.1	9.8	8.5	8.0	14.1	5.3	20.0	9.5	3.0	5.3	9.5	6.2	4.5	8.5	13.5	14.5	14.3	10.4	5.5	17.5	13.9	8.7	60.5	4.7	12.2	10.5	10.4	8.4	7.1	9.2	8.0	10.5	6.7	6.9	7.9	4.8	11.0	8.0	10.8	21.9	10.6	10.0	8.0	14.8	11.5	5.4	9.7	7.2	0.4	2.3	2.1	2.6	4.4	3.5	1.8	2.9	3.2	2.1	2.3	2.9	3.4	0.7	3.7	1.7	1.2	3.5	2.2	2.5	2.5	7.7	3.3	2.3	2.5	2.3	2.4	2.5	2.3	2.6	2.6	4.3	6.4	5.9	7.5	7.2	9.7	3.9	3.0	5.2	6.3	4.1	4.6	1.8	1.5	5.4	0.0	12.5	5.9	6.7	3.7	1.9	3.0	209.7	5.5	5.8	5.2	6.0	13.9	16.9	2.5	7.5	4.0	2.0	4.6	5.7	14.0	4.2	4.8	4.1	3.3	16.7	5.5	4.1	3.5	4.1	57.8	3.7	3.4	7.2	3.7	2.5	2.9	6.2	7.5	7.9	3.8	0.6	4.5	10.3	5.1	7.8	2.5	3.5	8.0	6.6	7.1	3.7	27.7	22.1	12.4	8.2	6.2	6.4	11.5	4.8	5.7
CGA	"FSHA, GPA1, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095106	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 4389.4"	"Cell type enriched"	"Detected in some"	15	"Syncytiotrophoblasts: 85317.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.9;testis cancer: 13.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"BEWO: 776.1;SuSa: 1437.9"	"Region enriched"	"Detected in many"	6	"hypothalamus: 22.2"	"Region enriched"	"Detected in many"	40	"hypothalamus: 82.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.8	4.1	0.2	0.1	0.4	1.9	0.1	0.7	0.7	0.0	0.3	0.3	0.5	1.0	1.2	1.2	0.1	0.2	1.5	0.3	0.3	2.7	2.0	0.7	0.3	2.1	1.6	0.5	1.3	18.9	4389.4	725.8	0.9	2.7	0.3	0.3	0.5	1.1	3.3	2.1	0.3	3.4	0.1	1.1	38.1	0.5	1.0	0.8	0.5	0.0	0.3	0.4	0.2	1.5	0.0	1.0	0.0	0.1	0.0	0.0	776.1	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	4.2	1.8	0.3	40.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	1.0	0.6	0.1	22.6	0.0	1437.9	0.1	0.0	0.0	0.9	0.2	0.4	0.3	3.1	0.4	0.5	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.4	0.2	0.4	0.6	0.2	0.3	0.4	0.1	0.0	0.2	0.4	0.7	0.7	0.3	0.3	2.1	1.6	0.9	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.9	0.0	0.0	7.3	0.0	1414.2	0.1	0.0	0.0	0.0	0.2	20.2	1.1	22.9	1.8	0.0	0.2	0.0	5400.7	65.5	0.0	28.4	0.0	0.0	0.0	0.0	625.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	85317.2	6.0	0.0	0.2	9.9
CH25H		ENSG00000138135	"Cholesterol 25-hydroxylase"	O95992	10	89205629-89207317	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 125.9;Basal squamous epithelial cells: 224.3;Macrophages: 47.3;Microglial cells: 40.3;Smooth muscle cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.8;ASC TERT1: 4.4;fHDF/TERT166: 32.8;HSkMC: 8.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"spinal cord: 6.3"							NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"				"unprognostic (6.07e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-3)"	"unprognostic (7.74e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.62e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.29e-2)"	21.5	5.1	4.3	7.0	5.0	3.1	7.4	6.5	6.6	3.5	4.4	3.6	3.2	1.3	12.6	14.7	6.0	14.6	4.5	4.2	8.4	7.8	3.6	17.2	4.0	18.4	9.5	2.1	1.6	1.1	9.0	4.2	11.4	4.1	5.5	0.4	2.1	1.3	1.8	3.0	5.6	5.5	8.6	2.0	5.8	0.1	6.0	35.3	2.8	1.0	3.7	18.5	2.1	8.2	0.0	0.0	0.0	0.0	8.8	4.4	0.0	0.1	3.1	0.8	0.9	0.0	0.0	0.0	1.1	32.8	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	8.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	4.2	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.0	6.5	6.6	4.2	8.4	18.4	9.5	11.4	8.6	6.0	8.2	125.9	3.2	3.4	0.3	1.8	6.9	4.4	11.7	224.3	0.0	6.4	1.0	0.6	0.0	10.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	1.5	0.9	23.6	0.0	0.0	2.9	0.0	0.2	33.4	2.0	3.1	1.3	0.0	2.5	0.0	10.2	1.7	0.5	0.0	2.0	12.9	8.2	0.0	0.3	47.3	7.2	40.3	0.0	0.6	0.0	0.0	0.4	0.1	0.0	0.7	4.4	1.0	0.0	0.0	4.5	0.5	6.6	3.6	59.3	0.0	0.0	30.8	6.7	0.1	11.6	0.5	0.0	6.2
CHI3L1	"GP39, YK-40, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186704	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 232.4;brain: 239.4;liver: 447.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 88.7;Ductal cells: 88.9;Hepatocytes: 61.8;Hofbauer cells: 317.5"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	495	"neutrophil: 470.4"	"Lineage enriched"	"Detected in single"	495	"granulocytes: 470.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 322.9;ASC TERT1: 712.9;HSkMC: 637.0;THP-1: 1068.4;U-138 MG: 303.5;U-87 MG: 303.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	10	"olfactory bulb: 16.0"	HPA077365			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	25100000	180000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Vesicles	"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	79.8	2.0	58.9	138.9	75.9	232.4	62.8	55.3	94.7	30.5	56.8	6.5	0.4	19.5	1.0	14.4	23.4	3.0	9.8	47.4	129.6	60.9	447.8	38.4	32.4	239.4	112.8	6.6	13.8	0.2	134.5	10.1	135.6	13.7	2.0	50.9	99.4	0.9	21.0	75.6	16.8	6.8	70.0	13.9	9.7	1.0	156.4	12.4	15.0	1.0	36.9	97.8	9.1	70.8	0.8	0.0	0.0	0.3	322.9	712.9	0.0	0.0	0.2	0.0	0.0	75.3	0.2	0.1	1.2	0.4	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	8.3	0.3	0.3	637.0	0.0	1.9	0.3	30.8	0.0	0.0	0.0	1.0	0.2	0.3	0.0	5.8	2.7	0.0	0.0	0.0	0.1	15.4	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.2	0.0	1068.4	0.0	303.5	1.6	0.0	0.4	2.3	41.9	0.3	303.7	1.2	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	470.4	0.0	0.9	0.0	0.0	1.3	58.9	75.9	55.3	94.7	47.4	129.6	239.4	112.8	135.6	70.0	156.4	70.8	0.7	6.4	42.8	20.5	0.1	4.2	47.1	88.7	0.0	0.1	29.8	21.5	1.0	2.8	17.3	27.6	0.0	1.3	0.6	0.0	0.0	88.9	0.0	4.8	2.2	2.1	0.0	0.4	1.1	0.0	1.1	18.6	0.0	7.2	0.0	0.0	0.0	61.8	317.5	0.0	0.1	0.0	6.1	0.8	0.4	0.0	0.9	23.7	14.2	0.0	1.0	45.1	0.0	0.0	0.1	2.0	0.0	0.0	1.4	4.2	0.0	0.2	3.4	2.8	0.0	1.0	2.3	0.0	0.0	1.5	1.1	0.8	0.9	0.0	0.0	2.2
CHRNA6		ENSG00000147434	"Cholinergic receptor nicotinic alpha 6 subunit"	Q15825	8	42752620-42796392	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 9.3;retina: 3.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.0;Inhibitory neurons: 2.6;Late spermatids: 1.9;Rod photoreceptor cells: 1.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 9.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.2;HDLM-2: 2.7;HMC-1: 1.2;JURKAT: 1.2;RPMI-8226: 1.0;U-698: 3.6"	"Group enriched"	"Detected in many"	7	"midbrain: 20.2;thalamus: 6.3"	"Region enriched"	"Detected in all"	6	"midbrain: 76.1"							NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.91e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.60e-4)"	"unprognostic (4.99e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.66e-2)"	0.0	0.3	0.5	0.1	0.7	0.0	0.1	9.3	0.4	0.2	1.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.1	1.7	2.9	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.0	3.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.6	0.1	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.7	9.3	0.4	0.2	0.2	1.7	2.9	0.8	0.0	3.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CHRNE	ACHRE	ENSG00000108556	"Cholinergic receptor nicotinic epsilon subunit"	Q04844	17	4897771-4934438	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 55.3;pituitary gland: 27.6"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 161.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"HEL: 5.0;HMC-1: 11.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	14	"basal ganglia: 6.3"							NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.00e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.35e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.80e-4)"	"unprognostic (7.75e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.70e-2)"	0.7	0.4	0.1	0.4	0.1	0.7	0.7	0.6	0.4	0.7	0.0	0.3	0.3	0.4	1.3	0.4	0.6	1.0	55.3	0.2	0.1	1.0	3.5	0.8	0.5	0.3	0.0	0.8	1.7	0.2	27.6	0.6	0.1	0.6	0.0	5.1	0.8	0.2	1.8	2.2	0.8	0.2	0.0	1.8	0.5	0.7	0.1	0.1	0.4	2.1	0.2	0.3	0.5	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	5.0	0.0	0.8	0.4	0.0	11.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	1.3	2.5	0.4	0.0	0.0	0.1	0.8	0.2	0.4	0.1	0.7	1.1	0.8	0.6	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.2	0.1	0.3	0.0	0.1	0.0	0.1	0.2	4.9	0.0	0.0	0.3	4.2	1.7	1.4	0.8	1.2	5.0	1.6	2.0	6.5	1.5	0.6	1.8	4.2	0.6	10.2	0.0	1.9	0.3	27.8	0.6	1.1	3.3	0.0	0.0	0.5	0.9	7.3	2.3	1.1	0.8	8.2	1.4	2.9	7.4	3.4	3.3	0.4	0.1	2.0	1.3	13.0	161.5	0.9	9.9	0.0	2.8	5.3	1.1	8.2	0.5	0.7	0.7	0.0	0.4	3.5	1.1	0.0	2.9	0.6	10.0	0.0	0.9	1.1	5.6	8.4	0.2	1.1	11.1	3.5	6.2	0.2	0.7
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305707-190322446	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 309.8;skin 1: 288.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 440.1;Basal prostatic cells: 291.1;Prostatic glandular cells: 501.6;Squamous epithelial cells: 298.2;Suprabasal keratinocytes: 836.1;Urothelial cells: 562.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"EFO-21: 658.6;HaCaT: 236.5;hTCEpi: 288.6;RPTEC TERT1: 414.9;RT4: 267.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	12	"spinal cord: 25.4"	"CAB002602, HPA048319"	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	40.8	47.9	1.5	1.2	1.1	0.2	22.7	0.8	1.3	17.7	20.7	1.7	1.1	64.2	31.9	40.9	56.6	15.5	2.5	1.5	1.2	10.5	309.8	9.1	0.5	1.2	2.8	6.3	34.3	0.4	2.4	5.3	1.7	13.6	1.6	0.9	34.0	46.0	1.1	288.2	0.7	126.6	0.7	1.5	1.0	4.3	1.1	9.4	36.2	4.9	44.2	40.4	35.9	1.0	34.0	29.7	0.2	0.1	0.0	0.1	0.0	2.5	52.7	1.1	2.1	17.7	69.1	0.0	658.6	0.3	58.5	236.5	1.5	77.7	6.2	0.9	1.4	0.1	9.3	41.5	49.6	0.4	0.2	0.5	288.6	6.0	87.0	2.4	0.6	0.0	0.1	0.1	0.1	6.5	0.1	0.1	1.5	2.3	5.5	0.0	0.6	0.2	414.9	267.0	0.2	0.0	31.0	5.7	18.4	3.5	53.5	0.5	12.9	0.6	9.9	0.2	1.4	0.7	0.6	1.2	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.8	1.3	1.5	1.2	1.2	2.8	1.7	0.7	1.1	1.0	0.4	12.8	34.7	0.0	0.5	440.1	291.1	217.3	84.2	0.0	35.6	2.0	1.0	170.1	143.2	31.3	0.0	2.4	0.6	0.6	0.0	203.3	0.1	44.4	10.0	7.0	1.8	0.0	0.7	56.3	0.3	29.2	2.0	100.0	1.3	0.4	1.4	188.2	1.0	0.0	1.6	0.3	54.9	3.8	66.5	1.7	15.5	8.5	32.0	0.0	5.7	0.0	0.0	24.6	0.0	139.9	0.0	35.3	0.0	501.6	0.1	4.1	144.6	0.0	0.0	0.3	11.2	0.3	0.8	298.2	836.1	33.8	2.6	5.0	1.0	562.9
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"choroid plexus: 19.8;kidney: 39.1;placenta: 9.8"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 221.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 3.0;Hep G2: 6.3;SuSa: 3.5"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.4"	"Region enriched"	"Detected in many"	6	"spinal cord: 41.8"							NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	0.8	0.1	0.1	0.0	0.1	0.1	1.1	0.4	0.5	0.0	19.8	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	1.3	0.0	39.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.8	0.6	0.3	0.0	0.0	0.8	0.7	0.2	0.5	0.1	0.0	0.1	0.0	0.3	0.0	0.1	1.6	0.0	0.9	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.5	1.3	0.0	0.1	0.0	0.6	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	8.3	0.3	0.0	0.6	12.9	0.0	12.5	0.0	0.0	33.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	221.6	0.7	0.0	0.2	0.0	0.0	0.7	0.0	5.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	12.4	0.1	0.2	0.1	0.0
CNPY1		ENSG00000146910	"Canopy FGF signaling regulator 1"	Q3B7I2	7	155474206-155555450	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 23.4"	"Group enriched"	"Detected in some"	6	"Astrocytes: 2.6;Oligodendrocytes: 2.0;Spermatocytes: 2.3;Spermatogonia: 6.3"	"Cancer enriched"	"Detected in single"	10	"glioma: 1.6"	"Group enriched"	"Detected in many"	6	"cerebellum: 23.4;midbrain: 6.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"AF22: 30.7"	"Region enriched"	"Detected in some"	29	"cerebellum: 192.3"	"Region enriched"	"Detected in some"	10	"cerebellum: 58.6"	HPA047400	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA047400: AB_10960413"					"unprognostic (4.28e-3)"	"unprognostic (2.12e-1)"					"unprognostic (4.18e-2)"		"unprognostic (8.27e-12)"	"unprognostic (1.44e-1)"	"unprognostic (2.16e-1)"			0.1	0.1	0.4	0.1	0.7	0.4	0.0	23.4	1.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.5	0.3	0.0	0.0	0.1	0.2	0.7	6.6	0.1	3.6	0.0	0.1	0.0	2.5	0.0	0.1	1.1	0.2	0.0	0.0	0.5	0.3	0.0	0.4	0.0	0.1	0.9	0.6	0.0	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.0	30.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.4	0.0	2.7	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.2	0.1	0.0	0.1	0.8	0.2	0.1	0.6	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	23.4	1.1	0.5	0.3	0.7	6.6	2.5	0.4	0.6	1.9	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 229.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 307.0;Endothelial cells: 190.5;Fibroblasts: 202.3;Leydig cells: 326.8;Peritubular cells: 483.3;Theca cells: 333.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 26.4;BJ hTERT+: 55.6;HDLM-2: 24.5;K-562: 18.8;U-2197: 45.6;U-87 MG: 20.6;WM-115: 31.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"spinal cord: 44.3"	"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		28000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (3.08e-4)"	84.7	36.9	0.6	50.6	0.9	0.1	46.7	0.8	1.0	31.2	4.0	44.5	12.9	53.8	19.2	26.9	17.3	42.8	58.0	0.4	0.8	12.9	1.0	11.1	10.4	0.6	0.9	23.2	26.8	11.8	6.0	229.2	0.7	21.6	16.3	0.0	35.9	14.3	56.5	15.1	17.7	108.9	0.6	3.7	27.3	27.0	2.4	13.0	21.1	34.4	8.6	42.1	15.1	0.7	0.0	0.0	0.1	0.0	4.6	2.6	0.1	26.4	55.6	1.4	0.5	0.0	0.0	0.2	0.7	5.8	0.2	0.1	0.0	0.0	0.2	24.5	0.0	0.3	12.9	0.0	1.1	0.4	2.5	7.6	0.0	6.0	0.2	0.0	0.0	0.0	18.8	0.0	2.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	14.7	0.2	0.0	0.0	0.1	0.1	0.8	3.9	7.4	0.3	0.2	0.6	0.0	0.1	0.6	45.6	0.5	0.2	0.0	0.0	20.6	0.2	31.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.9	0.8	1.0	0.4	0.8	0.6	0.9	0.7	0.6	2.4	0.7	307.0	0.0	0.0	0.7	0.5	19.5	0.1	0.0	5.2	0.0	2.6	4.1	8.1	0.0	0.0	0.0	0.0	3.8	1.8	0.0	0.0	2.4	5.7	3.9	103.4	190.5	0.0	0.0	0.4	0.8	3.7	202.3	0.5	2.2	0.0	0.3	0.0	0.0	7.6	0.0	2.9	0.0	0.0	0.3	27.2	22.5	326.8	3.1	17.8	46.9	0.6	0.0	1.0	1.0	0.3	0.6	0.0	483.3	0.3	1.2	0.0	0.5	0.0	0.0	13.1	107.8	52.8	1.9	1.2	1.3	16.3	7.7	2.1	333.4	0.0	0.7
COL27A1	"FLJ11895, KIAA1870, MGC11337"	ENSG00000196739	"Collagen type XXVII alpha 1 chain"	Q8IZC6	9	114155537-114312511	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 93.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 60.1;Extravillous trophoblasts: 75.5;Gastric mucus-secreting cells: 43.8;Hepatocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 29.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;Hep G2: 48.7"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in all"	19	"cerebellum: 71.0"	"HPA021884, HPA048471"	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA021884: AB_2670857, HPA048471: AB_2680407"	"unprognostic (4.45e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.00e-2)"	"prognostic unfavorable (7.11e-4)"	"unprognostic (4.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.31e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.50e-3)"	9.2	8.7	4.0	3.5	3.4	0.3	9.1	29.6	4.8	93.7	3.0	11.2	3.9	39.7	16.1	8.1	16.7	7.9	10.9	3.6	4.7	33.1	42.7	7.0	3.1	7.0	7.9	27.6	21.2	1.0	4.1	11.7	6.5	22.5	1.4	1.5	5.4	13.7	5.8	15.7	6.9	10.5	4.9	4.7	11.9	6.4	6.4	9.2	13.5	2.8	2.2	8.1	37.7	4.3	3.8	7.8	17.9	6.6	1.3	1.9	54.8	8.7	5.9	6.3	5.2	8.1	0.2	0.0	2.1	4.3	4.7	9.2	6.2	8.1	3.4	0.0	0.7	0.0	7.5	48.7	1.9	0.0	19.8	4.9	2.3	7.6	3.4	3.6	9.4	7.4	0.0	1.9	3.6	1.8	0.1	3.5	6.5	15.1	2.1	25.9	18.1	3.7	14.6	4.2	0.3	0.2	0.4	0.2	1.1	6.8	1.6	5.8	8.9	5.5	11.1	0.7	13.9	1.0	0.0	0.0	4.5	0.1	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.0	3.4	29.6	4.8	3.6	4.7	7.0	7.9	6.5	4.9	6.4	4.3	2.9	3.2	23.0	15.0	0.8	27.1	4.9	14.2	18.2	1.2	24.3	22.1	34.4	60.1	6.1	9.2	6.2	1.0	2.0	0.5	3.9	12.8	3.7	3.3	25.3	7.1	4.8	0.0	11.0	5.1	75.5	15.0	43.8	11.5	0.0	6.9	3.6	43.6	6.5	1.7	4.6	1.8	0.0	1.0	4.1	1.6	19.3	0.8	23.2	8.4	0.1	5.6	0.0	25.6	0.8	4.7	2.5	4.5	0.4	10.6	0.3	9.8	0.6	1.4	26.3	4.9	40.1	0.5	2.0	5.8	22.4	2.3	1.4	23.8	2.4	3.2
COL28A1		ENSG00000215018	"Collagen type XXVIII alpha 1 chain"	Q2UY09	7	7356203-7535873	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.5;Cone photoreceptor cells: 18.8;Endometrial ciliated cells: 21.1;Excitatory neurons: 23.4;Inhibitory neurons: 22.6;Oligodendrocyte precursor cells: 12.5;Respiratory ciliated cells: 16.3"	"Cancer enhanced"	"Detected in many"		"glioma: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.3;U-266/70: 9.8;U-266/84: 2.8;WM-115: 4.9"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 3.6"	"Region enriched"	"Detected in some"	31	"spinal cord: 33.5"	"HPA043844, HPA060468"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"		"HPA043844: AB_2732508, HPA060468: AB_2684288"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.71e-3)"	"unprognostic (1.89e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.61e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.45e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.09e-2)"	1.0	3.2	0.8	1.6	1.0	0.3	2.8	1.9	2.7	3.3	1.4	11.7	1.2	2.2	14.1	2.1	4.9	1.5	3.7	1.1	0.9	6.3	0.7	1.2	0.2	0.9	3.6	1.2	5.8	0.2	11.2	0.5	1.4	3.9	4.1	6.7	18.2	5.1	5.9	2.1	3.4	1.7	0.2	0.4	6.5	3.7	1.1	0.2	1.2	3.2	0.1	2.9	4.5	1.5	1.5	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.4	0.0	0.0	1.1	0.4	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.2	1.4	0.1	0.2	0.0	0.7	0.9	0.3	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.1	0.7	0.0	0.3	0.1	0.5	0.7	0.1	0.5	1.3	0.0	9.8	2.8	0.0	0.2	0.6	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.8	1.0	1.9	2.7	1.1	0.9	0.9	3.6	1.4	0.2	1.1	1.5	0.4	0.0	4.1	39.5	0.0	0.3	0.1	0.2	0.0	5.3	1.6	1.5	0.9	0.0	3.3	3.7	18.8	0.3	0.1	0.8	0.0	0.1	2.0	21.1	0.5	0.1	0.0	0.0	23.4	0.2	0.0	3.1	0.0	3.9	1.3	0.5	1.8	0.0	0.1	5.0	22.6	0.5	0.0	0.3	0.3	1.1	0.9	0.1	0.0	7.5	0.0	2.2	0.0	12.5	9.1	0.4	5.4	0.7	0.0	0.1	0.2	0.5	16.3	5.4	0.0	1.8	0.2	0.9	1.0	0.1	0.1	0.3	0.1	0.2	0.3	0.1
COL6A3		ENSG00000163359	"Collagen type VI alpha 3 chain"	P12111	2	237324003-237414207	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Congenital muscular dystrophy, Disease variant, Dystonia, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 391.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 355.2;Fibroblasts: 567.9;Leydig cells: 315.1;Smooth muscle cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 3311.7;ASC TERT1: 4227.5;BJ hTERT+: 1279.6;HSkMC: 2705.3"	"Region enhanced"	"Detected in some"		"basal ganglia: 4.5"	"Region enriched"	"Detected in many"	4	"spinal cord: 12.0"	"HPA010007, HPA010080"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1000000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"HPA010007: , HPA010080: AB_1078550"	"unprognostic (8.94e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.20e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (5.57e-11)"	"unprognostic (1.54e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-3)"	150.8	8.3	0.1	126.5	1.0	0.4	74.5	0.2	3.0	212.6	5.2	94.8	22.9	156.3	10.2	44.1	91.8	236.4	61.2	2.4	0.1	5.7	10.3	65.8	30.7	0.6	0.1	123.8	21.1	17.3	2.8	132.9	0.7	47.7	51.7	0.0	45.2	55.4	32.5	35.7	46.6	391.3	0.8	19.0	41.5	15.6	1.8	24.8	38.1	62.3	16.1	188.4	62.7	0.9	0.2	0.5	0.6	0.0	3311.7	4227.5	60.9	815.6	1279.6	167.0	188.2	0.0	0.1	4.5	0.1	818.7	67.4	0.6	0.7	0.9	98.8	2.0	0.1	0.0	0.0	0.0	669.9	0.0	0.4	2705.3	0.0	596.3	1.8	7.8	0.2	0.0	0.1	0.6	6.2	0.0	0.1	0.2	0.5	0.0	7.4	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	17.3	0.0	0.4	2.9	19.0	45.1	27.6	142.4	1.0	0.0	0.1	859.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.2	3.0	2.4	0.1	0.6	0.1	0.7	0.8	1.8	0.9	48.2	0.0	10.5	0.3	0.6	61.1	0.5	0.5	1.8	1.0	2.5	2.9	10.6	1.5	3.8	0.0	0.0	4.5	1.2	0.0	0.0	0.9	5.4	11.0	355.2	17.6	0.0	0.0	0.8	0.0	6.2	567.9	6.6	8.7	1.3	1.8	25.4	1.8	8.1	0.0	0.4	0.0	0.0	1.3	85.4	9.6	315.1	5.5	72.9	29.0	2.2	1.1	1.0	0.0	0.3	2.4	0.0	103.4	2.0	0.9	0.0	0.2	1.0	2.3	32.9	19.2	197.7	1.5	1.3	3.3	61.5	5.7	9.3	48.7	0.0	1.0
COL6A6		ENSG00000206384	"Collagen type VI alpha 6 chain"	A6NMZ7	3	130560334-130678155	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"parathyroid gland: 97.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.6;Fibroblasts: 20.6;Inhibitory neurons: 5.3;Oligodendrocytes: 4.6;Skeletal myocytes: 3.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SuSa: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"spinal cord: 10.0"	HPA045239	Uncertain				"Secreted to extracellular matrix"	NA	NA		700000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"			"HPA045239: AB_2679268"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.08e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-5)"	"unprognostic (3.74e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.96e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.07e-1)"	1.8	0.0	0.0	0.0	0.2	0.2	2.5	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.3	0.9	0.3	0.1	3.3	0.0	0.0	0.0	0.8	7.3	0.0	0.0	0.0	0.2	0.0	97.8	3.6	0.7	0.0	0.0	0.0	0.3	1.5	0.0	0.1	0.4	0.0	0.5	0.0	1.2	0.1	0.4	0.1	1.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	1.1	1.3	0.0	0.9	0.0	0.0	0.0	1.1	0.2	0.4	2.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.9	0.1	0.0	0.0	4.6	0.0	0.0	20.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	5.3	0.0	0.0	0.0	1.5	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	3.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	3.3	0.8	0.0	0.4	0.0	0.9	0.1	0.2	0.0	0.0	0.0
CPAMD8	"K-CAP, KIAA1283, VIP"	ENSG00000160111	"C3 and PZP like alpha-2-macroglobulin domain containing 8"	Q8IZJ3	19	16892951-17026815	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.7;prostate: 34.1;seminal vesicle: 36.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 19.5;Alveolar cells type 1: 22.4;Alveolar cells type 2: 29.8;Collecting duct cells: 27.6;Leydig cells: 31.4;Prostatic glandular cells: 19.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 19.5;EFO-21: 12.6;T-47d: 34.4"					"Region enriched"	"Detected in single"	8	"spinal cord: 5.6"	"HPA031327, HPA031328, HPA031329, HPA031330"	Uncertain		Uncertain	"Focal adhesion sites"	"Secreted to blood"	NA	NA		2700000		"Cluster 21: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Focal adhesion sites"		"HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788"	"unprognostic (4.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-2)"	6.8	2.5	7.9	0.5	15.6	0.5	6.2	35.7	3.7	7.7	4.3	1.0	0.3	2.2	10.5	0.5	1.8	0.3	23.8	2.4	7.2	19.0	0.8	15.0	0.2	23.5	26.2	1.6	0.4	3.2	4.1	4.2	21.3	34.1	0.1	0.5	2.8	36.1	2.8	1.6	1.2	0.4	25.5	1.7	0.8	2.3	17.8	1.2	21.0	2.9	0.3	1.6	3.1	32.0	0.0	0.0	0.8	0.0	0.0	0.0	19.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	12.6	0.3	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.7	0.1	0.0	1.1	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	3.2	0.7	0.0	0.0	1.9	0.0	0.1	0.5	2.8	0.1	0.0	0.0	0.6	0.0	0.1	34.4	0.2	0.0	0.1	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	15.6	35.7	3.7	2.4	7.2	23.5	26.2	21.3	25.5	17.8	32.0	19.5	22.4	29.8	3.6	0.5	0.9	10.1	5.8	1.2	2.3	7.5	9.0	6.1	1.5	10.7	27.6	0.0	9.1	0.4	1.0	0.0	0.9	1.8	3.1	3.2	15.1	0.0	0.0	0.8	0.0	6.1	2.8	2.0	6.1	2.5	1.8	11.7	0.3	3.1	0.0	0.8	0.7	0.0	6.3	1.4	4.3	31.4	5.8	0.0	1.9	3.3	0.1	2.1	1.5	1.0	1.2	1.4	6.4	3.4	19.3	0.0	0.1	4.7	0.1	0.0	1.6	2.1	6.2	1.2	0.4	0.6	6.0	0.4	1.7	0.2	6.0
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872643	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Group enriched"	"Detected in some"	4	"dendritic cells: 63.8;Plasma cells: 16.0;T-cells: 54.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 54.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 54.0;T-cells: 33.3"	"Cell line enriched"	"Detected in single"	34	"SCLC-21H: 12.9"	"Region enriched"	"Detected in some"	44	"cerebellum: 102.6"	"Region enriched"	"Detected in all"	7	"cerebellum: 25.7"							NA	NA		6800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"	0.3	0.3	0.3	2.3	0.5	1.8	0.5	38.2	1.4	0.3	0.3	0.5	0.6	0.8	0.5	0.3	0.3	1.5	0.2	0.2	0.4	0.1	1.0	1.8	8.8	1.1	1.4	0.3	0.1	0.1	0.1	0.2	4.2	0.3	0.6	0.0	0.7	0.2	0.1	0.3	1.2	0.2	0.5	3.6	0.8	0.2	0.7	4.9	0.2	0.0	3.5	0.8	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	4.6	0.6	13.0	5.6	12.9	0.1	1.5	27.0	3.6	0.2	4.3	33.3	1.2	54.0	10.5	0.2	0.1	6.0	0.3	0.5	38.2	1.4	0.2	0.4	1.1	1.4	4.2	0.5	0.7	1.6	1.1	0.0	1.1	0.3	0.8	1.5	0.4	0.1	0.0	0.0	0.4	0.9	0.3	0.0	0.0	0.0	0.0	0.1	63.8	0.1	0.0	0.0	1.2	0.4	0.4	0.3	0.0	0.4	0.5	0.0	0.2	1.6	2.0	0.6	1.3	0.0	0.4	0.2	5.9	0.0	0.7	0.0	0.0	8.8	8.1	1.2	0.0	10.3	3.6	0.0	9.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	16.0	0.3	0.0	0.1	0.0	0.0	0.0	0.8	0.6	0.3	0.5	0.0	0.9	0.1	54.1	0.0	0.0	0.5
CTBS	CTB	ENSG00000117151	Chitobiase	Q01459	1	84549611-84574480	"Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	7	"basal ganglia: 7.4"	"CAB017043, HPA023594, HPA048810"	Approved		Uncertain	Cytosol	"Intracellular and membrane"	NA	NA		370000000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"CAB017043: , HPA023594: AB_1847311, HPA048810: "	"unprognostic (7.76e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-2)"	1.5	1.4	0.4	1.4	0.8	3.3	1.6	1.0	0.6	1.2	2.1	1.2	0.9	1.5	3.1	1.0	1.1	1.2	1.0	0.2	0.6	1.7	3.7	1.4	1.6	1.3	0.9	0.8	1.7	1.6	0.5	1.2	1.5	2.2	1.4	1.4	3.3	0.8	0.8	2.4	1.2	1.1	0.5	2.5	1.4	0.5	0.8	1.0	1.3	0.9	1.0	1.0	0.5	1.3	0.9	0.3	0.2	0.2	2.7	3.2	0.6	0.6	2.2	0.3	0.8	0.1	1.1	1.2	0.2	1.4	0.3	0.4	0.0	0.9	0.9	1.1	0.3	0.8	0.1	0.1	1.6	0.8	0.4	2.4	1.6	0.8	1.2	1.9	0.9	0.5	0.7	2.2	0.6	0.0	0.5	0.9	0.2	0.2	0.3	0.2	0.3	0.8	1.9	0.4	0.1	0.4	0.2	0.9	1.1	0.5	0.5	0.9	1.5	1.1	0.1	1.5	0.7	0.6	0.2	0.3	0.8	1.1	0.8	0.5	0.1	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.3	0.1	0.0	0.0	0.4	0.8	1.0	0.6	0.2	0.6	1.3	0.9	1.5	0.5	0.8	1.3	43.6	9.6	23.4	10.4	37.4	30.3	30.2	28.0	34.1	5.9	33.1	15.6	5.8	31.5	25.5	23.9	41.7	26.8	25.4	30.2	43.0	20.2	3.3	24.1	24.4	29.9	23.0	14.1	6.2	19.2	24.2	28.1	25.0	19.4	43.8	9.7	49.6	70.8	48.2	3.3	4.3	18.9	16.2	75.5	27.9	3.7	21.1	58.8	7.2	20.6	56.5	21.8	18.6	5.5	9.0	19.1	25.2	24.5	59.8	36.7	30.0	44.4	38.2	41.9	13.1	20.2	16.6	10.4	12.8	27.3	24.7	25.6	26.8	25.3	18.4	29.9
DACH1	DACH	ENSG00000276644	"Dachshund family transcription factor 1"	Q9UI36	13	71437966-71867204	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 88.5;Excitatory neurons: 77.0;Horizontal cells: 87.5;Late spermatids: 103.7;Microglial cells: 143.4;Muller glia cells: 143.8;Spermatocytes: 58.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 4.2;eosinophil: 8.4;NK-cell: 4.2;plasmacytoid DC: 6.4"	"Group enriched"	"Detected in many"	33	"dendritic cells: 6.4;granulocytes: 8.4;NK-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"AF22: 14.2;HAP1: 22.5;HEK 293: 16.8;HL-60: 37.9;NB-4: 16.7;SCLC-21H: 36.9;SH-SY5Y: 29.5;THP-1: 26.9"	"Region enriched"	"Detected in all"	5	"basal ganglia: 38.8"	"Region enriched"	"Detected in all"	5	"basal ganglia: 34.2"	"HPA012672, HPA012938, HPA073222"	Approved		Supported	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear speckles"		"HPA012672: AB_1847466, HPA012938: , HPA073222: "	"unprognostic (3.16e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.17e-2)"	4.4	11.1	2.3	1.2	14.0	6.0	4.0	1.6	2.9	9.7	0.3	3.1	5.2	3.8	1.3	0.9	2.8	7.2	2.2	1.0	4.6	8.9	2.0	5.9	0.5	7.0	9.3	0.5	1.9	6.6	3.5	6.9	5.9	7.0	3.3	16.7	2.0	2.3	1.9	1.8	6.7	2.0	2.6	5.4	1.9	6.3	4.3	3.5	0.2	1.2	0.4	2.0	2.7	2.4	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	22.5	0.0	0.0	0.0	16.8	0.2	0.0	0.0	0.4	37.9	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.9	16.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	36.9	29.5	0.0	0.0	0.0	0.1	0.9	26.9	0.0	0.4	0.3	0.0	0.8	0.0	0.0	0.0	1.0	0.0	0.2	4.2	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	4.2	0.0	6.4	0.0	0.1	2.3	14.0	1.6	2.9	1.0	4.6	7.0	9.3	5.9	2.6	4.3	2.4	36.4	0.0	0.6	15.7	0.5	1.7	3.6	0.0	0.0	15.4	19.4	9.3	2.1	1.5	0.0	7.3	4.2	0.0	12.5	0.9	5.9	1.0	88.5	5.0	4.7	34.2	34.1	2.5	77.0	0.0	0.0	4.6	1.1	3.2	5.1	0.3	2.9	0.0	0.2	87.5	28.2	21.4	0.0	1.2	1.2	103.7	3.4	2.5	0.0	143.4	1.1	143.8	0.0	6.6	3.9	0.6	0.3	1.9	0.0	5.8	3.5	6.9	0.7	6.9	13.1	1.5	4.3	58.8	10.2	0.2	1.3	0.0	1.0	1.3	12.6	2.7
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636363-133659329	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 272.7;brain: 236.6"	"Cell type enriched"	"Detected in some"	6	"Hepatic stellate cells: 10.0"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.7"	"Region enriched"	"Detected in many"	8	"pons: 236.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	346	"SH-SY5Y: 1826.4"	"Region enriched"	"Detected in some"	6	"pons and medulla: 22.1"	"Region enriched"	"Detected in single"	26	"pons: 18.5"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		1600000000	"Cluster 32: T-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	2.8	272.7	0.1	1.0	0.2	0.2	0.1	0.0	0.8	0.4	0.0	0.1	0.4	0.3	0.2	0.1	0.3	0.3	0.5	0.3	0.2	1.3	36.1	0.8	2.3	9.8	29.4	0.4	4.3	0.0	1.4	1.4	236.6	0.4	0.0	0.1	0.6	0.2	0.1	0.2	0.6	0.0	0.0	0.9	0.4	0.2	0.6	0.2	0.4	0.0	0.0	0.4	1.1	1.0	0.0	0.0	0.1	0.9	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	3.2	0.9	0.1	0.0	0.0	0.3	5.2	4.7	0.0	0.0	2.1	1826.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	0.3	0.2	9.8	29.4	236.6	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183217	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1218.7;Fibroblasts: 7960.2;Leydig cells: 6281.9;Peritubular cells: 1856.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 24.5"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 3291.1;ASC TERT1: 2371.6;BJ hTERT+: 2546.6;HSkMC: 2289.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"spinal cord: 544.7"	"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"	NA	NA		1900000	"Cluster 46: Basophils - DNA binding"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	1522.3	1171.7	60.6	272.0	80.0	4.4	2342.2	63.5	119.2	1493.0	111.6	549.9	163.5	1308.5	1302.0	932.8	1213.4	1802.7	2108.9	66.8	60.3	394.8	459.6	955.8	130.4	68.9	60.9	2681.4	257.9	80.2	112.0	1534.8	75.7	451.6	493.0	3.1	362.5	462.3	469.0	713.4	336.6	1027.8	70.2	20.0	434.5	279.6	72.8	183.0	479.3	1328.3	293.6	1895.5	783.7	57.9	0.2	0.4	4.4	0.6	3291.1	2371.6	6.2	608.7	2546.6	28.8	28.5	0.3	0.9	1.1	0.5	523.5	0.6	2.1	0.8	1.9	4.9	0.7	0.5	0.6	20.4	0.1	717.4	1.3	1.4	2289.4	8.9	78.3	38.5	12.1	1.0	0.2	0.8	0.7	63.0	0.6	1.5	10.8	1.2	0.4	1.6	0.7	2.3	2.8	3.4	0.5	2.7	11.9	10.3	1.1	0.9	1.8	0.6	0.4	0.9	132.3	1.2	497.5	0.6	3.3	3.1	2.0	8.0	2.0	0.8	24.5	0.3	0.6	0.3	0.1	0.3	0.3	0.3	0.2	0.1	0.6	0.4	0.4	2.7	0.4	0.2	0.7	0.2	0.0	60.6	80.0	63.5	119.2	66.8	60.3	68.9	60.9	75.7	70.2	72.8	57.9	351.1	41.7	44.1	2.3	4.1	609.1	5.4	0.0	264.6	1.9	25.5	31.5	154.7	10.0	11.8	20.2	0.0	31.2	12.8	0.0	1.9	1.0	25.0	39.4	1218.7	158.7	0.0	2.7	0.8	0.0	30.0	7960.2	54.0	22.0	21.5	0.2	214.9	1.4	58.8	0.0	17.1	0.1	0.0	2.8	962.7	103.0	6281.9	52.5	606.5	122.7	0.0	3.3	0.0	0.0	1.4	2.7	0.5	1856.9	23.2	5.8	0.0	0.4	5.8	0.7	210.4	236.8	408.2	13.4	9.2	36.8	482.5	63.9	72.3	70.2	0.0	10.7
DCX	"DBCN, DC, LISX, SCLH, XLIS"	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;endometrium 1: 1.4;retina: 2.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 39.1;Inhibitory neurons: 90.2;Oligodendrocyte precursor cells: 49.8;Rod photoreceptor cells: 21.8"	"Cancer enriched"	"Detected in some"	5	"glioma: 5.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 52.5;SH-SY5Y: 22.1"	"Region enriched"	"Detected in many"	9	"olfactory bulb: 74.0"	"Region enriched"	"Detected in all"	4	"olfactory bulb: 68.6"	HPA036121	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA036121: AB_2674950"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.24e-2)"		"unprognostic (2.33e-3)"	"unprognostic (3.67e-1)"	"unprognostic (4.90e-4)"	"unprognostic (5.02e-3)"	"unprognostic (1.27e-1)"		"unprognostic (1.85e-1)"	0.1	0.2	2.1	0.0	2.4	0.0	1.3	0.0	2.5	0.1	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.0	1.4	2.7	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.3	0.0	0.8	0.0	0.0	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	52.5	22.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	0.0	2.5	1.4	2.7	0.2	1.3	0.8	0.0	2.4	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.5	1.6	2.2	0.7	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	39.1	0.0	0.2	6.8	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	90.2	0.2	0.0	0.0	0.4	0.5	0.0	0.0	1.8	1.9	0.0	1.6	0.0	49.8	2.3	0.1	0.0	1.5	0.0	0.0	0.0	0.1	0.0	21.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.2	0.0	0.0
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426734	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 13020.7;intestine: 8627.2;skeletal muscle: 16532.0"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 2531.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1;stomach cancer: 400.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 70.2;LHCN-M2: 145.3;NB-4: 39.5;RH-30: 333.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"midbrain: 29.5"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1600000	"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	235.3	57.1	2.1	436.2	4.9	1.1	51.2	2.1	9.6	504.3	5.0	8627.2	291.3	3015.2	86.0	1481.2	1085.0	452.1	13020.7	2.4	2.5	37.6	15.5	173.9	7.2	3.4	2.5	171.8	14.6	0.5	8.4	52.7	2.4	2218.8	245.6	0.0	255.3	2253.1	16532.0	152.4	1343.5	2557.5	2.1	25.2	1965.6	16.1	2.6	3.2	66.2	5753.8	1.2	4761.8	669.4	2.4	0.0	0.0	0.1	0.0	0.0	2.2	5.3	0.2	0.0	0.1	0.1	0.5	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	17.0	0.1	1.3	70.2	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	145.3	0.0	0.0	39.5	0.5	0.0	0.0	0.0	333.1	2.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	9.2	0.0	5.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.1	4.9	2.1	9.6	2.4	2.5	3.4	2.5	2.4	2.1	2.6	2.4	0.4	0.0	0.0	0.0	0.0	4.1	2.7	0.0	0.0	0.0	0.1	0.0	2531.9	1.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	90.6	0.5	6.7	22.7	0.0	0.0	0.1	0.0	5.2	104.6	0.0	0.1	0.0	0.0	1.8	0.0	5.6	0.0	0.0	0.9	0.0	0.0	10.7	71.6	28.9	2.8	12.4	0.0	0.6	0.0	0.0	0.5	0.0	0.5	0.0	50.4	0.0	8.7	0.0	0.1	0.0	0.0	46.0	497.8	210.5	5.0	5.1	0.1	9.8	8.5	2.4	0.0	0.2	2.9
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 476.0;breast: 133.6;liver: 331.8;skin 1: 151.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 259.3;Hepatocytes: 116.4;Late spermatids: 64.1;Spermatocytes: 53.9;Spermatogonia: 53.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 19.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"eosinophil: 137.7;neutrophil: 348.6"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 348.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 80.4;HDLM-2: 62.5;Hep G2: 64.9;OE19: 124.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 22.0"	HPA013351			Approved	Vesicles,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (2.28e-1)"	"unprognostic (3.69e-1)"	"unprognostic (9.38e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.59e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.49e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.60e-2)"	476.0	5.1	5.8	19.4	11.7	7.2	133.6	2.9	6.1	2.6	5.3	9.0	14.5	1.2	1.8	24.1	2.1	5.8	11.7	5.7	6.4	3.4	331.8	5.6	4.0	3.7	3.9	1.8	4.6	2.1	1.6	1.5	5.5	2.2	4.9	0.6	10.5	1.6	4.1	151.5	16.5	2.8	3.4	15.0	12.8	38.1	6.9	4.3	8.8	5.6	18.2	21.3	12.6	5.1	13.3	6.4	0.4	11.2	80.4	6.4	1.0	1.3	1.7	1.6	1.0	46.6	13.5	21.1	16.8	0.3	11.9	0.5	1.8	6.5	4.4	62.5	1.2	1.5	4.0	64.9	0.9	7.4	7.2	26.8	33.6	7.3	10.6	4.4	1.2	20.9	1.2	27.6	0.7	8.5	5.1	16.7	3.6	124.0	31.5	0.0	0.1	24.8	1.2	35.8	22.6	1.4	12.3	1.9	2.9	2.7	4.4	26.6	1.6	14.1	7.0	0.3	9.1	16.3	40.0	28.8	10.2	23.7	25.3	19.4	22.1	137.7	0.0	4.4	0.4	7.4	0.4	0.0	6.1	7.6	0.1	0.2	348.6	0.0	5.0	1.8	0.0	5.7	5.8	11.7	2.9	6.1	5.7	6.4	3.7	3.9	5.5	3.4	6.9	5.1	3.2	6.4	5.4	0.3	5.0	1.1	0.9	3.0	0.6	0.9	5.2	7.0	3.5	0.0	2.7	0.0	2.1	0.5	0.3	0.6	0.0	1.7	259.3	3.3	0.2	0.5	1.2	2.7	2.9	0.5	0.1	0.7	10.7	0.2	0.0	2.1	2.9	116.4	2.2	1.7	1.3	4.8	0.0	4.1	13.1	64.1	2.1	4.2	1.8	0.0	4.0	0.4	0.0	0.0	1.0	3.7	2.2	0.7	0.9	2.8	1.2	2.2	3.4	0.0	6.6	0.6	1.0	53.9	53.5	0.3	8.0	0.8	0.5	0.2	3.0	15.7
DHH	"HHG-3, MGC35145"	ENSG00000139549	"Desert hedgehog signaling molecule"	O43323	12	49086656-49094801	"Disease related genes, Human disease related genes, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 16.7"	"Cell type enriched"	"Detected in some"	7	"Granulosa cells: 17.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"AN3-CA: 1.8;EFO-21: 2.3;HUVEC TERT2: 1.5;K-562: 5.6;TIME: 2.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"spinal cord: 8.2"						"Secreted in male reproductive system"	NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (7.56e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-3)"	"unprognostic (2.36e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.22e-3)"	"unprognostic (8.21e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	0.8	0.2	0.2	0.5	0.3	0.0	0.7	0.7	0.5	0.5	0.1	0.4	0.0	0.6	0.2	0.3	0.4	0.3	0.6	0.2	0.1	0.7	0.1	0.5	0.1	0.5	0.4	0.3	0.1	0.0	0.6	0.6	0.4	0.4	0.1	0.0	0.3	0.3	0.1	0.3	0.4	0.4	0.6	0.2	0.3	16.7	0.4	0.0	0.3	0.4	0.0	0.7	0.5	0.8	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.5	0.2	0.1	0.5	0.4	0.4	0.6	0.4	0.8	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	17.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0
DLX1		ENSG00000144355	"Distal-less homeobox 1"	P56177	2	172084740-172089677	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 18.8"	"Cell type enriched"	"Detected in some"	23	"Inhibitory neurons: 30.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 18.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 134.5;U-138 MG: 36.9;WM-115: 42.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 28.6;olfactory bulb: 82.6"	"Region enriched"	"Detected in many"	4	"olfactory bulb: 48.8"	"HPA007175, HPA045884"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Vesicles, Cytosol"	"HPA007175: , HPA045884: AB_10960361"	"unprognostic (2.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.92e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.40e-9)"	"unprognostic (2.22e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.91e-3)"	0.1	1.3	5.9	0.2	4.8	0.0	0.1	0.0	4.4	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.5	18.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.0	3.5	0.0	1.0	0.1	0.3	0.1	0.2	2.7	2.4	0.6	0.6	134.5	2.0	4.5	0.3	3.2	6.5	7.7	4.1	1.0	0.2	0.0	7.8	7.2	7.5	9.4	7.4	1.2	5.2	0.3	33.3	21.1	14.4	5.7	0.1	7.9	15.9	0.0	2.2	1.9	3.2	5.4	0.0	6.7	12.4	0.0	6.3	8.1	0.1	1.9	0.1	0.0	22.9	0.4	15.8	0.0	0.9	4.5	11.3	0.0	6.1	0.8	17.5	0.4	5.2	9.5	7.1	36.9	0.2	16.4	16.4	0.2	0.0	0.1	15.2	21.4	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	4.8	0.0	4.4	3.5	18.8	0.0	0.2	0.0	0.0	3.5	2.7	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DLX2	TES-1	ENSG00000115844	"Distal-less homeobox 2"	Q07687	2	172099438-172102900	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 3.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 6.5;Early spermatids: 6.9;Gastric mucus-secreting cells: 5.6;Inhibitory neurons: 10.0;Melanocytes: 5.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"hypothalamus: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"AN3-CA: 79.7;HEK 293: 50.8"	"Region enhanced"	"Detected in many"		"olfactory bulb: 29.4"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 23.2"	HPA056965			Approved	"Nuclear speckles"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"		"HPA056965: AB_2683291"	"unprognostic (8.12e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.60e-3)"	"unprognostic (3.03e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.69e-10)"	"unprognostic (9.38e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.95e-3)"	0.0	0.3	1.4	0.0	1.1	0.1	0.2	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	79.7	0.5	0.3	2.2	4.3	1.0	0.7	0.2	0.5	0.2	0.0	2.4	2.0	3.8	4.1	2.6	0.3	0.2	0.1	50.8	1.3	8.8	2.0	0.2	0.4	0.3	0.0	3.7	0.1	0.5	0.3	0.0	2.0	0.6	0.0	0.5	0.2	0.1	0.6	0.1	0.0	1.1	0.0	0.4	0.0	0.1	0.1	2.8	0.0	2.1	1.2	5.0	1.3	0.6	0.4	0.4	5.5	0.0	3.0	0.5	0.1	0.1	0.5	4.7	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.1	0.0	0.9	0.4	3.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.0	0.0	0.0	1.3	1.8	0.2	0.9	0.6	0.0	3.1	3.6	0.4	0.0	0.2	0.0	0.0	0.4	6.5	1.0	0.0	0.0	6.9	1.6	0.3	0.5	0.0	0.0	0.1	0.0	0.3	0.2	5.6	1.1	0.0	0.0	0.0	0.0	0.5	0.0	10.0	1.1	0.0	0.0	0.3	0.1	0.0	1.8	5.4	1.0	0.0	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.4	0.1	1.3	0.0	0.1	0.0	0.0	0.3	1.5	0.9	0.7	1.6	0.0	0.4	1.5	0.2	0.6	0.0
DRD1		ENSG00000184845	"Dopamine receptor D1"	P21728	5	175440036-175444182	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 21.3;retina: 8.4"	"Group enriched"	"Detected in some"	12	"Bipolar cells: 40.1;Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 26.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 164.4"	"Region enriched"	"Detected in many"	13	"basal ganglia: 86.7"	"HPA013393, HPA017304"		Supported	Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	Cytosol	"HPA013393: AB_1847833, HPA017304: "	"unprognostic (2.74e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.15e-6)"	"unprognostic (6.69e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.60e-4)"	"unprognostic (5.86e-2)"	"unprognostic (5.43e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.10e-2)"	0.4	0.6	4.7	0.0	21.3	0.0	0.2	0.0	8.5	0.4	0.1	0.2	0.1	0.1	0.2	0.3	0.2	0.4	0.0	3.1	0.4	0.7	1.1	0.7	0.0	0.3	0.9	0.1	0.0	0.0	0.1	1.1	0.0	1.1	0.3	8.4	0.0	0.4	0.0	0.0	0.3	0.1	0.7	0.1	0.2	0.0	1.8	0.3	0.1	0.6	0.1	0.7	0.4	2.9	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	26.4	0.7	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	21.3	0.0	8.5	3.1	0.4	0.3	0.9	0.0	0.7	1.8	2.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	40.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.0	33.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DRD2		ENSG00000149295	"Dopamine receptor D2"	P14416	11	113409605-113475691	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 77.8;pituitary gland: 59.6"	"Cell type enriched"	"Detected in some"	12	"Horizontal cells: 60.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 77.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 88.3"	"Region enriched"	"Detected in many"	10	"basal ganglia: 205.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 146.3"	"HPA015139, HPA015691"	Supported	Supported				NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA015139: , HPA015691: AB_1847834"	"unprognostic (8.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.49e-3)"	0.3	8.4	6.1	0.1	77.8	0.0	1.3	0.2	18.3	1.6	0.0	0.4	0.0	1.1	0.1	0.5	1.3	0.2	0.1	1.4	13.6	1.2	0.0	0.2	0.0	3.9	40.7	0.2	0.2	0.0	59.6	0.0	21.1	0.9	0.3	11.7	11.9	0.7	0.8	0.9	0.2	1.5	0.7	0.0	0.1	1.0	14.8	0.0	0.0	0.3	0.0	0.2	0.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.6	0.2	0.0	0.0	0.0	6.1	0.0	0.0	0.1	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	1.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	1.0	0.1	0.0	0.0	9.6	0.0	0.0	0.1	88.3	10.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	77.8	0.2	18.3	1.4	13.6	3.9	40.7	21.1	0.7	14.8	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.7	0.1	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	60.6	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRD3		ENSG00000151577	"Dopamine receptor D3"	P35462	3	114127580-114199407	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 5.6"	"Group enriched"	"Detected in some"	12	"Early spermatids: 6.2;Late spermatids: 19.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basal ganglia: 5.6;cerebral cortex: 2.8;hypothalamus: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 7.4"	"Region enriched"	"Detected in many"	10	"basal ganglia: 17.9"							NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"		"Cluster 25: Spermatids - Spermatogenesis"								"unprognostic (2.32e-1)"													0.0	0.0	0.3	0.0	5.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	5.6	0.0	2.8	0.1	4.1	0.0	0.2	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUOX1	"LNOX1, NOXEF1, THOX1"	ENSG00000137857	"Dual oxidase 1"	Q9NRD9	15	45129933-45165576	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 108.5;skin 1: 81.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 83.3;Alveolar cells type 2: 168.6;Endometrial ciliated cells: 67.1;Glandular and luminal cells: 88.5;Respiratory ciliated cells: 64.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.4"	"Group enriched"	"Detected in many"	6	"cerebellum: 12.4;white matter: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 64.4;hTCEpi: 30.5;RT4: 36.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 9.6"	HPA023544	Approved					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA023544: AB_1847878"	"unprognostic (2.85e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (2.49e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.02e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.03e-1)"	1.5	14.1	0.7	1.0	1.0	0.2	4.5	12.4	1.2	44.5	0.0	1.0	0.6	3.0	50.0	108.5	14.0	3.3	3.3	1.0	0.3	0.7	0.4	70.1	0.3	0.3	0.3	1.8	0.5	5.2	1.3	1.5	0.6	13.8	0.3	0.6	18.7	13.0	0.4	81.7	0.7	0.4	0.1	0.3	64.3	1.6	0.4	1.1	70.4	0.0	14.7	11.1	42.0	3.2	8.3	0.1	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	64.4	0.0	6.1	0.0	0.8	0.4	0.0	0.9	0.1	0.0	0.0	0.3	0.0	30.5	0.0	1.9	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.2	0.1	0.0	0.0	36.3	0.8	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.0	12.4	1.2	1.0	0.3	0.3	0.3	0.6	0.1	0.4	3.2	0.9	83.3	168.6	4.2	4.5	11.1	14.3	22.8	11.4	21.3	4.7	2.8	2.4	8.6	32.5	3.7	8.4	5.3	7.6	2.5	0.0	3.8	0.7	67.1	9.4	3.8	21.7	2.7	5.1	5.4	0.6	5.1	17.9	88.5	8.2	7.9	7.9	1.5	1.2	6.7	3.9	4.0	16.2	3.1	43.5	0.3	3.4	3.3	16.0	1.0	3.2	3.5	33.0	9.5	10.6	4.7	4.0	3.8	0.1	9.5	6.8	0.5	64.9	4.4	0.0	8.5	4.7	11.5	7.5	36.4	18.0	3.7	4.5	0.4	5.6	30.0
DUSP5	HVH3	ENSG00000138166	"Dual specificity phosphatase 5"	Q16690	10	110497907-110511533	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 175.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 409.1;Langerhans cells: 298.4;Plasma cells: 412.2;Urothelial cells: 1063.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 10.3;plasmacytoid DC: 14.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 408.0;Karpas-707: 161.2;U-266/70: 227.8"	"Region enhanced"	"Detected in all"		"cerebellum: 60.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 45.4"							NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (1.25e-1)"	"unprognostic (3.57e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	"unprognostic (6.35e-2)"	"prognostic unfavorable (8.30e-6)"	"unprognostic (1.70e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.20e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.32e-1)"	"unprognostic (9.09e-2)"	38.8	37.6	8.5	26.8	8.6	38.5	26.6	26.1	17.3	39.4	13.3	22.3	12.2	19.7	2.0	115.5	12.7	51.4	34.1	17.9	12.4	26.4	25.6	23.2	12.8	7.7	9.3	7.6	8.0	6.7	20.0	48.3	7.4	17.7	26.3	9.8	23.4	12.5	2.7	16.9	19.5	21.1	8.3	28.4	26.5	20.1	10.7	14.9	18.8	3.7	32.5	175.7	37.9	7.9	22.0	14.6	3.0	7.3	11.1	46.5	10.6	50.9	114.6	26.8	32.2	9.4	28.9	2.6	9.4	12.4	56.9	7.0	2.8	26.7	43.2	62.8	1.8	12.1	2.6	5.8	41.8	3.2	15.1	17.9	35.9	85.7	408.0	11.8	17.1	1.2	2.1	161.2	81.4	5.9	0.9	9.2	9.6	2.1	22.2	0.2	6.3	38.8	92.0	42.3	1.6	4.0	3.3	8.0	17.4	25.6	4.5	3.8	26.5	9.0	6.2	21.7	24.7	227.8	44.7	6.2	34.9	16.4	6.4	0.5	0.2	0.0	3.5	2.2	1.3	0.2	1.8	1.0	0.9	0.0	0.1	1.0	0.2	0.0	10.3	14.5	0.1	0.6	8.5	8.6	26.1	17.3	17.9	12.4	7.7	9.3	7.4	8.3	10.7	7.9	150.7	3.2	7.8	0.3	71.2	66.0	409.1	91.4	30.7	9.0	72.7	77.0	33.5	11.5	78.3	35.0	6.2	44.0	97.7	63.5	5.9	29.1	1.5	50.6	32.2	90.8	48.9	0.4	4.4	4.8	11.2	42.7	39.3	196.6	3.8	5.5	158.5	4.1	10.7	0.0	2.2	12.8	22.4	16.6	298.4	3.3	1.5	91.5	158.3	1.0	46.9	2.3	4.1	1.0	0.0	49.1	93.2	0.7	412.2	127.0	44.4	0.6	27.3	12.6	0.0	25.8	37.3	1.2	19.8	61.8	101.9	137.4	122.0	3.3	9.2	1063.2
EBF2	"COE2, FLJ11500"	ENSG00000221818	"EBF transcription factor 2"	Q9HAK2	8	25841725-26045413	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 17.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.9;Fibroblasts: 23.2;Microglial cells: 13.1;Sertoli cells: 39.5;Smooth muscle cells: 53.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 22.7;ASC TERT1: 45.7;HSkMC: 46.9;hTEC/SVTERT24-B: 26.7;U-138 MG: 17.1;U-2197: 22.7;U-87 MG: 19.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 5.7;cerebellum: 3.1;hypothalamus: 2.0;midbrain: 4.4;pons and medulla: 2.8"	"Region enriched"	"Detected in many"	5	"spinal cord: 8.7"	"HPA003954, HPA055101"			Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA003954: , HPA055101: "	"unprognostic (3.70e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.13e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.51e-6)"	"unprognostic (7.41e-4)"	"unprognostic (2.28e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.82e-2)"	17.8	0.7	0.2	0.9	0.5	0.0	8.0	0.2	0.1	0.7	0.1	1.4	0.0	0.8	1.9	0.8	4.0	2.6	9.8	0.0	0.7	0.5	0.0	0.6	0.6	1.3	3.1	1.0	0.8	2.2	0.4	0.5	2.7	0.5	0.4	0.2	1.4	0.4	4.7	1.5	0.7	1.7	3.8	0.0	0.8	1.1	0.9	1.4	6.2	9.6	0.2	1.9	1.2	0.3	0.0	0.0	0.8	0.0	22.7	45.7	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	26.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	17.1	0.2	22.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.7	1.3	3.1	2.7	3.8	0.9	0.3	11.9	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.6	0.1	0.2	0.3	5.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	5.6	0.0	0.0	0.5	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.4	3.2	5.9	0.6	0.0	13.1	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	39.5	2.6	53.4	1.0	0.2	0.4	0.3	0.0	0.2	0.1	0.0	0.1
EMILIN3	"C20orf130, dJ620E11.4, EMILIN5"	ENSG00000183798	"Elastin microfibril interfacer 3"	Q9NT22	20	41359962-41366818	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 53.6"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 17.7;Granulosa cells: 7.6;Microglial cells: 4.7;Oligodendrocyte precursor cells: 3.5;Peritubular cells: 4.9;Skeletal myocytes: 3.2"	"Group enriched"	"Detected in many"	5	"glioma: 10.8;testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.3;HAP1: 11.1;NTERA-2: 7.0;SCLC-21H: 13.0"	"Region enriched"	"Detected in single"	30	"cerebellum: 3.3"	"Region enriched"	"Detected in single"	4	"spinal cord: 4.1"	"HPA044034, HPA059912, HPA078559"	Enhanced		Approved	"Golgi apparatus,Microtubules,Cytokinetic bridge"	"Secreted to extracellular matrix"	Yes	NA		1200000		"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus"	"Microtubules, Cytokinetic bridge"	"HPA044034: AB_2678783, HPA059912: AB_2684158, HPA078559: "	"unprognostic (1.66e-4)"	"unprognostic (1.85e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.54e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.13e-7)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.62e-2)"	0.6	1.4	2.5	0.1	2.4	0.0	3.5	2.3	3.8	8.6	1.8	4.9	0.6	2.3	53.6	0.8	4.2	0.3	7.8	2.1	2.2	1.0	0.6	0.3	0.1	3.7	2.7	8.9	0.2	0.1	1.8	0.0	3.0	6.7	0.3	0.0	1.0	9.9	0.9	3.9	1.7	0.9	2.5	0.1	2.0	1.7	2.6	0.5	0.3	2.6	0.2	2.3	4.7	3.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	11.1	0.0	0.2	0.0	1.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.0	1.3	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.4	2.3	3.8	2.1	2.2	3.7	2.7	3.0	2.5	2.6	3.0	0.6	0.0	0.0	0.7	0.0	0.9	0.2	0.0	0.0	0.3	1.2	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	17.7	0.4	0.0	0.0	1.1	0.0	0.0	0.8	0.0	0.7	0.0	7.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	1.8	0.1	0.0	4.7	0.0	0.1	0.0	3.5	0.1	0.0	1.2	4.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	3.2	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1
EN1		ENSG00000163064	"Engrailed homeobox 1"	Q05925	2	118842171-118847648	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.2;skeletal muscle: 13.9;skin 1: 10.4"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 5.6;Fibroblasts: 4.8;Melanocytes: 12.4;Skeletal myocytes: 12.0;Smooth muscle cells: 5.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.6"	"Region enriched"	"Detected in many"	6	"midbrain: 18.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;ASC TERT1: 7.2;fHDF/TERT166: 13.3;HSkMC: 13.5;PC-3: 7.8;U-138 MG: 9.9;U-2197: 11.2"	"Region enriched"	"Detected in single"	5	"midbrain: 4.9"	"Region enriched"	"Detected in some"	6	"midbrain: 23.6"	"CAB014884, HPA073141"	Enhanced		Approved	"Nucleoplasm,Nucleoli rim"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli rim"	Nucleoplasm	"CAB014884: , HPA073141: AB_2686573"	"unprognostic (5.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.84e-7)"	"unprognostic (1.87e-3)"	"unprognostic (1.90e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.38e-9)"	"unprognostic (2.15e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-3)"	3.5	0.2	0.1	0.0	0.1	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	0.7	18.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	13.9	10.4	0.0	0.0	0.5	0.0	0.0	0.1	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.5	4.0	0.2	0.6	0.2	16.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	4.7	0.5	0.6	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	2.3	0.0	0.0	0.0	9.9	1.0	11.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.5	0.7	18.2	3.2	0.5	1.4	0.5	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	5.6	2.8	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	12.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.4	0.1	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0
EN2		ENSG00000164778	"Engrailed homeobox 2"	P19622	7	155458129-155464831	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"brain: 19.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3.6;Glandular and luminal cells: 8.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.3"	"Group enriched"	"Detected in many"	6	"cerebellum: 19.2;midbrain: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.1;AN3-CA: 15.2;HAP1: 9.0;HEK 293: 25.1;SK-MEL-30: 12.9"	"Region enriched"	"Detected in some"	8	"cerebellum: 27.8"	"Region enriched"	"Detected in some"	5	"cerebellum: 52.3"	"HPA045646, HPA069809"			Supported	"Nucleoplasm,Nucleoli,Nucleoli fibrillar center"		No	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	"Nucleoli, Nucleoli fibrillar center"	"HPA045646: AB_2679404, HPA069809: AB_2686205"	"unprognostic (2.44e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (1.74e-6)"	"unprognostic (2.54e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.03e-13)"	"unprognostic (4.91e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.64e-3)"	0.1	0.1	0.1	0.0	0.2	0.0	0.1	19.2	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.2	8.0	0.6	0.3	0.5	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.8	0.7	41.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.1	0.0	1.4	0.0	9.0	0.0	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	5.5	0.0	0.0	0.0	0.0	2.0	0.0	3.2	0.0	0.1	0.3	0.0	0.0	3.0	0.0	12.9	0.0	0.0	2.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	19.2	0.7	0.2	0.4	0.2	8.0	2.3	0.3	0.9	2.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.6	0.6	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.0	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.4	1.5	0.6	0.0	0.1	0.0	0.1	0.3	0.0	0.0
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 32.1;intestine: 44.5"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 160.0;Glandular and luminal cells: 387.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	86	"basophil: 30.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 30.6"	"Group enriched"	"Detected in some"	18	"HEL: 4.4;Hep G2: 14.6;HMC-1: 6.2"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"spinal cord: 2.6"	HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		1100000	"Cluster 38: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	1.2	6.2	0.4	1.1	0.4	0.1	6.6	0.9	0.5	32.1	0.2	9.3	16.2	3.8	1.2	0.5	2.3	1.3	0.1	0.3	0.5	10.0	5.0	0.9	0.5	0.5	0.6	0.5	0.1	0.3	0.1	0.1	0.5	2.4	8.4	0.3	18.1	15.6	0.1	0.6	44.5	0.8	0.4	0.3	0.5	0.8	0.5	9.6	0.3	0.2	0.4	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.4	0.0	14.6	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.5	0.3	0.5	0.5	0.6	0.5	0.4	0.5	0.4	0.4	0.0	1.1	5.2	0.2	0.0	2.6	0.7	1.2	0.2	1.0	0.6	0.3	0.0	2.5	0.0	0.0	0.0	0.2	9.2	1.9	0.0	1.6	160.0	46.3	1.4	0.0	2.1	2.1	0.0	0.1	0.5	0.0	387.2	36.0	0.1	0.7	1.7	0.1	0.0	4.1	1.5	0.0	0.6	1.1	0.4	1.2	1.5	1.8	2.8	0.0	0.1	1.0	3.5	0.9	0.0	1.9	0.7	0.3	2.7	53.3	9.1	5.4	0.1	0.0	0.2	1.0	2.5	0.8	0.0	0.6	0.1	2.2	0.1	4.9	1.1
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
EPHA8	"EEK, Hek3"	ENSG00000070886	"EPH receptor A8"	P29322	1	22563489-22603595	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"choroid plexus: 27.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.2;Cone photoreceptor cells: 2.1;Early spermatids: 2.8;Horizontal cells: 3.3;Late spermatids: 5.8;Rod photoreceptor cells: 8.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"SCLC-21H: 59.6"	"Region enhanced"	"Detected in many"		"cerebellum: 13.0"	"Region enriched"	"Detected in many"	4	"cerebellum: 11.7"	"CAB009660, HPA031433"	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB009660: AB_2099696, HPA031433: AB_10601371"	"unprognostic (8.58e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.69e-4)"	"unprognostic (3.58e-1)"		"unprognostic (7.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.84e-14)"	"unprognostic (2.14e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.68e-2)"	0.0	3.5	2.7	0.0	2.3	0.0	0.0	1.5	2.3	0.0	27.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.3	0.0	0.0	0.0	0.0	1.9	3.1	0.0	3.3	0.0	1.5	0.0	2.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	2.3	4.6	0.0	2.2	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.6	4.8	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	1.5	2.3	4.9	5.3	1.9	3.1	2.0	2.3	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.3	1.3	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.1	1.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPS8L2	"FLJ21935, FLJ22171, MGC3088"	ENSG00000177106	"EPS8 like 2"	Q9H6S3	11	694438-727727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 188.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 211.4;Paneth cells: 175.3;Proximal enterocytes: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 3.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 234.3;BEWO: 220.8;CAPAN-2: 206.6;SK-BR-3: 257.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 9.2"	HPA041143	Approved		Supported	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA041143: AB_10794985"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.03e-2)"	7.8	11.2	5.2	5.7	4.8	0.0	27.0	8.9	5.5	49.4	4.9	42.7	100.8	11.4	3.5	188.5	19.2	13.3	4.3	4.5	6.8	98.4	101.7	32.4	0.7	10.9	9.2	11.8	43.7	3.8	11.5	17.7	6.2	29.3	15.5	1.0	94.6	15.2	1.3	76.3	105.0	2.9	7.1	1.4	48.1	3.2	7.1	2.0	70.2	0.4	10.9	17.5	80.1	6.5	234.3	68.6	0.2	1.6	2.7	14.4	220.8	20.1	20.3	29.2	12.5	51.4	206.6	0.4	81.6	21.4	5.4	122.4	0.6	117.8	6.4	0.6	5.4	0.0	27.7	94.7	16.3	0.3	0.4	8.1	77.8	8.0	18.7	12.3	0.2	0.1	1.8	1.1	3.2	72.1	0.5	1.3	2.7	71.5	24.0	0.5	0.8	1.8	103.8	55.2	0.8	0.8	75.9	257.5	0.5	14.3	94.9	0.2	1.5	11.2	27.3	7.2	1.6	0.9	1.0	0.8	6.1	0.6	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.1	5.2	4.8	8.9	5.5	4.5	6.8	10.9	9.2	6.2	7.1	7.1	6.5	1.8	141.1	51.8	3.9	11.2	19.8	26.2	48.8	51.8	0.6	39.1	37.0	4.5	57.2	62.4	90.1	0.0	47.9	21.6	211.4	27.4	55.2	1.0	47.3	7.1	4.7	43.8	1.3	3.1	80.0	33.4	11.5	131.0	60.8	7.0	0.4	0.7	59.4	4.7	0.0	3.8	76.8	32.6	2.1	7.8	2.3	18.0	2.7	14.2	2.8	3.1	10.0	16.5	2.0	0.7	83.2	175.3	11.7	7.6	33.6	235.9	108.2	60.9	1.5	0.0	0.9	7.5	1.1	4.8	74.9	24.4	92.5	18.6	0.9	77.2	32.1
ETNK2	"EKI2, FLJ10761"	ENSG00000143845	"Ethanolamine kinase 2"	Q9NVF9	1	204131062-204152044	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 108.1;liver: 235.5;testis: 125.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 417.0;Late spermatids: 1337.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 32.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 53.8;MCF7: 55.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 22.6"	HPA057167	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA057167: AB_2683358"	"unprognostic (1.64e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.56e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-3)"	"unprognostic (4.28e-2)"	"unprognostic (6.54e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (6.50e-4)"	"unprognostic (5.50e-3)"	"unprognostic (4.69e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.20e-1)"	14.4	6.1	12.8	2.1	12.5	2.8	17.4	7.9	12.0	18.8	28.3	5.7	1.9	10.8	29.9	23.9	13.1	5.3	6.3	10.6	14.0	108.1	235.5	3.3	2.1	10.5	13.4	36.1	9.5	18.5	25.6	4.3	11.1	13.7	2.1	5.7	27.7	16.2	2.0	20.3	3.7	6.5	8.5	7.2	4.9	125.0	15.1	3.7	10.6	4.1	9.3	10.0	26.0	7.5	11.3	3.8	11.0	20.9	4.0	1.3	10.9	11.4	25.2	15.6	6.8	19.2	5.4	0.4	18.4	2.8	18.2	9.9	19.7	15.9	10.7	0.4	17.3	0.2	2.5	30.6	16.2	0.5	0.7	5.4	53.8	3.2	0.7	8.0	11.1	11.9	1.6	0.4	2.0	55.1	3.2	0.3	23.0	0.4	8.4	0.8	13.0	0.4	13.4	4.3	2.9	15.4	7.2	33.6	5.4	35.1	32.5	0.7	0.7	4.4	23.8	1.0	8.4	0.5	0.2	0.5	0.3	0.6	6.3	0.0	0.1	0.0	2.2	0.0	2.1	0.0	0.5	1.3	0.0	0.1	1.3	1.6	0.1	0.8	0.0	0.0	0.3	0.6	12.8	12.5	7.9	12.0	10.6	14.0	10.5	13.4	11.1	8.5	15.1	7.5	1.3	0.0	0.0	1.3	1.0	4.1	13.8	8.2	1.8	4.2	12.3	11.6	1.1	4.3	2.5	3.7	4.2	6.1	1.6	0.1	39.2	9.5	417.0	4.5	1.9	2.1	1.2	13.5	1.2	6.3	9.2	6.4	1.1	3.2	8.9	47.4	6.8	196.9	0.8	0.0	2.9	0.1	2.0	6.5	1.1	1337.3	29.2	1.6	10.6	0.0	0.0	3.8	1.0	2.5	0.2	4.5	0.0	42.2	0.0	14.9	0.3	147.2	3.1	0.8	0.0	4.1	4.4	11.0	7.4	16.1	2.4	9.4	2.9	34.1	0.2	13.5
EXPH5	SLAC2-B	ENSG00000110723	"Exophilin 5"	Q8NEV8	11	108505435-108593768	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.7;skin 1: 25.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Basal keratinocytes: 107.7;Glandular and luminal cells: 89.5;Respiratory ciliated cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	15	"cerebellum: 67.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 7.9;hTERT-HME1: 11.2;RT4: 20.5;SK-BR-3: 9.7"	"Group enriched"	"Detected in many"	4	"cerebellum: 20.9;cerebral cortex: 6.7"	"Region enriched"	"Detected in many"	8	"cerebellum: 30.9"							NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"				"unprognostic (1.34e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favorable (3.42e-6)"	"unprognostic (2.91e-1)"	"prognostic favorable (1.46e-4)"	"unprognostic (4.57e-3)"	"prognostic favorable (5.12e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.51e-1)"	0.4	0.1	1.3	0.5	2.5	0.2	2.9	67.7	2.3	2.2	12.8	3.9	0.7	0.7	2.7	7.4	1.7	0.3	0.2	2.1	1.9	2.4	7.7	3.9	0.1	1.5	3.6	0.3	1.0	4.7	0.5	2.8	4.6	1.5	4.4	0.3	4.4	0.3	0.1	25.8	0.8	0.4	1.1	0.2	3.2	0.7	1.7	0.8	1.0	0.2	1.4	0.7	3.8	3.4	3.9	0.4	0.2	0.1	0.0	0.1	3.2	0.2	0.1	0.0	0.6	1.0	5.9	0.0	0.2	0.2	0.9	7.9	5.7	2.1	0.2	0.1	1.7	1.6	0.8	0.0	0.5	0.8	0.1	0.1	3.3	0.0	11.2	0.5	0.0	1.3	3.0	0.0	3.1	0.6	1.0	0.0	0.2	6.4	2.4	0.0	0.1	0.0	0.6	20.5	1.4	0.8	1.0	9.7	0.2	1.1	6.4	0.1	0.1	0.0	2.3	0.0	1.1	0.1	0.0	0.0	0.1	0.4	0.0	0.8	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.5	0.5	0.8	0.9	0.1	0.2	0.0	0.1	1.3	2.5	67.7	2.3	2.1	1.9	1.5	3.6	4.6	1.1	1.7	3.4	0.6	147.4	60.0	18.6	0.9	107.7	12.9	16.6	58.6	0.6	14.1	8.6	5.7	4.3	65.3	20.2	14.6	44.5	2.4	47.9	3.9	5.4	10.3	74.8	7.8	2.5	4.9	3.2	9.0	4.9	4.9	5.6	20.9	89.5	1.3	0.9	0.7	24.2	3.8	0.0	4.9	38.6	14.2	0.6	15.2	2.3	0.6	1.8	5.4	16.9	1.3	0.5	1.0	3.0	0.6	3.6	17.5	0.0	1.5	30.4	1.9	3.7	98.5	1.4	0.0	0.3	2.1	1.1	0.5	46.9	72.2	54.6	2.8	0.4	29.1	19.3
FAT2	"CDHF8, CDHR9, HFAT2, MEGF1"	ENSG00000086570	"FAT atypical cadherin 2"	Q9NYQ8	5	151504093-151568944	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 113.4;esophagus: 50.9;skin 1: 56.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 18.0;Basal respiratory cells: 31.6;Basal squamous epithelial cells: 27.9;Early spermatids: 16.0;Extravillous trophoblasts: 20.6;Squamous epithelial cells: 53.2;Suprabasal keratinocytes: 19.6"	"Group enriched"	"Detected in many"	6	"cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6"	"Region enriched"	"Detected in many"	7	"cerebellum: 113.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BEWO: 35.1;EFO-21: 21.0;HaCaT: 51.7;HBEC3-KT: 23.6;hTCEpi: 70.5"	"Region enriched"	"Detected in some"	18	"cerebellum: 32.0"	"Region enriched"	"Detected in many"	56	"cerebellum: 224.4"	CAB033680	Enhanced					NA	NA		300000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"CAB033680: AB_2100956"	"unprognostic (8.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.43e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-7)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.64e-3)"	0.4	0.2	0.4	0.0	3.8	0.1	3.6	113.4	4.8	11.5	0.0	0.1	0.1	0.1	1.7	50.9	1.0	0.0	0.1	0.5	0.4	0.6	0.1	0.2	0.0	15.1	2.8	0.1	0.2	0.2	0.5	0.9	17.2	5.3	0.0	0.1	8.9	4.8	0.2	56.0	0.2	0.0	0.4	0.1	0.1	13.2	0.5	2.2	0.1	0.0	3.4	2.9	24.4	2.2	1.7	0.0	0.0	0.1	0.0	0.0	35.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	21.0	0.0	0.2	51.7	0.0	23.6	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	70.5	0.0	3.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.7	0.1	0.0	0.1	1.1	0.2	0.5	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.8	113.4	4.8	0.5	0.4	15.1	2.8	17.2	0.4	0.5	2.2	0.1	0.0	0.0	0.7	0.0	18.0	5.8	31.6	27.9	0.0	3.4	12.8	1.9	0.0	11.1	1.8	0.0	0.4	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.3	0.0	0.0	5.0	0.0	20.6	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	2.9	0.0	0.0	0.0	1.5	7.8	0.0	0.0	7.2	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.1	3.0	0.0	0.0	0.0	0.4	0.5	0.1	53.2	19.6	1.0	0.1	0.0	0.0	13.0
FBXO15	"FBX15, MGC39671"	ENSG00000141665	"F-box protein 15"	Q8NCQ5	18	74073353-74147843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.1;testis: 7.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Endometrial ciliated cells: 41.1;Oligodendrocytes: 19.3;Respiratory ciliated cells: 59.2;Spermatocytes: 41.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"GAMG: 1.6;JURKAT: 2.6;SCLC-21H: 2.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"basal ganglia: 17.6"							NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.69e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.34e-6)"	"unprognostic (1.65e-2)"	"unprognostic (4.20e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.46e-5)"	"unprognostic (4.64e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.62e-4)"	"unprognostic (2.87e-1)"	0.1	0.7	0.9	0.0	1.2	0.1	0.3	1.0	1.1	0.5	1.1	0.1	0.1	0.1	2.2	0.1	4.1	0.2	0.1	1.0	1.1	1.1	0.4	0.4	0.1	2.6	3.4	0.3	0.4	0.6	1.4	0.0	2.4	0.2	0.0	3.4	0.3	0.7	0.1	0.2	0.1	0.0	1.8	0.3	0.2	7.1	0.9	0.2	0.6	0.0	0.0	0.1	0.1	2.9	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.7	0.0	0.0	0.3	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.0	2.6	0.0	0.2	0.1	0.1	0.1	0.1	0.5	0.3	0.8	0.3	0.0	0.0	0.3	0.0	2.7	0.8	0.0	0.0	1.0	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	1.2	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.2	0.0	0.2	1.6	0.9	0.0	0.0	0.1	0.2	0.0	0.4	0.9	1.2	1.0	1.1	1.0	1.1	2.6	3.4	2.4	1.8	0.9	2.9	0.3	6.4	1.1	12.4	1.0	0.3	0.8	3.9	0.0	8.1	1.5	1.8	0.6	0.0	5.9	1.8	0.0	0.5	0.1	0.1	3.9	0.9	36.0	41.1	0.5	0.3	0.0	0.4	6.4	0.2	0.7	0.2	0.0	1.2	0.0	2.2	0.7	0.4	3.1	5.0	8.8	0.2	0.0	0.6	0.3	17.8	1.2	0.4	0.0	2.8	0.0	7.8	0.0	9.0	19.3	0.1	0.1	1.5	0.0	0.2	0.0	5.8	59.2	10.3	0.0	0.8	2.1	41.5	11.7	0.0	0.0	0.4	0.4	0.3	0.2	0.6
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880810-134887523	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 99.7"	"Cell type enriched"	"Detected in some"	18	"Hepatic stellate cells: 1192.6"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5;intermediate monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"Region enriched"	"Detected in some"	23	"spinal cord: 38.6"						"Secreted to blood"	NA	NA	8100000000	1400000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		4.7	24.6	0.4	0.0	0.4	0.1	7.6	0.3	0.5	0.3	0.5	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.6	0.4	6.4	99.7	0.1	0.1	0.3	0.5	0.5	0.5	0.2	3.1	0.0	0.4	3.2	0.0	0.0	3.2	0.4	0.1	0.2	0.1	0.0	0.2	3.1	0.2	0.2	0.4	0.0	2.1	0.1	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	5.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.1	0.0	2.2	0.0	0.0	9.0	0.4	0.4	0.3	0.5	0.6	0.4	0.3	0.5	0.4	0.2	0.4	0.3	0.1	0.0	0.0	0.7	3.8	0.0	0.1	0.0	0.0	0.0	3.8	0.4	0.1	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	34.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1192.6	12.6	0.0	0.0	0.1	0.0	0.0	64.1	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1
FERD3L	"bHLHa31, N-TWIST, NATO3"	ENSG00000146618	"Fer3 like bHLH transcription factor"	Q96RJ6	7	19144782-19145421	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"brain: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	109	"SCLC-21H: 10.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	16	"midbrain: 20.2"	HPA043494	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"				"HPA043494: AB_10964193"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	5.3	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	1.8	5.3	1.9	0.4	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FEZF1	ZNF312B	ENSG00000128610	"FEZ family zinc finger 1"	A0PJY2	7	122301303-122310691	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 126.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 5.1;Spermatocytes: 5.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"thalamus: 126.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"NTERA-2: 152.1;SCLC-21H: 66.0"	"Region enriched"	"Detected in some"	11	"hypothalamus: 11.7"	"Region enriched"	"Detected in single"	14	"hypothalamus: 7.4"	"HPA064639, HPA073693"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA064639: AB_2685308, HPA073693: AB_2686626"		"unprognostic (8.48e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.17e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-3)"			"unprognostic (2.54e-1)"	"unprognostic (1.34e-1)"		"unprognostic (2.96e-2)"	"unprognostic (2.55e-1)"		"unprognostic (1.48e-2)"	0.1	0.0	2.9	0.0	3.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	24.8	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.0	3.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.5	126.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	152.1	3.8	2.7	0.0	0.0	0.0	0.0	0.2	66.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	7.2	0.3	0.0	0.1	2.0	0.0	0.0	0.9	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.1	0.2	1.8	0.6	24.8	0.3	2.6	0.5	0.2	126.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGF20		ENSG00000078579	"Fibroblast growth factor 20"	Q9NP95	8	16992181-17002345	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5"	"Cell type enriched"	"Detected in some"	7	"Microglial cells: 8.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;CAPAN-2: 5.3;OE19: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.8"						"Secreted in other tissues"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.93e-2)"		"unprognostic (2.19e-1)"	"unprognostic (5.57e-3)"	"unprognostic (3.95e-2)"			"unprognostic (1.59e-3)"		"unprognostic (1.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.08e-2)"		0.1	0.6	0.8	0.0	0.8	0.0	0.2	2.5	1.4	0.9	0.5	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.1	0.8	1.2	0.0	0.0	0.1	0.1	1.1	1.2	0.6	0.1	0.0	0.4	0.1	1.4	0.2	0.0	0.1	1.1	0.1	0.0	0.0	0.1	0.0	1.1	1.0	0.6	0.2	1.4	0.2	0.2	0.0	0.4	0.1	0.1	1.6	0.0	0.0	0.1	0.0	0.4	0.6	0.0	0.6	1.6	0.2	0.8	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	2.5	1.4	0.8	1.2	1.1	1.2	1.4	1.1	1.4	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 9.9;brain: 26.7;parathyroid gland: 12.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.6;Exocrine glandular cells: 30.1;Intestinal goblet cells: 24.5;Ionocytes: 26.4;Late spermatids: 36.1;Pancreatic endocrine cells: 28.6;Spermatogonia: 16.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.7;MCF7: 32.8;OE19: 22.9;RPTEC TERT1: 24.4;THP-1: 12.5;U-2 OS: 14.1;U-251 MG: 13.5"	"Group enriched"	"Detected in many"	4	"basal ganglia: 17.6;hippocampal formation: 68.4"	"Region enriched"	"Detected in many"	5	"hippocampal formation: 57.3"	HPA055353	Approved		Approved	"Cell Junctions"		NA	NA		19000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cell Junctions"		"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.1	9.9	8.0	0.0	1.8	0.0	0.5	0.0	15.8	0.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.2	0.5	26.7	1.4	0.1	0.0	2.1	0.0	8.3	6.3	0.1	0.0	12.5	0.1	0.9	5.2	0.1	0.7	1.3	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.3	0.1	6.6	5.4	0.0	0.0	0.0	0.0	0.9	0.1	2.7	0.3	3.5	1.2	0.0	0.1	0.0	0.0	5.9	8.7	0.4	1.2	0.0	3.7	0.0	2.3	0.3	6.3	2.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.7	0.4	0.2	0.3	0.0	0.1	3.9	0.0	13.7	0.0	0.0	0.7	0.0	0.0	32.8	0.0	2.8	2.1	22.9	0.6	0.0	5.7	0.4	24.4	0.0	0.2	0.0	1.1	0.1	0.8	0.9	2.0	12.5	0.0	1.3	14.1	0.1	13.5	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	8.0	1.8	0.0	15.8	26.7	1.4	8.3	6.3	5.2	0.0	5.4	2.7	0.2	0.0	0.0	0.3	0.0	0.0	0.9	5.0	0.0	3.2	0.8	0.0	1.3	0.0	2.3	1.8	0.0	11.6	0.0	10.4	0.0	0.3	19.6	0.0	0.1	0.4	0.0	0.0	0.3	30.1	0.9	0.9	0.0	0.0	0.0	0.8	0.0	0.0	1.1	3.3	0.3	24.5	26.4	0.0	0.0	36.1	0.6	0.5	0.0	1.9	0.4	0.6	0.0	0.0	0.1	28.6	6.3	3.4	0.0	0.7	2.5	0.1	2.1	0.2	0.0	0.0	0.8	9.5	16.3	0.0	0.0	4.0	0.0	0.9	6.7	1.5
FOXA1	HNF3A	ENSG00000129514	"Forkhead box A1"	P55317	14	37589552-37596059	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 74.7;stomach 1: 28.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 113.8;Basal squamous epithelial cells: 76.8;Breast glandular cells: 87.9;Enteroendocrine cells: 84.6;Prostatic glandular cells: 89.8;Respiratory ciliated cells: 66.7;Urothelial cells: 154.5"	"Group enriched"	"Detected in many"	5	"breast cancer: 80.0;prostate cancer: 127.0"	"Region enriched"	"Detected in single"	5	"midbrain: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 48.9;MCF7: 105.3;PC-3: 69.5;RT4: 96.7;SK-BR-3: 97.0;T-47d: 135.9"	"Region enhanced"	"Detected in some"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	6	"midbrain: 5.4"	"CAB011595, HPA050505"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB011595: AB_2104842, HPA050505: AB_2681148"	"unprognostic (1.61e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.65e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.30e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.00e-4)"	0.2	0.1	0.0	1.6	0.0	0.0	22.3	0.0	0.0	1.5	0.0	12.4	8.4	0.1	0.6	11.9	2.4	2.3	0.0	0.0	0.3	0.1	26.9	7.5	0.0	0.1	3.5	0.0	0.5	0.0	0.7	0.0	0.2	74.7	10.4	0.0	19.3	0.3	0.0	1.3	4.8	0.2	0.2	0.0	28.0	0.4	0.7	0.0	0.0	0.0	2.3	20.5	4.4	0.0	4.9	4.4	0.0	2.8	0.0	0.0	0.5	0.0	0.4	0.0	0.0	21.3	2.7	0.0	1.4	0.0	0.1	23.4	13.2	3.3	0.1	0.0	23.4	0.0	4.1	48.9	0.0	0.0	0.2	0.0	0.7	0.0	0.4	1.9	0.0	0.4	0.9	0.0	0.0	105.3	0.1	0.3	0.0	32.0	69.5	0.0	1.1	0.4	9.9	96.7	11.8	0.0	4.8	97.0	0.0	0.0	135.9	0.4	0.0	0.9	0.1	0.4	3.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	3.5	0.2	0.2	0.7	0.0	0.3	28.9	43.5	0.0	0.1	1.0	113.8	47.8	76.8	0.0	87.9	34.8	1.3	30.0	52.3	3.7	0.0	0.0	0.5	27.5	0.0	1.5	0.4	2.7	0.2	1.2	84.6	0.0	0.0	2.4	0.0	1.0	35.7	4.4	2.5	0.0	1.1	31.7	0.0	0.0	0.0	34.9	42.7	0.9	0.3	0.9	0.0	0.7	3.6	0.0	1.0	0.0	0.0	0.0	0.0	4.3	27.2	0.0	1.2	89.8	4.9	0.0	66.7	0.0	0.0	0.0	2.3	0.9	1.2	62.9	0.1	0.0	1.4	0.1	27.9	154.5
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22580998-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 36.2;pancreas: 26.6;stomach 1: 31.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 96.1;Alveolar cells type 2: 78.0;Cholangiocytes: 47.1;Exocrine glandular cells: 37.0;Gastric mucus-secreting cells: 37.8;Hepatocytes: 63.7;Intestinal goblet cells: 87.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"midbrain: 2.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.5;HBEC3-KT: 19.3;Hep G2: 28.8;hTERT-HME1: 12.6;OE19: 22.7;PC-3: 24.7;SCLC-21H: 42.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"midbrain: 3.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	14.2	0.0	7.3	3.7	2.1	0.0	0.1	4.3	4.0	0.0	0.0	0.0	0.2	36.2	13.7	0.0	0.0	2.5	0.0	26.6	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	31.1	0.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.6	0.0	0.3	0.0	0.1	0.0	0.0	19.3	0.0	0.0	1.2	0.0	0.0	28.8	0.0	0.0	0.0	0.0	10.3	0.0	12.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	22.7	24.7	0.0	0.0	0.0	0.8	0.0	42.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.5	0.0	0.0	96.1	78.0	0.0	0.1	0.0	0.8	0.5	0.0	0.0	0.1	0.3	0.3	47.1	12.5	0.0	0.0	0.0	0.0	21.7	0.0	25.6	0.1	30.8	2.6	0.1	28.1	0.0	0.0	37.0	0.0	0.3	37.8	27.1	4.5	0.0	0.7	63.7	0.0	0.0	0.0	87.2	6.1	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	24.4	6.8	0.0	0.2	1.0	1.0	0.0	10.0	0.0	0.0	0.0	0.2	4.1	0.2	0.0	0.0	0.0	1.0	0.0	28.7	0.1
FOXC2	"FKHL14, MFH-1"	ENSG00000176692	"Forkhead box C2"	Q99958	16	86566829-86569728	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.6"	"Group enriched"	"Detected in some"	4	"Peritubular cells: 30.9;Sertoli cells: 19.7;Smooth muscle cells: 33.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.2;HUVEC TERT2: 19.5;LHCN-M2: 31.2;TIME: 36.0;U-138 MG: 18.4;U-2197: 31.5;U-87 MG: 24.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"spinal cord: 42.7"	HPA056302			Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA056302: AB_2683093"	"unprognostic (3.17e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.71e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (1.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.84e-4)"	2.4	1.5	0.5	0.3	1.1	0.0	1.8	0.9	1.6	2.2	3.2	0.5	0.1	0.8	0.6	0.5	2.0	1.3	5.6	0.4	0.4	5.4	0.1	2.1	0.4	0.5	0.5	1.1	0.2	0.1	2.4	0.1	0.5	1.0	0.1	0.1	2.4	0.6	0.7	0.8	0.4	0.4	0.7	0.0	0.4	1.9	0.7	0.1	2.0	0.5	0.1	0.8	1.5	0.3	0.0	0.0	0.0	0.0	5.8	7.8	0.0	11.3	14.3	8.0	1.5	0.0	0.0	0.0	1.5	1.4	11.2	0.0	0.2	3.3	7.0	0.0	0.6	0.0	7.9	0.0	2.7	0.0	0.0	1.3	3.4	25.2	7.9	14.5	19.5	0.0	0.0	0.0	31.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	1.7	0.0	0.1	0.1	0.0	0.0	1.8	0.0	0.0	5.9	0.0	0.0	36.0	18.4	0.0	31.5	0.0	0.0	0.0	0.0	24.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.9	1.6	0.4	0.4	0.5	0.5	0.5	0.7	0.7	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.8	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	5.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.6	1.5	0.1	1.8	1.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	30.9	1.2	0.8	0.0	0.0	0.0	0.1	19.7	0.6	33.2	0.2	5.0	0.5	0.0	0.0	0.0	0.0	0.1	1.4
FOXD2	"FKHL17, FREAC9"	ENSG00000186564	"Forkhead box D2"	O60548	1	47438044-47440691	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.8"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 22.2;Enteroendocrine cells: 9.1;Intestinal goblet cells: 12.6;Paneth cells: 11.1;Sertoli cells: 6.6;Undifferentiated cells: 18.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 3.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AN3-CA: 14.4;WM-115: 23.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"spinal cord: 4.0"							NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (5.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.79e-12)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (5.91e-2)"	0.4	0.8	0.3	0.6	0.4	0.0	0.3	0.3	1.0	1.1	2.1	5.8	0.3	0.3	0.2	0.1	0.3	0.0	0.1	0.2	0.6	1.9	0.6	0.3	0.1	0.1	1.4	0.1	0.1	0.1	1.1	0.2	0.2	1.3	4.6	0.2	0.3	0.2	0.2	0.2	0.4	0.1	0.2	0.6	0.7	0.4	0.3	0.1	0.2	1.0	0.0	0.2	0.4	0.2	0.8	0.4	0.0	14.4	0.1	0.1	0.4	0.4	0.1	0.0	0.1	1.0	0.2	0.2	0.6	0.0	1.2	0.2	0.6	0.0	0.0	1.8	2.3	0.5	0.3	0.1	0.0	0.2	1.3	0.0	0.8	0.0	0.0	0.3	0.0	0.8	0.4	0.1	0.1	0.4	0.2	0.6	0.0	0.4	0.5	1.9	1.1	0.7	0.0	0.9	2.0	0.0	0.6	0.8	2.0	0.4	4.0	1.1	0.3	0.5	1.5	0.1	0.7	0.4	0.2	0.3	0.6	0.9	23.2	0.2	0.1	0.4	0.5	0.1	0.4	0.2	0.2	0.4	0.0	0.2	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.3	0.4	0.3	1.0	0.2	0.6	0.1	1.4	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.3	0.1	1.3	0.0	0.2	0.0	0.0	0.0	1.4	22.2	0.0	0.2	0.4	0.1	1.1	0.3	9.1	0.0	0.0	0.7	0.0	0.8	1.1	0.1	0.0	0.0	0.0	1.3	0.1	0.0	0.0	12.6	0.0	1.4	0.8	1.1	0.0	0.4	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	11.1	0.7	0.0	0.0	1.3	0.2	0.4	0.2	6.6	0.2	2.0	0.7	1.5	0.0	0.1	0.0	1.0	0.0	18.1	0.0
FOXL1	"FKH6, FKHL11, FREAC7"	ENSG00000176678	"Forkhead box L1"	Q12952	16	86576368-86583478	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Pancreatic endocrine cells: 10.4;Peritubular cells: 7.9;Sertoli cells: 6.6;Smooth muscle cells: 4.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.4;CAPAN-2: 31.9;hTEC/SVTERT24-B: 21.2;PC-3: 46.7;REH: 27.9;U-87 MG: 86.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"spinal cord: 5.0"							NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.21e-1)"	"unprognostic (3.31e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.79e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.36e-8)"	"unprognostic (1.50e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.17e-3)"	1.4	0.4	0.4	0.7	0.6	0.0	0.7	0.3	0.6	0.9	0.9	2.0	2.5	0.6	0.3	0.2	1.0	4.2	2.3	0.3	0.4	1.9	0.2	1.5	0.1	0.4	0.4	0.5	0.1	0.0	0.6	0.0	0.4	1.0	1.9	0.0	0.6	0.3	2.7	0.5	2.6	0.3	0.3	0.0	2.7	1.0	0.5	0.1	0.6	1.3	0.0	3.5	0.9	0.3	2.0	0.2	0.1	0.0	3.1	10.5	0.0	7.9	24.4	6.2	2.3	0.0	31.9	0.0	1.9	2.0	3.0	0.9	0.0	2.3	7.4	0.0	0.1	0.0	7.5	0.0	3.0	0.0	0.0	2.5	0.8	21.2	5.3	2.5	3.1	0.0	0.0	0.1	3.1	0.0	0.1	0.0	0.3	0.7	46.7	27.9	1.7	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	5.7	11.3	0.0	17.6	4.7	0.0	0.0	2.2	86.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	0.6	0.3	0.4	0.4	0.4	0.4	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	7.9	0.0	0.2	0.0	0.0	0.1	0.0	6.6	0.4	4.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.3
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.7;smooth muscle: 2.2"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.7	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 3645.4"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1595.6;Distal tubular cells: 2952.4;Ductal cells: 892.8;Proximal tubular cells: 3423.7"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"memory CD8 T-cell: 14.8;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.3;NK-cell: 9.6;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;NK-cells: 9.6;T-cells: 14.8"	"Group enriched"	"Detected in some"	25	"MOLT-4: 2255.4;RPTEC TERT1: 4711.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"spinal cord: 27.7"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	2.0	0.9	0.7	1.4	0.6	3.3	1.2	1.4	1.7	1.0	0.0	2.1	1.4	1.5	1.2	0.8	1.8	353.1	1.2	0.8	0.0	3645.4	23.8	4.4	8.9	0.0	0.1	2.4	612.6	0.2	1.6	0.8	0.0	1.7	0.8	1.1	835.6	0.7	0.3	1.0	1.6	2.2	0.0	3.1	2.8	0.6	0.0	74.8	1.0	0.6	4.5	1.8	0.9	0.4	0.0	118.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	3.5	0.0	0.2	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.2	83.6	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.9	140.3	0.0	0.0	0.2	0.3	2255.4	0.0	1.2	0.0	0.0	0.6	0.0	4.6	4711.9	0.0	1.9	0.0	0.0	2.9	0.2	0.2	0.8	0.3	0.8	0.0	1.3	0.5	0.0	1.0	0.3	0.2	0.1	0.2	0.0	0.0	1.2	0.0	1.0	0.0	1.0	0.2	1.8	14.8	0.2	0.3	5.1	4.3	0.0	9.6	0.0	3.8	1.7	2.1	0.7	0.6	1.4	1.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.0	33.6	1.1	0.1	0.8	0.6	0.2	0.1	0.5	1.2	1595.6	0.1	435.9	0.0	0.1	0.7	0.0	2952.4	892.8	21.8	1.6	4.1	2.2	15.1	2.7	0.0	10.0	0.1	3.5	0.5	41.3	0.0	0.6	4.2	3.9	3.6	0.0	0.0	0.3	16.2	4.5	4.1	25.9	9.3	24.8	0.0	0.0	8.8	0.5	1.0	0.0	0.0	23.2	0.0	7.5	0.4	0.2	0.0	3423.7	0.1	3.3	6.6	1.6	3.8	0.3	0.3	0.2	0.9	0.3	27.7	1.2	0.1	0.0
GABRA6		ENSG00000145863	"Gamma-aminobutyric acid type A receptor subunit alpha6"	Q16445	5	161547063-161702593	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	114	"brain: 71.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	14	"cerebellum: 71.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	40	"cerebellum: 1073.8"	"Region enriched"	"Detected in some"	37	"cerebellum: 262.3"	CAB022462	Approved					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022462: "																"unprognostic (3.79e-2)"		0.0	0.1	0.1	0.0	0.3	0.0	0.0	71.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	71.1	2.8	0.1	0.3	0.2	1.8	4.9	0.4	0.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAS2L3		ENSG00000139354	"Growth arrest specific 2 like 3"	Q86XJ1	12	100573683-100628288	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;monocytes: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"spinal cord: 13.8"	HPA048593	Approved					NA	Yes			"Cluster 7: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"			"HPA048593: AB_2680455"	"unprognostic (1.03e-1)"	"unprognostic (5.13e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.04e-7)"	"unprognostic (2.79e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.58e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.67e-2)"	1.8	0.8	0.1	1.6	1.4	5.6	0.8	0.1	0.7	1.2	0.5	3.3	2.7	0.7	0.4	1.6	0.3	4.8	1.5	0.5	0.1	1.3	1.0	2.5	1.3	0.5	0.5	1.1	0.5	0.2	0.2	3.5	0.5	0.3	3.8	0.4	0.5	1.1	0.8	3.4	2.7	1.6	0.3	1.4	1.4	4.0	1.4	0.9	0.6	1.2	1.2	1.6	0.5	1.1	35.4	14.0	18.6	14.8	5.7	7.3	6.2	16.2	15.3	21.3	23.8	10.4	9.5	0.6	4.8	12.8	20.8	11.8	12.0	5.9	31.0	10.0	9.1	0.0	12.2	7.0	1.9	0.0	8.0	2.9	0.6	12.8	36.1	10.1	20.2	0.0	2.2	0.0	17.7	10.4	0.0	0.2	5.9	6.5	16.7	2.4	32.5	0.8	9.2	9.6	8.4	8.1	17.0	11.7	22.2	6.5	21.3	1.9	13.6	13.6	14.3	12.2	17.8	7.4	9.3	0.0	5.3	5.6	39.3	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.1	0.1	1.4	0.1	0.7	0.5	0.1	0.5	0.5	0.5	0.3	1.4	1.1	3.6	0.0	0.0	1.0	0.2	3.4	0.4	0.5	2.8	0.2	2.0	2.2	2.0	11.5	0.2	0.0	0.0	9.9	0.4	9.8	0.0	2.7	4.5	3.6	5.5	5.6	3.6	6.9	2.5	0.7	4.5	2.2	11.2	7.4	1.3	7.2	2.5	1.4	13.9	0.0	5.9	14.2	0.0	8.0	11.1	0.5	0.6	14.7	7.2	4.7	1.5	2.2	0.0	2.5	0.3	0.3	8.2	0.7	0.3	0.6	2.6	3.4	1.0	0.1	0.0	4.8	2.7	16.0	2.3	4.7	3.7	33.9	1.0	6.8	8.3	0.6
GCG	"GLP-1, GLP1, GLP2, GRPP"	ENSG00000115263	Glucagon	P01275	2	162142882-162152404	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"pancreas: 1943.6"	"Cell type enriched"	"Detected in some"	23	"Enteroendocrine cells: 5457.0"	"Cancer enriched"	"Detected in some"	209	"pancreatic cancer: 428.4"	"Region enriched"	"Detected in single"	55	"medulla oblongata: 6.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 133.4;U-2 OS: 186.8;U-698: 44.5"	"Region enriched"	"Detected in single"	10	"pons and medulla: 3.5"	"Region enriched"	"Detected in some"	5	"spinal cord: 13.7"	"CAB000040, HPA036760, HPA036761"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	127000	420000		"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	"Endoplasmic reticulum"	Vesicles	"CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297"			"unprognostic (3.13e-3)"								"unprognostic (9.99e-2)"	"unprognostic (1.16e-2)"		"unprognostic (1.26e-2)"				20.3	0.1	0.0	3.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	84.4	3.4	0.6	0.0	5.3	0.0	4.1	2.5	0.0	0.0	41.9	0.0	0.2	3.5	6.2	0.0	0.1	1943.6	0.0	0.0	0.1	0.1	0.8	151.9	0.0	0.3	0.0	0.0	37.2	130.2	0.8	0.0	0.2	41.2	0.0	0.0	0.4	0.6	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	133.4	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	186.8	0.2	12.1	0.0	5.6	44.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.2	0.0	0.0	0.3	0.1	5457.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	91.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	230.9	8.5	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.9	0.0
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142333-96160806	"Disease related genes, Human disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease variant, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 10.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.3;Distal tubular cells: 1.9;Excitatory neurons: 1.6;Fibroblasts: 3.1;Oligodendrocyte precursor cells: 7.1;Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8;thyroid cancer: 2.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 20.4;LHCN-M2: 33.1;SuSa: 15.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 1.2"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	1.3	0.1	0.3	0.9	0.3	0.0	0.4	0.4	0.8	0.2	0.0	0.7	0.3	1.4	0.4	0.4	0.5	2.4	2.8	0.3	0.4	0.2	0.4	0.2	0.1	0.8	0.4	0.1	0.7	0.1	0.1	10.9	1.0	0.3	0.3	0.0	0.0	1.4	0.0	0.0	0.9	1.1	0.4	0.0	0.6	0.6	0.8	0.1	0.6	0.0	0.0	0.8	0.9	0.4	0.0	0.0	0.2	0.0	1.1	0.6	3.9	2.6	0.0	2.3	2.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	3.2	0.0	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	3.0	0.0	20.4	0.2	0.0	0.0	0.0	33.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.4	0.8	0.3	0.4	0.8	0.4	1.0	0.4	0.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.8	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	1.0	2.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1
GFY	Goofy	ENSG00000261949	"Golgi associated olfactory signaling regulator"	I3L273	19	49423749-49428987	"Predicted membrane proteins"	"Olfaction, Sensory transduction"			"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 1.8;SCLC-21H: 4.0;T-47d: 1.1;U-266/84: 2.7"	"Region enriched"	"Detected in single"	13	"olfactory bulb: 1.4"	"Region enriched"	"Detected in some"	6	"cerebellum: 6.6"							NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (8.04e-2)"	"unprognostic (8.21e-2)"		"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.50e-2)"		"unprognostic (8.99e-2)"		"unprognostic (8.85e-2)"				"unprognostic (1.42e-1)"	"unprognostic (1.82e-1)"		"unprognostic (9.62e-3)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.5	0.1	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GNAL		ENSG00000141404	"G protein subunit alpha L"	P38405	18	11689264-11885685	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Transducer	"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 99.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 76.9;Inhibitory neurons: 119.5;Oligodendrocyte precursor cells: 58.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 99.0"	"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.4;HeLa: 27.4;U-2 OS: 13.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"basal ganglia: 164.1"	"CAB015464, HPA051160"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"		"CAB015464: AB_831819, HPA051160: AB_2732564"	"unprognostic (2.29e-3)"	"unprognostic (7.43e-2)"	"unprognostic (8.14e-3)"	"unprognostic (3.41e-5)"	"unprognostic (4.71e-2)"	"unprognostic (9.58e-3)"	"unprognostic (9.93e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.82e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.03e-2)"	7.7	1.5	29.2	2.9	99.0	0.8	4.1	3.5	36.7	7.3	0.0	7.1	1.5	6.6	2.2	8.0	3.9	4.6	3.5	39.6	16.7	4.0	2.0	2.7	4.9	8.3	8.9	2.9	1.8	4.8	16.3	2.8	6.8	9.3	3.6	4.1	4.7	17.0	21.7	7.2	3.2	7.5	1.9	2.9	3.1	6.5	14.4	4.3	7.8	13.1	5.5	13.2	7.0	4.8	0.7	8.7	10.3	0.7	0.8	0.2	1.2	0.1	0.4	0.7	0.0	9.2	1.6	26.4	1.6	0.1	5.7	0.4	9.7	8.1	0.0	5.6	9.0	0.2	27.4	5.2	0.1	0.3	0.6	1.2	11.9	0.0	0.2	0.4	0.0	0.3	2.4	0.3	0.3	0.3	0.3	0.8	8.4	7.2	0.2	0.2	1.4	0.2	0.6	0.3	9.4	0.2	12.3	0.6	3.0	2.3	0.2	0.3	1.5	1.1	13.2	0.5	2.6	0.5	0.3	0.1	0.5	0.3	0.3	0.6	0.0	0.1	1.3	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.5	29.2	99.0	3.5	36.7	39.6	16.7	8.3	8.9	6.8	1.9	14.4	4.8	4.3	3.2	5.9	17.0	1.1	10.6	11.6	6.6	10.2	7.2	2.4	8.9	3.6	0.0	8.0	3.7	16.7	0.5	13.8	3.2	1.9	0.4	4.2	1.7	3.6	5.7	0.0	0.0	76.9	3.0	3.5	7.2	1.5	3.8	5.7	3.2	1.8	1.9	0.9	3.3	119.5	0.6	30.5	0.8	5.2	2.7	0.9	2.3	14.2	8.4	0.0	1.1	21.6	58.8	3.7	1.2	1.9	3.0	1.7	6.8	1.5	5.0	10.4	3.9	6.6	14.5	10.9	4.3	10.5	11.5	7.5	0.5	2.9	0.3	1.4	15.0
GPR151	"GALR4, PGR7"	ENSG00000173250	"G protein-coupled receptor 151"	Q8TDV0	5	146513103-146516190	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"brain: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	40	"midbrain: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	19	"thalamus: 30.6"	"Region enriched"	"Detected in single"	9	"thalamus: 4.7"	HPA065728		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA065728: "					"unprognostic (2.09e-1)"					"unprognostic (2.30e-1)"				"unprognostic (1.14e-1)"	"unprognostic (1.32e-2)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176584-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 17.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HEK 293: 5.0;SuSa: 4.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 14.4;white matter: 5.0"	"Region enriched"	"Detected in single"	10	"hypothalamus: 4.8"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"		"Plasma membrane"	Nucleoplasm	"HPA049862: AB_2680920, HPA054678: AB_2682570"						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	17.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.6	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR6		ENSG00000146360	"G protein-coupled receptor 6"	P46095	6	109978256-109980718	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 24.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	11	"basal ganglia: 91.1"	"Region enriched"	"Detected in many"	4	"basal ganglia: 29.7"							NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"								"unprognostic (1.14e-2)"						"unprognostic (1.59e-2)"				"unprognostic (7.10e-3)"			0.0	0.0	3.6	0.0	24.5	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	24.5	0.0	5.1	3.2	4.5	0.1	0.3	0.2	0.2	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR88		ENSG00000181656	"G protein-coupled receptor 88"	Q9GZN0	1	100538139-100542021	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 93.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.1;Excitatory neurons: 1.8;Hepatocytes: 2.2"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 12.0"	"Region enriched"	"Detected in many"	7	"basal ganglia: 93.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HSkMC: 1.6;SCLC-21H: 2.0"	"Region enriched"	"Detected in many"	10	"basal ganglia: 718.8"	"Region enriched"	"Detected in many"	42	"basal ganglia: 273.1"	HPA007488		Approved				NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA007488: AB_2667844"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.37e-3)"	"unprognostic (5.41e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.76e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.45e-1)"	"unprognostic (3.93e-4)"	"unprognostic (1.85e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.35e-2)"	0.4	0.3	4.8	0.3	93.9	0.0	7.2	0.1	14.4	0.1	0.1	0.9	0.3	0.1	0.0	0.1	0.1	0.0	0.2	3.1	2.6	0.1	8.9	0.1	0.1	10.1	1.4	2.6	0.0	1.0	1.1	0.0	1.0	0.3	0.3	0.3	0.4	0.0	0.2	0.0	0.4	0.1	0.9	10.5	0.2	0.1	7.5	0.2	0.1	0.2	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	93.9	0.1	14.4	3.1	2.6	10.1	1.4	1.0	0.9	7.5	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRID2	"GluD2, GluR-delta-2"	ENSG00000152208	"Glutamate ionotropic receptor delta type subunit 2"	O43424	4	92303966-93810157	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 40.2;testis: 34.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 380.6;Excitatory neurons: 787.2;Inhibitory neurons: 982.0;Late spermatids: 674.2;Microglial cells: 382.2;Oligodendrocyte precursor cells: 2319.7;Oligodendrocytes: 453.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.8"	"Region enhanced"	"Detected in all"		"cerebellum: 40.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"U-2 OS: 7.7;U-266/70: 3.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 68.3"	"HPA056253, HPA058538"	Enhanced					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA056253: AB_2683079, HPA058538: AB_2683747"	"unprognostic (2.78e-1)"			"unprognostic (1.29e-4)"	"unprognostic (7.23e-3)"			"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.38e-3)"		0.0	2.2	5.6	0.0	6.2	0.0	0.0	40.2	4.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	3.1	10.7	0.1	0.0	0.0	0.0	4.6	5.3	2.4	0.0	0.0	0.0	0.0	4.8	0.0	0.0	4.9	0.0	0.2	0.0	0.0	0.1	0.0	3.4	0.0	0.1	34.0	14.2	0.0	0.0	0.2	0.0	0.1	0.1	3.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.0	0.0	3.5	0.0	0.3	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.2	40.2	4.0	3.1	10.7	4.6	5.3	4.8	3.4	14.2	3.8	0.0	0.0	0.0	86.8	0.0	0.0	0.0	0.0	2.2	108.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	380.6	0.0	0.1	1.5	0.0	0.0	787.2	0.0	0.0	0.3	0.0	0.0	0.0	3.3	0.0	0.0	0.1	28.6	982.0	0.0	0.0	0.0	0.0	674.2	5.0	0.2	0.0	382.2	0.0	115.3	0.0	2319.7	453.5	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	7.7	6.6	0.0	1.2	3.7	2.9	0.2	0.0	0.0	0.0	6.4	0.0	0.0
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 58.7;heart muscle: 18.6;thyroid gland: 16.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 138.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.3;RPMI-8226: 2.3;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"cerebellum: 43.2"							NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	0.7	2.4	27.3	0.2	29.5	0.6	0.2	58.7	27.6	0.4	8.9	0.6	0.2	0.2	0.1	0.2	0.2	0.2	18.6	23.2	18.0	0.3	0.1	0.1	0.1	33.8	19.7	0.3	0.2	0.1	0.6	1.8	36.7	0.2	0.1	3.3	10.5	0.2	0.4	0.2	0.4	0.2	14.5	0.2	0.3	3.8	24.9	0.0	16.6	0.2	0.0	0.3	0.3	22.0	0.0	0.2	0.2	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.2	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	2.3	0.0	0.1	2.8	0.2	1.2	0.1	0.4	0.4	0.4	0.0	0.1	0.2	1.1	0.2	0.1	0.6	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.3	29.5	58.7	27.6	23.2	18.0	33.8	19.7	36.7	14.5	24.9	22.0	0.5	0.0	0.0	138.7	0.0	0.1	0.1	0.0	0.0	6.9	0.2	0.0	16.6	1.5	0.2	1.8	0.0	0.2	0.7	0.0	0.0	0.1	1.1	0.7	0.4	0.4	0.0	0.0	0.4	0.2	0.2	0.9	0.0	3.4	0.0	21.5	0.7	0.1	12.5	1.7	1.3	0.4	0.0	0.6	0.3	6.5	0.0	0.5	1.8	11.2	0.1	20.7	2.1	4.5	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.4	0.0	0.9	2.8	5.8	3.4	0.0	0.0	0.7	0.6	8.5	0.1	0.1
GRIN3B	GluN3B	ENSG00000116032	"Glutamate ionotropic receptor NMDA type subunit 3B"	O60391	19	1000419-1009732	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.9;fallopian tube: 4.1"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 15.1;Respiratory ciliated cells: 18.5;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"U-266/70: 3.5"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.6"	"Region enriched"	"Detected in single"	9	"spinal cord: 4.8"							NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (7.86e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.78e-3)"	"unprognostic (9.35e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.34e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.33e-1)"	0.1	0.1	0.3	0.1	0.4	0.1	0.1	0.6	0.5	0.8	0.2	0.1	0.2	0.1	0.0	0.1	4.1	0.0	0.1	0.2	0.5	0.7	0.1	1.4	0.3	2.0	1.9	0.2	0.2	0.0	0.5	0.1	2.9	0.2	0.0	0.3	0.2	0.0	0.1	0.4	0.1	0.0	0.5	0.9	0.1	0.5	0.2	0.0	0.4	0.0	0.0	0.1	0.2	0.8	0.1	0.4	0.3	0.1	0.1	0.6	1.0	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.2	0.3	0.0	0.0	0.0	0.2	1.1	0.2	0.3	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.3	0.1	0.1	0.1	0.0	0.0	1.1	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.1	0.2	0.3	0.0	3.5	0.9	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.5	0.2	0.5	2.0	1.9	2.9	0.5	0.2	0.8	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	15.1	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.7	1.3	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.2	1.7	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	18.5	0.0	0.0	0.0	0.1	1.5	10.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
GRM4	"GPRC1D, mGlu4, MGLUR4"	ENSG00000124493	"Glutamate metabotropic receptor 4"	Q14833	6	34018643-34155622	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	93	"brain: 80.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.3;Early spermatids: 3.7;Enteroendocrine cells: 3.0;Excitatory neurons: 9.5;Inhibitory neurons: 10.8;Spermatogonia: 5.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Region enriched"	"Detected in all"	7	"cerebellum: 80.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 7.6;SCLC-21H: 18.2"	"Region enhanced"	"Detected in all"		"cerebellum: 79.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 138.8"	CAB022096	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022096: "	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.15e-11)"	"unprognostic (5.32e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.07e-1)"	0.0	0.2	3.1	0.0	10.7	0.0	0.0	80.3	5.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	2.6	3.5	0.1	0.7	0.0	0.5	0.0	5.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.1	1.1	0.0	0.0	0.8	6.5	0.0	0.0	0.0	0.1	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	10.7	80.3	5.2	2.2	1.7	2.6	3.5	5.0	1.1	6.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	5.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	0.4	0.1	0.2	3.0	0.0	9.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	10.8	1.1	0.0	0.3	0.3	2.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.0	0.1	0.9	5.0	0.0	0.0	0.1	0.4	0.0	0.3	0.1
HCRT	"OX, PPOX"	ENSG00000161610	"Hypocretin neuropeptide precursor"	O43612	17	42184060-42185452	"Disease related genes, Human disease related genes, Predicted secreted proteins"		Neuropeptide	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1067	"brain: 384.8"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 1.8;Enteroendocrine cells: 3.0;Kupffer cells: 1.6;Oligodendrocyte precursor cells: 2.0;Proximal enterocytes: 1.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Region enriched"	"Detected in many"	7	"hypothalamus: 384.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"hypothalamus: 93.5"	"Region enriched"	"Detected in some"	21	"hypothalamus: 25.3"	"HPA064801, CAB079778"	Enhanced	Supported			"Secreted to blood"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 58: T-cells - T-cell receptor"			"CAB079778: , HPA064801: "			"unprognostic (3.34e-2)"		"unprognostic (7.76e-5)"					"unprognostic (3.21e-2)"	"unprognostic (3.01e-2)"		"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"			0.1	0.0	1.8	0.1	1.9	0.1	0.0	0.6	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	384.8	0.0	0.0	0.0	0.0	0.6	3.1	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	52.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.1	0.5	0.3	0.2	0.3	0.1	0.6	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.0	1.8	1.9	0.6	1.2	0.5	384.8	0.6	3.1	1.7	0.3	52.6	0.6	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	1.8	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.5	0.1	0.1	3.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.7	0.2	0.6	0.0	0.4	0.8	0.0	1.6	1.0	0.2	0.0	0.3	0.0	1.0	0.8	0.1	0.0	2.0	0.3	0.4	0.1	0.0	0.4	0.0	1.6	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.9	0.1	0.9	0.1
HENMT1	"C1orf59, FLJ30525, HEN1"	ENSG00000162639	"HEN methyltransferase 1"	Q5T8I9	1	108648290-108661526	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 72.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 58.7;Spermatocytes: 178.5;Spermatogonia: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 71.4;MOLT-4: 68.2;NB-4: 75.3;U-937: 98.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"cerebellum: 9.1"	"HPA028464, HPA028497"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Plasma membrane, Focal adhesion sites"		"HPA028464: AB_10600103, HPA028497: AB_10601552"	"unprognostic (1.82e-1)"	"prognostic favorable (2.56e-4)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (2.53e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.65e-1)"	5.4	2.9	8.6	8.0	8.9	13.3	8.0	6.8	9.2	8.5	4.9	6.5	5.0	3.9	4.7	2.7	2.3	6.5	1.8	8.9	9.6	3.4	2.0	4.7	13.5	8.0	8.1	5.2	2.1	0.9	5.3	5.6	8.9	3.7	9.5	3.0	3.0	3.4	3.2	3.8	7.6	3.6	7.8	11.1	4.7	72.0	10.6	18.7	2.2	6.2	11.3	6.2	2.0	8.6	16.9	8.5	0.7	0.0	0.7	0.5	0.1	4.0	1.5	9.4	1.5	24.7	26.0	0.0	8.9	7.5	0.0	0.1	0.0	0.2	5.9	5.5	0.0	42.4	31.7	0.0	8.1	25.4	36.4	7.8	0.5	2.1	0.0	0.0	1.9	71.4	0.0	18.5	0.4	42.8	68.2	75.3	24.0	13.5	3.7	29.3	0.0	1.5	0.0	18.0	40.1	0.0	35.3	9.8	0.1	2.4	0.0	55.7	0.5	0.0	31.4	17.5	0.1	11.2	15.0	0.1	0.0	98.6	0.3	43.3	19.7	43.2	61.8	24.0	55.6	12.6	30.0	56.4	24.6	7.1	24.7	45.1	19.6	55.6	29.8	19.5	31.2	39.9	8.6	8.9	6.8	9.2	8.9	9.6	8.0	8.1	8.9	7.8	10.6	8.6	2.4	0.0	1.1	2.3	5.4	1.7	1.4	6.6	1.2	5.2	8.1	7.1	1.8	14.3	4.0	5.5	0.0	12.8	28.0	4.0	3.9	3.0	12.2	2.2	3.6	3.0	4.9	13.9	5.2	1.3	21.5	5.2	2.6	2.4	7.0	2.9	6.1	0.5	15.8	0.0	3.7	4.0	4.1	11.7	3.3	20.1	5.0	7.5	1.8	3.7	11.2	3.6	58.7	4.0	2.7	2.8	7.4	3.0	8.0	1.2	5.5	0.8	2.8	2.4	6.6	3.0	3.5	178.5	107.7	2.9	1.6	5.2	23.0	8.5	6.1	3.3
HOXA10	"HOX1, HOX1H"	ENSG00000253293	"Homeobox A10"	P31260	7	27170592-27180261	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 76.8;skeletal muscle: 76.4"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 174.0;Enteroendocrine cells: 68.1;Paneth cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 10.7;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.7;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEK 293: 179.0;THP-1: 96.7;U-937: 100.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	190	"spinal cord: 18.9"	"CAB019384, HPA071918"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Nuclear bodies"	"CAB019384: , HPA071918: "	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.13e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.35e-2)"	13.4	6.8	0.0	6.1	0.0	4.3	6.8	0.0	0.0	40.8	0.0	32.6	0.1	76.8	9.1	0.2	8.3	0.1	0.0	0.0	0.0	13.7	0.1	0.1	2.3	0.0	0.0	0.8	0.0	0.0	0.0	13.4	0.0	26.3	13.2	0.0	0.0	15.4	76.4	6.0	7.9	44.9	0.1	0.2	0.1	0.3	0.0	5.2	0.1	0.0	0.2	20.4	17.2	0.1	20.6	4.3	0.0	59.9	29.3	28.0	0.2	40.1	27.2	18.0	16.8	6.1	17.8	0.0	10.9	31.6	0.0	22.6	15.5	0.0	13.2	9.5	179.0	21.6	15.0	0.5	0.8	9.6	31.4	17.8	0.9	1.5	0.0	0.0	27.5	6.3	0.9	0.0	13.3	0.0	0.0	63.1	0.0	16.6	18.8	1.9	4.0	0.1	34.7	9.6	46.7	0.1	13.8	0.0	0.1	6.4	0.1	96.7	0.0	0.0	16.1	21.1	0.2	0.4	0.1	0.0	0.0	100.4	0.5	10.7	0.1	0.3	2.2	0.0	0.0	0.1	0.0	0.2	1.2	0.3	0.0	0.0	0.0	13.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.5	0.0	0.0	0.0	0.2	3.7	10.0	0.0	0.6	0.0	4.4	4.6	1.6	0.0	0.0	7.3	0.0	0.5	4.5	28.8	19.6	0.0	0.0	3.1	174.0	5.4	68.1	15.5	0.0	0.0	0.4	13.3	0.0	2.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	25.0	0.0	2.5	4.7	0.0	0.0	2.0	5.4	0.0	0.5	0.0	7.2	0.0	0.0	0.0	32.1	0.4	1.3	18.1	18.8	27.1	0.0	0.0	0.0	13.3	15.7	2.3	4.6	0.5	4.1	0.5	3.1	0.0	25.5	10.1
HOXA11	"HOX1, HOX1I"	ENSG00000005073	"Homeobox A11"	P31270	7	27181157-27185232	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 44.8;endometrium 1: 96.7;smooth muscle: 41.2"	"Cell type enriched"	"Detected in some"	19	"Endometrial stromal cells: 116.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 32.5;HEK 293: 44.0;THP-1: 34.7;U-937: 43.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	36	"spinal cord: 3.5"	"HPA006770, HPA035623"	Enhanced		Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA006770: AB_2667672, HPA035623: AB_10601576"	"unprognostic (5.95e-2)"	"unprognostic (9.23e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.29e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.82e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (2.17e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.56e-1)"	3.5	0.7	0.0	1.4	0.0	0.0	0.4	0.0	0.0	44.8	0.0	23.1	0.0	96.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	10.0	0.0	14.7	3.9	0.0	0.1	9.6	7.9	1.5	0.2	41.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	17.0	10.4	0.0	4.8	0.3	0.0	13.1	15.2	11.1	0.0	26.8	32.5	18.9	13.8	0.3	1.7	0.0	6.1	23.5	0.1	3.2	16.3	0.0	14.7	1.6	44.0	5.7	11.2	0.7	0.9	12.5	1.7	6.5	0.6	0.1	0.0	0.0	14.1	1.1	0.4	0.0	2.2	0.4	0.0	9.4	0.0	4.4	13.1	0.7	0.0	0.3	9.6	8.1	5.6	0.0	6.7	0.0	2.0	3.6	1.2	34.7	0.0	0.2	12.9	3.2	1.5	0.0	0.0	0.0	0.2	43.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.1	0.3	1.1	5.9	0.0	0.8	4.0	116.8	1.3	5.3	0.0	0.0	0.0	0.1	3.6	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.8	0.2	0.2	0.0	0.0	0.0	0.9	5.8	1.2	0.1	0.0	0.0	0.0	0.6	0.1	1.1	1.3
HOXA7	"HOX1, HOX1A"	ENSG00000122592	"Homeobox A7"	P31268	7	27153716-27157936	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 29.1;Distal tubular cells: 131.0;Early spermatids: 29.4;Proximal tubular cells: 53.4;Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"medulla oblongata: 4.6;pons: 2.1;spinal cord: 8.2;white matter: 5.1"	"Immune cell enriched"	"Detected in single"	6	"NK-cell: 4.7"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 36.9;RPTEC TERT1: 45.4;SCLC-21H: 36.3"	"Region enriched"	"Detected in single"	12	"pons and medulla: 1.3"	"Region enriched"	"Detected in some"	6	"spinal cord: 21.4"	HPA074048			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear membrane"	"HPA074048: AB_2686655"	"unprognostic (5.40e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (3.30e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.15e-5)"	"unprognostic (9.08e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	8.2	17.8	0.0	5.9	0.0	0.3	9.4	0.0	0.1	4.2	0.0	13.8	0.2	5.8	17.8	2.8	15.5	0.1	0.0	0.0	0.0	20.1	0.0	2.7	2.1	4.6	0.1	0.8	0.2	0.2	0.0	0.3	2.1	4.9	8.9	0.0	0.0	6.7	16.5	12.0	8.6	3.8	8.2	1.7	3.9	2.4	0.1	2.9	0.5	0.1	0.4	7.3	5.2	5.1	13.6	4.6	0.0	14.1	0.0	0.0	0.8	4.7	8.0	9.6	11.0	7.0	5.1	9.2	12.8	3.7	0.3	9.1	36.9	0.0	5.8	0.0	23.2	0.6	4.8	0.2	0.9	0.8	0.5	7.5	0.4	1.1	12.9	0.0	18.5	15.7	0.0	0.0	3.7	2.4	0.0	2.2	0.5	9.6	1.4	4.8	8.5	0.0	45.4	9.1	36.3	0.1	25.6	0.0	0.1	2.5	0.4	3.7	1.6	0.0	8.6	26.0	4.6	0.0	0.2	0.2	0.0	17.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	4.7	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.1	2.1	8.2	0.1	5.1	11.0	0.0	0.0	0.0	0.6	9.1	7.2	0.1	12.0	0.0	18.7	29.1	0.4	0.0	0.1	12.9	0.0	1.1	1.3	10.3	131.0	0.0	29.4	0.2	2.1	5.9	16.2	5.5	0.0	0.0	3.9	5.8	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.0	12.5	0.0	0.0	1.9	7.2	0.6	0.6	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.8	0.0	1.7	5.2	2.3	53.4	0.1	0.0	0.0	10.8	16.1	27.4	4.1	8.6	12.4	0.3	1.0	1.2	16.1	5.3
HOXB7	"HOX2, HOX2C"	ENSG00000260027	"Homeobox B7"	P09629	17	48607232-48633572	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"epididymis: 135.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 86.5;Distal enterocytes: 131.3;Distal tubular cells: 148.7;Endometrial ciliated cells: 82.9;Glandular and luminal cells: 73.1;Intestinal goblet cells: 77.6;Paneth cells: 67.8;Proximal enterocytes: 140.3;Undifferentiated cells: 63.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"medulla oblongata: 5.6;spinal cord: 13.3;white matter: 7.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 81.9;OE19: 74.7;RPTEC TERT1: 66.5;SK-MEL-30: 84.3"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.7"	"Region enriched"	"Detected in some"	7	"spinal cord: 22.2"	HPA049940	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA049940: AB_2616461"	"unprognostic (6.76e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-3)"	"unprognostic (9.16e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	"prognostic favorable (2.39e-4)"	13.2	11.0	0.1	3.9	0.1	0.2	12.4	0.0	0.3	21.8	0.1	16.9	1.1	5.2	135.1	0.4	8.7	0.7	0.3	0.1	0.1	30.4	0.4	2.2	2.7	5.6	0.1	0.5	0.8	5.5	0.1	5.8	1.1	2.4	15.9	0.0	0.2	16.9	1.7	3.3	18.1	6.7	13.3	3.0	5.9	1.9	0.3	0.2	0.4	0.2	0.9	7.7	5.5	7.5	48.1	20.6	0.0	0.5	14.2	21.1	0.0	0.0	0.0	0.2	0.8	31.9	0.9	0.9	81.9	19.9	23.9	6.9	0.1	0.0	0.0	22.3	15.1	7.4	15.4	0.0	11.7	0.0	14.8	13.8	6.3	14.2	0.0	3.5	43.8	14.7	8.0	0.3	46.0	12.5	1.0	0.4	0.0	74.7	0.1	0.0	39.2	5.5	66.5	15.8	0.0	0.1	16.0	0.0	84.3	1.1	3.8	4.7	38.1	0.0	24.8	20.5	36.9	2.6	6.3	0.1	0.4	0.0	58.6	0.0	0.0	0.0	1.5	0.0	0.8	0.7	0.2	0.8	0.0	1.4	0.0	0.5	0.0	1.0	0.0	0.7	2.1	0.2	0.1	0.1	0.0	0.3	0.1	0.1	5.6	0.1	1.1	13.3	0.3	7.5	55.4	0.0	0.0	0.0	2.0	5.5	0.9	0.0	0.6	0.0	0.9	1.0	0.3	0.0	0.0	86.5	0.0	6.8	1.6	131.3	148.7	0.1	0.3	82.9	6.3	20.3	36.5	1.3	0.0	1.3	19.3	6.4	0.0	73.1	5.1	0.0	1.4	0.2	11.5	0.0	0.0	77.6	0.0	10.6	5.4	0.2	0.6	2.8	24.9	0.0	1.7	0.0	2.1	0.0	0.0	0.3	67.8	0.0	5.1	0.6	140.3	31.6	0.0	0.0	0.0	3.5	8.9	1.7	20.9	0.2	2.0	1.8	2.6	0.1	63.1	3.5
HOXB8	"HOX2, HOX2D"	ENSG00000120068	"Homeobox B8"	P17481	17	48611377-48615292	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 114.1;epididymis: 48.1;kidney: 37.6"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 88.3;Distal tubular cells: 72.4;Endometrial ciliated cells: 21.3;Enteroendocrine cells: 44.1;Glandular and luminal cells: 26.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 33.3"	"Region enhanced"	"Detected in many"		"spinal cord: 114.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 34.0;HDLM-2: 17.2;HEK 293: 36.9;LHCN-M2: 17.3;RPTEC TERT1: 35.3"	"Region enriched"	"Detected in single"	65	"pons and medulla: 6.5"	"Region enriched"	"Detected in all"	5	"spinal cord: 51.2"	HPA075905			Supported	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA075905: AB_2686767"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.07e-5)"	"unprognostic (6.63e-3)"	"unprognostic (1.40e-3)"	"unprognostic (6.00e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (1.30e-7)"	"unprognostic (1.77e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.88e-3)"	7.2	7.2	0.1	1.5	0.0	0.0	2.7	0.0	0.0	10.7	0.0	4.7	0.0	2.8	48.1	0.0	1.4	0.0	0.0	0.0	0.0	37.6	0.0	0.4	0.0	36.4	0.0	0.1	0.1	0.8	0.1	0.3	1.8	1.0	1.2	0.0	0.0	20.8	0.4	0.5	7.1	1.5	114.1	0.1	6.6	1.0	0.0	0.0	0.1	0.0	0.0	3.7	0.7	20.8	2.1	5.3	0.0	0.8	0.7	1.0	0.8	0.0	0.0	0.0	0.0	0.3	0.8	0.0	34.0	5.3	0.6	0.0	0.1	0.0	0.0	17.2	36.9	1.0	0.1	0.0	0.3	0.0	5.5	1.1	0.0	0.1	0.0	0.7	2.1	0.2	11.6	0.0	17.3	0.0	0.0	0.4	0.0	11.3	0.0	0.0	3.6	0.1	35.3	1.0	0.0	0.1	0.6	0.0	5.4	0.1	0.4	0.0	8.8	0.0	1.6	0.1	0.7	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	36.4	0.0	1.8	114.1	0.0	20.8	4.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	88.3	0.0	0.0	0.1	1.8	72.4	0.0	0.3	21.3	2.1	2.6	44.1	0.0	0.0	0.0	0.8	0.3	0.0	26.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.7	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.2	2.7	8.9	0.0	0.0	0.0	0.1	0.8	2.3	9.2	0.0	0.0	0.0	0.3	0.0	5.0	0.0
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621156-48626358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 87.9;intestine: 26.3;kidney: 22.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 58.8;Distal enterocytes: 30.4;Distal tubular cells: 39.2;Enteroendocrine cells: 176.7;Intestinal goblet cells: 40.7;Undifferentiated cells: 45.5"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 56.0;endometrial cancer: 26.4"	"Region enhanced"	"Detected in single"		"spinal cord: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 339.3;HEK 293: 126.4;HMC-1: 127.7;K-562: 145.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	69	"spinal cord: 6.8"	HPA004928			Supported	Nucleoplasm		NA	No				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"HPA004928: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	1.0	0.0	4.6	0.0	0.0	0.5	0.0	0.0	11.4	0.0	26.3	0.0	0.9	87.9	0.0	0.3	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	0.0	0.6	0.0	0.4	22.3	0.0	0.0	15.8	0.1	0.1	13.4	1.3	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.7	18.0	5.8	0.0	32.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.6	7.0	0.1	34.6	0.9	3.9	0.1	5.5	0.0	0.0	339.3	126.4	59.1	2.3	0.0	2.3	1.1	127.7	0.1	0.2	0.1	3.3	9.8	0.0	2.7	145.7	0.1	5.5	0.3	0.0	0.4	0.0	8.0	5.4	0.3	21.9	1.9	57.1	0.2	0.0	0.0	4.4	0.0	37.4	0.5	0.6	0.3	0.4	0.1	32.1	0.2	10.4	0.2	0.4	0.2	0.1	0.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.7	3.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	58.8	0.0	0.0	0.5	30.4	39.2	0.0	0.1	5.5	0.4	3.0	176.7	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.7	0.0	0.0	0.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.3	0.0	0.0	0.3	6.0	0.9	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.0	0.0	0.0	0.4	0.0	45.5	0.2
HOXC10	HOX3I	ENSG00000180818	"Homeobox C10"	Q9NYD6	12	53985065-53990279	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 113.5"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 21.2;Collecting duct cells: 16.5;Distal tubular cells: 62.6;Proximal tubular cells: 100.4;Skeletal myocytes: 22.4;Suprabasal keratinocytes: 19.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 20.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 291.5;ASC diff: 82.5;ASC TERT1: 75.6;fHDF/TERT166: 67.6;T-47d: 99.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	319	"spinal cord: 31.8"	HPA053919	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear bodies"	Nucleoplasm	"HPA053919: AB_2682308"	"unprognostic (1.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.56e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.98e-1)"		"unprognostic (1.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.60e-3)"	"unprognostic (3.96e-2)"	"unprognostic (7.37e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.91e-1)"	13.1	1.1	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.7	0.0	0.2	0.0	1.5	0.0	0.1	8.8	0.0	0.0	0.0	0.0	22.5	0.0	0.0	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.5	113.5	16.4	2.1	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.1	0.7	3.3	0.0	291.5	82.5	75.6	0.5	10.1	24.4	13.6	12.6	0.6	0.9	0.5	2.7	67.6	1.9	31.4	4.1	0.0	6.5	15.2	5.6	3.0	36.2	0.0	0.4	0.0	3.7	36.0	0.5	1.0	0.0	0.0	0.1	8.5	2.3	0.0	9.4	1.8	0.1	7.5	0.1	36.4	1.1	0.0	0.4	0.0	30.6	0.0	0.0	3.9	6.9	10.0	15.7	0.4	99.4	2.2	0.0	8.0	10.2	0.2	13.3	1.3	0.2	0.1	0.1	1.7	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.0	21.2	0.0	0.0	0.0	0.0	4.8	7.9	0.3	0.0	0.0	16.5	0.0	0.0	0.1	0.0	62.6	0.0	0.2	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.2	0.4	0.6	0.9	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	100.4	0.0	0.0	0.0	22.4	5.2	3.6	4.4	0.0	19.2	0.1	0.4	0.0	0.0	0.0
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 1.8;skin 1: 5.0"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 7.5;Distal tubular cells: 1.9;Melanocytes: 3.6;Proximal enterocytes: 3.7;Spermatocytes: 3.5;Suprabasal keratinocytes: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 34.7;BJ hTERT+: 17.5;HaCaT: 15.4;HeLa: 12.4;T-47d: 27.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 1.3"	HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.6	1.8	5.0	1.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	9.3	1.1	0.0	34.7	3.2	4.9	0.0	5.1	17.5	7.4	5.3	0.3	1.3	0.0	0.3	4.8	0.0	15.4	6.6	0.0	3.3	1.0	0.1	0.2	12.4	0.0	0.0	0.1	0.1	0.9	1.4	0.0	0.4	0.0	0.0	0.3	1.5	0.0	4.8	2.2	0.0	0.1	0.0	10.1	0.1	0.0	0.6	0.0	0.7	1.2	0.0	0.2	3.2	7.8	3.1	0.3	27.4	0.0	0.0	0.0	5.8	0.4	0.3	0.0	0.0	0.0	0.0	0.6	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.7	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.9	0.0	0.0	0.0	1.0	1.0	3.5	0.9	0.0	3.8	0.0	0.1	0.0	0.2	0.0
HOXC6	"HOX3, HOX3C"	ENSG00000197757	"Homeobox C6"	P09630	12	53990624-54030823	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 27.1;ovary: 26.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 17.6;Fibroblasts: 14.0;Granulosa cells: 13.2;Leydig cells: 22.4;Peritubular cells: 15.1;Skeletal myocytes: 13.5;Spermatocytes: 34.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"medulla oblongata: 4.1;pons: 4.3;spinal cord: 3.1;white matter: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 94.4;fHDF/TERT166: 47.9;HDLM-2: 80.6"	"Region enriched"	"Detected in single"	14	"pons and medulla: 1.4"	"Region enriched"	"Detected in single"	32	"spinal cord: 9.7"	HPA054981			Supported	Nucleoplasm,Cytosol		No	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA054981: AB_2682662"	"unprognostic (3.54e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.68e-6)"	"unprognostic (3.92e-2)"	"unprognostic (1.10e-3)"	"unprognostic (5.01e-4)"	"unprognostic (5.52e-3)"	"unprognostic (3.32e-3)"	"unprognostic (2.81e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (8.63e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.71e-2)"	18.9	14.8	0.0	1.1	0.0	0.0	13.4	0.0	0.1	1.1	0.0	1.0	0.3	5.3	19.3	2.9	27.1	0.1	0.6	0.0	0.1	17.8	0.0	0.7	4.3	4.1	0.2	26.2	0.4	0.3	0.0	5.7	4.3	1.3	0.2	0.5	0.2	0.5	17.3	13.3	11.4	8.8	3.1	0.2	0.7	3.5	0.1	0.1	1.0	0.0	0.0	1.3	1.5	1.5	6.6	4.5	0.0	94.4	34.1	32.0	1.0	4.9	4.7	7.9	7.1	4.1	7.4	3.0	6.3	47.9	2.3	10.7	3.8	0.5	6.7	80.6	27.3	5.2	14.6	0.0	3.8	0.5	12.0	30.7	5.0	15.7	5.6	0.0	0.3	0.3	3.5	0.0	27.4	1.5	0.0	3.3	0.0	0.8	4.1	0.0	3.6	0.0	24.1	0.2	0.0	11.8	7.3	7.0	21.7	8.2	16.6	1.3	0.0	9.7	21.1	10.7	7.0	0.7	0.9	0.2	3.7	0.8	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.1	0.2	4.3	3.1	0.1	1.5	3.9	0.0	0.0	0.0	0.3	6.2	0.0	0.0	9.1	0.0	3.2	5.8	0.6	0.0	0.0	3.7	0.0	0.4	0.2	0.0	17.6	0.0	1.6	0.0	0.6	1.1	0.0	0.0	0.0	0.0	3.0	14.0	0.0	0.0	0.0	13.2	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	1.8	1.0	22.4	0.4	12.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	15.1	0.1	0.0	0.8	9.6	0.0	2.1	6.6	13.5	11.8	34.0	2.7	5.1	4.0	0.3	0.4	7.4	0.2	0.0
HOXC8	"HOX3, HOX3A"	ENSG00000037965	"Homeobox C8"	P31273	12	54008985-54012769	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 15.4;skeletal muscle: 16.8"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 12.2;Granulosa cells: 11.0;Melanocytes: 10.6;Peritubular cells: 7.9;Proximal tubular cells: 7.4;Skeletal myocytes: 17.9;Smooth muscle cells: 7.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 41.6;ASC TERT1: 27.6;fHDF/TERT166: 49.8;HSkMC: 33.2;LHCN-M2: 38.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"spinal cord: 10.5"	"HPA028911, CAB037020"	Uncertain		Supported	Nucleoplasm,Microtubules		NA	NA				"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Nucleoplasm	Microtubules	"CAB037020: AB_1840935, HPA028911: AB_10602236"	"unprognostic (1.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (6.26e-6)"	"unprognostic (4.89e-2)"	"unprognostic (5.20e-4)"	"unprognostic (5.34e-3)"		"unprognostic (2.43e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.47e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.14e-2)"	5.2	5.2	0.0	0.7	0.0	0.0	5.6	0.0	0.0	0.4	0.0	0.4	0.0	0.4	15.4	0.2	7.9	0.0	0.0	0.0	0.0	4.9	0.0	0.1	1.8	0.1	0.0	4.5	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.3	0.0	0.1	16.8	3.1	5.7	7.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.0	1.0	2.7	0.0	15.0	41.6	27.6	0.2	2.8	0.1	4.9	3.1	4.4	2.4	0.0	0.3	49.8	0.8	2.0	3.9	1.2	5.4	5.3	5.3	0.9	2.1	0.0	4.9	0.0	5.8	33.2	3.9	15.7	9.0	0.5	0.4	0.8	0.6	0.0	38.7	1.2	0.0	0.4	0.0	0.3	0.7	0.0	0.0	0.0	6.1	0.0	0.0	2.0	5.4	1.0	13.8	3.6	1.6	0.0	0.0	1.0	8.0	6.8	1.7	0.1	0.0	0.0	0.9	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	4.6	0.1	0.0	1.2	0.0	1.5	2.9	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.2	1.9	0.0	0.1	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.2	12.2	0.0	0.0	0.0	11.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.2	6.2	0.2	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.3	7.4	0.0	1.3	6.6	17.9	7.6	5.6	3.1	0.2	4.3	0.3	0.3	3.2	0.1	0.1
HOXC9	"HOX3, HOX3B"	ENSG00000180806	"Homeobox C9"	P31274	12	53994895-54003337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 11.0;skeletal muscle: 25.9"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 41.1;Fibroblasts: 20.1;Granulosa cells: 26.7;Melanocytes: 39.2;Proximal tubular cells: 22.0;Skeletal myocytes: 28.3;Smooth muscle cells: 19.6;Spermatogonia: 21.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.5;HDLM-2: 28.4;HEK 293: 33.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"spinal cord: 7.7"	"HPA063965, HPA072160"			Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA063965: AB_2685162, HPA072160: AB_2686491"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.23e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.53e-1)"	11.0	1.7	0.0	0.3	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.3	0.0	1.0	1.3	0.4	8.1	0.0	0.0	0.0	0.0	9.8	0.0	0.1	1.0	0.0	0.0	2.7	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	25.9	7.8	6.2	0.7	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.5	0.5	0.0	0.8	3.3	0.0	21.5	8.5	7.0	1.5	2.3	2.0	2.8	1.8	0.9	3.3	0.0	1.7	8.8	0.5	3.9	0.5	2.3	2.4	28.4	33.7	0.7	5.9	0.9	0.9	0.1	5.1	7.9	3.6	4.2	1.9	0.0	2.7	0.1	7.1	0.0	5.8	2.5	0.0	2.0	0.0	1.7	0.3	0.4	4.1	0.0	6.5	2.1	0.0	6.2	7.9	4.1	9.5	0.5	6.5	0.3	0.0	5.1	9.0	1.5	2.7	0.0	0.0	0.0	0.1	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	9.6	0.0	0.0	1.8	0.0	6.5	7.9	0.5	0.0	0.0	1.8	0.0	0.3	0.2	0.0	41.1	0.0	3.7	0.1	0.2	2.1	0.0	0.0	0.0	0.4	11.5	20.1	0.0	0.0	0.0	26.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.9	4.1	4.7	0.5	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.9	0.0	0.1	0.6	22.0	0.0	0.0	6.6	28.3	19.6	9.3	21.2	0.7	9.5	0.4	0.5	7.2	0.1	0.0
HOXD10	"HOX4, HOX4D"	ENSG00000128710	"Homeobox D10"	P28358	2	176108790-176119937	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.6;endometrium 1: 35.9;vagina: 25.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.0;Collecting duct cells: 14.7;Distal enterocytes: 10.6;Distal tubular cells: 15.6;Endometrial stromal cells: 25.3;Endothelial cells: 13.5;Enteroendocrine cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HEK 293: 40.3;RPTEC TERT1: 32.3;SCLC-21H: 11.8;SiHa: 18.4;U-251 MG: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	66	"spinal cord: 6.6"	HPA065871			Approved	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		No	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"HPA065871: AB_2685573"	"unprognostic (4.29e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-5)"	"unprognostic (1.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.92e-6)"	"unprognostic (2.15e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.27e-1)"	2.0	0.1	0.0	0.5	0.0	0.0	2.6	0.0	0.0	20.6	0.0	18.7	0.0	35.9	0.5	0.5	4.1	0.1	0.0	0.0	0.0	19.9	0.0	0.1	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	16.8	5.8	0.0	0.1	6.7	0.1	1.5	0.1	18.1	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.2	2.2	25.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.2	6.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.1	12.0	0.0	0.0	0.5	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.9	0.0	32.3	0.0	11.8	3.1	18.4	0.0	0.1	2.2	0.0	0.0	2.7	0.0	2.1	1.0	14.4	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.0	0.0	0.0	0.0	0.0	0.9	6.2	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	14.7	0.0	0.0	0.1	10.6	15.6	0.0	0.0	1.2	25.3	13.5	24.1	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.8	0.2	1.8	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.5	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	1.1	0.0	0.2	0.0	4.4	2.9
HOXD11	"HOX4, HOX4F"	ENSG00000128713	"Homeobox D11"	P31277	2	176104216-176109754	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 7.1;intestine: 3.8;kidney: 4.7;prostate: 3.3;vagina: 4.3"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 26.7;Collecting duct cells: 22.0;Distal enterocytes: 22.8;Endometrial stromal cells: 29.0;Enteroendocrine cells: 20.6;Urothelial cells: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 21.9;RPTEC TERT1: 2.6;SCLC-21H: 6.1;U-251 MG: 4.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	40	"spinal cord: 3.9"	HPA055155			Supported	Nucleoplasm		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA055155: AB_2682719"	"unprognostic (1.99e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.48e-1)"		"unprognostic (1.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (6.73e-2)"		"unprognostic (5.00e-2)"	"unprognostic (2.11e-8)"	"unprognostic (2.09e-3)"	"unprognostic (2.49e-2)"		"unprognostic (2.27e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	0.0	3.8	0.0	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.9	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	1.4	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	6.1	0.3	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.4	26.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.0	0.0	0.1	0.0	22.8	9.8	0.0	0.0	1.1	29.0	1.7	20.6	0.0	0.0	0.0	0.1	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	8.6	0.0	0.0	1.2	0.2	0.9	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	1.2	0.0	8.8	0.0	0.3	0.0	0.0	0.0	0.1	2.3	0.1	0.4	0.0	0.9	0.0	0.1	0.0	9.2	14.0
HOXD8	"HOX4, HOX4E"	ENSG00000175879	"Homeobox D8"	P13378	2	176129694-176132695	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 99.6;kidney: 76.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.8;Collecting duct cells: 60.7;Distal tubular cells: 213.2;Early spermatids: 124.6;Leydig cells: 51.3;Peritubular cells: 53.8;Spermatocytes: 82.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"medulla oblongata: 1.5;spinal cord: 4.0;white matter: 5.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 45.4;RPTEC TERT1: 74.8;TIME: 32.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	70	"spinal cord: 34.6"							NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.22e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.80e-2)"	16.4	20.6	0.0	4.8	0.0	0.0	18.8	0.0	0.0	13.3	0.0	10.8	1.2	19.5	99.6	2.7	17.2	3.1	0.9	0.0	0.0	76.2	0.3	0.9	4.9	1.5	0.0	34.2	1.4	1.1	0.0	0.7	0.8	6.0	4.9	0.0	1.7	24.0	7.8	4.8	8.6	13.1	4.0	10.5	1.6	20.1	0.0	1.0	3.5	1.5	1.3	6.5	9.2	5.8	13.7	2.1	0.0	0.0	8.8	14.1	0.3	1.7	7.2	2.2	0.2	0.1	0.1	0.0	16.7	10.8	1.7	0.1	4.7	0.5	5.4	0.0	6.4	2.3	0.8	0.0	2.9	1.3	0.8	24.7	45.4	0.3	6.7	0.0	22.9	4.4	0.2	0.1	3.7	0.1	0.1	0.4	0.2	0.0	2.6	0.0	4.9	0.2	74.8	9.6	14.2	26.4	4.3	0.0	28.4	1.2	0.0	0.1	32.5	1.1	8.9	15.4	9.1	0.0	0.0	0.0	21.1	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	4.0	0.0	5.8	51.8	0.0	1.1	0.0	0.5	2.7	2.1	0.0	0.6	0.0	0.7	0.6	2.3	0.0	0.0	60.7	0.0	0.0	0.2	2.7	213.2	0.0	124.6	0.7	9.4	36.4	4.8	0.0	0.0	0.0	0.0	14.9	0.0	0.3	0.0	0.0	2.5	0.0	0.1	0.0	0.0	1.8	0.0	0.0	3.4	29.9	51.3	0.5	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	53.8	0.0	1.3	0.5	25.1	0.7	0.0	32.9	14.1	9.8	82.1	20.4	0.2	2.8	0.1	1.0	31.9	3.4	1.1
HOXD9	"HOX4, HOX4C"	ENSG00000128709	"Homeobox D9"	P28356	2	176122719-176124937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 42.2;endometrium 1: 57.8;kidney: 52.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.4;Collecting duct cells: 23.9;Distal tubular cells: 37.2;Endothelial cells: 39.2;Leydig cells: 34.2;Peritubular cells: 26.7;Sertoli cells: 39.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.3;HEK 293: 16.1;RPTEC TERT1: 19.0;SH-SY5Y: 21.7;SK-MEL-30: 13.2;TIME: 16.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	80	"spinal cord: 8.0"	HPA068683			Supported	Nucleoplasm,Nucleoli		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nucleoli"		"HPA068683: AB_2686018"	"unprognostic (1.89e-1)"	"unprognostic (9.41e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (9.58e-4)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (6.62e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-3)"	"unprognostic (6.71e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.38e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.44e-2)"	11.6	6.4	0.0	1.3	0.0	0.0	13.9	0.0	0.0	42.2	0.0	29.3	0.1	57.8	14.8	3.5	16.1	0.9	0.2	0.0	0.0	52.1	0.1	0.7	2.4	0.5	0.0	11.1	0.3	0.3	0.0	0.5	0.1	32.3	2.9	0.0	1.2	8.0	1.6	5.8	3.0	15.2	0.5	2.4	0.5	5.6	0.1	0.5	1.4	0.2	0.8	6.1	35.3	0.8	0.1	0.0	0.0	0.0	0.5	0.4	0.2	1.6	1.1	1.3	1.1	0.0	0.0	0.0	11.3	1.6	0.8	7.6	0.1	0.0	0.9	0.0	16.1	0.0	0.8	0.0	0.1	0.0	0.0	3.6	0.6	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.0	19.0	7.1	4.3	21.7	5.5	0.0	13.2	1.1	0.0	0.0	16.9	0.0	3.6	5.3	6.0	0.0	0.0	0.0	1.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.1	0.8	38.4	0.0	0.0	0.0	0.4	2.4	1.9	0.0	0.0	0.0	0.8	0.5	0.7	0.0	0.0	23.9	0.0	0.0	1.0	8.5	37.2	0.0	0.2	0.8	10.9	39.2	7.8	0.0	0.0	0.0	0.2	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	3.0	1.3	34.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	26.7	0.0	1.1	0.0	3.0	0.0	0.0	39.5	1.9	3.3	2.2	1.4	0.1	1.8	0.0	1.1	13.9	3.8	0.8
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Basal respiratory cells: 580.8;Fibroblasts: 1360.5;Leydig cells: 1030.8;Peritubular cells: 1495.9;Sertoli cells: 1170.1;Smooth muscle cells: 420.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 145.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 31.6;non-classical monocyte: 20.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 1163.6;BJ: 476.9;BJ hTERT+: 683.3;fHDF/TERT166: 1045.9;hTERT-RPE1: 468.5;U-87 MG: 631.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 120.2"	"HPA008005, HPA075088"	Uncertain				"Secreted to blood"	NA	NA	199000000	300000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA008005: AB_1851499, HPA075088: "	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	145.8	90.2	28.1	9.2	32.6	0.4	150.5	31.8	40.8	276.6	71.6	75.5	20.8	117.2	129.5	75.8	237.4	36.8	107.0	28.4	33.1	30.6	7.7	40.4	8.7	32.7	29.2	136.8	15.9	4.8	106.3	15.7	33.2	129.3	28.0	6.6	35.9	122.2	38.5	39.2	52.5	39.0	36.7	45.2	67.6	22.2	41.7	6.8	58.4	102.2	9.2	127.1	214.1	27.2	135.3	219.6	0.2	177.3	313.9	1163.6	0.8	476.9	683.3	126.9	69.0	23.2	294.7	0.0	68.5	1045.9	96.4	453.3	3.0	42.3	26.2	1.2	2.8	4.4	37.1	33.3	111.9	0.8	1.1	325.5	2.3	57.4	11.9	468.5	30.5	7.5	0.6	9.3	53.1	0.5	6.6	1.0	6.8	4.1	150.4	2.3	4.9	5.6	10.1	3.3	1.3	8.7	152.2	0.0	10.9	4.0	6.3	0.5	132.2	87.2	41.2	95.5	18.0	5.3	10.7	0.6	631.6	6.7	49.5	0.0	0.0	31.6	0.6	6.8	3.4	0.1	1.0	5.4	2.1	0.0	0.5	6.8	0.0	0.0	20.1	0.0	0.0	1.5	28.1	32.6	31.8	40.8	28.4	33.1	32.7	29.2	33.2	36.7	41.7	27.2	83.9	6.4	4.2	2.0	3.4	113.6	41.0	580.8	23.9	2.5	5.9	29.0	21.1	10.0	37.6	20.2	0.0	3.0	3.5	0.2	11.7	87.9	9.6	4.9	99.2	71.9	0.0	3.2	3.1	8.0	4.9	1360.5	30.5	2.5	0.0	2.3	116.4	0.8	7.6	0.0	3.6	0.3	50.8	6.8	122.8	32.6	1030.8	15.2	144.1	19.7	2.5	51.1	0.0	1.5	0.9	77.1	0.0	1495.9	9.6	94.9	0.0	15.2	13.9	2.8	1170.1	102.3	420.9	3.8	6.8	8.0	87.8	3.4	14.1	0.4	0.0	34.1
IL15RA	"CD215, IL-15RA"	ENSG00000134470	"Interleukin 15 receptor subunit alpha"	Q13261	10	5943639-5978187	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 39.1;Exocrine glandular cells: 55.2;Fibroblasts: 37.6;Hepatic stellate cells: 36.0;monocytes: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 70.8;EFO-21: 41.3;HDLM-2: 78.5;HHSteC: 42.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	8	"cerebellum: 7.1"	CAB026215	Approved				"Secreted to blood"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"CAB026215: "	"unprognostic (2.86e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.87e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavorable (2.67e-6)"	"unprognostic (5.09e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.18e-3)"	"prognostic unfavorable (1.27e-12)"	"unprognostic (4.43e-2)"	"unprognostic (4.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.75e-2)"	19.3	7.5	3.3	20.4	3.7	11.7	18.3	3.0	4.6	21.5	3.6	12.3	16.2	15.0	4.6	11.5	18.8	23.2	17.8	2.8	4.4	14.1	19.5	44.5	21.3	5.7	3.9	3.7	11.5	2.2	4.6	16.1	4.6	10.4	10.9	0.3	8.0	5.3	7.1	11.2	15.7	12.1	4.8	15.1	16.3	3.2	4.6	5.7	12.1	10.2	11.6	25.7	12.7	3.5	16.8	2.4	0.0	0.7	21.5	4.9	4.3	8.6	18.4	10.7	11.4	0.3	70.8	1.9	41.3	16.0	6.0	15.6	2.0	12.1	2.4	78.5	3.5	2.0	4.9	1.2	42.7	0.9	0.6	4.1	4.2	6.0	0.2	4.4	29.1	1.3	20.5	23.5	0.3	9.3	3.6	8.9	0.4	6.7	6.8	10.0	0.0	13.4	2.8	1.3	0.1	0.1	12.9	1.4	0.6	0.2	6.1	8.0	10.8	0.5	1.3	30.1	11.2	20.5	6.2	0.4	4.9	12.4	0.7	10.2	26.0	6.6	18.9	32.8	29.1	10.8	14.7	19.7	7.1	6.4	6.1	11.0	7.5	11.5	21.0	0.1	17.7	12.8	3.3	3.7	3.0	4.6	2.8	4.4	5.7	3.9	4.6	4.8	4.6	3.5	25.2	6.4	5.0	1.3	6.0	5.7	5.7	9.9	4.6	0.0	4.4	3.0	5.8	22.8	3.3	0.0	0.0	0.6	4.2	5.8	0.0	39.1	1.7	5.1	23.0	21.0	5.4	19.8	3.3	55.2	1.6	37.6	9.7	6.7	3.8	0.1	36.0	8.7	6.6	0.0	0.9	6.8	2.0	14.7	5.5	2.1	5.0	7.3	3.6	12.2	55.0	0.0	4.1	1.0	0.3	35.5	13.3	0.7	22.2	20.1	9.3	0.1	3.4	0.0	0.0	7.1	6.4	0.2	0.4	4.6	6.5	0.1	7.8	0.0	9.3	6.8
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 135.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 57.3"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1"	"Group enriched"	"Detected in all"	11	"cerebellum: 54.5;hippocampal formation: 27.0"	"Region enriched"	"Detected in many"	12	"cerebellum: 48.8"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	208000	7300	"Cluster 5: Granulocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	18.9	6.3	3.5	63.3	3.0	62.1	15.5	57.3	4.1	9.6	13.8	14.4	11.3	9.9	7.7	7.4	17.8	16.2	5.9	2.9	5.7	3.2	9.7	23.7	132.6	5.9	5.7	6.1	2.6	2.3	2.1	9.0	10.5	5.8	16.8	0.5	11.2	4.5	3.3	12.0	39.9	9.8	5.8	86.2	15.6	4.2	5.2	130.4	6.9	8.5	135.3	18.9	10.4	7.6	0.0	0.0	0.0	0.1	17.5	7.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	27.7	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	29.4	0.0	0.0	0.9	21.0	50.6	0.9	0.0	0.1	0.6	0.0	0.4	3.5	3.2	10.7	0.1	0.0	1.7	22.2	0.0	0.1	0.0	0.1	0.1	51.0	0.0	0.2	0.1	0.1	0.1	0.0	9.9	0.0	0.0	4.6	0.2	0.3	0.2	1.0	0.0	60.3	5.5	25.8	1.8	35.1	1.5	252.8	116.2	321.3	164.5	142.7	185.9	166.0	170.6	180.6	150.9	157.2	224.9	185.6	282.5	213.2	149.1	113.7	197.0	338.0	3.5	3.0	57.3	4.1	2.9	5.7	5.9	5.7	10.5	5.8	5.2	7.6	9.4	3.2	6.6	0.0	135.3	8.2	0.2	0.8	1.2	0.2	0.8	1.4	2.7	8.6	1.9	1.8	0.0	0.3	78.1	0.3	0.0	0.1	1.4	3.1	6.6	7.5	0.0	20.2	3.4	0.2	0.3	15.9	1.1	0.7	27.1	0.0	26.7	9.2	19.0	0.0	4.9	0.3	0.0	59.2	94.4	1.4	10.8	33.1	28.4	18.7	30.2	0.3	121.5	0.0	0.3	0.0	1.2	18.0	55.6	0.1	0.1	0.4	7.7	0.7	6.6	1.1	3.2	2.1	7.5	1.2	3.7	0.4	76.3	0.2	0.7	0.2
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161221	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism"	Hormone	"Cancer-related genes, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	135	"pancreas: 12983.6"	"Cell type enriched"	"Detected in some"	21	"Pancreatic endocrine cells: 1475.2"	"Cancer enriched"	"Detected in single"	7165	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"EFO-21: 268.3;U-2 OS: 376.2;U-698: 132.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"midbrain: 1.3"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"	NA	NA	437000			"Cluster 25: Pancreas - Digestion"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"			"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							19.2	4.0	0.1	0.2	0.1	49.8	0.6	0.0	0.0	0.7	0.0	12.8	1.5	1.4	0.0	1.8	0.3	3.7	5.6	0.1	0.1	40.7	1.4	1.7	5.4	0.2	0.4	2.6	12983.6	0.0	0.3	1.4	0.8	0.5	0.0	0.0	3.1	0.0	0.3	96.4	0.7	0.0	0.0	1.4	42.2	0.3	0.0	0.0	1.3	0.0	0.0	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	268.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	376.2	0.0	31.8	0.0	15.9	132.4	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	67.2	0.0	0.0	0.0	0.0	1475.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ISL2	FLJ10160	ENSG00000159556	"ISL LIM homeobox 2"	Q96A47	15	76336773-76342475	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 2.6;prostate: 2.3;vagina: 3.5"	"Cell type enriched"	"Detected in some"	7	"Cone photoreceptor cells: 27.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 15.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"spinal cord: 1.8"	HPA075192			Approved	"Rods & Rings"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Rods & Rings"		"HPA075192: AB_2686738"	"unprognostic (7.30e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.01e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.84e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.55e-15)"	"unprognostic (1.78e-1)"	"unprognostic (4.19e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.26e-1)"	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.8	0.0	1.9	0.8	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.8	0.2	0.0	0.0	0.0	2.6	0.0	0.2	2.3	0.0	1.4	1.8	0.0	0.0	0.6	1.2	0.0	0.0	0.5	1.6	0.8	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.8	1.5	1.8	0.0	1.7	0.1	0.1	1.5	4.5	2.1	1.2	1.5	3.4	0.7	3.3	2.1	0.0	1.1	1.9	6.4	0.1	0.2	3.2	15.4	1.6	4.0	4.1	1.4	3.6	4.3	0.0	0.8	0.0	0.0	0.0	0.0	4.8	5.1	2.6	0.3	0.1	4.4	8.4	0.0	0.6	2.8	2.7	2.0	4.4	0.0	0.6	4.9	5.0	3.0	0.0	0.0	0.9	0.3	8.2	0.0	1.5	3.2	0.6	4.3	3.8	4.1	2.0	1.1	2.5	0.0	0.0	0.8	0.0	0.1	0.9	0.0	0.8	0.0	0.5	0.1	1.7	0.1	0.0	9.5	0.0	3.5	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.8	0.2	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.6	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	27.1	0.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	3.5	0.6	0.0	0.0	0.0	2.1	0.0	0.2	0.5	1.5	1.0	0.0	0.0	0.3	0.2	0.0	0.0	3.0
ISLR	HsT17563	ENSG00000129009	"Immunoglobulin superfamily containing leucine rich repeat"	O14498	15	74173710-74176872	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 118.0"	"Region enriched"	"Detected in all"	5	"spinal cord: 124.7"	"HPA040326, HPA050811"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"	NA	NA		130000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus"	"HPA040326: AB_2676928, HPA050811: AB_2681243"	"unprognostic (2.58e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.16e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.89e-8)"	"unprognostic (1.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.28e-1)"	"unprognostic (9.86e-3)"	89.3	17.5	4.4	5.5	11.8	0.0	66.9	1.7	10.4	216.2	5.4	75.1	5.7	181.4	18.9	17.1	78.7	38.6	63.3	4.6	5.2	20.9	8.2	37.7	9.9	2.8	3.2	170.9	10.1	2.1	44.6	10.2	2.8	51.4	5.2	0.3	33.6	22.9	18.5	46.7	31.3	26.3	2.3	33.0	32.5	14.9	4.5	3.3	63.4	19.7	5.3	63.5	111.9	5.0	0.0	1.5	0.1	0.0	62.7	33.5	0.2	10.2	0.1	0.0	0.0	0.0	4.0	0.0	0.6	148.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	25.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.5	5.8	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	0.4	7.6	0.1	0.1	1.1	0.0	0.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	11.8	1.7	10.4	4.6	5.2	2.8	3.2	2.8	2.3	4.5	5.0	10.3	0.0	1.3	0.7	0.1	11.7	0.1	0.2	0.0	0.1	4.8	3.9	3.9	1.5	0.7	0.0	0.0	1.3	0.8	0.0	0.0	0.2	2.4	7.2	193.5	14.0	0.0	0.0	1.9	0.2	1.4	154.5	2.0	4.2	0.0	0.0	7.5	0.0	3.8	0.0	0.2	0.0	0.0	0.0	16.2	6.1	214.9	2.6	12.4	34.7	0.0	0.2	0.0	0.5	0.7	0.8	0.0	159.9	0.0	0.1	0.0	0.1	1.5	0.5	26.3	7.0	49.8	0.7	0.7	1.3	8.8	1.0	2.6	7.0	0.0	0.2
ITGA4	CD49D	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181538940	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 47.1;lymphoid tissue: 74.1"	"Group enriched"	"Detected in many"	4	"B-cells: 86.3;dendritic cells: 151.5;Erythroid cells: 169.3;Macrophages: 72.0;monocytes: 73.8;NK-cells: 126.7;Plasma cells: 141.6;T-cells: 129.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 164.0;HEL: 308.1;JURKAT: 142.3;MOLT-4: 373.6"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 12.9"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"		"HPA074961: AB_2732273"	"unprognostic (5.31e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.76e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.08e-5)"	"unprognostic (2.26e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.57e-2)"	3.3	2.3	1.2	31.5	0.5	47.1	3.8	4.1	1.5	12.7	3.0	8.7	8.7	3.3	1.4	2.3	1.5	9.8	1.5	4.1	1.3	2.7	5.7	12.7	37.2	1.4	1.6	1.4	1.5	0.9	0.4	14.7	2.9	3.5	10.3	8.6	2.9	2.5	0.6	1.2	11.7	5.2	0.9	45.5	10.4	0.8	2.4	74.1	2.0	0.9	26.1	9.5	1.4	1.3	0.3	1.3	4.6	0.1	38.9	55.0	0.0	42.3	46.7	19.5	42.0	0.0	0.0	32.4	0.2	164.0	17.4	23.4	14.0	0.7	22.3	0.0	3.4	308.1	1.1	0.0	4.0	123.4	6.8	39.2	0.0	1.2	0.0	20.5	2.3	142.3	0.1	45.5	12.7	0.0	373.6	117.9	3.7	0.0	0.2	78.1	20.3	5.1	0.0	0.0	8.2	2.6	0.1	0.4	1.4	1.6	0.0	82.9	23.2	6.5	4.1	0.7	8.5	90.9	77.5	18.6	3.7	59.5	90.3	29.5	55.0	137.4	42.0	131.3	32.1	37.3	46.9	52.4	66.0	33.0	26.5	33.1	7.1	32.2	139.6	17.5	13.4	65.2	1.2	0.5	4.1	1.5	4.1	1.3	1.4	1.6	2.9	0.9	2.4	1.3	2.8	0.0	6.7	0.0	86.3	0.3	0.2	1.2	0.0	2.3	1.1	1.4	1.2	2.8	1.8	0.0	6.2	0.1	151.5	0.1	0.0	0.0	0.0	4.4	6.5	1.4	0.0	169.3	9.4	0.0	0.3	6.3	7.1	6.4	18.9	0.3	1.8	0.2	5.9	0.0	0.5	0.1	0.0	24.5	4.4	0.0	0.6	72.0	0.0	7.5	73.8	0.2	126.7	15.6	0.3	0.0	0.4	0.0	141.6	0.3	0.0	0.2	0.8	6.4	0.0	0.7	8.3	0.7	1.2	0.3	0.6	0.4	129.9	0.4	0.2	0.2
ITGBL1	"OSCP, TIED"	ENSG00000198542	"Integrin subunit beta like 1"	O95965	13	101452593-101720856	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 76.1;Skeletal myocytes: 93.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 208.3;ASC TERT1: 138.7;fHDF/TERT166: 345.3;LHCN-M2: 311.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"spinal cord: 56.9"						"Secreted - unknown location"	NA	NA		37000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.70e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.13e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.70e-4)"	16.9	9.2	1.8	0.7	1.8	0.1	18.0	2.6	2.3	23.8	2.5	1.5	0.5	2.0	0.5	9.7	4.9	38.3	18.3	1.9	3.6	2.7	7.7	25.4	1.3	3.9	2.3	5.3	7.9	5.6	10.3	33.4	4.3	4.0	2.5	0.1	11.7	4.4	4.5	13.2	0.5	4.1	3.5	4.0	7.2	2.5	2.2	0.9	8.4	14.9	4.3	17.8	10.0	6.5	4.2	0.3	0.0	0.0	208.3	138.7	0.0	65.8	67.7	29.3	18.7	0.0	2.4	0.0	0.3	345.3	13.9	70.9	0.0	24.1	46.0	0.0	0.0	21.3	0.6	0.0	21.7	0.0	0.0	59.3	1.5	16.8	46.6	55.3	76.8	0.0	1.5	0.7	311.8	0.0	0.0	0.0	0.0	0.0	24.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	8.8	24.0	33.2	27.3	0.1	8.3	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	2.6	2.3	1.9	3.6	3.9	2.3	4.3	3.5	2.2	6.5	1.9	3.2	0.5	5.5	0.1	4.0	0.1	1.3	0.6	1.8	4.2	19.0	0.5	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.5	4.5	0.5	7.7	1.2	0.0	0.0	3.6	0.2	0.8	76.1	5.6	1.1	0.0	0.0	8.6	0.5	0.7	5.0	6.7	0.0	0.0	0.0	4.7	2.1	0.0	0.8	5.4	13.1	0.0	0.5	0.0	2.0	5.0	1.1	0.0	8.2	0.6	0.2	0.0	0.1	0.0	0.7	0.0	93.0	4.8	11.6	8.4	0.7	2.4	0.8	0.4	1.2	0.0	0.2
JAML	"AMICA, AMICA1, Gm638"	ENSG00000160593	"Junction adhesion molecule like"	Q86YT9	11	118193725-118225094	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.3;lymphoid tissue: 68.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 136.9;Kupffer cells: 125.8;Macrophages: 166.6;monocytes: 204.7;T-cells: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 3529.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 1017.6;granulocytes: 3529.6;monocytes: 1023.8"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 28.0"					"Region enriched"	"Detected in many"	11	"cerebellum: 58.0"	"HPA005854, HPA047919"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA005854: , HPA047919: AB_2680209"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-3)"	"unprognostic (2.87e-3)"	"prognostic favorable (3.11e-4)"	"unprognostic (2.80e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.08e-1)"	"unprognostic (6.43e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.58e-2)"	13.9	4.5	0.9	68.7	1.0	20.9	5.6	2.4	2.1	5.6	2.3	16.8	17.8	3.5	1.5	8.5	4.3	20.4	3.2	0.7	0.9	3.4	9.8	43.3	31.1	1.3	0.9	1.8	2.9	1.0	1.6	7.8	1.0	4.4	22.7	0.3	2.9	3.6	1.2	4.6	32.1	15.3	1.0	60.0	9.4	1.5	1.0	24.3	2.9	7.8	31.6	24.9	3.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.9	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.0	0.0	0.0	28.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.3	3.1	0.4	3.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.2	0.0	137.4	1023.8	3529.6	60.1	616.5	386.5	7.1	107.4	113.7	1017.6	2.9	124.7	103.1	2121.1	24.3	310.3	765.1	191.3	844.1	0.9	1.0	2.4	2.1	0.7	0.9	1.3	0.9	1.0	1.0	1.0	1.1	1.2	6.4	34.2	0.0	6.9	0.0	0.2	0.0	0.0	0.3	0.9	1.3	0.0	2.8	5.6	1.8	0.0	0.3	136.9	0.9	0.0	0.1	1.0	0.4	0.2	1.3	0.0	5.0	0.0	0.4	0.4	1.8	2.6	0.6	15.2	0.0	5.7	2.8	31.0	0.0	0.0	0.2	0.0	125.8	0.0	1.1	0.0	166.6	0.0	0.0	204.7	0.0	9.2	0.0	0.0	0.1	0.1	0.0	6.3	0.1	0.6	0.8	2.2	0.2	0.0	0.4	0.5	2.2	5.9	0.2	0.0	0.4	56.0	0.0	0.1	0.2
KANK3	"ANKRD47, FLJ46061"	ENSG00000186994	"KN motif and ankyrin repeat domains 3"	Q6NY19	19	8322584-8343262	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 196.2;Endothelial cells: 83.8;Hepatic stellate cells: 55.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 7.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"NK-cells: 1.2;T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.1;TIME: 14.8;U-266/70: 5.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"olfactory bulb: 16.2"	HPA051153	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA051153: AB_2681365"	"unprognostic (1.56e-1)"	"unprognostic (1.63e-4)"	"unprognostic (1.54e-2)"	"unprognostic (8.95e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.84e-3)"	"unprognostic (1.82e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.77e-1)"	"prognostic favorable (1.69e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.24e-1)"	25.6	7.6	12.0	2.3	9.7	0.6	26.1	9.6	12.2	8.2	5.8	6.2	2.9	10.2	0.7	5.1	11.2	2.5	32.9	8.7	8.9	22.2	4.2	33.4	2.8	12.5	11.5	3.6	3.9	1.5	6.9	14.6	11.5	7.6	0.5	0.3	4.1	1.8	13.7	6.7	7.3	2.4	9.7	35.5	6.2	2.4	13.2	0.7	15.5	6.0	0.8	7.9	6.8	8.9	0.1	0.6	0.2	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.7	0.2	0.0	2.3	0.0	0.0	0.1	0.5	2.6	0.0	0.7	1.4	0.3	0.3	0.4	0.1	0.2	1.3	0.0	0.8	0.0	0.0	0.0	8.1	0.6	0.0	0.3	0.0	0.4	0.0	0.4	0.5	0.5	0.2	1.4	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	0.5	0.0	14.8	0.0	1.3	0.3	0.1	5.9	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	1.0	0.0	0.5	0.1	0.5	0.1	0.0	0.1	0.2	0.4	0.2	1.2	0.0	0.0	0.4	0.2	12.0	9.7	9.6	12.2	8.7	8.9	12.5	11.5	11.5	9.7	13.2	8.9	196.2	6.4	3.2	2.0	0.3	2.5	0.4	0.6	0.6	0.3	1.5	2.5	2.2	0.0	0.8	0.0	4.2	0.4	3.8	0.1	5.9	0.1	6.6	0.5	0.7	83.8	0.0	2.7	0.6	1.8	0.3	6.4	1.5	0.8	0.0	0.2	55.3	1.0	0.5	0.0	0.9	0.0	0.0	1.3	2.1	8.1	0.6	0.9	5.4	18.7	0.0	0.4	12.3	0.5	1.6	0.6	0.1	0.4	0.4	1.0	0.0	0.4	0.7	0.7	19.7	8.3	12.9	6.5	3.6	1.1	1.3	0.3	2.8	4.0	0.1	0.8
KBTBD12	"FLJ46299, KLHDC6"	ENSG00000187715	"Kelch repeat and BTB domain containing 12"	Q3ZCT8	3	127915232-127987671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 13.8;skeletal muscle: 58.8;tongue: 25.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 43.4;Early spermatids: 32.0;Excitatory neurons: 29.9;Microglial cells: 74.0"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 5.1"							NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (3.60e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.51e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.70e-2)"	"unprognostic (9.49e-2)"	0.3	0.2	1.3	0.3	1.5	0.2	0.2	1.6	1.6	0.2	2.7	1.8	0.8	0.3	0.1	0.7	0.9	0.7	13.8	1.6	0.6	1.2	0.0	0.2	0.1	0.7	0.7	0.1	4.0	0.0	0.5	0.1	0.7	0.5	1.2	0.7	1.9	0.2	58.8	0.3	0.7	0.7	0.5	0.0	2.0	1.0	0.7	0.0	0.0	25.8	0.0	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	1.5	1.6	1.6	1.6	0.6	0.7	0.7	0.7	0.5	0.7	1.2	0.0	3.2	3.7	43.4	0.0	0.1	0.1	0.0	0.0	1.0	0.4	0.1	12.1	0.0	1.4	1.8	6.2	0.0	0.1	2.3	1.9	0.1	32.0	1.3	0.0	0.2	2.4	1.7	29.9	9.3	0.0	0.7	7.1	0.8	0.0	0.1	0.0	0.0	0.1	1.7	15.7	5.8	0.0	0.0	1.0	3.2	0.0	0.3	0.0	74.0	0.0	1.6	0.0	3.0	2.2	5.9	5.8	0.0	0.1	0.0	1.4	0.0	1.2	0.9	0.0	1.6	1.0	6.2	5.7	0.0	0.3	0.0	0.0	0.1	1.9	0.1
KCNG2	"KCNF2, Kv6.2"	ENSG00000178342	"Potassium voltage-gated channel modifier subfamily G member 2"	Q9UJ96	18	79863668-79900184	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 19.2;Horizontal cells: 114.4;Inhibitory neurons: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hippocampal formation: 10.3"	HPA048628	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 62: Horizontal cells - Visual perception"			"HPA048628: AB_2680466"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.78e-1)"	"unprognostic (3.61e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.18e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.63e-2)"	0.1	0.0	0.9	0.0	1.2	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.7	0.3	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.2	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.2	0.0	2.7	3.2	1.7	0.1	1.5	0.1	0.8	0.6	0.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.5	0.0	0.0	0.0	0.0	6.9	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	19.2	0.0	8.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	114.4	31.3	0.1	0.0	1.5	0.0	0.0	0.3	0.8	0.0	6.5	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.1	0.0	1.2	0.6	0.0	0.9	0.0	0.0	0.0	1.2	2.1	0.0	0.0	6.3	0.0	0.1	0.2	0.0
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745865-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Collecting duct cells: 9.2;Exocrine glandular cells: 7.0;Granulosa cells: 6.3;Leydig cells: 6.5;Prostatic glandular cells: 5.6;Urothelial cells: 7.4"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 47.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"MCF7: 48.9"	"Region enriched"	"Detected in single"	18	"olfactory bulb: 6.8"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 3.9"	HPA064861	Uncertain					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA064861: AB_2685373"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.38e-4)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.11e-1)"	4.0	2.1	0.3	0.2	0.5	0.0	3.0	0.1	0.4	3.2	0.2	0.5	0.2	2.3	0.2	0.7	5.2	1.0	1.7	0.1	0.9	2.0	0.3	2.0	0.0	0.2	0.3	2.2	1.6	0.1	3.5	0.1	0.1	1.6	0.0	0.2	1.7	1.3	0.4	1.4	0.6	1.1	0.1	0.1	2.8	3.3	0.2	0.0	2.7	0.2	0.0	1.0	1.5	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.4	0.3	0.1	0.1	0.3	0.0	0.0	0.8	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.4	0.0	1.4	0.6	4.6	0.0	0.5	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.1	0.9	0.2	0.3	0.1	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.1	0.5	1.9	0.0	0.6	0.1	1.6	1.0	0.7	15.7	0.4	9.2	0.0	0.0	0.0	0.3	0.0	3.9	0.2	1.7	2.3	2.5	1.2	0.0	1.0	7.0	0.0	3.9	1.1	1.6	0.0	6.3	1.4	0.3	0.1	0.0	0.5	0.4	0.0	0.0	0.3	0.3	6.5	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	1.5	0.3	0.4	0.0	5.6	0.0	0.2	0.1	0.1	0.0	0.5	0.6	0.2	0.4	1.4	0.9	0.0	0.1	0.3	1.0	7.4
KCTD17	FLJ12242	ENSG00000100379	"Potassium channel tetramerization domain containing 17"	Q8N5Z5	22	37051736-37063390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Ubl conjugation pathway"		"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 113.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 90.8"	HPA018459	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 65: Brain - Ion transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA018459: AB_1852169"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.09e-3)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (4.22e-5)"	"unprognostic (8.62e-2)"	"prognostic unfavorable (5.13e-12)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.94e-2)"	8.2	15.6	64.8	9.8	113.7	2.4	6.7	46.0	71.6	14.2	44.4	15.9	3.4	14.9	1.8	7.2	10.7	8.5	26.6	68.0	54.1	5.8	3.5	9.3	10.6	44.8	70.4	13.7	3.7	7.8	43.0	6.5	52.4	11.2	5.2	3.6	3.4	9.0	1.7	21.1	10.4	9.4	43.8	11.1	7.9	46.0	83.8	7.0	7.6	3.0	6.9	16.9	13.0	55.5	15.9	20.5	31.7	23.7	14.9	14.8	1.2	16.2	15.6	25.9	22.3	4.4	4.6	12.2	10.9	20.8	20.3	4.2	10.0	19.0	10.9	23.8	26.8	5.2	5.6	4.9	22.1	0.0	6.1	17.3	9.2	26.6	5.8	17.5	33.6	15.9	1.2	13.2	16.5	12.8	11.0	0.3	20.3	9.4	17.4	19.8	8.4	3.6	6.7	4.1	26.4	32.9	15.0	14.1	7.5	6.6	3.8	4.2	19.6	33.5	31.2	16.0	12.0	17.7	5.5	2.0	29.6	7.3	18.6	0.0	0.8	0.0	0.9	1.0	0.9	1.2	0.6	0.9	0.9	0.4	0.8	0.6	0.0	1.6	0.4	0.2	1.0	0.4	64.8	113.7	46.0	71.6	68.0	54.1	44.8	70.4	52.4	43.8	83.8	55.5	8.8	0.0	0.5	11.1	5.8	1.5	4.6	2.8	1.2	17.3	1.3	1.5	5.0	4.3	0.8	5.5	2.1	0.4	5.0	17.7	0.0	11.9	24.9	0.7	12.7	9.7	13.1	0.8	22.4	6.1	2.8	9.9	4.1	0.9	4.5	12.0	12.8	0.5	9.2	13.5	11.6	5.3	0.0	9.6	17.0	28.1	10.5	9.8	3.6	1.9	13.0	16.4	8.2	4.5	7.1	3.2	16.0	9.1	4.6	1.2	0.5	2.5	1.5	7.8	0.0	7.8	11.7	19.7	7.1	1.3	4.8	7.5	8.5	10.2	7.0	2.4
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586895	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 6940.5"	"Group enriched"	"Detected in many"	9	"Basal keratinocytes: 35588.3;Suprabasal keratinocytes: 11677.1"	"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 5910.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 4065.2;HBEC3-KT: 2003.9;hTCEpi: 2448.6;hTERT-HME1: 794.2;U-2197: 696.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	7	"spinal cord: 36.3"	"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		1600000000		"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Intermediate filaments"		"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favorable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	15.8	1.2	0.0	0.0	0.0	2.7	332.7	0.0	0.0	412.0	0.0	1.7	0.0	0.9	0.0	1304.2	1.7	0.0	3.5	0.0	0.0	0.8	2.5	1.7	0.0	0.0	0.0	1.3	2.9	0.0	4.3	2.2	0.1	29.1	0.0	0.0	702.1	3.8	15.9	6940.5	2.1	0.1	0.0	0.9	1.7	1.5	0.0	186.7	2.3	0.0	262.3	0.7	846.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.7	0.0	4065.2	0.0	2003.9	0.2	0.0	0.0	0.1	1.6	0.0	0.1	0.2	2.5	0.1	2448.6	3.0	794.2	0.0	0.1	0.0	0.5	3.6	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.6	0.2	0.6	0.0	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.4	0.0	0.3	9.1	1.7	696.0	0.0	0.9	0.0	0.0	3.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.5	35588.3	1072.7	181.5	2407.4	0.0	103.5	740.9	0.3	0.0	6.0	0.0	0.0	17.9	3.2	7.3	0.0	0.1	0.0	0.1	0.0	129.0	0.0	0.0	0.0	0.0	127.0	116.5	0.0	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.4	0.0	0.0	1833.4	0.0	0.0	9.3	1990.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	3.5	0.0	9.9	702.0	96.8	0.0	2.3	0.0	0.0	0.0	96.3	0.0	0.1	83.2	11677.1	2.5	62.1	0.1	2.3	100.0
KRT27	KRT25C	ENSG00000171446	"Keratin 27"	Q7Z3Y8	17	40776808-40782550	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	45	"skin 1: 71.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Endothelial cells: 1.5;Hepatic stellate cells: 2.2;Melanocytes: 8.8;Muller glia cells: 3.0;Spermatogonia: 2.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9;thyroid cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"EFO-21: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"hippocampal formation: 80.6"	HPA055114	Enhanced					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA055114: AB_2682700"		"unprognostic (1.13e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.18e-1)"	"unprognostic (5.75e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.08e-2)"		"unprognostic (8.41e-2)"		"unprognostic (4.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.64e-3)"	1.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	8.8	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	2.3	0.0	0.4	0.3	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520530	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 5865.0;skin 1: 5885.4;vagina: 2150.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 5870.1;Basal prostatic cells: 1037.6;Basal squamous epithelial cells: 1571.3;Squamous epithelial cells: 4370.9;Suprabasal keratinocytes: 2020.2"	"Group enriched"	"Detected in many"	4	"cervical cancer: 1863.2;head and neck cancer: 3340.4"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	326	"plasmacytoid DC: 32.6"	"Lineage enriched"	"Detected in single"	326	"dendritic cells: 32.6"	"Group enriched"	"Detected in some"	7	"HaCaT: 3368.0;HBEC3-KT: 5990.5;hTCEpi: 13326.8"					"Region enriched"	"Detected in many"	8	"spinal cord: 36.4"	"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"		NA	NA		3600000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034"	"prognostic favorable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	10.0	1.7	0.2	1.8	0.8	4.6	252.5	0.7	0.5	826.2	58.9	1.9	0.0	2.0	97.2	5865.0	12.5	2.0	3.8	1.7	0.0	1.3	3.5	6.4	3.0	0.1	0.0	2.2	4.7	0.1	8.2	2.0	0.1	125.8	0.0	0.0	880.3	100.0	9.9	5885.4	1.8	0.6	0.1	1.7	5.0	2.1	0.6	527.1	3.0	0.3	648.6	93.2	2150.9	0.4	50.6	0.0	0.0	0.0	2.3	0.2	0.8	0.0	0.0	0.0	0.0	1.0	0.3	2.4	0.5	0.2	0.0	3368.0	0.2	5990.5	0.2	0.0	0.0	0.2	0.1	0.0	0.6	1.4	2.8	0.3	13326.8	0.6	1049.7	0.0	0.8	0.0	1.8	4.0	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.2	1.0	1.2	0.8	0.9	0.0	0.1	1.2	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.5	0.2	10.1	1.0	0.9	4.0	1.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.1	0.2	0.8	0.7	0.5	1.7	0.0	0.1	0.0	0.1	0.1	0.6	0.4	1.7	0.0	1.1	0.0	0.4	5870.1	1037.6	627.1	1571.3	0.0	43.6	226.2	0.5	0.0	180.7	0.0	0.0	0.0	39.8	0.0	0.0	0.5	0.8	31.3	1.2	26.4	0.0	0.0	0.5	0.0	0.0	29.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	273.6	0.1	0.6	7.3	286.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	22.2	789.7	0.0	0.1	34.8	0.0	0.0	0.2	33.4	0.0	0.0	4370.9	2020.2	0.0	17.8	0.0	0.1	459.8
KRT8	"CARD2, CK8, CYK8, K2C8, K8, KO"	ENSG00000170421	"Keratin 8"	P05787	12	52897187-52949954	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1335.5;stomach 1: 800.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 4302.8;Ductal cells: 6037.3;Exocrine glandular cells: 5457.6;Extravillous trophoblasts: 5323.4;Pancreatic endocrine cells: 5278.1;Paneth cells: 4937.3;Proximal enterocytes: 6802.6;Syncytiotrophoblasts: 5268.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 6130.6;BEWO: 3998.7;CACO-2: 7686.4;CAPAN-2: 4774.8;MCF7: 10521.8;SK-BR-3: 5126.4;T-47d: 4325.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	10	"spinal cord: 44.0"	"CAB000131, CAB001696, HPA049866"	Enhanced		Supported	"Intermediate filaments"		NA	NA		1700000000	"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Intermediate filaments"		"CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923"	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (8.99e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.19e-2)"	135.0	43.6	2.2	158.6	1.3	1.0	113.8	2.0	1.6	183.4	21.3	1079.2	1112.0	34.7	66.4	48.2	134.3	217.5	147.8	1.9	1.9	240.2	463.9	172.5	7.9	8.3	4.5	10.3	654.1	59.9	278.7	368.7	8.8	151.6	564.2	0.4	318.0	73.6	1.5	49.3	1335.5	50.6	0.4	16.3	800.1	7.6	4.9	47.6	237.5	0.3	13.8	209.0	36.7	1.7	2787.7	6130.6	0.2	7.8	0.7	3.2	3998.7	11.1	47.9	6.1	6.3	7686.4	4774.8	1.1	1130.2	14.7	6.9	947.1	17.6	752.6	5.9	4.6	130.8	4.3	1184.4	2234.2	212.8	1.2	2.4	9.5	12.6	14.8	50.8	419.9	17.0	1.0	484.7	1.7	0.1	10521.8	6.5	10.6	418.5	2740.6	132.8	3.8	2.2	15.2	1198.1	1354.5	129.9	5.0	1063.2	5126.4	7.8	1263.8	4325.7	10.5	18.8	5.7	443.4	9.3	10.0	1.6	7.0	7.6	3.3	1.7	13.4	1.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0.4	0.5	0.1	1.7	0.1	0.2	2.2	1.3	2.0	1.6	1.9	1.9	8.3	4.5	8.8	0.4	4.9	1.7	7.7	400.6	176.5	0.3	26.9	6.0	1948.0	684.7	303.3	2.3	521.6	342.8	30.2	1069.5	734.8	491.1	0.0	2208.2	8.5	4302.8	297.4	6037.3	13.9	419.2	41.0	42.3	942.5	8.6	0.5	5457.6	5323.4	94.7	1740.1	557.1	76.3	88.0	24.3	310.9	252.2	1.7	0.5	2876.3	1625.5	9.9	7.2	69.9	8.1	22.2	131.6	0.0	55.0	3.4	1.0	1.0	0.3	5278.1	4937.3	1.9	6.6	994.7	6802.6	569.1	594.8	4.3	0.0	2.2	167.4	2.0	11.4	258.9	1.7	5268.8	33.4	13.4	2337.3	1542.5
LEMD1	"CT50, LEMP-1"	ENSG00000186007	"LEM domain containing 1"	Q68G75	1	205381378-205455954	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"epididymis: 14.8;testis: 55.1"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4203.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 2.6;medulla oblongata: 2.4;midbrain: 1.2;pons: 2.8;thalamus: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 39.6"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"cerebellum: 3.9"	HPA045425			Approved	Nucleoli,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA045425: AB_10960538"	"unprognostic (1.78e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.20e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.48e-1)"		"unprognostic (2.72e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (1.26e-4)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.31e-1)"	"unprognostic (5.66e-6)"	"unprognostic (2.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-2)"	0.1	0.3	0.2	0.0	0.2	0.0	0.3	2.6	0.4	0.3	0.0	0.0	0.6	0.3	14.8	0.8	1.6	0.1	0.0	0.1	0.4	1.0	0.0	0.4	0.0	2.4	1.2	0.6	0.0	0.0	0.5	0.1	2.8	0.2	0.0	1.4	1.9	0.4	0.0	0.4	0.2	0.1	0.4	0.0	0.9	55.1	2.2	0.0	0.6	0.0	0.7	0.1	0.5	0.3	4.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	39.6	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	2.4	1.3	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	2.6	0.4	0.1	0.4	2.4	1.2	2.8	0.4	2.2	0.3	0.0	0.0	2.6	1.0	0.0	0.0	1.2	8.4	4.6	12.1	1.6	0.9	0.0	0.0	6.4	0.0	4.2	0.1	0.0	0.0	0.0	1.9	968.7	0.8	0.1	0.7	0.0	0.0	1.4	0.7	0.1	0.2	0.0	1.1	0.0	0.6	1.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	4203.7	12.8	1.1	0.0	0.0	0.0	1.3	0.0	1.0	0.5	6.8	0.1	13.9	0.0	8.5	0.3	4.3	1.6	0.7	6.6	0.0	0.4	15.6	9.7	0.7	0.0	0.4	0.1	0.1	0.3	4.4
LETM2	"FLJ25409, SLC55A2"	ENSG00000165046	"Leucine zipper and EF-hand containing transmembrane protein 2"	Q2VYF4	8	38386207-38409527	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 23.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.9;Late spermatids: 57.6;Pancreatic endocrine cells: 48.6;Spermatocytes: 54.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 21.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 21.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.2;hTERT-HME1: 26.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 24.0"	HPA025032	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		Yes	No			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA025032: AB_1852808"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.27e-4)"	"unprognostic (3.20e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.27e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.25e-2)"	1.2	1.0	3.4	1.1	3.6	5.3	0.7	5.7	4.9	1.6	2.9	0.7	0.8	1.4	1.1	1.1	1.4	1.2	0.8	3.2	2.8	2.3	0.7	2.0	1.3	2.3	2.9	2.1	0.7	1.6	1.3	1.8	3.1	1.1	0.8	4.2	0.4	0.8	0.2	1.1	0.5	0.6	2.0	1.6	2.7	23.8	2.6	2.4	1.0	0.3	1.4	1.9	0.6	4.2	21.2	4.5	3.0	2.9	2.3	7.0	2.5	7.5	9.2	10.6	6.2	1.5	8.3	2.8	16.5	1.5	3.1	2.2	5.9	25.2	11.7	1.2	2.9	3.2	2.3	4.2	2.7	0.7	2.8	1.7	7.2	11.7	26.9	5.9	10.7	3.4	2.6	3.9	9.3	4.2	7.5	1.8	0.8	1.6	18.2	2.9	4.8	1.6	16.8	1.1	2.4	2.3	2.5	0.4	0.9	1.8	2.4	1.2	20.0	3.3	22.5	7.4	1.7	2.6	1.6	2.0	5.6	3.3	2.5	1.3	4.1	0.7	0.9	1.6	2.0	1.5	0.9	1.5	1.7	1.8	1.7	1.7	21.5	1.4	5.0	0.7	5.2	1.3	3.4	3.6	5.7	4.9	3.2	2.8	2.3	2.9	3.1	2.0	2.6	4.2	3.0	3.2	6.4	2.3	10.3	0.5	13.9	7.6	6.8	6.6	2.1	3.3	1.8	4.3	3.2	5.5	6.2	2.6	10.1	1.4	1.9	4.0	76.9	21.8	7.1	4.2	0.0	0.8	3.6	20.5	7.9	5.0	16.8	20.5	9.5	1.1	1.4	0.0	1.4	6.7	7.3	1.9	2.0	2.2	2.3	57.6	2.1	3.6	1.8	1.0	2.0	3.6	1.0	1.5	1.6	48.6	0.1	1.5	4.5	2.9	0.3	3.0	4.9	8.4	0.0	4.5	3.3	54.8	3.3	2.5	0.9	8.1	9.1	1.5	1.3	4.5
LHFPL1		ENSG00000182508	"LHFPL tetraspan subfamily member 1"	Q86WI0	X	112630648-112680054	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.2;salivary gland: 2.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Inhibitory neurons: 1.1;Ionocytes: 2.0;Microglial cells: 1.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 2.6;SuSa: 3.8"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"olfactory bulb: 3.3"	HPA003029	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA003029: AB_1079248"	"unprognostic (2.23e-2)"	"unprognostic (2.78e-3)"		"unprognostic (2.49e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.41e-3)"	"unprognostic (5.19e-5)"	"unprognostic (1.33e-1)"	"unprognostic (7.63e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.92e-1)"	0.0	0.1	4.1	0.1	5.3	0.0	0.6	0.5	2.5	0.4	0.0	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.7	2.2	6.1	0.1	0.0	0.0	0.1	1.2	11.2	0.3	0.0	0.1	1.3	0.1	4.6	0.3	0.1	0.1	2.9	0.8	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	7.3	0.9	0.5	0.7	0.1	0.1	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.6	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.6	3.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	4.1	5.3	0.5	2.5	2.2	6.1	1.2	11.2	4.6	0.1	7.3	0.8	0.0	0.0	0.0	4.6	0.0	0.0	0.4	0.4	0.0	0.0	0.4	0.4	0.9	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.0	0.1
LHX1	"LIM-1, LIM1"	ENSG00000273706	"LIM homeobox 1"	P48742	17	36936785-36944612	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	12	"kidney: 10.7"	"Cell type enriched"	"Detected in some"	8	"Horizontal cells: 361.7"	"Group enriched"	"Detected in some"	4	"ovarian cancer: 8.1;testis cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 3.8;HMC-1: 1.6;WM-115: 7.0"	"Region enhanced"	"Detected in many"		"cerebellum: 19.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 15.7"	"HPA044307, HPA073521, HPA074382"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nuclear membrane, Golgi apparatus"	"HPA044307: , HPA073521: AB_2732226, HPA074382: "	"unprognostic (3.86e-5)"	"unprognostic (1.64e-1)"		"prognostic unfavorable (3.63e-5)"	"unprognostic (3.85e-2)"	"unprognostic (1.06e-4)"		"unprognostic (2.67e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.20e-3)"		"unprognostic (1.74e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.62e-2)"		"unprognostic (3.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	10.7	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.5	0.2	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	42.3	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	361.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	13.0	0.0	1.6	0.0	0.0	0.2	1.1	2.3	0.0	0.0	0.4	0.3	0.0	0.2	0.0
LHX8	Lhx7	ENSG00000162624	"LIM homeobox 8"	Q68G74	1	75128434-75161533	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.2;salivary gland: 2.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 1.2;Late spermatids: 1.4;Spermatocytes: 3.3;Spermatogonia: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 6.2;hypothalamus: 6.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 25.6;U-266/70: 8.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 9.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 9.7"	HPA071806			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA071806: AB_2686449"	"unprognostic (2.28e-2)"					"unprognostic (6.23e-2)"		"unprognostic (3.85e-3)"					"unprognostic (1.52e-9)"		"unprognostic (1.64e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-2)"	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.2	1.3	1.7	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.3	0.0	0.0	8.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	6.2	0.0	6.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LINGO4	LRRN6D	ENSG00000213171	"Leucine rich repeat and Ig domain containing 4"	Q6UY18	1	151800264-151805419	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 21.3;tongue: 5.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebellum: 1.8;hypothalamus: 1.0;midbrain: 2.7;pons and medulla: 4.0;thalamus: 1.4"	"Region enriched"	"Detected in many"	7	"spinal cord: 19.7"	HPA060781	Uncertain		Uncertain	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 80: Striated muscle - Unknown function"		"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA060781: AB_2684361"	"unprognostic (2.71e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-5)"	"unprognostic (1.14e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.94e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.94e-4)"	"unprognostic (3.84e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (5.60e-2)"	0.0	2.0	0.1	0.1	0.1	0.0	0.1	4.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.7	0.1	0.7	0.3	0.5	0.3	1.1	0.2	0.2	2.8	1.6	0.0	0.4	0.5	1.4	0.0	3.9	0.7	0.1	0.1	0.6	0.2	21.3	0.6	0.2	0.0	1.3	0.1	0.4	0.6	1.6	1.2	0.6	5.6	0.2	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.2	0.3	0.5	2.8	1.6	3.9	1.3	1.6	2.1	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111494	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 739.0;placenta: 535.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 966.4;Fibroblasts: 2136.1;Leydig cells: 401.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebral cortex: 5.6"	"Immune cell enriched"	"Detected in single"	122	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.1"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 1991.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	9	"spinal cord: 149.2"	"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"	NA	NA		29000000000	"Cluster 38: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	161.5	133.5	0.6	68.1	0.7	0.3	153.2	0.6	5.6	199.8	4.2	85.0	56.1	301.0	88.3	75.7	59.2	739.0	183.8	0.7	0.9	85.0	34.6	211.4	41.3	0.9	0.8	92.9	72.9	26.3	5.3	535.9	0.8	115.2	133.0	5.7	14.3	67.4	9.6	20.0	90.6	354.5	0.7	4.8	47.1	17.5	1.3	13.4	30.8	73.0	80.3	486.0	39.2	0.8	0.0	0.3	6.9	0.0	237.4	115.9	0.7	400.8	1991.0	16.0	24.3	0.0	0.1	0.0	0.0	339.9	0.0	0.6	0.0	0.0	5.4	0.0	0.0	0.0	21.5	0.0	183.7	0.6	0.1	160.5	0.0	33.7	1.0	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.6	1.2	0.0	0.9	0.0	0.2	0.1	0.0	0.0	0.3	14.9	0.1	0.0	10.8	16.3	0.0	0.0	0.0	17.0	4.5	14.3	0.0	0.2	0.0	0.0	8.8	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.6	5.6	0.7	0.9	0.9	0.8	0.8	0.7	1.3	0.8	77.5	12.8	30.9	0.0	0.6	97.6	1.2	0.8	3.4	0.2	9.4	8.6	15.2	0.0	5.0	0.0	2.1	44.9	4.0	0.1	0.0	0.7	3.5	27.0	966.4	27.2	0.0	0.0	0.0	0.0	38.9	2136.1	8.6	15.2	18.3	0.0	55.0	0.3	63.6	0.0	0.2	0.3	0.0	0.3	143.5	8.7	401.7	9.5	117.4	16.9	1.0	86.9	0.0	0.0	0.0	2.1	0.0	44.8	6.3	4.9	0.4	0.3	0.8	3.0	0.0	39.1	165.5	0.2	0.9	5.9	100.2	84.0	14.5	27.4	0.0	4.1
LVRN	"APQ, AQPEP, FLJ90650, TAQPEP"	ENSG00000172901	Laeverin	Q6Q4G3	5	115962454-116027619	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adipose tissue: 11.1;placenta: 21.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 29.3;Extravillous trophoblasts: 33.1;Late spermatids: 68.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"spinal cord: 2.5"	HPA053254	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"		"Cluster 50: Fibroblasts - ECM organization"			"HPA053254: AB_2682092"	"unprognostic (1.47e-1)"	"unprognostic (3.38e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-7)"	"unprognostic (1.05e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.31e-2)"	11.1	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	21.8	0.0	0.0	0.4	0.0	0.2	0.1	0.3	0.4	0.8	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	1.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	29.3	0.0	0.1	0.1	0.0	0.0	2.1	0.0	33.1	7.9	0.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	68.1	4.7	0.3	0.0	1.9	0.0	0.0	0.0	3.0	1.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.3	0.3	0.1	0.0	10.7	0.0	1.0	0.0	0.1
MAB21L3	"C1orf161, FLJ38716"	ENSG00000173212	"Mab-21 like 3"	Q8N8X9	1	116111755-116135240	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.3;esophagus: 7.0;skin 1: 6.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 48.3;Club cells: 18.5;granulocytes: 17.7;Oligodendrocytes: 31.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;EFO-21: 13.4;RT4: 14.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 6.2"	HPA039551			Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm		"HPA039551: AB_2676565"	"unprognostic (9.25e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-3)"	"unprognostic (5.23e-5)"	"unprognostic (2.22e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.61e-2)"	0.1	0.0	0.8	0.1	1.4	0.6	0.3	2.0	5.2	1.7	0.0	1.5	0.2	0.2	0.1	7.0	0.0	0.0	0.0	1.0	0.8	1.3	1.7	0.2	0.1	1.5	2.1	0.1	0.0	0.0	0.0	0.7	3.5	0.8	1.3	1.3	0.8	0.6	0.3	6.2	0.3	0.0	0.5	0.2	0.2	0.4	3.3	0.2	0.1	0.1	0.6	0.6	2.9	5.3	2.6	0.0	0.4	0.2	0.0	0.0	4.6	0.2	0.1	0.0	0.0	0.3	0.7	1.8	13.4	0.0	0.1	2.5	0.1	0.1	0.0	0.4	0.0	0.4	0.2	2.7	0.0	0.5	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.5	1.3	0.0	0.2	0.2	0.2	1.1	0.4	0.9	0.4	0.5	0.2	0.5	14.4	0.3	0.3	2.0	1.4	0.3	1.4	1.6	0.3	0.2	0.6	1.1	0.3	0.2	1.2	2.2	0.7	0.3	0.2	0.7	0.9	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.6	0.1	0.1	1.5	1.2	0.1	0.3	0.0	0.0	0.8	1.4	2.0	5.2	1.0	0.8	1.5	2.1	3.5	0.5	3.3	5.3	0.1	44.8	48.3	2.0	0.0	0.6	2.5	0.4	0.6	0.1	0.1	0.0	0.4	0.0	18.5	3.7	0.0	6.3	0.0	5.3	1.9	0.1	0.6	3.1	0.3	2.9	0.0	0.0	13.2	0.2	0.6	4.4	0.0	4.8	17.7	0.0	0.0	0.5	0.3	0.0	10.1	1.2	6.1	0.3	0.0	0.0	0.0	3.2	0.0	1.0	0.0	0.2	0.0	6.0	31.6	0.0	1.1	0.0	0.0	0.8	1.2	0.9	13.2	0.3	0.0	0.1	0.2	0.0	0.2	3.7	1.7	13.7	2.6	0.1	1.4	0.5
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 146.2;Late spermatids: 282.5;Proximal enterocytes: 178.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.8;RPMI-8226: 40.2;RT4: 47.0"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in all"	14	"cerebellum: 37.5"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	8.7	55.9	3.1	8.8	3.0	9.4	14.2	0.5	4.4	18.6	0.0	44.6	30.9	3.4	11.5	102.4	7.6	7.5	2.5	2.9	2.2	17.3	6.7	23.8	7.9	0.6	0.0	5.4	47.7	38.9	33.3	5.6	0.2	16.7	24.4	2.7	49.5	15.5	1.2	74.1	40.1	1.9	0.1	16.1	24.1	40.0	4.2	6.9	18.9	1.0	12.4	12.2	39.3	2.7	31.4	0.3	0.7	0.5	2.4	11.2	4.3	3.3	0.4	0.3	0.8	22.3	28.4	7.0	2.0	2.5	4.6	24.4	0.3	63.8	0.7	20.0	7.9	0.2	1.2	22.8	4.0	0.4	2.2	9.2	25.9	4.3	1.0	4.5	4.1	1.2	0.6	9.4	0.9	12.7	0.4	2.6	0.4	30.9	0.4	21.0	0.5	40.2	11.6	47.0	30.5	0.7	2.5	0.5	0.2	1.3	33.0	4.1	6.3	2.4	0.4	1.0	0.7	0.8	12.7	2.3	0.1	1.3	0.2	7.6	0.4	6.5	18.3	0.1	12.3	13.9	14.5	15.4	0.1	22.0	12.8	14.4	4.6	3.8	0.1	0.2	38.0	8.6	3.1	3.0	0.5	4.4	2.9	2.2	0.6	0.0	0.2	0.1	4.2	2.7	1.5	28.9	33.0	1.0	16.4	27.3	43.5	24.9	15.4	0.7	58.8	17.7	1.7	25.8	27.3	29.5	6.2	55.3	14.9	146.2	15.6	56.9	110.3	9.1	2.8	2.1	65.5	0.0	10.0	115.9	11.8	5.0	32.1	26.2	2.5	21.1	1.1	1.7	40.3	0.0	6.7	83.2	34.6	6.8	3.3	282.5	7.2	8.8	17.8	3.7	14.2	2.1	21.6	1.5	1.2	103.6	102.2	9.8	11.4	37.1	178.4	11.5	3.7	2.4	0.0	2.2	3.4	56.6	2.9	62.6	53.3	32.3	18.5	2.5	93.0	59.9
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52772784	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2810	"liver: 280.9"	"Cell type enriched"	"Detected in some"	66	"Hepatocytes: 238.5"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"Hep G2: 2.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	NA	NA	1220000000	1900000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	280.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	238.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0
MEGF11	"DKFZp434L121, KIAA1781"	ENSG00000157890	"Multiple EGF like domains 11"	A6BM72	15	65895079-66253747	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 23.0;fallopian tube: 7.8;kidney: 8.4;retina: 14.2"	"Group enriched"	"Detected in many"	9	"Early spermatids: 175.8;Horizontal cells: 126.2;Late spermatids: 177.8;Oligodendrocyte precursor cells: 460.4"	"Group enriched"	"Detected in some"	5	"endometrial cancer: 0.7;glioma: 2.3;renal cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.3;HEK 293: 2.7;RPTEC TERT1: 9.2;SCLC-21H: 7.2;U-698: 2.0"	"Region enriched"	"Detected in all"	4	"cerebellum: 35.0"	"Region enriched"	"Detected in all"	7	"cerebellum: 25.8"							NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"				"unprognostic (2.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.84e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.79e-3)"	"unprognostic (6.81e-3)"	"unprognostic (5.71e-5)"	"unprognostic (7.94e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.89e-2)"	0.0	0.1	8.3	0.2	5.3	0.3	0.1	23.0	7.0	0.1	0.4	0.1	0.0	0.1	0.8	0.1	7.8	0.0	0.1	10.5	7.5	8.4	0.0	0.5	0.1	6.6	8.8	0.3	0.2	0.0	3.0	0.0	7.0	0.1	0.0	14.2	0.1	0.1	0.1	1.3	0.1	0.0	4.5	0.2	0.3	3.9	8.0	0.1	0.0	0.0	0.0	0.0	0.1	7.4	0.0	0.1	0.3	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.2	0.0	0.1	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.2	0.0	0.0	9.2	0.2	7.2	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	5.3	23.0	7.0	10.5	7.5	6.6	8.8	7.0	4.5	8.0	7.4	0.2	0.0	3.7	5.2	0.4	2.2	0.7	1.0	0.6	5.3	0.8	0.0	1.4	0.0	0.3	3.7	8.4	0.3	0.4	0.0	0.0	0.1	175.8	0.3	0.3	1.5	0.0	0.4	9.5	0.2	0.1	0.7	2.6	0.8	0.0	0.2	2.9	0.0	0.1	126.2	18.4	0.0	0.0	0.3	3.5	177.8	2.5	0.4	0.0	1.0	0.0	4.4	0.0	460.4	1.7	0.1	0.1	1.5	1.3	0.6	0.0	2.2	0.8	25.7	0.0	1.0	0.5	2.9	1.9	0.6	3.8	0.5	0.9	0.1	0.0	0.5
MEI1	"MGC40042, SPATA38"	ENSG00000167077	"Meiotic double-stranded break formation protein 1"	Q5TIA1	22	41699503-41799456	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Meiosis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.4;testis: 39.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 32.8;Early spermatids: 61.3;Late spermatids: 50.8;NK-cells: 29.9;Plasma cells: 94.7;Spermatocytes: 38.1;T-cells: 28.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 5.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HeLa: 11.6;HMC-1: 8.5;Karpas-707: 26.8;U-266/70: 29.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"olfactory bulb: 1.4"	HPA049240	Approved				"Intracellular and membrane"	NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA049240: AB_2680689"	"unprognostic (1.95e-3)"	"prognostic favorable (1.59e-6)"	"unprognostic (6.13e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.45e-10)"	"unprognostic (2.82e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.39e-2)"	1.3	1.0	2.3	6.7	4.0	12.1	3.0	2.1	2.9	1.5	1.7	6.4	2.6	0.7	0.3	1.6	1.8	1.3	1.0	2.1	2.2	2.8	1.4	4.5	6.6	2.5	3.5	0.8	0.6	0.1	0.9	0.8	2.3	1.5	3.0	1.3	7.0	0.5	0.5	1.2	8.5	0.8	2.1	22.4	4.4	39.5	4.9	2.5	2.3	0.1	8.1	2.7	1.3	2.6	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	2.3	0.0	0.3	0.6	0.2	0.5	0.5	0.2	0.2	0.2	0.0	0.0	0.0	6.7	0.0	2.0	11.6	1.3	1.8	1.4	8.5	0.1	0.1	0.0	0.0	0.3	0.5	0.8	0.4	26.8	0.1	0.0	0.0	6.5	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	3.7	1.0	0.5	0.0	0.0	0.1	29.9	5.1	1.2	0.4	2.8	0.1	18.5	7.2	15.7	29.9	5.6	29.1	21.7	30.1	25.8	6.5	15.4	21.7	24.0	1.3	16.9	2.3	2.3	57.2	18.1	2.3	4.0	2.1	2.9	2.1	2.2	2.5	3.5	2.3	2.1	4.9	2.6	0.7	0.0	3.2	0.0	32.8	0.9	0.3	0.3	0.0	0.6	0.3	0.3	0.9	0.0	0.1	0.0	0.0	0.1	19.9	0.0	0.0	0.1	61.3	0.3	1.0	1.4	0.0	0.4	2.1	0.0	0.2	2.0	2.0	0.1	14.0	0.5	3.3	0.5	7.0	0.0	1.1	2.9	0.0	1.2	3.5	50.8	0.6	11.1	17.8	3.7	15.5	0.1	29.9	1.0	1.1	5.3	0.0	1.2	94.7	0.3	0.1	0.4	0.1	1.1	0.0	0.7	1.7	38.1	26.1	0.0	1.0	0.0	28.4	0.1	0.4	0.3
MFAP5	"MAGP2, MP25"	ENSG00000197614	"Microfibril associated protein 5"	Q13361	12	8637346-8662888	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 242.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 140.5;Extravillous trophoblasts: 1015.1;Fibroblasts: 579.7;Syncytiotrophoblasts: 252.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 31.7"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 172.2;BJ: 63.7;EFO-21: 150.4;HeLa: 55.9;SuSa: 137.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"spinal cord: 42.6"	HPA010553	Enhanced				"Secreted to extracellular matrix"	NA	NA		3200000	"Cluster 34: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"HPA010553: AB_1853843"	"unprognostic (1.80e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.79e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.05e-1)"	"unprognostic (4.41e-7)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.05e-2)"	"prognostic unfavorable (5.81e-4)"	141.7	10.9	3.5	5.4	5.0	3.5	79.7	31.7	9.2	59.9	1.8	37.8	7.2	242.1	11.1	35.0	25.8	28.2	54.4	4.8	0.8	3.1	12.7	8.7	4.8	2.9	0.4	2.4	5.5	2.4	3.7	94.5	1.9	6.4	42.0	7.9	17.2	49.7	28.5	38.7	19.0	142.1	0.0	1.9	23.6	6.9	1.7	3.2	14.4	118.1	3.4	43.1	60.7	6.6	1.4	5.7	1.6	2.6	29.4	12.4	172.2	63.7	1.2	0.8	1.1	2.3	1.0	0.6	150.4	19.8	1.6	9.1	0.6	13.1	0.0	0.5	0.4	1.6	55.9	1.9	0.4	1.3	0.6	8.7	4.4	7.3	0.0	3.3	0.0	2.0	2.7	3.7	52.7	0.8	1.9	0.8	3.2	0.9	2.9	1.2	1.3	6.5	6.5	2.6	0.7	0.9	1.9	0.7	1.0	137.1	24.0	0.8	2.3	10.7	21.5	45.7	3.0	2.1	1.9	2.3	6.0	0.7	0.1	2.9	0.8	0.7	0.2	0.7	0.4	0.1	0.1	0.1	0.4	0.3	0.4	0.1	1.1	0.2	0.5	0.3	0.0	0.3	3.5	5.0	31.7	9.2	4.8	0.8	2.9	0.4	1.9	0.0	1.7	6.6	61.5	12.8	5.8	0.3	0.5	23.1	0.4	1.8	0.6	0.2	0.6	0.9	7.0	0.0	2.0	0.0	0.0	140.5	0.5	0.0	0.0	0.5	0.3	5.1	3.9	20.1	0.0	0.0	0.2	0.0	1015.1	579.7	3.6	28.0	0.0	0.2	4.2	0.0	27.7	0.0	0.1	0.0	0.0	9.5	36.3	0.5	61.2	8.8	12.4	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	1.6	0.1	0.0	0.2	1.6	0.9	0.0	40.2	35.2	0.1	0.2	0.6	18.0	252.3	5.3	0.1	0.0	0.3
MMP24	MT5-MMP	ENSG00000125966	"Matrix metallopeptidase 24"	Q9Y5R2	20	35226690-35276998	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 40.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Excitatory neurons: 24.6;Horizontal cells: 15.2;Inhibitory neurons: 38.4;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.0;Proximal tubular cells: 11.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.4;testis cancer: 10.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 40.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 36.3;CACO-2: 56.0;EFO-21: 15.8;RPTEC TERT1: 24.6;U-2 OS: 17.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 51.5"	"HPA049280, HPA078816"	Approved		Approved	"Nucleoli,Plasma membrane"	"Secreted to extracellular matrix"	Yes	No				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Plasma membrane"		"HPA049280: , HPA078816: "	"unprognostic (1.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.51e-4)"	"unprognostic (2.47e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.12e-2)"	"prognostic favorable (8.17e-11)"	"unprognostic (3.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.90e-4)"	3.4	1.0	6.1	0.5	5.8	0.7	0.5	40.0	8.1	0.7	3.5	0.7	2.1	1.3	0.1	0.3	2.2	0.6	0.6	6.0	5.6	7.8	0.5	4.7	0.4	4.4	5.6	0.4	5.8	0.3	3.8	0.2	5.4	1.7	0.2	2.5	0.5	4.2	0.3	1.2	1.4	2.0	2.7	0.4	0.6	0.4	7.2	0.0	0.7	0.1	0.0	0.4	0.3	4.8	0.6	36.3	0.1	0.2	0.2	0.0	1.0	1.9	2.3	3.8	2.0	56.0	9.7	0.0	15.8	2.5	1.2	0.6	8.5	0.0	1.6	0.2	0.3	1.9	1.2	0.6	0.0	0.1	0.4	0.2	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.5	0.4	0.5	0.1	0.2	13.6	0.1	2.4	0.1	0.2	0.0	24.6	0.1	14.1	9.7	2.5	0.7	0.3	2.9	0.5	0.3	0.6	7.4	17.7	1.8	0.7	0.3	0.2	0.1	1.6	0.2	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	6.1	5.8	40.0	8.1	6.0	5.6	4.4	5.6	5.4	2.7	7.2	4.8	0.3	16.0	1.5	5.2	0.0	0.1	0.2	0.0	0.0	3.9	0.2	0.8	0.5	8.6	1.3	1.8	0.0	0.1	0.1	0.7	5.9	8.5	0.6	0.8	0.3	1.4	0.0	0.0	24.6	0.9	0.1	0.6	0.0	0.5	0.0	0.1	0.4	0.4	0.0	15.2	38.4	0.1	0.0	0.6	0.0	0.0	0.3	0.1	1.8	10.3	0.0	0.2	0.0	12.5	12.0	1.9	0.1	0.0	0.0	0.4	2.3	11.4	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.1	0.1
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010663	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 7.2;pancreas: 16.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 6.6;Enteroendocrine cells: 25.1;Intestinal goblet cells: 19.7;Paneth cells: 7.0;Proximal enterocytes: 7.3;Undifferentiated cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;BEWO: 12.7;EFO-21: 16.2;HEK 293: 13.2;RPMI-8226: 37.6;SCLC-21H: 19.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	39	"spinal cord: 3.9"	HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: AB_2686437"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.3	0.6	0.0	0.0	3.7	7.2	0.0	0.0	0.2	0.0	0.8	0.0	0.5	0.2	0.1	0.0	0.0	0.0	1.3	0.3	0.0	16.3	0.0	2.6	0.0	0.9	0.3	3.0	0.0	1.1	0.0	0.0	0.1	6.1	0.0	0.8	0.0	2.2	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.4	5.8	0.0	17.2	0.0	0.0	12.7	0.0	0.0	0.1	0.0	7.6	2.5	1.4	16.2	0.0	0.5	0.3	3.0	2.3	1.3	2.2	13.2	0.0	1.5	3.6	0.0	0.0	2.5	0.0	0.2	0.0	0.0	0.0	0.0	6.1	5.7	2.9	0.0	10.1	0.9	0.2	0.0	1.7	1.1	0.0	2.5	37.6	6.5	0.6	19.3	0.0	2.5	2.2	0.4	0.1	5.4	4.4	0.0	0.0	0.0	0.0	0.0	5.3	2.9	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.6	0.5	0.2	1.3	0.3	0.9	0.8	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	6.6	0.0	4.4	1.3	0.1	0.0	0.1	25.1	0.0	0.0	3.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	19.7	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	3.1	7.0	0.0	0.4	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.8	0.0	0.0	0.0	0.2	0.0	13.6	0.0
MPZ	"CMT1, CMT1B, CMT2I, CMT2J, HMSNIB, P0"	ENSG00000158887	"Myelin protein zero"	P25189	1	161304735-161309968	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Sertoli cells: 6.6;Skeletal myocytes: 9.3"	"Cancer enriched"	"Detected in many"	11	"melanoma: 83.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"WM-115: 139.3"	"Group enriched"	"Detected in some"	4	"olfactory bulb: 2.9;pons and medulla: 1.3"	"Region enriched"	"Detected in some"	10	"spinal cord: 2142.4"	HPA068925	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA068925: AB_2732123"	"unprognostic (6.77e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.88e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.62e-8)"	"unprognostic (6.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.32e-2)"	19.1	6.9	2.1	2.1	3.0	1.1	12.6	2.5	2.7	8.3	1.4	22.3	1.6	2.0	2.0	4.4	5.3	2.4	15.2	1.9	3.9	6.3	5.4	2.9	1.1	3.0	2.2	3.1	2.3	0.6	6.2	0.6	9.9	12.2	2.7	1.2	15.8	8.0	5.1	9.1	8.5	0.8	3.3	4.4	7.6	2.4	2.0	1.4	3.7	18.4	0.9	9.5	15.9	2.2	0.4	0.0	0.3	0.1	2.7	1.3	0.3	0.3	0.5	0.1	1.6	0.0	0.1	2.3	1.5	0.4	0.5	0.1	1.8	0.6	0.1	1.1	0.0	1.0	0.4	31.0	1.2	4.7	3.7	4.2	0.0	6.2	0.3	0.0	2.8	1.9	9.9	0.0	4.3	0.0	0.7	7.6	1.4	0.0	0.0	0.3	0.2	1.4	0.3	0.1	2.0	0.3	0.0	0.0	14.0	0.8	0.1	9.5	2.7	0.3	0.4	2.7	0.2	0.9	0.9	1.2	4.8	17.5	139.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	3.0	2.5	2.7	1.9	3.9	3.0	2.2	9.9	3.3	2.0	2.2	1.7	3.2	0.6	1.0	2.1	0.5	3.1	0.4	4.0	2.5	0.4	1.3	0.7	0.0	0.5	3.7	2.1	0.5	1.6	0.1	0.0	0.2	5.5	0.3	0.2	1.5	1.8	1.3	1.7	1.2	0.7	2.5	0.0	0.1	0.0	0.8	1.8	1.0	1.6	1.7	2.2	0.7	2.0	1.9	0.8	1.8	1.5	2.0	3.6	1.0	3.8	0.5	0.0	0.5	1.6	0.1	0.1	0.4	1.4	0.9	0.3	1.0	0.6	1.1	6.6	9.3	3.9	0.4	0.6	1.1	0.4	0.3	1.6	0.4	0.4	2.0
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253416-118264536	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 222.5;urinary bladder: 155.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 332.5;Basal prostatic cells: 504.4;Basal respiratory cells: 289.1;Squamous epithelial cells: 336.4;Suprabasal keratinocytes: 467.4;Urothelial cells: 489.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.6;intermediate monocyte: 9.2;myeloid DC: 17.0;neutrophil: 13.2"	"Group enriched"	"Detected in many"	10	"dendritic cells: 17.0;granulocytes: 13.2;monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 120.9;EFO-21: 130.4;HaCaT: 166.9;RT4: 321.7;TIME: 351.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 38.8"	HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	28.6	4.7	2.5	11.9	2.1	0.7	19.6	2.3	4.8	56.7	5.2	31.1	17.0	16.9	38.5	222.5	46.4	33.5	7.2	2.3	2.6	26.4	23.2	47.0	2.3	3.2	3.0	3.8	13.5	27.1	10.7	1.7	3.2	48.6	30.8	0.9	58.0	69.5	4.7	38.8	11.3	14.7	3.6	4.6	37.0	0.9	3.4	18.1	30.3	1.0	52.6	155.9	120.5	2.8	65.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.0	120.9	0.3	130.4	0.0	0.6	166.9	0.0	38.9	0.0	0.2	9.5	0.1	1.7	35.8	0.0	0.0	0.4	0.0	90.2	0.0	3.0	0.0	86.8	0.8	0.0	0.2	0.0	51.3	0.2	0.2	1.6	34.2	0.1	0.0	0.0	6.4	14.9	321.7	0.1	0.0	5.8	61.4	0.0	0.5	26.1	0.7	351.9	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.0	0.0	2.3	11.6	3.0	0.1	9.2	1.3	0.0	0.6	0.4	17.0	0.0	0.8	0.9	13.2	0.4	1.4	0.3	0.2	3.8	2.5	2.1	2.3	4.8	2.3	2.6	3.2	3.0	3.2	3.6	3.4	2.8	5.9	83.3	123.3	0.0	0.2	332.5	504.4	289.1	127.5	0.0	29.0	17.4	3.4	30.0	221.1	128.8	0.0	1.7	0.5	52.0	0.0	39.4	0.0	91.6	18.8	33.6	5.3	3.6	0.0	51.1	0.2	8.2	29.6	194.0	7.0	0.0	45.3	16.5	0.8	0.0	0.0	6.3	81.4	6.4	27.0	0.3	0.0	7.8	21.4	1.9	4.9	0.0	1.0	0.0	0.0	68.2	20.8	0.0	1.2	186.3	3.3	6.9	65.2	0.0	0.0	0.3	9.2	0.2	0.7	336.4	467.4	17.8	5.4	0.0	33.4	489.7
MS4A15		ENSG00000166961	"Membrane spanning 4-domains A15"	Q8N5U1	11	60756867-60776733	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lung: 43.9"	"Cell type enriched"	"Detected in some"	15	"Alveolar cells type 1: 96.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 6.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.2;HEL: 3.6;JURKAT: 1.6;MOLT-4: 1.6;U-266/70: 4.0;U-266/84: 2.1"	"Region enriched"	"Detected in some"	28	"olfactory bulb: 166.8"	"Region enriched"	"Detected in single"	26	"olfactory bulb: 20.2"	HPA054563			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 19: Lung - Lung function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	Cytosol	"HPA054563: "	"unprognostic (1.85e-1)"	"unprognostic (4.31e-3)"	"unprognostic (8.59e-2)"	"unprognostic (5.89e-4)"	"unprognostic (4.49e-1)"	"unprognostic (1.09e-3)"		"unprognostic (3.92e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.04e-9)"	"unprognostic (7.02e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-1)"	0.3	0.2	0.2	0.4	0.2	0.1	2.2	0.3	0.4	0.3	0.2	0.3	1.0	1.2	0.3	0.4	1.0	0.2	0.3	0.7	0.2	0.1	0.0	43.9	0.5	0.4	0.2	1.8	0.1	0.0	0.0	0.7	0.4	0.3	0.6	0.4	0.1	1.2	0.0	0.0	2.2	1.6	0.1	0.3	0.4	0.6	0.2	3.8	0.3	0.0	1.8	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.5	1.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.3	0.0	0.0	4.0	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	3.2	0.2	0.2	0.2	0.3	0.4	0.7	0.2	0.4	0.2	0.4	0.1	0.2	0.3	0.2	96.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	1.3	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	2.5	0.0	1.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760734-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 93.4;fallopian tube: 278.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 189.1;Alveolar cells type 2: 85.6;Club cells: 121.9;Glandular and luminal cells: 57.1;Paneth cells: 214.4"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 5.9"	"Group enriched"	"Detected in many"	39	"dendritic cells: 5.9;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 513.4;EFO-21: 77.4;HeLa: 173.4;hTCEpi: 111.5;OE19: 96.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	9	"spinal cord: 1.7"	"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	93.4	0.2	0.7	1.1	1.0	3.2	0.5	0.6	1.5	15.9	0.3	8.9	7.1	6.2	24.1	7.1	278.2	16.4	8.4	0.7	0.8	6.5	0.2	71.8	0.2	1.9	1.2	3.7	0.9	0.1	0.7	2.7	1.3	3.8	4.0	0.7	39.3	9.9	0.0	1.4	2.9	3.4	1.0	0.4	13.0	1.1	1.2	0.8	0.2	0.0	27.2	2.9	2.9	1.0	0.4	2.1	0.0	1.0	0.0	0.0	2.3	0.3	7.7	8.7	2.0	7.4	513.4	0.0	77.4	0.7	0.1	1.3	0.0	0.7	0.7	0.2	0.3	0.0	173.4	5.9	4.4	0.2	0.1	0.0	111.5	0.0	2.0	7.8	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.6	96.4	0.8	0.2	0.2	0.6	2.4	0.1	0.1	0.0	29.7	0.1	0.0	0.1	0.7	0.0	0.0	0.4	12.1	0.1	0.0	0.3	0.3	0.4	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.3	0.7	1.0	0.6	1.5	0.7	0.8	1.9	1.2	1.3	1.0	1.2	1.0	0.0	189.1	85.6	0.0	0.0	0.3	3.0	49.0	0.0	1.4	0.3	0.3	1.6	52.9	121.9	25.8	0.0	0.2	0.0	4.1	0.0	9.3	1.6	35.8	3.3	0.7	3.0	0.0	0.0	0.9	0.0	4.6	0.0	57.1	0.0	0.0	0.4	0.1	2.9	0.0	0.0	1.6	22.4	1.0	1.9	7.4	4.7	3.7	1.8	1.0	4.4	0.0	0.0	0.0	0.0	33.0	214.4	0.0	1.4	3.3	1.7	0.1	54.2	0.6	0.0	0.0	2.8	0.6	0.7	0.5	0.1	0.1	1.3	0.0	3.1	50.8
MUC4		ENSG00000145113	"Mucin 4, cell surface associated"	Q99102	3	195746765-195811973	"Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 19.2;intestine: 31.1;prostate: 14.8;vagina: 15.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 193.7;Distal enterocytes: 185.1;Gastric mucus-secreting cells: 163.1;Intestinal goblet cells: 193.3;Respiratory ciliated cells: 336.1;Undifferentiated cells: 174.5;Urothelial cells: 319.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 16.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"basal ganglia: 3.4"	"HPA005895, CAB013536"	Approved				"Secreted in other tissues"	NA	NA				"Cluster 37: Intestine - Unknown function"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB013536: , HPA005895: AB_1079427"	"unprognostic (4.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.22e-3)"	"unprognostic (6.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.19e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.97e-3)"	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.1	5.4	0.0	31.1	0.0	0.0	0.0	19.2	2.1	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.8	0.0	7.8	0.0	0.0	0.0	3.4	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.2	1.2	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	6.4	15.6	0.3	2.1	0.0	18.5	82.1	0.6	0.0	25.7	2.9	2.5	0.0	193.7	0.0	0.0	0.1	0.3	185.1	0.0	1.6	3.5	6.2	0.2	0.7	16.4	0.0	0.9	5.2	4.3	0.6	163.1	5.1	2.5	0.1	0.0	0.0	0.1	0.0	1.0	193.3	40.7	0.0	0.0	0.7	0.0	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.2	37.5	64.3	0.4	0.8	12.4	1.1	0.2	336.1	0.0	0.0	0.5	11.1	2.1	1.9	0.4	0.0	0.1	1.2	2.3	174.5	319.4
MYLK3	"caMLCK, MLCK"	ENSG00000140795	"Myosin light chain kinase 3"	Q32MK0	16	46702282-46790407	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 103.4;skeletal muscle: 46.5;tongue: 72.6"	"Group enriched"	"Detected in some"	12	"Cardiomyocytes: 169.0;Endometrial ciliated cells: 44.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.9;HEL: 40.2;K-562: 6.5;SK-BR-3: 7.9"	"Group enriched"	"Detected in some"	7	"cerebral cortex: 9.6;hippocampal formation: 5.1"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 3.5"	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Vesicles	"HPA073447: AB_2732225"	"unprognostic (6.01e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.41e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.97e-1)"	0.0	0.1	1.9	0.1	1.7	0.3	0.1	1.1	2.3	0.4	1.7	0.0	0.1	0.3	0.8	4.3	1.7	0.2	103.4	2.5	2.8	1.1	0.1	0.4	0.2	9.8	12.2	0.3	0.1	0.0	0.4	0.5	8.2	2.2	0.1	0.2	2.1	0.1	46.5	0.1	0.1	0.2	5.9	0.1	0.1	6.0	1.9	0.1	0.1	72.6	0.1	0.0	0.0	3.0	0.0	0.1	0.1	0.1	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	2.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	6.5	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	7.9	0.2	3.5	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	1.9	1.7	1.1	2.3	2.5	2.8	9.8	12.2	8.2	5.9	1.9	3.0	0.2	0.0	3.3	0.7	0.5	0.0	0.7	0.0	0.0	0.9	1.3	0.0	169.0	0.0	3.7	0.0	2.1	2.0	0.2	0.0	0.0	0.0	8.1	44.8	7.1	1.7	0.0	0.0	0.9	0.2	0.5	6.7	0.0	2.2	1.3	1.6	0.7	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	7.2	0.6	0.8	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.8	0.0	0.2	8.7	1.3	0.0	4.9	2.7	1.0	0.7	0.0	0.0	0.3	0.8	0.7	0.0	0.8
NCMAP	"C1orf130, FLJ42528, MP11"	ENSG00000184454	"Non-compact myelin associated protein"	Q5T1S8	1	24556087-24609328	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 7.3;pancreas: 8.5;salivary gland: 7.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 17.7;Ductal cells: 19.3;Exocrine glandular cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;RPTEC TERT1: 1.6;T-47d: 4.0;U-266/70: 3.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"spinal cord: 147.1"	HPA013656	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"			"HPA013656: AB_2275006"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.83e-6)"	"unprognostic (3.26e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.28e-3)"	"unprognostic (9.88e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.63e-2)"	"unprognostic (7.27e-3)"	0.3	0.2	0.4	0.2	0.5	0.5	1.5	1.2	0.7	1.1	0.3	0.6	5.0	0.4	0.2	0.2	1.0	7.3	0.1	0.4	0.5	1.2	4.7	3.9	0.3	0.5	0.3	0.1	8.5	0.0	3.4	0.8	0.8	1.4	0.3	1.3	7.8	0.1	0.3	0.4	2.2	0.0	0.2	0.1	4.9	0.1	0.5	0.0	4.2	0.4	0.4	0.6	0.1	1.7	0.1	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.5	1.6	0.5	0.1	0.1	0.0	0.1	0.0	0.5	4.0	0.1	0.3	0.1	0.1	0.1	0.1	3.0	0.4	0.0	0.0	0.1	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.5	1.2	0.7	0.4	0.5	0.5	0.3	0.8	0.2	0.5	1.7	0.0	3.2	17.7	0.3	0.1	0.0	1.6	0.7	0.0	0.4	3.6	1.9	1.1	8.6	3.2	3.7	4.2	1.4	0.2	0.8	0.0	19.3	0.0	1.8	1.0	0.3	1.8	0.0	0.6	48.3	0.2	0.4	0.5	5.7	1.3	0.0	0.0	2.0	0.1	0.0	0.6	0.7	4.1	0.0	0.4	0.0	0.0	0.2	3.6	7.5	1.1	3.6	0.0	0.5	1.2	10.4	1.7	0.0	2.8	2.3	4.2	1.1	1.0	0.5	0.0	1.4	0.3	0.1	0.1	0.0	0.1	9.3	0.6	0.0	0.9	2.2
NEB	"NEB177D, NEM2"	ENSG00000183091	Nebulin	P20929	2	151485336-151734487	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	69	"skeletal muscle: 9300.2;tongue: 2495.6"	"Cell type enriched"	"Detected in many"	8	"Skeletal myocytes: 662.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 8.8;RH-30: 34.3;U-266/70: 12.8"	"Group enriched"	"Detected in some"	6	"cerebellum: 6.5;olfactory bulb: 4.0"	"Region enriched"	"Detected in some"	6	"cerebellum: 11.8"	HPA016601	Enhanced					NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"			"HPA016601: AB_1854361"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-13)"	"unprognostic (6.80e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.06e-2)"	2.3	6.4	2.2	0.7	5.0	1.3	2.9	4.0	2.6	0.5	1.4	1.3	1.1	0.6	1.6	16.2	0.5	12.7	40.7	2.2	5.4	3.3	4.9	2.3	1.3	2.9	2.9	0.9	2.0	0.1	2.6	0.8	2.4	22.1	0.1	3.5	85.9	0.2	9300.2	9.3	1.8	0.2	2.0	3.0	1.1	1.7	2.9	1.1	13.0	2495.6	0.8	0.4	1.2	2.9	0.5	0.5	0.8	0.7	0.1	0.1	2.3	0.4	0.0	0.0	0.0	6.1	0.7	1.7	1.2	0.1	0.2	1.2	0.1	0.0	0.0	0.8	0.9	0.6	1.1	2.0	0.0	1.1	1.5	5.0	0.3	0.1	0.0	0.3	0.8	0.5	1.2	8.8	0.5	0.7	0.6	1.1	1.4	3.0	1.0	1.6	34.3	0.2	0.1	1.2	2.0	0.3	0.3	0.4	0.2	1.3	0.9	1.1	0.8	0.9	1.2	0.1	1.2	12.8	2.0	0.4	0.2	0.8	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.2	5.0	4.0	2.6	2.2	5.4	2.9	2.9	2.4	2.0	2.9	2.9	0.3	0.0	1.1	14.0	2.0	0.8	1.2	0.2	2.8	2.4	0.5	0.4	82.6	18.6	0.7	0.0	0.0	0.5	1.2	0.0	0.0	0.5	7.6	1.4	1.5	2.1	1.8	0.0	13.1	0.0	0.4	10.6	2.0	2.5	1.3	2.2	0.7	2.4	0.7	3.3	9.2	0.0	4.1	1.3	0.7	7.6	0.6	2.7	0.0	7.5	0.2	0.4	0.0	6.0	5.2	0.1	0.0	0.0	2.0	1.1	0.3	0.4	0.1	1.7	0.0	662.8	1.9	1.4	1.6	0.2	1.3	0.8	1.1	1.5	0.0	0.2
NEFH	"NF-H, NFH"	ENSG00000100285	"Neurofilament heavy"	P12036	22	29480218-29491390	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 544.0;prostate: 245.9"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 20.9;monocytes: 34.6;Prostatic glandular cells: 44.0;Spermatogonia: 29.5;Theca cells: 49.7"	"Cancer enriched"	"Detected in many"	4	"prostate cancer: 130.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	5	"monocytes: 4.7"	"Cell line enriched"	"Detected in many"	5	"SiHa: 182.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 1241.2"	"CAB007786, HPA061615"	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 35: Glandular cells - Unknown function"			"CAB007786: AB_598179, HPA061615: AB_2684568"	"prognostic favorable (2.33e-6)"	"unprognostic (6.17e-3)"	"unprognostic (9.74e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.85e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.47e-1)"	0.6	21.1	17.7	1.6	18.9	0.6	1.4	143.1	544.0	0.6	0.0	1.4	0.4	0.5	0.7	0.3	0.5	0.4	0.4	7.8	57.3	0.9	0.3	0.4	0.9	494.1	56.2	20.0	0.3	0.9	15.4	0.6	376.1	245.9	0.5	39.6	0.9	0.6	0.3	0.2	0.9	1.0	58.3	1.2	0.6	7.7	172.9	0.7	0.3	0.3	1.0	0.4	1.2	147.3	0.0	0.0	2.4	0.6	0.1	0.3	1.8	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.8	1.9	9.5	0.1	0.0	0.0	0.0	9.0	34.2	0.1	24.2	0.0	1.4	0.2	10.5	3.5	0.0	0.5	0.0	0.0	1.3	0.0	28.0	0.0	11.7	0.0	12.0	1.2	17.4	0.0	0.0	0.1	0.1	1.9	0.0	0.0	1.5	19.5	182.2	0.1	0.0	5.9	0.0	9.9	25.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.0	0.4	2.7	0.8	0.1	0.5	0.4	0.6	0.0	0.1	0.5	0.0	0.2	4.7	0.1	0.2	0.6	17.7	18.9	143.1	544.0	7.8	57.3	494.1	56.2	376.1	58.3	172.9	147.3	0.7	0.0	0.0	3.9	1.0	0.1	1.0	0.1	2.2	3.2	1.4	5.3	0.9	1.5	0.0	1.8	2.1	1.4	1.6	0.5	0.0	0.2	0.4	0.3	7.7	1.0	0.0	5.9	13.6	0.4	1.1	2.4	0.0	0.8	1.3	8.8	0.0	0.0	5.6	8.4	20.9	0.0	0.0	4.2	2.3	1.0	5.9	5.2	1.8	5.6	34.6	3.6	0.0	2.0	2.6	0.3	0.0	3.0	1.7	44.0	0.2	1.0	0.0	9.9	6.6	1.3	2.0	4.4	29.5	3.0	0.1	0.4	1.7	49.7	0.2	0.7
NEUROD1	"BETA2, BHF-1, bHLHa3, MODY6, NEUROD"	ENSG00000162992	"Neuronal differentiation 1"	Q13562	2	181673088-181680547	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 61.4;retina: 125.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 77.5;Cone photoreceptor cells: 150.1;Enteroendocrine cells: 424.2;Rod photoreceptor cells: 203.7"	"Group enriched"	"Detected in some"	4	"glioma: 1.9;pancreatic cancer: 4.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 61.4"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	74	"SCLC-21H: 321.5"	"Region enriched"	"Detected in all"	14	"cerebellum: 216.2"	"Region enriched"	"Detected in many"	19	"cerebellum: 217.0"	"HPA003278, CAB022450"	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"CAB022450: , HPA003278: AB_1845331"			"unprognostic (1.29e-1)"		"prognostic favorable (1.34e-4)"						"unprognostic (6.92e-3)"			"unprognostic (1.27e-1)"				0.0	0.1	3.0	0.1	2.1	0.1	0.0	61.4	7.2	0.0	0.7	1.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.7	0.0	0.0	0.0	0.0	0.9	2.4	0.0	10.2	0.0	0.7	0.0	5.2	0.0	1.4	125.7	0.0	0.0	0.1	0.0	4.7	0.0	0.9	0.0	5.4	0.2	0.8	0.2	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	321.5	4.3	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.3	0.3	0.4	0.2	0.2	0.1	3.0	2.1	61.4	7.2	9.2	0.7	0.9	2.4	5.2	0.9	0.8	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	77.5	0.0	0.0	0.5	0.0	0.0	0.0	150.1	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.9	424.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.1	23.8	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	25.9	0.0	0.0	0.1	1.7	12.6	0.0	0.0	0.2	0.7	0.1	0.0	203.7	0.0	0.3	0.0	1.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.2
NEUROG2	"Atoh4, bHLHa8, Math4A, ngn-2, NGN2"	ENSG00000178403	"Neurogenin 2"	Q9H2A3	4	112513516-112516180	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 3.3;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Breast myoepithelial cells: 3.4;Early spermatids: 1.9;Late spermatids: 1.1;Muller glia cells: 8.1;Spermatocytes: 1.4"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 203.2"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	10	"hippocampal formation: 12.3"	CAB012342	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"			"CAB012342: "	"unprognostic (1.09e-1)"	"unprognostic (2.52e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.75e-2)"		"unprognostic (1.04e-1)"	"unprognostic (1.13e-3)"						"unprognostic (1.02e-1)"	"unprognostic (3.30e-1)"		0.0	0.0	0.8	0.0	1.2	0.0	0.2	1.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.0	2.0	203.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	1.2	2.1	3.3	0.2	0.2	0.1	0.1	0.1	0.2	0.7	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NHLH1	"bHLHa35, HEN1, NSCL, NSCL1"	ENSG00000171786	"Nescient helix-loop-helix 1"	Q02575	1	160367071-160372846	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.5;Excitatory neurons: 22.5;Inhibitory neurons: 18.6;Microglial cells: 9.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 48.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 26.3"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.0"	"Region enriched"	"Detected in some"	12	"cerebellum: 19.1"	HPA017943			Approved	"Golgi apparatus"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA017943: AB_2732421"	"unprognostic (6.95e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.21e-8)"	"unprognostic (4.09e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.36e-1)"	0.2	0.1	1.2	0.1	1.9	0.0	0.1	1.5	1.9	0.0	0.9	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	1.5	1.3	0.1	0.2	0.2	0.0	2.2	1.6	0.1	0.1	0.0	0.3	0.0	1.5	0.1	0.0	0.7	0.2	0.0	0.3	0.6	0.2	0.0	2.9	0.6	0.1	0.3	1.4	0.6	0.1	0.0	0.0	0.1	0.1	1.5	0.0	0.1	2.6	0.0	0.6	0.1	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.2	1.2	0.5	0.2	0.6	0.0	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.4	0.4	0.5	0.0	0.0	0.0	0.5	0.6	0.0	0.2	0.0	0.2	0.1	0.0	0.0	26.3	0.2	0.1	0.1	0.2	0.5	0.0	0.0	0.1	0.1	0.2	0.3	0.0	1.9	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.9	1.5	1.9	1.5	1.3	2.2	1.6	1.5	2.9	1.4	1.5	0.5	0.0	0.0	8.5	0.5	0.3	0.0	0.1	0.6	0.9	0.5	0.8	0.7	0.0	0.1	0.0	2.1	0.1	0.3	0.2	0.0	0.2	0.0	0.2	0.3	0.3	1.8	0.0	22.5	0.2	0.1	0.2	0.0	0.5	0.0	0.2	0.4	0.0	0.2	3.3	18.6	0.6	0.0	1.9	0.6	0.0	0.3	1.1	0.0	9.4	0.4	0.2	0.0	16.6	48.6	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.1	1.4	0.0	0.5	0.1	1.1	0.6	0.3	0.0	0.3	0.2	0.2	0.0	0.1
NKX2-4	"NKX2.4, NKX2D"	ENSG00000125816	"NK2 homeobox 4"	Q9H2Z4	20	21395365-21397526	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 4.3;testis: 1.2"	"Group enriched"	"Detected in some"	24	"Cardiomyocytes: 1.3;Early spermatids: 3.0;Late spermatids: 2.7;Spermatocytes: 3.8;Spermatogonia: 1.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"hypothalamus: 3.4;thalamus: 4.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.5;HEK 293: 5.1;SCLC-21H: 3.2;SK-MEL-30: 4.2;WM-115: 1.2"	"Region enriched"	"Detected in single"	23	"hypothalamus: 2.7"	"Region enriched"	"Detected in single"	11	"hypothalamus: 1.1"	HPA074996			Approved	"Nuclear bodies"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear bodies"		"HPA074996: AB_2686725"					"unprognostic (3.77e-1)"				"unprognostic (2.15e-1)"						"unprognostic (1.68e-1)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	4.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.1	0.2	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPFF	FMRFAL	ENSG00000139574	"Neuropeptide FF-amide peptide precursor"	O15130	12	53506690-53507638	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"epididymis: 820.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 11.1;Excitatory neurons: 1.3;Inhibitory neurons: 1.2;Microglial cells: 1.9;Oligodendrocytes: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HHSteC: 13.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 11.4"	"Region enriched"	"Detected in all"	7	"cerebellum: 50.8"						"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 64: Astrocytes - Nervous system maintenance"																					0.2	0.4	1.4	0.0	1.4	0.0	0.1	1.4	9.7	0.2	1.4	0.1	0.8	0.0	820.5	0.1	0.1	0.1	0.2	1.4	2.1	0.1	0.1	0.3	0.0	3.4	3.2	0.2	0.1	0.0	0.1	0.0	1.6	0.1	0.0	0.2	0.3	0.3	0.0	0.1	0.1	0.0	3.1	0.1	0.1	0.1	1.8	0.1	0.1	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.5	0.2	0.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	1.6	0.3	0.0	0.6	0.2	0.0	0.2	0.2	0.4	1.5	0.0	0.0	0.2	0.0	0.5	0.1	1.7	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.4	1.4	9.7	1.4	2.1	3.4	3.2	1.6	3.1	1.8	1.6	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0
NPVF	"C7orf9, RFRP"	ENSG00000105954	"Neuropeptide VF precursor"	Q9HCQ7	7	25224570-25228486	"Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"retina: 220.5"	"Cell type enriched"	"Detected in some"	40	"Muller glia cells: 526.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"hypothalamus: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"hypothalamus: 6.1"	"Region enriched"	"Detected in single"	8	"hypothalamus: 3.0"	HPA041733	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 5: Muller glia cells - Visual perception"			"HPA041733: AB_10794524"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	220.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	526.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPY2R		ENSG00000185149	"Neuropeptide Y receptor Y2"	P49146	4	155208636-155217078	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.3;breast: 1.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 3.8;Excitatory neurons: 6.7;Leydig cells: 21.1;Oligodendrocytes: 13.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;ASC diff: 2.1;HSkMC: 1.0;SH-SY5Y: 7.5"	"Group enriched"	"Detected in many"	5	"amygdala: 12.9;basal ganglia: 12.3;hippocampal formation: 46.7;hypothalamus: 23.7"	"Region enriched"	"Detected in many"	6	"hippocampal formation: 14.2"							NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (7.14e-2)"				"unprognostic (4.36e-3)"					"unprognostic (7.08e-2)"		"unprognostic (5.50e-2)"			"unprognostic (9.35e-2)"			0.3	0.2	2.0	0.2	1.1	0.0	1.6	0.1	2.4	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.5	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.5	0.2	0.7	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.1	0.1	2.4	5.3	3.5	1.5	0.6	0.6	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	6.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NR5A1	"AD4BP, ELP, FTZ1, FTZF1, hSF-1, SF-1, SF1"	ENSG00000136931	"Nuclear receptor subfamily 5 group A member 1"	Q13285	9	124481236-124507420	"Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 188.3;lymphoid tissue: 142.8"	"Group enriched"	"Detected in some"	8	"Granulosa cells: 47.9;Theca cells: 180.1"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 1.7;ovarian cancer: 2.4;testis cancer: 2.6"	"Region enriched"	"Detected in some"	9	"thalamus: 18.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 82.9;Hep G2: 59.2;K-562: 20.6"	"Region enriched"	"Detected in single"	52	"hypothalamus: 5.2"	"Region enriched"	"Detected in single"	8	"hypothalamus: 1.2"	HPA079181			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA079181: "	"unprognostic (1.66e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.13e-5)"	"unprognostic (2.32e-7)"	"unprognostic (3.95e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.14e-2)"			"unprognostic (4.75e-3)"	"unprognostic (1.14e-1)"		"unprognostic (1.49e-2)"	0.1	188.3	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	2.0	0.0	0.1	0.0	0.1	0.0	0.0	35.8	0.0	0.0	21.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	142.8	0.1	14.1	18.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	82.9	0.0	59.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.3	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	180.1	0.0	0.0
NTN5		ENSG00000142233	"Netrin 5"	Q8WTR8	19	48661407-48673081	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 5.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Bipolar cells: 5.4;Early spermatids: 9.2;Horizontal cells: 8.4;Late spermatids: 11.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 4.8"						"Secreted in brain"	NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (8.20e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.26e-6)"	"unprognostic (4.48e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.89e-3)"	"unprognostic (9.40e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.60e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.51e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-3)"	0.3	0.4	2.0	0.2	2.2	0.3	1.2	1.6	2.8	1.4	0.6	0.6	0.2	1.0	0.5	0.5	3.2	0.7	0.3	1.9	1.4	0.8	0.4	0.4	0.8	1.9	1.8	2.3	0.4	0.5	5.1	0.0	1.5	2.8	0.0	1.2	1.0	0.8	0.2	1.2	0.6	0.1	1.7	0.9	0.3	0.6	1.8	0.6	1.9	0.1	0.3	0.4	0.8	2.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.3	0.5	0.2	0.0	0.0	0.6	0.0	0.2	0.9	0.1	0.0	0.0	0.3	0.2	0.4	0.0	1.2	0.0	0.3	0.3	0.2	0.0	0.0	0.6	0.1	0.0	0.0	0.3	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.2	1.6	2.8	1.9	1.4	1.9	1.8	1.5	1.7	1.8	2.2	1.1	0.0	0.0	4.6	0.1	0.5	0.4	0.1	0.0	5.4	0.8	1.9	0.3	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.1	9.2	0.5	1.3	0.6	0.0	0.0	1.1	0.0	0.0	0.4	0.0	1.0	0.0	2.3	0.4	0.1	0.1	8.4	0.6	0.1	0.0	0.0	0.4	11.8	0.6	0.1	1.8	1.0	0.0	1.6	1.0	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	2.8	0.0	0.7	0.4	3.1	0.2	0.1	0.1	0.1	0.2	3.1	0.0	0.2
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815640-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 7.0;brain: 21.7"	"Group enriched"	"Detected in some"	10	"Bipolar cells: 22.8;granulocytes: 55.9;Horizontal cells: 57.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 7.6;medulla oblongata: 19.8;pons: 21.7"	"Immune cell enriched"	"Detected in single"	116	"basophil: 94.5"	"Lineage enriched"	"Detected in single"	768	"granulocytes: 94.5"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 82.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.4"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.1"	"CAB004606, HPA035799, HPA076570"	Approved		Approved	Vesicles,Cytosol		NA	NA		79000	"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 62: Horizontal cells - Visual perception"	"Vesicles, Cytosol"		"CAB004606: AB_628397, HPA035799: AB_2674788, HPA076570: "	"unprognostic (5.89e-3)"	"unprognostic (7.56e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.99e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.42e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.18e-11)"	"unprognostic (2.18e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-1)"	0.8	7.0	0.7	0.4	1.8	0.7	0.2	1.8	7.6	0.7	0.7	0.8	0.5	1.0	0.0	0.1	0.5	0.4	1.0	0.3	2.8	3.0	0.0	0.5	0.1	19.8	1.5	0.1	0.2	0.0	0.7	0.2	21.7	1.4	0.0	1.9	0.5	0.3	0.4	0.1	0.3	0.6	0.2	0.1	0.5	1.6	0.4	0.3	0.2	0.2	0.0	0.3	0.5	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.0	11.9	0.0	14.0	0.0	0.0	0.0	0.0	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.4	1.6	0.0	0.2	0.0	2.4	0.2	0.0	1.5	2.5	0.0	0.2	0.0	0.5	1.5	18.2	0.0	0.1	0.0	0.3	0.0	0.1	0.3	0.0	1.1	0.0	0.0	3.5	0.6	0.0	0.0	0.0	0.1	94.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.7	1.8	1.8	7.6	0.3	2.8	19.8	1.5	21.7	0.2	0.4	0.6	0.1	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	4.2	0.7	0.0	0.0	4.3	0.0	0.1	55.9	0.0	0.0	0.0	0.1	57.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.9	3.2	2.7	0.0	0.1	0.0	1.0	0.1	0.0	0.0
NXPH3	NPH3	ENSG00000182575	"Neurexophilin 3"	O95157	17	49575871-49583827	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Bipolar cells: 23.3;Fibroblasts: 7.6;Muller glia cells: 8.5;Peritubular cells: 14.3;Smooth muscle cells: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 11.4;BJ: 3.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 41.1"	HPA073819			Approved	"Vesicles,Mitotic spindle"	"Secreted in brain"	Yes	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	"Mitotic spindle"	"HPA073819: "	"unprognostic (2.39e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.62e-4)"	"unprognostic (2.59e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.05e-3)"	3.9	0.9	1.8	1.0	1.8	0.0	2.9	16.4	3.5	9.0	0.7	11.0	0.4	12.0	0.6	1.5	7.0	1.7	2.9	3.5	0.5	0.4	0.1	2.7	0.5	6.3	3.8	5.2	0.6	1.3	7.5	1.3	6.4	5.9	0.3	0.6	3.1	4.7	1.2	2.3	1.7	2.5	0.1	1.0	3.4	1.6	3.9	0.3	1.4	2.0	0.3	8.9	6.9	3.0	0.0	0.0	0.1	0.0	0.0	0.2	11.4	3.2	0.4	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	16.4	3.5	3.5	0.5	6.3	3.8	6.4	0.1	3.9	3.0	0.5	0.0	1.3	14.0	0.0	0.4	0.3	0.2	0.6	23.3	0.9	0.5	1.7	1.5	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.6	0.0	0.0	2.5	0.2	3.2	7.6	0.0	0.5	0.0	0.0	6.4	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.4	0.0	4.4	0.3	1.8	0.0	4.2	8.5	0.0	2.5	0.5	0.0	0.0	14.3	0.7	0.3	0.0	0.0	0.0	1.2	0.0	0.8	8.9	0.1	1.3	0.0	1.1	0.1	0.2	0.1	0.0	0.1
OR51I1		ENSG00000167359	"Olfactory receptor family 51 subfamily I member 1"	Q9H343	11	5440570-5441514	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"olfactory bulb: 3.0"							NA	NA						"Cluster 25: Spermatids - Spermatogenesis"																		"unprognostic (2.36e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
OR52D1		ENSG00000181609	"Olfactory receptor family 52 subfamily D member 1"	Q9H346	11	5488685-5489749	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	4	"testis: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory bulb: 3.1"	HPA046965	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"					"HPA046965: AB_2679878"																		0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTOGL	"C12orf64, FLJ90579"	ENSG00000165899	"Otogelin like"	Q3ZCN5	12	80099537-80380880	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 1.9;kidney: 5.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 51.2;Oligodendrocyte precursor cells: 42.3"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.3;U-87 MG: 2.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"HPA040364, HPA053392"	Uncertain		Approved	Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA040364: AB_10795365, HPA053392: AB_2682135"	"unprognostic (2.43e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.76e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.04e-2)"	0.1	0.0	0.5	0.0	0.7	0.0	0.1	0.0	1.0	0.1	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.1	1.9	0.3	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.1	0.1	0.1	0.5	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.1	0.1	0.2	0.0	0.0	51.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	42.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1
P2RX1	P2X1	ENSG00000108405	"Purinergic receptor P2X 1"	P51575	17	3896592-3916476	"Predicted membrane proteins"	"Apoptosis, Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.0;pancreas: 65.1;urinary bladder: 75.5"	"Cell type enriched"	"Detected in some"	5	"granulocytes: 185.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 46.3"	"Group enriched"	"Detected in many"	30	"dendritic cells: 15.1;granulocytes: 23.5;monocytes: 46.3"	"Cell line enhanced"	"Detected in some"		"HEL: 13.8;HMC-1: 8.4;Karpas-707: 16.8;THP-1: 14.7;U-937: 7.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"midbrain: 1.3"	HPA057678			Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Endoplasmic reticulum"		"HPA057678: "	"unprognostic (1.27e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.89e-5)"	"unprognostic (1.77e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.47e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.09e-2)"	9.8	2.0	0.5	4.4	0.8	42.0	1.5	0.8	0.7	7.7	0.4	13.4	9.3	7.3	1.8	23.0	3.9	2.0	2.0	0.5	0.7	1.0	0.7	4.8	2.9	0.8	0.9	2.1	65.1	0.1	0.3	3.8	0.8	10.7	9.2	0.1	1.6	34.1	0.5	5.9	9.0	6.0	0.7	13.0	2.8	2.6	0.6	2.0	0.4	0.3	3.2	75.5	8.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.2	0.1	1.1	1.8	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.1	3.3	0.0	0.4	0.0	2.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.1	7.4	0.0	0.0	10.8	11.9	0.0	20.4	0.0	0.4	0.0	0.0	5.9	0.9	0.0	0.0	23.5	0.0	46.3	15.1	0.0	8.2	0.5	0.8	0.8	0.7	0.5	0.7	0.8	0.9	0.8	0.7	0.6	1.0	0.1	3.2	4.2	0.7	15.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.3	0.0	0.0	0.1	8.9	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	18.5	0.3	2.0	0.1	0.9	0.5	0.0	185.4	0.0	0.0	0.0	3.6	0.0	0.2	0.1	0.0	5.1	2.4	0.2	0.0	22.5	0.0	1.0	7.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	36.0	0.0	0.0	0.1	0.7	0.0	0.0	0.4	3.4	0.0	0.1	0.1	0.9	0.0	1.8	0.5	0.3	0.0
P3R3URF		ENSG00000250719	"PIK3R3 upstream reading frame"	A0A087WWA1	1	46175486-46176488	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"testis: 141.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.6"							NA	NA				"Cluster 74: Testis - Spermatogenesis"																							0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	141.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PABPN1L	ePABP2	ENSG00000205022	"PABPN1 like, cytoplasmic"	A6NDY0	16	88863333-88866660	"Predicted intracellular proteins"		RNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"adrenal gland: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.6;NB-4: 1.8;SCLC-21H: 4.7;T-47d: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.6"	HPA043415	Uncertain					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"				"HPA043415: AB_10981610"	"unprognostic (2.19e-1)"							"unprognostic (1.50e-2)"			"unprognostic (1.40e-3)"	"unprognostic (8.96e-3)"		"unprognostic (1.57e-1)"	"unprognostic (3.19e-1)"			0.1	2.4	0.1	0.0	0.3	0.8	0.1	0.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	2.6	0.3	1.8	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.9	0.4	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PCP2	"GPSM4, MGC41903"	ENSG00000174788	"Purkinje cell protein 2"	Q8IVA1	19	7631611-7633719	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 53.4;retina: 33.3;testis: 112.4"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 4139.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 53.4;white matter: 16.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 8.4;Karpas-707: 4.2;NB-4: 17.7"	"Region enriched"	"Detected in many"	44	"cerebellum: 2160.4"	"Region enriched"	"Detected in all"	28	"cerebellum: 552.9"	HPA057428			Approved	"Nuclear speckles,Vesicles"		Yes	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear speckles"	Vesicles	"HPA057428: AB_2683436"	"prognostic favorable (7.93e-4)"	"unprognostic (6.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.79e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.11e-1)"	"unprognostic (6.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.70e-2)"	"prognostic favorable (2.76e-5)"	0.4	1.6	0.4	1.1	0.6	3.7	5.5	53.4	2.3	2.1	0.0	0.6	1.4	0.9	3.3	2.0	2.4	2.3	2.2	0.5	0.0	8.0	3.7	2.2	3.0	0.1	3.5	0.1	5.4	1.1	1.4	0.4	5.5	5.9	0.3	33.3	16.3	1.9	0.2	7.0	1.6	0.0	0.1	3.0	3.1	112.4	0.0	3.1	5.7	0.0	1.4	0.9	1.6	16.8	1.8	0.4	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	1.6	0.7	1.1	0.0	0.0	1.3	0.0	0.2	0.0	0.8	0.6	2.6	2.8	0.1	0.0	0.3	8.4	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.2	4.2	0.0	0.3	0.3	17.7	0.4	0.3	0.0	0.8	0.2	0.7	0.8	0.1	0.1	0.0	1.4	1.4	0.0	0.4	3.7	3.4	0.2	0.0	0.5	0.4	0.0	1.4	0.7	0.2	0.0	2.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.1	0.1	0.1	0.2	0.3	0.2	0.3	0.8	0.2	0.0	0.6	0.0	1.7	0.4	0.6	53.4	2.3	0.5	0.0	0.1	3.5	5.5	0.1	0.0	16.8	0.1	0.0	2.3	0.0	0.2	0.8	1.1	1.4	0.0	734.7	7.7	5.8	0.0	2.8	1.8	5.5	22.9	0.2	2.7	0.7	9.8	0.8	836.5	1.0	0.1	2.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.5	1.3	1.3	0.0	0.5	0.4	23.5	0.0	0.4	0.0	0.8	1.3	4139.3	10.5	7.1	1.8	1.0	1.5	40.7	2.1	0.0	0.0	0.4	0.1	13.2	0.3	1.0	1.3	0.5	0.4	100.3	19.7	0.0	0.1	14.5	9.0	0.0	1.1	0.0	1.0	0.0	0.6	0.6
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165988078	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 67.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 204.7;Inhibitory neurons: 209.6;Microglial cells: 89.0;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 51.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 67.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 9.0;LHCN-M2: 12.5;RT4: 6.9;SH-SY5Y: 8.1;TIME: 11.3;U-2 OS: 7.0"	"Region enriched"	"Detected in all"	11	"basal ganglia: 350.1"	"Region enriched"	"Detected in all"	5	"basal ganglia: 194.1"	"CAB045998, HPA047200"	Supported					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (1.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (4.44e-7)"	"unprognostic (3.59e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.90e-3)"	2.6	1.3	3.1	0.8	67.2	0.0	2.3	5.5	10.7	1.3	0.0	1.0	0.2	2.0	2.4	0.4	2.4	1.5	3.6	2.1	2.5	3.8	0.3	1.0	0.5	1.6	2.3	2.3	0.5	0.5	2.7	2.5	0.9	1.7	0.2	1.9	0.4	1.7	0.4	0.3	0.7	2.1	0.5	1.4	1.1	3.4	9.6	0.3	6.0	0.5	0.4	3.2	0.9	0.1	0.0	2.4	5.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.8	0.0	0.0	0.0	3.8	0.1	2.2	0.0	0.0	0.1	3.9	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.5	0.0	0.0	0.0	12.5	0.3	0.9	0.0	1.1	0.0	4.7	1.5	5.8	0.0	5.9	6.9	1.8	8.1	0.0	0.0	0.4	0.7	0.0	0.0	11.3	0.1	7.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	67.2	5.5	10.7	2.1	2.5	1.6	2.3	0.9	0.5	9.6	0.1	13.8	0.0	0.0	10.4	0.1	0.4	3.3	0.4	0.0	7.2	0.3	0.3	7.3	0.0	1.2	5.5	2.1	7.8	0.0	0.0	3.9	2.0	14.3	0.2	1.7	13.4	0.0	0.0	204.7	0.0	6.1	6.6	1.1	0.4	1.3	0.1	7.9	0.0	0.8	16.8	209.6	0.0	0.0	0.0	0.0	14.9	0.0	0.2	1.8	89.0	0.0	12.6	0.0	48.7	51.8	0.1	0.0	0.4	0.0	17.9	0.0	7.2	0.9	1.1	0.0	12.4	5.0	8.8	2.1	0.1	0.3	2.9	0.1	1.6	0.1	6.9
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549601-54579239	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 76.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.6;Inhibitory neurons: 10.2;Kupffer cells: 13.0;Macrophages: 9.4;Sertoli cells: 13.1;Smooth muscle cells: 13.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 76.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;HMC-1: 14.9;NB-4: 10.7;THP-1: 9.0;U-937: 7.2"	"Region enriched"	"Detected in all"	6	"basal ganglia: 999.4"	"Region enriched"	"Detected in all"	7	"basal ganglia: 228.7"	HPA018492	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	9.1	1.1	8.4	4.0	76.9	4.8	4.6	0.0	13.7	2.0	0.0	7.4	1.0	2.7	1.8	1.7	2.0	2.2	1.4	6.3	0.1	0.8	1.0	2.3	1.3	0.0	0.0	8.6	0.4	6.1	0.3	0.2	0.0	1.3	1.0	0.4	1.0	1.4	0.6	1.4	3.4	4.0	0.0	4.0	3.3	0.7	2.4	0.9	2.0	1.0	0.8	8.7	1.5	4.9	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	2.1	0.0	0.0	12.7	0.6	4.3	0.0	0.0	0.0	5.5	14.9	0.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	2.3	0.0	0.0	0.5	10.7	3.5	0.0	0.0	2.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	9.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	2.5	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	76.9	0.0	13.7	6.3	0.1	0.0	0.0	0.0	0.0	2.4	4.9	2.3	0.0	1.1	1.6	1.8	1.0	0.2	0.0	0.6	2.7	0.2	0.6	3.6	0.0	0.6	3.7	0.0	0.1	1.4	0.0	0.0	0.0	6.3	0.1	0.0	0.8	1.8	3.6	18.6	0.0	0.0	1.5	0.0	0.0	0.0	4.4	0.0	0.3	8.5	5.0	10.2	0.0	0.0	13.0	2.5	4.9	2.1	9.4	0.0	2.8	6.7	0.1	4.1	1.0	0.9	0.0	0.0	3.0	2.6	0.4	0.0	0.0	0.0	0.2	13.1	0.6	13.7	0.8	0.6	0.2	0.4	0.3	2.8	0.4	0.1	0.1
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446671	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 376.2;brain: 164.1;testis: 129.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 758.4;Leydig cells: 1137.9;Peritubular cells: 225.7;Spermatocytes: 274.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.3;ASC TERT1: 8.6;BJ: 7.7;THP-1: 7.7"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3626.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 923.2"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	NA	NA		220000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	8.6	376.2	29.9	4.4	164.1	0.0	4.9	45.2	45.6	9.2	0.5	23.1	1.1	8.1	0.0	1.4	7.6	12.5	25.6	2.7	74.0	0.2	0.2	3.7	0.1	81.4	15.9	29.7	1.1	0.0	17.1	2.9	51.3	22.4	2.0	0.6	2.7	23.4	3.0	0.8	4.2	4.6	54.0	0.1	10.0	129.0	38.0	0.2	1.0	5.3	0.1	0.6	6.2	10.1	0.0	0.0	0.1	0.0	14.3	8.6	0.0	7.7	2.5	1.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.9	164.1	45.2	45.6	2.7	74.0	81.4	15.9	51.3	54.0	38.0	10.1	0.2	0.0	1.5	0.3	0.5	0.1	0.2	758.4	0.0	0.3	0.1	0.6	0.8	0.0	8.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	85.7	0.1	3.1	0.9	0.0	0.0	0.4	0.0	0.1	16.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.4	0.0	2.0	0.0	0.7	60.8	1137.9	1.2	0.0	1.9	0.0	0.0	0.0	0.5	0.4	0.0	0.0	225.7	0.0	0.2	0.0	0.0	3.6	0.0	6.6	1.7	1.2	274.1	19.1	0.1	0.4	0.0	0.2	3.1	0.0	0.0
PERCC1		ENSG00000284395	"Proline and glutamate rich with coiled coil 1"	A0A1W2PR82	16	1431078-1434441	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"prostate: 1.8;stomach 1: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	56	"SCLC-21H: 33.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 4.0"							NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 7: SCLC-21H - Neuronal signaling"																						0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.6	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	33.3	0.4	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PI15	P25TI	ENSG00000137558	"Peptidase inhibitor 15"	O43692	8	74824534-74855029	"Predicted secreted proteins"		"Developmental protein, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.4;prostate: 31.0;smooth muscle: 49.9"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 36.8;Breast glandular cells: 73.2;Breast myoepithelial cells: 13.6;Prostatic glandular cells: 19.3;Smooth muscle cells: 36.2;Urothelial cells: 15.7"	"Group enriched"	"Detected in many"	7	"breast cancer: 11.1;melanoma: 8.6;prostate cancer: 18.8"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 23.3;SH-SY5Y: 21.3;SK-MEL-30: 30.0;U-266/70: 7.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"spinal cord: 6.3"	"HPA006593, HPA030057"	Uncertain		Approved	Vesicles,Cytosol	"Secreted in other tissues"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Cytosol	"HPA006593: AB_1078568, HPA030057: AB_10602143"	"unprognostic (2.77e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.63e-14)"	"unprognostic (2.54e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	5.8	1.1	0.6	54.4	0.8	0.0	22.1	0.1	1.6	11.0	0.0	7.8	0.2	19.8	2.1	2.5	20.9	1.5	1.8	0.9	0.9	0.9	0.2	2.2	0.6	0.7	0.8	6.3	0.3	0.0	0.5	0.3	0.4	31.0	4.6	0.6	2.0	6.8	0.4	0.4	4.6	49.9	1.1	1.3	0.7	0.5	2.4	0.4	0.6	0.2	0.2	8.3	6.5	0.6	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.1	21.3	0.0	0.1	30.0	0.4	0.5	0.5	0.0	0.0	0.5	0.0	0.1	7.9	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.1	1.6	0.9	0.9	0.7	0.8	0.4	1.1	2.4	0.6	0.2	0.0	0.0	2.3	0.1	0.1	36.8	0.0	0.6	0.2	73.2	13.6	0.5	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.6	0.2	9.1	2.5	0.0	0.0	4.3	0.0	0.4	3.9	0.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	3.6	0.0	0.0	0.0	0.6	1.9	0.9	0.2	3.6	1.0	0.0	0.0	0.0	0.5	2.0	0.0	0.0	0.0	0.1	19.3	0.0	0.1	0.0	0.5	0.0	1.7	36.2	0.0	0.0	0.4	0.0	0.1	0.4	0.0	0.0	15.7
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 140.6;heart muscle: 127.7;vagina: 127.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 204.8;Leydig cells: 205.9;Oligodendrocytes: 67.3;Peritubular cells: 149.7"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 66.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 66.1"	"Cell line enriched"	"Detected in some"	6	"JURKAT: 29.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	7	"spinal cord: 33.2"	HPA076574	Approved				"Secreted to blood"	NA	NA		2900000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	57.8	3.5	12.2	3.1	17.7	0.2	66.1	14.3	15.1	140.6	7.9	11.6	1.5	5.7	29.0	10.6	15.0	46.4	127.7	10.1	16.1	1.5	0.7	11.4	2.2	15.3	14.2	3.4	5.6	0.9	8.4	2.4	15.8	31.3	7.9	0.0	14.0	34.2	15.1	51.7	4.5	8.4	13.4	1.3	22.1	14.7	16.4	2.4	23.2	33.6	6.0	116.1	127.6	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.9	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	29.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.8	0.6	19.7	5.7	0.0	1.3	6.4	2.2	0.5	13.5	0.0	0.5	66.1	3.3	12.2	17.7	14.3	15.1	10.1	16.1	15.3	14.2	15.8	13.4	16.4	19.3	10.9	0.0	1.5	3.3	0.7	21.5	0.1	0.0	0.6	0.0	0.4	0.4	4.5	0.0	0.6	1.8	0.0	0.0	0.4	0.0	1.9	0.1	10.8	0.1	0.2	11.0	0.0	0.0	0.1	0.0	0.0	204.8	4.1	0.1	0.0	0.0	10.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	39.6	19.0	205.9	1.9	10.6	3.7	0.0	0.0	0.0	0.0	67.3	0.1	0.0	149.7	0.6	0.1	0.0	0.2	0.0	0.0	0.0	7.7	4.2	2.4	1.3	0.4	18.5	0.1	3.5	0.3	0.0	0.2
PLAC9		ENSG00000189129	"Placenta associated 9"	Q5JTB6	10	80131682-80145359	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 124.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 926.5;Leydig cells: 873.5;Peritubular cells: 659.7;Sertoli cells: 295.9;Smooth muscle cells: 446.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 98.5;ASC TERT1: 85.3;BEWO: 32.1;HSkMC: 28.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 37.9"	HPA043469	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA043469: AB_10795770"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.57e-3)"	"unprognostic (5.88e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (6.60e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-3)"	112.3	18.4	10.2	6.6	9.2	1.2	85.7	10.3	15.5	77.3	53.3	22.1	4.0	26.9	5.0	21.4	30.4	9.0	124.3	14.3	5.9	17.9	6.4	56.1	2.7	5.9	5.8	11.5	5.7	4.1	4.9	12.5	6.4	35.9	4.6	0.6	20.1	7.6	16.9	47.8	19.7	6.5	6.5	5.0	21.4	14.9	6.9	2.2	44.6	19.2	1.9	54.0	75.7	8.5	0.2	0.0	0.8	0.0	98.5	85.3	32.1	10.3	8.7	0.9	1.2	0.0	0.7	0.0	0.2	6.0	0.1	0.8	0.1	0.0	0.0	0.8	0.3	0.0	0.5	0.0	16.4	0.0	2.3	28.7	0.0	2.1	1.2	10.6	3.4	0.4	0.0	0.4	0.0	0.3	0.1	0.6	1.9	0.4	1.5	0.0	0.1	1.5	0.0	0.6	0.0	1.8	0.0	1.2	0.7	0.2	0.1	0.2	3.6	6.6	3.6	21.0	0.2	0.7	0.9	0.1	1.9	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	10.2	9.2	10.3	15.5	14.3	5.9	5.9	5.8	6.4	6.5	6.9	8.5	246.2	3.2	1.8	0.0	1.6	126.4	0.7	1.1	8.0	0.4	7.4	14.0	24.4	0.0	0.3	0.0	0.0	7.0	3.6	0.1	0.0	0.3	4.6	3.1	75.7	102.5	1.8	0.0	0.5	0.2	17.7	926.5	5.6	4.4	1.3	0.1	115.6	0.3	14.1	0.0	0.5	0.0	0.0	0.0	191.3	26.7	873.5	7.9	136.9	7.5	0.0	50.2	0.0	0.0	0.2	0.7	0.0	659.7	2.1	1.0	0.0	0.2	0.9	1.7	295.9	89.7	446.6	2.6	2.9	4.6	126.3	11.5	14.1	1.1	0.0	1.8
PLEKHA4	PEPP1	ENSG00000105559	"Pleckstrin homology domain containing A4"	Q9H4M7	19	48837097-48868617	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 53.4;Smooth muscle cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 63.4;BJ hTERT+ SV40 Large T+ RasG12V: 49.5;SK-MEL-30: 77.0"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"spinal cord: 45.0"	"HPA042978, HPA048473"	Uncertain		Approved	"Plasma membrane,Cytokinetic bridge,Centriolar satellite,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Cytosol"	"Cytokinetic bridge, Centriolar satellite"	"HPA042978: AB_2678249, HPA048473: AB_2680409"	"prognostic favorable (1.97e-4)"	"unprognostic (4.39e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.20e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-3)"	"unprognostic (6.38e-2)"	34.0	24.6	8.8	12.1	8.8	0.7	31.7	8.0	9.5	28.7	10.9	43.0	5.6	34.6	5.0	14.3	30.5	11.1	41.4	8.7	10.6	32.4	32.8	25.7	5.8	16.9	14.7	47.5	13.2	9.5	29.9	5.6	10.4	28.3	3.9	2.5	15.1	8.4	19.3	17.2	16.0	10.7	10.8	16.2	21.1	11.0	12.4	5.5	31.0	13.1	3.3	34.4	21.7	10.3	9.0	0.5	9.9	63.4	14.2	41.7	8.0	7.0	24.7	26.8	49.5	5.9	2.5	0.4	11.8	9.8	10.4	2.7	3.5	3.6	4.2	0.0	3.4	2.3	1.7	6.6	11.0	0.0	14.2	21.5	2.2	15.6	1.0	11.1	8.0	11.2	9.5	5.3	7.4	5.4	3.2	0.5	1.5	6.0	0.8	0.3	31.5	0.6	8.3	0.1	0.0	11.0	3.0	2.6	77.0	2.5	3.9	3.0	1.3	8.5	6.8	11.2	1.8	28.3	25.4	5.3	10.2	0.7	23.0	0.0	0.3	0.9	1.8	0.3	1.3	1.7	1.7	1.1	0.1	3.9	2.8	2.6	0.1	0.8	0.3	1.2	0.6	0.9	8.8	8.8	8.0	9.5	8.7	10.6	16.9	14.7	10.4	10.8	12.4	10.3	6.4	0.0	18.7	2.3	1.4	9.6	31.3	17.6	12.0	0.7	11.4	18.3	37.1	17.2	27.2	7.3	0.0	3.3	2.9	3.2	1.9	23.3	0.8	11.6	34.1	7.0	1.2	3.2	0.4	5.1	6.8	41.7	7.7	11.6	0.0	18.8	6.4	13.3	2.9	0.0	0.5	2.5	4.1	0.8	9.2	2.0	41.3	1.9	12.4	1.9	1.3	9.9	2.1	0.5	0.2	6.9	0.5	53.4	0.7	29.8	0.7	14.6	20.5	1.0	6.6	33.0	48.4	4.0	3.7	5.7	9.8	2.9	2.4	16.0	3.3	21.4
PMCH	MCH	ENSG00000183395	"Pro-melanin concentrating hormone"	P20382	12	102196459-102197833	"Predicted secreted proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Hormone, Neuropeptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"brain: 92.8"	"Group enriched"	"Detected in some"	4	"B-cells: 2.7;Exocrine glandular cells: 2.0;monocytes: 1.0;T-cells: 1.7"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 92.8;thalamus: 60.2"	"Immune cell enriched"	"Detected in some"	10	"T-reg: 9.5"	"Lineage enriched"	"Detected in single"	85	"T-cells: 9.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 44.9"	"Group enriched"	"Detected in many"	129	"hypothalamus: 624.3;thalamus: 339.8"	"Region enriched"	"Detected in some"	34	"hypothalamus: 83.0"	"HPA046055, HPA061884"	Enhanced	Supported			"Secreted to blood"	NA	NA	274000		"Cluster 35: T-regs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA046055: AB_2679517, HPA061884: AB_2684632"	"unprognostic (3.23e-3)"	"unprognostic (8.04e-2)"	"unprognostic (3.96e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.73e-2)"		"unprognostic (4.31e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.16e-6)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.53e-2)"	0.0	0.0	0.2	0.5	2.7	0.6	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.0	92.8	0.0	0.0	0.1	1.0	0.3	22.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.2	0.0	0.0	0.4	0.5	0.0	60.2	1.0	0.0	0.1	0.4	0.1	0.0	0.0	0.4	0.2	0.5	0.4	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.2	0.2	0.0	0.0	0.0	44.9	0.0	0.7	0.8	0.4	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.2	5.3	0.5	0.9	0.0	0.0	0.0	0.8	1.5	0.6	0.7	1.3	0.4	0.6	1.8	0.0	0.3	0.5	0.5	0.6	0.8	0.1	0.3	0.3	0.1	0.6	0.6	0.5	0.2	0.7	0.1	0.8	0.6	0.5	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.2	2.7	0.1	0.3	0.0	92.8	0.3	22.2	0.3	0.0	60.2	0.0	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.0
PMP2	"FABP8, M-FABP, MP2"	ENSG00000147588	"Peripheral myelin protein 2"	P02689	8	81440326-81447439	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Transport		"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	50	"brain: 278.7;choroid plexus: 97.2"	"Group enriched"	"Detected in some"	16	"Astrocytes: 84.9;Muller glia cells: 48.5;Oligodendrocyte precursor cells: 88.4;Oligodendrocytes: 90.3"	"Cancer enriched"	"Detected in some"	59	"glioma: 239.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"WM-115: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	9	"spinal cord: 1313.6"							NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"					"unprognostic (5.87e-2)"			"unprognostic (5.81e-2)"	"unprognostic (1.12e-2)"		"unprognostic (1.95e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.43e-2)"		"unprognostic (7.21e-2)"	"unprognostic (4.41e-1)"		"unprognostic (3.27e-3)"	1.8	1.4	155.1	1.4	168.0	0.0	0.7	231.4	193.1	1.3	97.2	1.4	0.4	0.1	1.8	0.8	0.3	1.1	2.0	146.1	206.4	0.4	0.2	0.1	0.0	278.7	243.1	0.2	0.4	0.0	0.7	0.0	257.4	1.8	0.7	0.2	1.0	3.7	0.3	0.3	0.6	0.3	247.1	0.0	0.6	0.1	214.0	0.0	0.3	0.8	0.0	0.9	1.1	275.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.1	168.0	231.4	193.1	146.1	206.4	278.7	243.1	257.4	247.1	214.0	275.2	1.4	0.0	0.0	84.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	4.7	0.0	48.5	0.0	88.4	90.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
PODNL1	"FLJ23447, SLRR5B"	ENSG00000132000	"Podocan like 1"	Q6PEZ8	19	13931187-13953392	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 13.4;Bipolar cells: 38.7;Leydig cells: 18.3;Peritubular cells: 38.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 6.6;HSkMC: 11.6;hTERT-RPE1: 18.8;SiHa: 9.7;U-2 OS: 6.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	11	"spinal cord: 18.9"	HPA042807	Approved				"Secreted - unknown location"	NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"			"HPA042807: AB_10795514"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.61e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.94e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.49e-4)"	1.8	0.7	1.9	0.9	1.7	0.5	4.9	2.3	1.8	5.6	0.8	2.8	0.4	1.5	0.2	8.2	2.1	1.3	4.7	1.2	3.6	1.7	0.5	5.1	0.2	4.3	4.4	3.3	1.5	0.1	5.1	3.7	3.0	7.9	0.3	2.0	5.3	0.9	1.6	11.4	2.3	0.5	3.1	1.0	1.7	7.2	3.7	0.0	3.1	1.3	0.2	2.7	12.0	2.0	0.3	0.4	0.4	0.2	0.6	1.5	0.1	4.1	2.4	0.8	1.6	0.3	0.4	0.2	0.3	6.6	0.2	1.6	0.1	0.1	0.4	1.5	0.6	0.8	0.4	0.0	5.1	0.2	0.5	11.6	0.7	1.1	0.1	18.8	0.0	0.1	0.4	0.3	1.6	2.7	0.2	0.2	0.1	0.3	0.4	0.1	0.1	0.0	0.3	0.0	0.7	0.4	9.7	0.1	0.3	0.4	0.1	0.5	0.7	2.0	6.7	0.5	0.2	0.3	0.0	0.1	0.8	0.9	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.9	1.7	2.3	1.8	1.2	3.6	4.3	4.4	3.0	3.1	3.7	2.0	1.4	0.0	0.5	2.3	0.0	1.3	0.9	13.4	0.0	38.7	2.1	8.0	1.6	0.0	1.4	0.0	2.1	0.4	0.2	1.8	0.0	0.2	1.7	0.5	6.1	0.9	0.0	2.7	0.5	0.0	0.2	4.7	0.0	0.4	0.0	0.5	0.7	0.1	9.8	1.7	0.7	1.1	0.0	1.2	1.7	2.1	18.3	0.9	1.8	1.9	0.0	1.8	0.0	1.5	0.3	0.6	9.0	38.0	0.0	0.5	0.6	0.1	1.4	4.6	0.0	0.6	1.0	1.0	0.7	2.6	4.3	0.8	0.2	0.1	1.4	1.6
POMC	"ACTH, CLIP, LPH, MSH, NPP, POC"	ENSG00000115138	Proopiomelanocortin	P01189	2	25160853-25168903	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted secreted proteins"		"Endorphin, Hormone"	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	903	"pituitary gland: 34360.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 119.8;Late spermatids: 352.6;Spermatocytes: 83.0"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 18.5"	"Group enriched"	"Detected in all"	6	"hypothalamus: 38.0;thalamus: 13.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;THP-1: 2.1"	"Region enriched"	"Detected in all"	7	"hypothalamus: 44.0"	"Region enriched"	"Detected in all"	5	"hypothalamus: 88.1"	"CAB002762, HPA046135, HPA063644, CAB079881"	Enhanced				"Secreted to blood"	NA	NA	380000		"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB002762: , CAB079881: , HPA046135: AB_2679552, HPA063644: AB_2685071"	"unprognostic (8.02e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (5.70e-4)"	"unprognostic (8.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.84e-2)"	6.1	19.1	2.7	1.2	2.8	1.1	3.5	3.2	4.4	3.0	2.2	6.9	0.4	3.1	0.3	13.7	2.2	0.2	12.1	2.3	38.0	4.9	12.9	3.5	1.1	4.5	3.3	5.0	22.6	0.1	34360.0	1.2	3.7	5.0	0.0	0.2	5.8	0.3	5.7	35.7	4.8	0.1	4.0	11.1	15.5	25.7	13.1	1.2	8.4	5.2	0.4	2.5	3.7	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	12.6	8.6	11.5	13.2	9.1	16.8	8.8	11.3	15.9	17.4	11.6	12.6	3.8	18.2	8.0	27.9	10.5	9.7	2.7	2.8	3.2	4.4	2.3	38.0	4.5	3.3	3.7	4.0	13.1	3.5	22.3	0.0	2.2	1.0	16.1	4.5	2.2	6.9	2.2	2.6	6.1	6.7	2.5	2.8	2.5	0.0	0.0	0.5	24.4	0.2	15.6	7.8	119.8	0.6	4.9	11.6	0.0	28.8	0.3	17.3	6.0	5.2	4.6	0.6	7.0	9.7	15.4	2.0	34.5	6.7	0.6	0.0	6.1	10.9	7.9	352.6	4.7	17.2	17.8	1.9	8.5	11.5	15.5	0.0	0.3	10.1	1.1	13.2	17.8	4.1	0.1	3.9	0.7	7.5	13.1	4.6	3.8	83.0	27.3	1.6	5.5	0.4	14.9	12.9	0.6	3.8
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 207.2;stomach 1: 174.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 295.7;Breast myoepithelial cells: 158.1;Endothelial cells: 134.6;Fibroblasts: 191.5;Smooth muscle cells: 151.5"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"hTEC/SVTERT24-B: 490.2;SuSa: 440.5;U-138 MG: 619.3;U-2197: 427.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"spinal cord: 87.9"	HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"	NA	NA		660000000		"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (1.83e-7)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	71.4	5.2	4.5	23.8	0.1	0.3	84.0	0.0	4.4	20.3	2.9	61.3	5.1	53.2	13.0	20.5	83.5	64.3	83.2	3.0	0.0	28.1	13.0	45.1	12.8	0.9	0.0	3.6	2.2	21.6	2.4	60.9	2.0	16.1	84.9	0.0	17.7	44.8	10.6	207.2	15.0	66.6	0.0	1.1	174.6	3.4	0.1	5.8	19.1	29.9	3.9	91.4	10.7	0.4	0.0	0.0	71.0	1.6	85.0	51.0	0.2	23.1	0.0	5.5	0.7	0.0	1.4	0.1	0.0	18.7	0.1	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	14.2	0.2	0.1	90.8	0.0	490.2	1.9	15.9	0.7	0.0	0.0	0.0	11.8	0.0	0.3	0.4	4.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.6	0.0	440.5	0.9	0.0	0.0	619.3	0.3	427.2	3.4	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.0	4.4	3.0	0.0	0.9	0.0	2.0	0.0	0.1	0.4	46.7	6.4	10.6	0.7	0.3	295.7	1.3	51.5	0.0	0.0	2.9	158.1	22.8	0.0	18.7	0.0	0.0	2.5	1.0	0.0	0.0	0.0	0.5	0.5	9.8	134.6	0.0	0.0	1.5	0.0	0.2	191.5	0.0	0.3	3.8	0.0	22.5	0.6	3.7	0.0	36.8	0.0	24.4	0.0	27.0	1.1	6.5	0.8	30.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.7	0.4	0.4	0.0	0.0	5.6	0.0	0.0	0.7	151.5	1.3	0.9	0.2	48.4	3.4	2.3	49.3	0.0	0.3
PPP1R1B	"DARPP-32, FLJ20940"	ENSG00000131771	"Protein phosphatase 1 regulatory inhibitor subunit 1B"	Q9UD71	17	39626740-39636626	"Metabolic proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 711.8;choroid plexus: 506.6;intestine: 211.4;salivary gland: 366.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 144.6;Distal tubular cells: 121.3;Intestinal goblet cells: 305.7;Melanocytes: 135.2;Paneth cells: 132.3;Undifferentiated cells: 423.7;Urothelial cells: 171.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 94.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"eosinophil: 1.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.6;CAPAN-2: 12.6;HSkMC: 31.7;OE19: 15.6;SCLC-21H: 27.4"	"Region enriched"	"Detected in all"	8	"basal ganglia: 1243.8"	"Region enriched"	"Detected in all"	26	"basal ganglia: 1534.8"	"CAB004026, HPA048630, HPA061142"	Approved	Approved				NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB004026: AB_2169007, HPA048630: AB_2680468, HPA061142: AB_2684438"	"unprognostic (2.71e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.91e-3)"	"unprognostic (2.42e-1)"	"unprognostic (3.01e-1)"	"unprognostic (7.69e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.55e-1)"	93.8	30.2	280.9	19.8	711.8	0.4	74.0	262.7	312.7	20.0	506.6	211.4	83.4	4.4	5.5	4.8	28.4	2.0	3.5	251.7	244.0	29.1	0.5	15.3	0.1	319.6	275.5	11.3	75.7	0.5	15.0	0.0	232.4	62.7	203.4	6.2	366.9	89.7	0.9	56.3	68.7	10.8	243.3	0.1	39.9	15.8	317.9	0.2	0.6	0.0	0.3	18.9	11.4	249.6	0.0	0.0	0.0	0.0	7.6	4.4	0.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.9	15.6	0.9	0.0	0.0	0.6	0.0	0.0	27.4	0.6	0.0	1.5	0.0	2.4	0.6	1.1	0.0	0.0	1.8	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	280.9	711.8	262.7	312.7	251.7	244.0	319.6	275.5	232.4	243.3	317.9	249.6	1.0	0.0	34.7	33.3	1.3	1.3	117.1	0.4	0.6	0.6	93.5	84.3	1.1	0.0	0.2	1.8	0.0	0.0	2.4	144.6	121.3	28.7	0.8	46.6	0.9	1.6	96.7	0.0	5.3	3.3	0.0	2.8	13.3	3.2	4.5	0.0	4.2	0.0	0.2	0.0	1.6	305.7	2.0	0.0	0.8	3.2	34.5	1.2	135.2	0.0	0.0	29.8	0.0	1.0	0.5	0.8	132.3	5.7	0.0	84.3	40.4	0.7	0.1	1.3	0.0	1.2	1.7	0.9	3.7	1.2	0.4	0.0	1.9	0.0	423.7	171.5
PRLH	PRH	ENSG00000071677	"Prolactin releasing hormone"	P81277	2	237566574-237567175	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 22.8"	"Cell type enhanced"	"Detected in single"		"Endometrial ciliated cells: 1.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.7"	"Region enhanced"	"Detected in many"		"medulla oblongata: 22.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.3;MCF7: 1.8;RPMI-8226: 1.4"	"Group enriched"	"Detected in some"	58	"hypothalamus: 11.3;pons and medulla: 21.5"	"Region enriched"	"Detected in single"	14	"medulla oblongata: 5.5"	HPA014976	Uncertain				"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA014976: AB_2732413"	"unprognostic (8.28e-4)"			"unprognostic (3.22e-2)"						"unprognostic (5.42e-2)"								0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	1.2	0.0	0.0	0.1	0.0	22.8	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.2	0.9	0.4	0.0	0.0	0.0	0.0	0.0	8.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.2	22.8	0.1	0.5	5.0	0.9	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PROSER2	"C10orf47, MGC35403"	ENSG00000148426	"Proline and serine rich 2"	Q86WR7	10	11823339-11872277	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 41.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 28.4;Glandular and luminal cells: 28.4;Hepatocytes: 31.2;Prostatic glandular cells: 34.6;Urothelial cells: 69.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 86.5;CAPAN-2: 99.5;HBEC3-KT: 64.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 14.4"	HPA041337	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA		220000		"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"HPA041337: AB_10794663"	"unprognostic (2.36e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.60e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.69e-2)"	4.5	1.6	1.9	1.0	2.0	10.4	4.1	1.4	1.6	3.6	4.8	3.1	1.2	3.4	0.5	9.9	3.8	1.7	1.8	1.7	1.8	14.0	41.0	9.8	0.3	1.9	2.3	2.4	7.5	0.5	1.9	7.2	2.0	9.1	1.8	0.1	6.9	2.2	2.0	5.1	1.7	1.0	1.7	7.3	6.6	6.1	3.1	1.9	6.7	0.4	2.8	4.0	6.0	1.3	86.5	12.1	0.7	0.3	2.5	3.1	4.9	3.8	1.8	3.0	1.5	28.1	99.5	0.0	15.1	0.3	1.3	22.1	8.4	64.2	1.5	0.1	20.3	9.8	4.8	18.4	14.2	0.0	5.9	3.6	13.6	17.8	19.9	0.3	9.2	1.6	15.0	0.1	4.3	11.7	0.0	3.2	5.3	11.3	6.9	13.9	11.3	0.0	6.6	4.2	0.1	1.1	6.5	24.9	11.1	4.1	13.1	5.3	6.8	0.1	19.7	33.2	0.4	0.0	0.2	0.1	0.1	3.4	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.9	2.0	1.4	1.6	1.7	1.8	1.9	2.3	2.0	1.7	3.1	1.3	3.0	9.6	5.9	1.3	0.0	5.7	28.4	8.2	8.6	0.0	5.5	5.2	1.1	18.6	6.5	5.5	0.0	5.5	0.2	3.2	5.9	11.6	3.0	18.6	2.8	3.7	1.8	2.5	0.7	3.8	18.3	3.6	6.1	28.4	0.0	1.9	1.1	31.2	0.8	0.0	0.7	1.3	2.0	0.3	0.7	3.0	1.8	3.7	3.6	6.5	0.1	0.1	0.0	0.5	0.4	20.0	1.5	4.5	0.0	34.6	0.2	0.8	6.8	0.1	0.0	0.6	1.3	3.7	5.6	4.6	4.7	0.7	0.5	0.7	2.6	69.4
PRPH	"NEF4, PRPH1"	ENSG00000135406	Peripherin	P41219	12	49293252-49298686	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.6;intestine: 21.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 327.5;Late spermatids: 920.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 1.6;glioma: 1.7;pancreatic cancer: 1.1;testis cancer: 1.5"	"Group enriched"	"Detected in many"	5	"medulla oblongata: 51.9;pons: 53.6;white matter: 15.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AN3-CA: 367.0"	"Group enriched"	"Detected in many"	4	"hypothalamus: 19.4;pons and medulla: 35.1"	"Region enriched"	"Detected in many"	8	"spinal cord: 256.8"	"CAB002437, HPA039277, HPA063887"	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB002437: AB_563956, HPA039277: AB_2676424, HPA063887: AB_2685142"	"unprognostic (1.73e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.04e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.25e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.86e-3)"	"unprognostic (6.36e-5)"	3.1	14.5	0.9	7.5	1.1	0.0	1.8	0.3	1.8	3.3	0.4	21.0	4.7	0.8	0.1	0.5	3.1	0.6	1.2	0.9	2.2	0.9	0.1	0.9	0.2	51.9	8.0	0.7	1.3	0.1	2.9	0.3	53.6	2.3	2.1	1.5	0.5	1.5	0.4	1.1	8.9	2.0	7.8	1.2	5.2	13.2	0.9	0.1	0.5	0.2	0.1	1.5	8.3	15.7	0.0	0.7	0.0	367.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.7	1.6	0.4	1.3	0.2	0.2	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	3.7	0.0	0.2	2.0	0.0	2.2	0.4	0.0	1.6	86.6	1.5	0.2	0.8	0.0	0.0	1.7	0.1	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.3	1.8	0.9	2.2	51.9	8.0	53.6	7.8	0.9	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	10.8	0.3	0.8	0.4	0.0	0.0	0.0	4.2	0.1	0.0	0.1	0.0	0.0	327.5	0.5	0.1	1.4	92.3	0.0	0.1	0.0	0.2	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	25.2	0.1	1.0	0.0	0.0	0.9	920.2	5.9	0.7	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.8	0.1	38.1	0.0	0.1	14.1	96.1	19.4	0.3	0.4	0.0	0.1	0.0	0.5	0.2
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 84.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 84.1;Early spermatids: 111.0;Late spermatids: 349.7;Spermatocytes: 453.2;Spermatogonia: 270.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 16.1;eosinophil: 33.0"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 33.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.0;HEL: 28.5;HeLa: 71.0;K-562: 34.3;U-698: 104.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	38	"basal ganglia: 8.9"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol		"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.1	0.0	0.1	0.5	0.1	7.8	1.3	0.0	0.1	1.6	0.0	0.7	0.5	0.2	0.0	1.5	2.7	1.8	0.0	0.0	0.1	0.1	0.1	2.5	1.2	0.1	0.0	0.1	2.0	1.5	0.1	0.0	0.1	3.8	0.5	0.0	20.5	0.3	0.0	0.9	0.8	0.1	0.0	1.7	0.8	84.6	0.1	1.1	0.0	0.0	1.2	0.4	1.4	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	25.0	0.0	0.1	0.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	28.5	71.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	0.0	0.0	13.8	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	104.8	0.0	0.0	0.0	16.1	3.5	33.0	3.1	2.6	4.8	1.2	1.5	2.6	0.9	0.8	2.2	3.2	0.3	1.8	0.5	2.2	1.0	2.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	4.6	1.1	37.9	9.4	13.1	0.0	6.1	8.4	84.1	0.0	2.7	0.0	0.0	0.3	2.1	1.4	0.0	1.1	111.0	0.3	2.6	1.6	0.0	9.7	0.0	0.4	9.0	0.7	0.0	0.4	0.0	0.4	0.0	0.0	11.1	0.0	0.0	1.5	4.1	0.6	0.7	349.7	6.5	5.7	0.0	0.0	1.1	0.0	4.1	0.0	0.1	0.7	0.6	3.8	20.4	32.7	0.1	0.1	0.5	0.0	46.0	0.0	1.0	453.2	270.2	2.8	0.6	0.1	3.4	0.0	2.4	14.5
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393766-40414793	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 34.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.8;Breast myoepithelial cells: 23.2;Cardiomyocytes: 15.4;Skeletal myocytes: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	8	"spinal cord: 114.2"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	4.5	4.7	6.2	1.3	6.8	1.6	3.9	5.2	6.5	4.8	2.9	3.6	1.1	4.4	1.0	2.0	4.2	1.8	3.1	4.7	4.4	6.7	1.0	34.6	1.3	5.4	4.9	6.2	3.8	5.9	1.5	5.1	6.7	4.6	0.7	0.8	3.8	3.5	4.9	3.2	2.2	2.0	4.9	2.0	3.7	1.6	5.7	0.7	9.6	5.5	0.8	4.3	3.1	4.1	1.6	2.6	2.1	2.7	1.3	4.4	2.6	1.4	1.5	1.9	1.4	1.0	1.7	0.5	1.6	1.3	1.2	0.9	1.0	0.6	0.7	0.8	0.9	0.3	0.3	0.5	2.1	0.1	2.3	3.3	3.2	1.2	1.1	1.7	1.6	2.9	2.0	0.5	1.0	2.2	1.0	0.6	0.6	3.8	1.7	3.2	1.8	1.5	0.4	1.8	0.2	1.0	2.7	2.3	2.0	0.9	3.2	1.2	1.4	3.8	2.9	1.6	0.8	5.3	5.0	0.7	1.1	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	6.2	6.8	5.2	6.5	4.7	4.4	5.4	4.9	6.7	4.9	5.7	4.1	17.8	3.2	5.9	0.7	1.4	6.2	2.3	0.3	5.7	0.1	8.1	23.2	15.4	2.8	0.9	1.8	0.0	1.1	1.7	1.0	0.0	0.3	0.1	1.3	1.7	9.2	0.0	0.4	0.6	0.6	0.7	7.0	0.0	3.0	0.0	2.0	6.8	1.3	1.1	0.0	0.5	0.7	2.0	1.6	2.5	0.1	3.4	2.5	3.6	7.5	0.3	3.3	0.0	0.0	0.5	0.5	1.4	4.5	0.9	1.7	1.2	1.9	0.2	0.1	0.0	30.3	6.1	0.3	0.7	5.0	4.1	2.7	1.1	1.3	1.5	1.0
PSCA		ENSG00000167653	"Prostate stem cell antigen"	O43653	8	142670308-142682725	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"stomach 1: 3019.3"	"Cell type enriched"	"Detected in many"	4	"Gastric mucus-secreting cells: 5332.3"	"Cancer enriched"	"Detected in many"	6	"urothelial cancer: 785.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 22.4;HeLa: 45.7;OE19: 17.6;RT4: 61.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"spinal cord: 38.2"	"HPA030783, HPA056418"	Approved		Supported	"Plasma membrane"		NA	NA		18000		"Cluster 4: Stomach - Digestion"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"HPA030783: AB_2673611, HPA056418: AB_2683123"	"unprognostic (1.21e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.81e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (5.60e-5)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-3)"	4.8	0.4	0.5	0.5	0.6	0.2	1.9	0.3	0.9	67.8	0.2	7.8	4.0	0.4	0.6	334.0	7.9	10.0	0.4	0.6	0.2	5.8	0.7	6.3	0.1	0.5	0.3	0.6	3.2	0.0	0.6	2.4	0.4	230.6	4.8	0.0	23.5	1.9	0.3	11.1	2.5	0.1	0.2	0.4	3019.3	1.4	0.5	0.4	0.4	0.0	15.0	629.0	167.7	0.5	10.7	0.7	0.0	0.0	2.1	6.8	10.6	4.9	1.1	2.1	1.8	0.1	22.4	0.0	0.4	0.4	8.1	2.1	0.0	0.4	1.3	0.6	0.0	0.0	45.7	0.0	0.1	0.0	1.5	6.0	7.8	4.6	0.0	0.6	0.0	0.0	0.0	0.0	1.7	5.8	1.7	0.6	1.2	17.6	1.2	0.7	0.0	0.9	1.0	61.7	0.2	0.5	5.1	15.6	3.5	0.3	0.2	0.2	1.0	1.5	1.7	2.7	0.0	1.9	0.1	0.0	2.9	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.3	0.9	0.6	0.2	0.5	0.3	0.4	0.2	0.5	0.5	0.2	3.2	1.5	1.6	7.7	0.9	26.0	120.0	0.0	0.0	3.9	2.7	1.2	71.4	894.2	1.8	0.0	2.3	0.0	1.9	7.9	3.2	0.3	1.3	0.1	1.1	275.1	0.0	0.3	1.2	5.0	3.3	5332.3	0.3	0.0	0.3	0.0	0.0	0.6	0.0	0.2	12.9	179.0	0.6	1.0	0.4	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	57.1	0.2	0.0	13.4	238.7	0.3	0.4	994.9	0.0	0.0	0.0	48.9	0.0	0.5	13.1	1.3	28.5	4.6	0.0	0.9	1241.5
PTPN7	"HEPTP, LC-PTP"	ENSG00000143851	"Protein tyrosine phosphatase non-receptor type 7"	P35236	1	202147013-202161588	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 46.8;dendritic cells: 112.7;granulocytes: 140.7;NK-cells: 99.9;Plasma cells: 63.9;T-cells: 127.2;Theca cells: 54.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"basal ganglia: 9.8"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 24.9;NK-cells: 14.9;T-cells: 14.0"	"Cell line enhanced"	"Detected in some"		"HEL: 54.1;HL-60: 118.6;HMC-1: 150.8;NB-4: 51.4;THP-1: 53.7;U-937: 84.0"	"Region enriched"	"Detected in single"	9	"basal ganglia: 6.1"	"Region enriched"	"Detected in many"	8	"basal ganglia: 13.3"	"CAB009530, HPA019118"	Approved		Supported	"Microtubules,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Microtubules, Mitotic spindle"	"CAB009530: AB_2173845, HPA019118: AB_1855755"	"unprognostic (4.19e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (2.91e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (3.01e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (1.46e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	1.3	4.2	0.6	10.2	9.8	39.7	0.7	1.0	1.8	0.8	0.5	2.2	4.5	1.1	0.0	1.5	0.6	3.2	0.5	0.6	1.2	1.3	1.1	2.5	20.8	2.3	1.5	0.3	0.4	0.1	0.3	0.5	1.8	0.8	2.7	0.0	1.3	0.6	0.1	1.2	5.6	1.5	1.4	9.9	2.4	8.3	2.9	31.1	0.8	0.5	20.8	3.2	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.6	0.0	54.1	0.0	0.0	0.0	118.6	150.8	0.0	0.0	0.0	0.0	0.0	0.1	40.0	2.3	5.0	0.0	0.0	16.3	51.4	0.0	0.0	0.0	2.4	0.0	39.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	53.7	0.3	0.0	0.5	0.0	0.1	22.8	6.3	33.7	0.1	84.0	0.1	17.9	1.5	24.9	13.7	1.5	12.5	2.6	9.2	14.0	2.9	3.2	6.7	8.2	9.9	14.9	0.6	3.8	12.8	4.5	0.6	9.8	1.0	1.8	0.6	1.2	2.3	1.5	1.8	1.4	2.9	2.5	3.2	3.2	5.1	3.3	46.8	2.3	1.3	0.1	0.0	2.7	1.5	1.8	0.7	1.5	0.7	0.0	0.0	0.5	112.7	0.5	0.0	0.5	0.6	0.9	0.8	5.6	0.0	35.5	0.7	0.0	0.2	2.2	1.5	0.7	140.7	6.7	3.6	0.4	15.4	0.0	0.7	0.1	0.0	11.2	31.2	2.4	5.3	21.3	8.8	1.0	10.4	3.8	99.9	1.0	4.6	0.1	0.1	2.2	63.9	0.6	0.2	0.7	0.1	3.7	0.0	0.9	1.1	0.8	0.7	0.5	2.4	0.8	127.2	54.6	0.5	0.6
RAB3D	"D2-2, GOV, RAB16, RAD3D"	ENSG00000105514	"RAB3D, member RAS oncogene family"	O95716	19	11322068-11346270	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.5;skin 1: 53.1"	"Cell type enhanced"	"Detected in many"		"monocytes: 53.1;Squamous epithelial cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 169.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 47.3;Karpas-707: 45.6;MCF7: 54.6;SK-BR-3: 68.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 73.1"	"CAB018067, HPA063283"	Approved		Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"CAB018067: AB_606903, HPA063283: AB_2684976"	"unprognostic (4.71e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.99e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (4.17e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.34e-1)"	5.5	3.4	11.5	5.1	9.9	17.6	12.2	8.5	13.0	15.0	6.3	8.1	8.1	7.3	6.1	34.1	8.7	3.9	3.6	16.1	13.0	5.8	1.8	8.7	2.4	20.7	10.8	4.2	68.5	4.4	4.7	7.2	23.4	17.1	8.6	1.7	30.1	8.1	2.5	53.1	6.1	8.8	12.2	8.8	19.5	1.4	15.2	4.7	6.2	4.2	9.1	7.0	15.2	14.1	1.5	14.2	4.4	17.7	7.1	12.3	0.9	1.3	3.8	2.5	2.5	5.1	0.5	0.6	16.0	8.6	4.7	19.1	7.5	11.9	2.2	7.8	1.1	5.8	6.7	5.8	4.4	3.1	13.2	5.3	47.3	2.1	5.1	6.5	20.5	4.3	2.1	45.6	0.8	54.6	2.2	6.9	3.7	28.7	14.4	2.1	0.0	16.1	22.0	14.2	4.9	9.5	4.3	68.8	9.3	6.0	41.1	35.1	7.9	2.4	0.8	11.4	0.2	15.5	21.3	3.2	8.4	19.0	2.6	123.5	84.1	95.6	3.2	51.4	5.6	2.2	3.2	2.6	35.5	2.2	2.2	2.7	169.1	1.6	41.3	0.9	5.7	26.3	11.5	9.9	8.5	13.0	16.1	13.0	20.7	10.8	23.4	12.2	15.2	14.1	10.0	6.4	17.2	4.6	4.0	15.7	4.5	13.7	12.5	0.7	23.6	14.1	4.3	10.0	19.1	14.7	0.0	8.0	4.4	5.7	11.7	4.8	0.5	5.4	6.6	9.7	18.6	5.9	9.2	25.6	6.6	5.4	23.0	14.0	12.7	4.1	17.9	1.5	9.4	0.0	5.4	29.3	4.1	40.0	2.4	0.2	4.4	16.0	8.8	5.6	53.1	5.3	2.1	1.0	1.3	12.7	5.8	4.9	8.5	11.7	1.4	3.6	1.8	0.4	6.6	3.3	8.5	0.1	2.5	47.8	37.8	10.4	3.9	3.8	15.4	5.9
RAP1GAP	"KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII"	ENSG00000076864	"RAP1 GTPase activating protein"	P47736	1	21596215-21669363	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 152.4;thyroid gland: 162.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 64.1;Distal tubular cells: 72.4;Excitatory neurons: 82.0;Horizontal cells: 92.5;Intestinal goblet cells: 112.6;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 46.3;OE19: 162.8;SCLC-21H: 52.1"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 231.1"	"HPA001922, CAB003851"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"CAB003851: AB_562338, HPA001922: AB_1079743"	"unprognostic (1.17e-2)"	"unprognostic (4.33e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (8.33e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (1.12e-6)"	"unprognostic (1.11e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.64e-2)"	0.6	80.8	74.0	2.6	118.6	0.8	4.4	24.6	91.9	7.5	0.0	19.7	12.4	1.9	1.9	7.5	4.2	24.9	9.5	76.2	34.5	152.4	36.1	14.2	1.0	35.8	22.0	1.6	106.2	57.1	37.9	2.1	32.8	12.8	17.3	27.3	88.7	0.8	0.2	3.5	21.7	0.7	15.8	1.2	110.8	3.6	32.4	0.5	162.8	0.3	0.9	4.0	3.4	67.3	6.2	46.3	0.5	3.6	0.0	0.0	0.8	0.0	0.1	0.1	0.0	4.3	6.4	0.1	4.6	0.2	30.2	7.9	4.4	0.3	0.1	1.0	2.3	2.2	4.3	22.1	0.7	0.0	6.6	0.3	3.1	0.0	0.0	0.0	0.0	22.1	29.6	1.1	0.0	15.6	7.7	0.7	2.8	162.8	7.0	4.3	1.2	1.1	10.2	3.4	52.1	9.3	7.7	27.4	8.9	1.8	2.7	5.2	0.1	0.0	3.1	0.0	0.1	0.6	0.1	0.0	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.0	118.6	24.6	91.9	76.2	34.5	35.8	22.0	32.8	15.8	32.4	67.3	0.0	9.6	29.3	10.4	0.5	1.3	1.1	1.1	0.6	64.1	8.5	5.6	5.1	25.8	4.5	14.7	0.0	0.2	0.1	4.3	72.4	25.1	0.8	3.1	0.6	0.4	6.7	4.0	82.0	28.8	1.4	1.0	17.3	8.0	0.0	6.2	0.4	8.5	0.3	92.5	45.8	112.6	6.1	0.6	0.3	0.3	0.0	0.6	16.0	3.7	0.6	11.5	0.0	51.8	18.6	15.3	17.2	0.0	0.2	5.0	6.0	13.5	1.2	7.3	0.0	0.0	0.7	1.0	3.6	0.5	1.1	1.5	0.3	2.5	7.7	2.6
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540831-35553999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 212.9"	"Group enriched"	"Detected in some"	4	"Intestinal goblet cells: 13.1;Sertoli cells: 46.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 212.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.1;hTERT-RPE1: 9.8;SK-BR-3: 5.6;U-2 OS: 3.1;U-87 MG: 4.0"	"Region enriched"	"Detected in all"	8	"basal ganglia: 589.6"	"Region enriched"	"Detected in all"	8	"basal ganglia: 429.3"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavorable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.8	7.3	30.8	2.5	212.9	3.8	2.3	0.0	30.7	3.1	0.0	28.2	2.3	4.7	15.0	1.9	5.6	2.2	8.6	12.5	9.9	1.5	0.4	3.2	0.4	4.6	12.5	1.2	1.6	1.2	2.1	0.2	6.4	15.2	4.0	0.5	4.0	22.7	15.0	1.6	6.2	7.3	1.8	0.2	3.8	0.7	48.4	0.7	1.2	4.5	1.2	4.3	2.5	9.0	0.1	2.2	0.0	0.4	0.0	0.0	0.0	0.5	0.2	0.8	0.6	0.1	0.4	0.0	0.1	1.9	3.1	0.1	0.1	0.0	0.7	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.1	2.5	1.6	0.2	9.8	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.1	0.1	0.2	1.0	0.0	0.7	0.0	0.0	1.5	0.2	1.6	5.6	0.0	0.1	0.4	0.1	0.0	1.3	3.1	0.1	0.7	1.4	0.5	0.0	4.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	212.9	0.0	30.7	12.5	9.9	4.6	12.5	6.4	1.8	48.4	9.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.6	1.7	2.9	3.3	1.9	0.0	0.2	0.0	0.0	0.0	0.7	3.0	0.0	0.2	0.1	0.1	0.2	2.9	0.0	0.0	3.2	0.2	0.0	3.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	6.6	13.1	2.0	0.0	0.8	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.0	0.7	0.0	2.3	0.7	0.0	0.5	0.1	0.0	0.1	0.2	46.0	0.4	6.9	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.5	0.3
RBM46	"CT68, MGC27016"	ENSG00000151962	"RNA binding motif protein 46"	Q8TBY0	4	154781213-154828813	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	55	"testis: 27.6"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 135.7;Spermatogonia: 82.1"	"Cancer enriched"	"Detected in single"	15	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	8	"spinal cord: 12.9"	HPA037746			Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Cytosol		"HPA037746: "	"unprognostic (4.79e-1)"				"unprognostic (1.14e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.24e-2)"		"unprognostic (2.99e-7)"	"unprognostic (4.86e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.27e-2)"		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	27.6	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.6	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	4.3	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	9.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	135.7	82.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 325.2;Rod photoreceptor cells: 480.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 9.7;MAIT T-cell: 2.5;memory CD8 T-cell: 6.8;naive CD8 T-cell: 3.2;NK-cell: 4.0"	"Group enriched"	"Detected in many"	42	"NK-cells: 4.0;T-cells: 9.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 25.9;HEL: 11.7;hTERT-RPE1: 4.7;SuSa: 4.1"	"Region enriched"	"Detected in all"	9	"basal ganglia: 248.1"	"Region enriched"	"Detected in all"	10	"basal ganglia: 110.0"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: AB_2668943"	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	0.8	1.5	6.2	1.2	23.5	0.2	0.8	4.3	9.4	1.6	3.8	8.5	1.1	1.7	2.5	1.5	10.3	1.0	0.8	5.1	9.3	2.4	2.3	5.1	2.1	5.3	5.9	2.6	1.4	5.5	12.1	1.2	6.9	4.6	1.3	1.3	1.3	3.3	0.1	1.4	3.8	1.4	5.2	1.7	3.8	0.4	7.4	0.6	0.6	0.3	3.0	2.9	2.8	4.6	0.4	0.0	1.3	0.1	0.1	0.2	0.0	0.1	2.6	0.0	0.3	0.2	0.0	1.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	25.9	0.6	11.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	4.7	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.2	4.1	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.7	0.0	2.5	0.0	0.8	6.8	0.0	0.0	0.0	3.2	0.1	4.0	0.0	0.1	0.0	1.7	6.2	23.5	4.3	9.4	5.1	9.3	5.3	5.9	6.9	5.2	7.4	4.6	1.3	3.2	1.5	33.3	0.4	0.4	1.4	0.9	0.6	25.0	7.8	14.5	0.4	0.0	1.3	1.8	325.2	0.0	27.5	0.1	3.9	8.9	0.6	2.5	1.8	2.6	59.7	0.0	2.3	3.1	0.1	5.8	1.1	4.2	0.0	3.3	1.1	0.0	0.1	52.2	2.3	2.3	0.0	0.0	3.0	2.4	0.9	2.9	1.8	1.9	19.4	39.2	18.6	2.5	1.2	2.7	0.1	4.9	6.3	0.1	0.1	14.2	0.8	480.2	0.0	0.5	1.9	0.1	0.4	0.0	0.1	0.1	10.3	12.8	0.6	0.3
RLN3	"H3, RXN3, ZINS4"	ENSG00000171136	"Relaxin 3"	Q8WXF3	19	14028148-14031551	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"parathyroid gland: 1.6;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"midbrain: 11.7;pons and medulla: 27.2"	"Region enriched"	"Detected in many"	9	"pons: 23.6"						"Secreted to blood"	NA	NA	60000000		"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 43: Cardiomyocytes - Nuclear processes"											"unprognostic (1.96e-2)"		"unprognostic (2.54e-2)"					"unprognostic (3.94e-1)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF17	"FLJ11045, Mmip-2, SPATA23, TDRD4"	ENSG00000132972	"Ring finger protein 17"	Q9BXT8	13	24764169-24879921	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 24.3"	"Group enriched"	"Detected in some"	7	"Early spermatids: 22.2;Late spermatids: 27.6;Spermatocytes: 67.0;Spermatogonia: 24.3"	"Cancer enriched"	"Detected in single"	41	"testis cancer: 4.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory bulb: 1.4"	"HPA039699, HPA040111"	Approved					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA039699: AB_10795254, HPA040111: AB_10795414"	"unprognostic (2.57e-1)"	"unprognostic (1.87e-2)"		"unprognostic (1.37e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.26e-1)"		"unprognostic (3.21e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.61e-2)"			"unprognostic (5.04e-1)"	"unprognostic (3.12e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.22e-1)"	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	3.8	0.0	0.0	0.1	0.8	1.2	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	22.2	0.0	0.1	0.2	0.0	0.0	2.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	27.6	0.9	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	67.0	24.3	0.0	0.0	1.0	0.0	0.0	0.0	0.1
RXFP2	"GPR106, GREAT, INSL3R, LGR8, RXFPR2"	ENSG00000133105	"Relaxin family peptide receptor 2"	Q8WXD0	13	31739526-31803389	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	7	"Early spermatids: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"classical monocyte: 1.7"	"Lineage enriched"	"Detected in single"	18	"monocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"basal ganglia: 2.6"							NA	NA			"Cluster 25: Monocytes - Inflammatory response"			"Cluster 23: Spermatids - Flagellum & Golgi organization"																			"unprognostic (1.77e-2)"		0.1	0.5	0.0	0.0	0.7	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.2	0.3	0.2	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.6"	"CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		9600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	982.3	77.1	25.5	353.9	26.2	1090.8	561.9	27.5	53.1	566.3	32.0	301.7	91.7	177.8	124.5	224.0	217.6	167.6	268.5	24.7	27.4	247.0	64.3	874.2	221.0	31.7	26.4	51.0	53.8	18.1	24.8	182.9	29.8	223.7	331.5	10.0	245.4	155.8	163.0	371.5	234.3	297.7	27.8	443.0	133.3	32.2	33.7	112.6	191.9	424.6	315.4	391.6	455.2	34.1	11.8	2614.3	13.2	77.0	3300.1	2410.9	3.7	1664.4	6738.6	32.1	148.4	20.0	180.3	0.8	299.7	4819.1	3.5	65.3	8.8	20.9	23.6	405.2	2.3	1186.8	529.0	59.4	4.3	106.9	1924.6	364.2	21.5	62.2	13.0	4.9	2.6	0.7	9.9	4.2	2468.1	10.6	3.8	1273.9	7.2	189.7	1050.4	64.1	3.7	2700.2	103.5	71.3	108.5	11.6	24.9	1286.6	9.4	412.5	77.1	1493.7	3.1	8.5	13.7	2159.5	9.3	82.8	647.5	14.3	6.1	1367.9	127.2	2789.7	13536.2	1408.0	5800.5	9099.6	6077.0	761.6	5167.7	4700.0	9268.4	282.5	882.4	2641.3	12129.7	837.1	11862.4	1626.0	7406.7	24075.8	25.5	26.2	27.5	53.1	24.7	27.4	31.7	26.4	29.8	27.8	33.7	34.1	226.0	490.4	398.4	0.0	266.1	772.9	19.5	159.0	93.9	0.7	44.9	65.9	14.9	35.8	273.8	893.8	0.0	52.4	1345.4	8.9	111.6	21.9	7.3	53.0	473.0	209.1	4.8	730.9	0.0	23.5	255.5	1378.8	54.0	41.9	1395.8	0.6	96.4	18.6	1966.1	45.4	0.0	10.0	345.8	2708.8	5952.7	24.0	235.8	2786.0	1193.5	12.2	3172.6	3.6	2130.8	0.0	0.1	35.7	17.0	45.9	266.5	12.9	3.2	19.7	154.9	2.3	151.2	2034.0	1309.6	1.9	5.5	77.6	694.0	53.4	2111.1	32.5	11.3	73.1
S100A5	S100D	ENSG00000196420	"S100 calcium binding protein A5"	P33763	1	153537147-153541765	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 3.6;thyroid gland: 5.2"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;Distal tubular cells: 3.9;Extravillous trophoblasts: 8.5;Langerhans cells: 3.1;Theca cells: 6.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.0;granulocytes: 1.4;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"OE19: 34.3;RPTEC TERT1: 11.9;RT4: 19.9;SCLC-21H: 17.3"	"Region enriched"	"Detected in many"	86	"olfactory bulb: 980.0"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 5.6"	HPA064184			Approved	Nucleoplasm		Yes	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA064184: AB_2685206"	"unprognostic (6.09e-2)"	"unprognostic (2.92e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.63e-5)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"		"unprognostic (1.52e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.70e-2)"	"unprognostic (4.68e-3)"	0.2	0.1	0.3	0.1	0.3	0.7	0.2	0.9	0.8	0.3	0.1	0.2	1.5	0.6	0.1	0.9	0.5	1.0	0.1	0.3	0.4	2.9	0.0	0.5	1.5	0.4	0.3	0.1	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.1	3.6	0.3	0.0	0.3	0.4	1.2	0.1	0.4	0.7	5.2	0.1	0.4	1.1	0.3	0.4	2.2	5.7	0.0	0.0	0.6	0.4	0.4	1.0	1.3	0.7	1.4	0.6	4.2	0.0	3.7	2.1	0.4	1.7	0.1	1.0	0.9	0.5	0.0	2.7	2.6	0.2	0.4	0.0	3.5	0.0	1.1	2.7	0.8	0.5	0.5	0.0	0.7	0.2	3.0	0.2	0.5	1.3	0.2	34.3	9.7	0.0	1.8	1.1	11.9	19.9	17.3	0.0	0.2	9.0	0.8	1.5	0.0	0.5	0.4	0.1	1.3	2.6	1.7	0.0	0.9	0.0	0.5	0.7	0.4	0.0	0.7	1.4	1.2	0.1	4.6	0.5	2.6	1.3	1.8	0.3	1.4	0.6	1.2	0.0	0.4	3.0	3.9	0.7	0.3	0.3	0.9	0.8	0.3	0.4	0.4	0.3	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.2	3.7	0.0	0.1	0.2	0.1	3.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	8.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	2.0	0.6	3.1	0.0	0.3	0.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.6	6.8	0.3	0.6
SCARA5	"FLJ23907, MGC45780, NET33"	ENSG00000168079	"Scavenger receptor class A member 5"	Q6ZMJ2	8	27869883-27992673	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 90.0"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 174.0;Leydig cells: 135.8;Theca cells: 44.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	121	"plasmacytoid DC: 21.1"	"Lineage enriched"	"Detected in single"	211	"dendritic cells: 21.1"	"Cell line enriched"	"Detected in some"	20	"ASC diff: 229.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	5	"spinal cord: 19.5"	HPA024661	Approved					NA	NA		1400000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA024661: AB_1853902"	"unprognostic (2.76e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.15e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.97e-1)"	60.5	4.0	0.4	7.2	0.8	0.0	34.6	0.8	1.8	16.6	4.9	38.5	8.7	2.9	8.2	21.1	23.7	22.5	90.0	0.6	0.4	1.0	4.1	20.2	2.4	0.3	0.2	11.2	2.4	0.2	5.4	12.5	0.2	8.4	33.7	0.3	29.0	3.3	15.1	31.1	26.3	6.5	0.5	3.3	27.3	11.6	0.2	3.2	21.1	34.5	2.1	77.1	36.8	0.3	0.0	7.9	0.0	0.0	229.1	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	11.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.0	0.1	0.4	0.8	0.8	1.8	0.6	0.4	0.3	0.2	0.2	0.5	0.2	0.3	7.1	0.0	0.0	0.0	0.1	6.5	0.1	0.0	0.6	0.0	0.5	0.6	4.6	0.0	0.0	0.0	0.0	0.1	6.7	0.2	0.0	0.0	1.5	0.7	27.9	2.4	0.0	0.0	0.3	0.0	0.4	174.0	4.1	0.8	0.0	0.0	0.0	0.0	0.4	0.0	2.9	0.0	0.0	0.0	17.0	4.6	135.8	1.3	7.2	5.6	0.0	1.9	0.0	0.0	0.2	0.0	0.0	11.3	0.8	0.1	0.0	0.0	0.0	0.1	0.0	7.4	3.6	0.7	1.1	0.9	6.0	0.1	1.1	44.5	0.3	0.1
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.5;pancreas: 67.1;pituitary gland: 38.5"	"Cell type enriched"	"Detected in some"	5	"Enteroendocrine cells: 600.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2;renal cancer: 22.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 23.6;hippocampal formation: 14.5;hypothalamus: 43.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7"	"Region enriched"	"Detected in many"	16	"olfactory bulb: 82.0"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 137.1"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		3.7	3.5	1.7	3.4	1.2	0.2	3.3	23.6	2.9	0.1	0.1	16.9	12.4	0.0	0.0	0.2	0.1	0.9	11.7	14.5	43.5	1.4	4.1	0.8	0.1	1.7	2.3	0.3	67.1	0.1	38.5	3.3	6.1	2.0	19.2	1.0	2.5	0.1	0.0	0.6	11.5	1.2	1.4	0.0	18.9	0.6	0.9	0.4	1.9	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	23.6	2.9	14.5	43.5	1.7	2.3	6.1	1.4	0.9	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.6	0.5	107.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.2	600.1	0.0	0.2	0.4	0.2	0.3	9.2	0.0	0.0	0.9	3.3	0.5	0.1	0.0	1.8	14.3	4.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	4.8	3.7	0.0	0.0	3.7	1.1	3.1	0.0	0.0	13.1	0.0	9.1	0.2	1.1	0.0	0.0	0.0	0.1	0.5	2.2	0.3
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 109.6;tongue: 56.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.3;Excitatory neurons: 18.2;Sertoli cells: 46.0;Smooth muscle cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HBEC3-KT: 1.0;NTERA-2: 1.4;U-2 OS: 1.2"	"Region enriched"	"Detected in all"	11	"basal ganglia: 816.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 134.6"	HPA017293	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	23.5	5.4	2.6	1.2	86.6	0.0	9.2	41.3	109.6	2.1	0.0	2.6	2.4	3.1	1.6	5.3	5.4	3.2	11.8	2.1	14.0	2.1	0.4	8.9	2.1	53.3	15.4	0.5	5.1	6.8	2.7	1.8	45.9	2.2	2.1	0.9	2.5	2.3	30.4	3.9	4.7	7.1	15.2	0.0	2.9	0.7	23.1	8.6	14.5	56.8	0.7	3.0	1.4	28.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	86.6	41.3	109.6	2.1	14.0	53.3	15.4	45.9	15.2	23.1	28.5	12.3	0.0	0.0	2.9	0.0	1.3	0.6	2.0	2.8	1.7	0.5	5.7	4.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.1	3.0	0.0	0.0	18.2	0.0	0.1	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	2.0	1.2	1.4	8.7	2.1	1.1	0.0	1.9	0.0	0.5	0.0	1.5	1.4	0.0	0.0	1.5	0.0	0.1	0.0	0.1	5.8	0.8	46.0	0.6	38.8	0.1	0.6	0.5	1.1	0.0	0.1	0.0	0.0	0.2
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747433-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 128.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 114.7;Oligodendrocyte precursor cells: 128.7;Plasma cells: 271.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 82.1"	"Group enriched"	"Detected in many"	4	"memory B-cell: 42.0;naive B-cell: 41.8;plasmacytoid DC: 38.2"	"Group enriched"	"Detected in many"	4	"B-cells: 42.0;dendritic cells: 38.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 287.9;OE19: 217.9;U-698: 187.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 100.4"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm		"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	9.3	5.5	8.7	61.5	11.3	13.6	9.3	82.1	11.1	54.0	8.7	72.1	82.0	7.9	68.8	8.7	11.0	53.6	5.3	12.5	4.2	14.5	11.6	40.7	124.8	2.8	5.2	5.6	48.5	45.5	3.7	37.5	4.7	18.9	68.8	35.2	38.3	4.0	2.9	2.9	72.4	7.8	2.9	63.2	104.8	6.6	8.2	18.7	10.9	2.8	128.3	42.4	2.2	5.9	21.5	23.0	16.7	5.6	2.7	3.3	2.6	10.4	28.3	7.9	25.2	14.6	97.0	287.9	48.9	72.0	66.7	13.3	12.4	45.1	10.6	15.7	7.2	3.3	35.4	19.6	70.0	40.1	2.0	5.7	35.8	27.8	10.9	31.3	105.7	5.8	19.3	0.3	5.6	16.2	0.1	2.8	48.2	217.9	20.1	1.5	91.3	40.6	60.9	71.2	41.0	8.0	69.2	1.0	7.1	23.0	3.3	49.0	46.6	0.5	32.6	0.6	30.6	1.8	0.5	187.9	125.0	16.7	19.3	0.9	0.2	0.0	5.7	0.0	6.8	42.0	7.0	6.4	1.4	41.8	3.0	4.8	0.7	8.0	0.3	38.2	9.6	3.3	8.7	11.3	82.1	11.1	12.5	4.2	2.8	5.2	4.7	2.9	8.2	5.9	13.2	12.8	36.0	57.1	114.7	0.9	3.4	16.8	1.2	4.0	1.6	0.9	1.8	61.5	51.9	3.7	0.0	30.7	71.0	46.3	0.0	64.9	60.8	6.0	1.5	11.5	11.5	10.5	40.1	33.2	1.3	2.5	71.9	19.3	2.5	3.4	13.6	4.2	4.9	0.0	26.6	92.6	22.4	23.1	4.6	78.3	1.5	14.4	8.8	4.7	14.6	33.2	10.3	128.7	1.4	38.3	22.6	0.4	271.7	13.6	46.9	10.7	24.2	32.8	0.0	0.8	4.7	0.7	2.5	0.7	1.6	16.4	27.8	0.2	36.8	6.1
SEMA3B	"LUCA-1, SemA, sema5, SEMAA, semaV"	ENSG00000012171	"Semaphorin 3B"	Q13214	3	50267558-50277546	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 174.5;brain: 184.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Distal enterocytes: 129.1;Gastric mucus-secreting cells: 208.0;Oligodendrocytes: 157.8;Proximal enterocytes: 336.4;Syncytiotrophoblasts: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 73.7;Hep G2: 105.7;SK-BR-3: 54.5;WM-115: 173.1"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 27.9"	HPA030651	Uncertain				"Secreted in other tissues"	NA	NA		790000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 45: Enterocytes - Digestion"			"HPA030651: AB_10602224"	"prognostic favorable (1.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.89e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.69e-2)"	33.6	174.5	50.2	9.0	124.4	0.2	17.3	87.7	78.2	46.2	35.2	53.6	41.3	45.7	2.2	9.1	37.0	10.0	40.3	53.1	66.4	70.9	6.1	49.2	0.3	125.7	101.9	24.5	41.4	10.6	10.4	35.3	98.6	34.0	10.5	2.0	12.7	20.6	7.4	7.9	62.8	14.2	76.2	5.1	56.8	14.8	110.4	0.6	24.2	8.7	0.3	19.6	32.3	184.2	12.7	8.2	0.8	8.0	0.6	1.0	2.0	16.3	22.3	4.7	7.9	5.5	29.7	0.0	14.3	15.3	0.0	1.8	0.4	26.2	1.8	0.2	0.7	0.0	73.7	105.7	16.8	0.0	0.8	5.1	0.5	5.4	4.1	19.9	0.0	0.1	0.2	2.2	0.8	22.4	0.0	0.7	1.1	23.4	4.5	0.3	1.2	0.6	7.4	1.4	1.0	3.8	4.2	54.5	9.2	2.4	3.6	0.1	0.5	1.3	15.4	4.3	5.3	4.4	0.2	0.2	7.9	0.2	173.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.2	124.4	87.7	78.2	53.1	66.4	125.7	101.9	98.6	76.2	110.4	184.2	6.5	163.5	18.6	45.1	1.8	0.0	8.3	0.0	6.2	3.7	19.3	8.5	14.5	44.3	18.6	64.4	0.0	3.6	1.2	129.1	1.9	38.3	11.2	29.8	11.6	6.1	10.3	0.0	0.6	23.1	1.0	35.3	208.0	73.1	11.4	11.4	5.7	1.2	1.9	0.0	0.8	45.7	0.0	1.6	0.0	21.4	4.1	2.8	0.0	12.2	0.7	17.3	0.0	3.0	157.8	32.5	79.9	3.0	0.6	14.1	336.4	40.4	5.1	1.6	6.6	19.0	7.5	6.6	11.4	2.0	0.0	111.6	2.4	0.2	31.5	32.7
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	45	"liver: 34022.4"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 42919.3"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 2482.1;intermediate monocyte: 3411.9;neutrophil: 2823.2;non-classical monocyte: 4518.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 2823.2;monocytes: 4518.8"	"Cell line enriched"	"Detected in many"	10	"Hep G2: 4769.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 130.6"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	140000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	49.1	9.7	7.3	225.0	7.1	157.1	100.6	9.1	21.3	105.7	11.1	151.0	278.6	42.3	5.3	10.1	22.4	352.3	12.5	7.3	11.1	621.2	34022.4	570.7	37.0	20.9	14.4	5.4	201.0	5.2	9.1	26.6	15.8	12.6	178.8	2.6	33.6	140.5	3.7	8.2	760.9	75.7	12.2	313.6	282.5	3.0	16.2	15.0	23.0	11.9	25.2	55.8	9.1	16.9	25.9	0.3	0.0	0.5	1.0	0.0	1.5	0.6	1.7	0.6	1.1	187.8	500.8	2.6	15.6	0.0	1.4	1.9	0.0	10.9	1.2	70.1	0.0	4.3	2.0	4769.1	0.3	16.8	2.3	4.1	5.4	0.3	18.5	1.9	0.0	0.0	3.2	0.4	0.0	0.8	1.1	12.1	2.0	5.5	8.0	1.9	16.7	2.4	300.8	3.0	0.6	1.3	6.4	1.6	1.4	0.4	262.1	2.7	1.6	2.1	59.4	1.9	7.1	3.3	1.8	7.0	4.4	41.8	0.6	10.6	2482.1	634.3	5.5	3411.9	6.8	7.7	3.6	4.1	683.6	3.6	4.3	3.6	2823.2	5.3	4518.8	14.9	4.5	2770.7	7.3	7.1	9.1	21.3	7.3	11.1	20.9	14.4	15.8	12.2	16.2	16.9	2.2	35.3	285.9	0.0	137.4	2.3	1.0	36.3	0.0	0.2	100.8	31.5	5.3	4520.9	165.5	150.8	0.0	1.6	3.9	52.0	68.4	3787.9	0.2	70.0	2.8	57.0	12.1	1227.4	0.0	225.8	4.5	3.6	36.2	51.3	1.3	0.1	938.8	42919.3	167.6	0.0	0.0	742.4	30.5	1454.0	74.1	1.1	0.0	413.3	1.8	1.0	291.7	0.3	9.2	0.0	0.0	2161.6	137.0	0.0	1.5	6.8	5270.0	745.9	108.3	0.2	0.0	0.6	17.4	0.0	0.2	0.6	1.7	6.4	75.5	0.0	83.2	6.7
SFRP4	"FRP-4, frpHE, FRZB-2"	ENSG00000106483	"Secreted frizzled related protein 4"	Q6FHJ7	7	37905932-38025695	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix: 619.9;endometrium 1: 467.1;fallopian tube: 214.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 472.1;Fibroblasts: 196.4;Granulosa cells: 102.8;Peritubular cells: 188.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.0;HSkMC: 3.9;U-937: 3.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 53.5"	"HPA009712, HPA050585"	Enhanced				"Secreted in female reproductive system"	NA	NA		2500000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA009712: AB_1856778, HPA050585: AB_2681183"	"unprognostic (5.93e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.36e-5)"	"unprognostic (7.37e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.89e-3)"	29.1	15.6	2.3	1.4	3.0	0.8	60.0	2.7	4.5	619.9	2.1	4.4	1.2	467.1	18.7	2.3	214.0	17.3	22.4	2.5	4.6	4.3	0.6	14.7	7.3	4.0	4.8	79.2	5.0	2.8	20.5	0.2	3.2	16.1	2.6	2.3	6.5	43.9	4.1	1.5	1.4	87.9	4.0	13.9	2.3	16.8	2.7	1.6	14.9	7.0	2.0	37.4	61.0	3.9	0.0	1.8	2.1	0.0	10.0	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	2.2	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.2	1.5	0.1	0.3	0.0	3.9	0.5	0.4	0.0	0.7	0.1	0.1	0.0	0.2	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.4	0.0	0.0	0.7	0.0	0.8	1.2	0.1	0.4	0.1	0.1	0.2	3.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	2.7	4.5	2.5	4.6	4.0	4.8	3.2	4.0	2.7	3.9	5.5	0.0	1.8	0.3	0.7	1.0	1.5	0.1	0.6	0.0	0.5	2.3	1.0	0.0	0.7	0.0	0.0	0.2	0.4	0.0	0.0	0.0	1.0	22.5	472.1	4.6	0.0	0.0	0.0	0.5	0.3	196.4	0.0	14.1	0.0	102.8	3.3	0.1	0.2	0.0	0.5	0.0	0.0	0.0	4.4	2.8	41.7	7.1	0.0	2.8	0.0	2.7	0.0	17.6	0.2	0.1	0.0	188.4	0.0	2.4	0.0	1.8	0.0	0.3	0.0	30.5	25.3	0.2	0.4	0.1	1.6	0.3	9.2	1.2	0.1	0.5
SFRP5	SARP3	ENSG00000120057	"Secreted frizzled related protein 5"	Q5T4F7	10	97766751-97771999	"Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"choroid plexus: 98.7;heart muscle: 78.7;intestine: 36.4;pancreas: 143.2"	"Cell type enriched"	"Detected in some"	7	"Cholangiocytes: 273.1"	"Cancer enriched"	"Detected in many"	4	"pancreatic cancer: 30.4"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"naive CD8 T-cell: 3.6"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;CACO-2: 12.4;RPMI-8226: 4.5;SCLC-21H: 2.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"spinal cord: 120.7"						"Secreted in other tissues"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (2.63e-4)"	"unprognostic (3.03e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.62e-1)"	2.9	9.6	2.8	0.3	3.9	0.3	2.4	1.6	0.6	3.5	98.7	36.4	29.8	1.8	2.2	2.0	2.2	4.1	78.7	5.6	7.5	0.4	8.8	3.4	0.3	3.6	8.3	0.6	143.2	0.0	0.9	0.0	3.6	6.8	0.5	0.2	2.8	4.0	1.3	3.1	26.3	0.4	1.6	0.1	10.5	0.8	14.7	0.1	1.0	2.9	0.1	3.2	4.9	0.2	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	4.5	0.0	0.0	2.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.8	0.0	0.2	2.8	3.9	1.6	0.6	5.6	7.5	3.6	8.3	3.6	1.6	14.7	0.2	0.0	3.2	3.6	0.3	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	7.8	273.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	16.8	0.0	3.2	0.0	0.0	0.0	0.0	2.2	0.7	0.0	0.0	0.3	1.3	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.2	3.3	2.5	0.0	0.0	0.0	37.8	0.0	0.0	0.2	0.0	1.2	0.4	0.1	5.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0
SHF		ENSG00000138606	"Src homology 2 domain containing F"	Q7M4L6	15	45167214-45201175	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 143.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 50.6;Granulosa cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 143.8"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 121.0;SH-SY5Y: 54.1"	"Region enriched"	"Detected in all"	5	"cerebellum: 240.6"	"Region enriched"	"Detected in all"	4	"cerebellum: 106.2"	HPA057381			Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA057381: AB_2683423"	"unprognostic (4.05e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.12e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.83e-2)"	6.1	22.7	21.9	4.3	20.5	1.0	6.3	143.8	27.8	14.4	0.2	13.4	13.1	11.9	4.7	5.0	10.5	6.6	9.0	21.5	19.5	4.4	38.6	5.6	2.7	12.8	16.9	23.7	3.1	4.4	8.3	1.9	15.9	10.1	5.3	7.1	6.7	5.9	3.8	12.7	8.4	7.5	9.4	4.3	6.7	8.4	21.4	2.4	7.5	4.7	1.9	10.2	11.7	13.4	0.1	1.4	24.0	0.7	1.8	0.9	11.2	3.0	2.1	6.7	9.5	3.6	11.6	1.3	9.5	4.2	6.6	2.1	9.2	0.7	3.2	2.2	4.2	0.8	2.2	24.8	1.0	0.1	8.0	2.2	0.6	0.9	0.2	5.0	5.2	12.0	5.0	0.5	9.5	4.1	5.5	0.9	9.6	4.5	0.6	15.0	19.1	0.5	2.3	0.5	121.0	54.1	0.7	0.8	0.4	7.4	1.2	2.4	0.3	0.8	10.0	0.7	0.4	1.1	0.9	1.1	0.3	0.6	3.8	0.1	0.6	0.5	1.3	0.6	1.4	0.8	0.5	0.8	0.6	1.5	0.7	0.5	0.8	2.0	0.6	0.9	0.1	0.5	21.9	20.5	143.8	27.8	21.5	19.5	12.8	16.9	15.9	9.4	21.4	13.4	4.1	0.0	0.6	3.3	4.2	3.6	5.8	1.7	0.0	50.6	3.6	5.5	2.8	0.0	1.3	0.0	0.0	1.1	2.6	2.1	0.0	0.8	7.9	1.1	3.5	5.7	13.1	0.0	5.9	1.3	0.5	5.8	1.5	2.2	2.5	58.8	5.3	11.7	0.6	10.1	6.9	10.9	2.0	1.0	15.0	15.3	4.4	2.9	8.8	5.6	0.1	5.9	2.1	9.0	1.8	0.7	5.6	4.1	0.7	3.5	18.0	1.1	0.8	5.0	6.6	6.7	9.6	5.4	2.9	1.4	2.6	0.7	2.8	1.8	4.6	9.7
SHISA3	hShisa3	ENSG00000178343	"Shisa family member 3"	A0PJX4	4	42397488-42402487	"Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.3;heart muscle: 15.5;kidney: 21.4"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 43.0;Fibroblasts: 19.4;Hepatic stellate cells: 55.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 7.6;renal cancer: 7.8"	"Group enriched"	"Detected in all"	4	"midbrain: 13.3;thalamus: 10.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AN3-CA: 219.6;PC-3: 130.4"	"Region enriched"	"Detected in many"	23	"olfactory bulb: 51.7"	"Region enriched"	"Detected in many"	8	"spinal cord: 21.4"	HPA054754			Approved	"Lipid droplets,Cytosol"		NA	Yes			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Cytosol	"Lipid droplets"	"HPA054754: AB_2682593"	"unprognostic (9.04e-3)"	"unprognostic (3.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.99e-3)"	4.1	1.8	1.8	1.8	1.6	0.0	2.3	1.1	1.6	0.7	1.2	6.2	2.2	0.2	0.3	1.7	0.5	1.0	15.5	1.0	2.2	21.4	0.6	5.7	7.0	1.7	13.3	0.3	0.2	0.2	0.6	0.0	2.6	0.8	3.0	0.1	0.6	1.0	1.6	0.5	10.4	4.3	1.4	0.4	2.9	0.6	10.1	0.1	5.0	1.4	0.8	3.5	1.3	1.2	0.0	0.0	0.0	219.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.7	0.1	0.0	0.0	23.3	0.0	0.0	0.0	2.6	0.0	0.1	0.0	6.6	0.0	0.8	0.4	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	1.2	0.0	10.1	0.0	130.4	0.2	0.0	0.0	9.0	0.0	0.1	0.3	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.6	1.1	1.6	1.0	2.2	1.7	13.3	2.6	1.4	10.1	1.2	4.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	2.2	0.0	0.0	3.7	0.0	0.0	0.1	0.1	43.0	0.0	0.0	0.1	2.5	3.7	0.0	5.3	0.0	0.0	0.0	19.4	0.5	0.1	0.0	1.1	55.0	0.2	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.0	3.4	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	2.4	0.0	0.1	0.0	0.2	1.4	0.5	0.4	0.1	0.0	0.0	0.0	2.4	0.1	0.0
SIX6	"OPTX2, Six9"	ENSG00000184302	"SIX homeobox 6"	O95475	14	60509146-60512850	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 28.4"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 29.2;Horizontal cells: 48.8;Muller glia cells: 160.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.0"	"Group enriched"	"Detected in some"	18	"hypothalamus: 3.9;thalamus: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"JURKAT: 13.4;MOLT-4: 44.0"	"Region enriched"	"Detected in single"	14	"hypothalamus: 3.6"	"Region enriched"	"Detected in single"	12	"hypothalamus: 1.6"	HPA001403	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA001403: AB_1079993"					"unprognostic (2.76e-1)"				"unprognostic (6.14e-2)"			"unprognostic (8.18e-2)"			"unprognostic (5.75e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	44.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	1.3	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	160.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	1.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SKOR1	"CORL1, FUSSEL15, LBXCOR1"	ENSG00000188779	"SKI family transcriptional corepressor 1"	P84550	15	67819704-67834582	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 5.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 5.6;Early spermatids: 20.5;Late spermatids: 36.2;Spermatocytes: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.0;U-266/70: 2.4;U-266/84: 2.0;U-698: 2.1"	"Group enriched"	"Detected in some"	11	"cerebellum: 3.7;pons and medulla: 1.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 5.0"	HPA071150	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA071150: "	"unprognostic (8.98e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.44e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-3)"	"unprognostic (8.40e-5)"	"unprognostic (5.51e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.13e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.28e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	0.5	0.4	0.4	0.0	0.3	0.3	0.5	5.5	1.2	0.7	0.0	0.7	0.2	0.7	0.1	0.2	0.6	0.1	0.3	0.4	0.8	0.3	0.2	0.4	0.0	2.5	0.5	0.9	0.4	0.0	1.1	0.1	1.6	0.5	0.0	0.5	0.3	0.1	0.4	0.8	0.5	0.1	2.1	0.4	0.4	1.1	0.3	0.2	0.4	0.0	0.0	0.5	0.5	0.9	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.0	1.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.1	0.2	0.4	0.0	0.0	0.1	0.3	0.1	0.5	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.2	0.1	0.1	2.4	2.0	2.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	5.5	1.2	0.4	0.8	2.5	0.5	1.6	2.1	0.3	0.9	0.2	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.6	0.7	0.2	0.1	5.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.9	0.0	20.5	0.0	0.1	0.4	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	36.2	0.9	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.6	0.0	0.0	0.7	0.1	0.0	0.0	3.0	0.0	0.1	0.0	0.5	0.3	8.0	0.3	0.1	0.4	0.0	0.0	0.2	0.1	0.1
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596029-59789855	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Early spermatids: 117.3;Excitatory neurons: 150.5;Inhibitory neurons: 128.2;Late spermatids: 135.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 22.2"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	6.8	1.2	3.9	1.2	4.7	4.1	5.7	3.9	2.8	3.7	2.0	1.6	3.0	1.5	6.3	2.2	5.4	34.4	1.3	0.3	11.6	3.9	4.5	4.9	2.9	0.4	2.7	9.8	1.0	1.5	1.6	2.9	1.6	2.5	1.8	2.9	1.6	1.8	7.9	2.5	3.5	0.5	6.3	10.0	2.2	1.3	4.5	1.6	3.6	4.2	4.0	3.0	4.2	0.2	3.6	0.8	0.5	10.9	18.1	0.2	8.8	8.1	4.0	3.4	0.3	6.3	5.8	2.5	16.8	3.8	0.8	1.0	1.7	6.0	2.4	0.5	10.7	12.6	0.5	5.9	14.3	0.1	8.5	3.9	1.4	10.3	7.5	1.6	7.2	0.2	13.0	6.5	3.4	5.5	3.2	0.8	1.2	3.3	0.5	0.1	2.7	9.5	16.0	3.0	1.0	0.1	0.4	6.2	0.7	0.5	2.4	0.0	8.6	3.3	15.6	0.5	11.3	0.2	10.0	10.2	0.1	1.6	0.2	1.5	0.0	4.2	3.2	5.6	1.8	3.3	3.6	1.5	4.1	3.5	5.8	0.1	3.0	8.4	2.1	3.8	2.3	1.2	1.2	5.7	3.9	1.3	0.3	2.9	0.4	2.9	0.5	1.3	4.2	15.3	28.9	21.4	13.7	28.4	10.1	7.8	9.9	16.5	24.5	1.5	3.9	135.4	90.1	16.5	46.0	10.4	0.3	29.7	0.8	23.5	53.3	117.3	2.1	25.0	22.0	0.0	2.5	150.5	67.1	0.3	36.2	7.1	9.1	10.1	4.7	9.3	14.5	3.6	8.4	128.2	27.2	6.1	32.7	6.1	135.5	6.8	24.8	3.6	14.0	14.9	1.3	37.0	63.8	82.8	28.0	1.2	10.1	26.3	8.1	1.0	0.7	14.4	6.0	6.6	14.0	18.9	4.2	4.5	61.5	12.6	0.7	35.8	80.1	1.5	3.4
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781199	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"gallbladder: 16.3;intestine: 31.9;liver: 47.3;pancreas: 22.7"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 94.4;Distal enterocytes: 133.5;Hepatocytes: 41.8;Paneth cells: 44.1;Proximal enterocytes: 51.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.5"	HPA055564	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	20.6	28.7	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	3.7	47.3	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.1	0.2	0.0	26.7	0.0	0.0	0.0	0.0	0.0	31.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	94.4	0.0	0.0	0.0	0.0	0.0	133.5	0.0	8.3	0.8	0.0	0.0	0.0	13.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	41.8	0.1	0.0	0.0	11.7	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	44.1	0.0	0.0	0.0	51.2	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	11.5	0.0
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.1;cervix: 30.0"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 636.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"hypothalamus: 20.8;midbrain: 81.1;pons: 70.5"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Cell line enriched"	"Detected in some"	19	"HMC-1: 351.0"	"Region enhanced"	"Detected in many"		"midbrain: 62.7"	"Region enriched"	"Detected in all"	4	"midbrain: 111.6"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.1	14.6	0.1	0.9	1.1	2.4	1.8	0.1	0.3	30.0	0.2	2.3	1.5	2.6	1.6	2.5	0.5	3.6	0.7	0.2	20.8	0.9	2.8	7.4	0.6	3.8	81.1	10.4	3.4	0.2	0.2	0.1	70.5	9.2	3.5	0.4	0.8	1.3	0.8	6.3	2.1	2.3	0.0	0.3	4.4	0.9	5.0	6.1	0.0	0.5	0.9	2.9	7.9	0.2	0.2	1.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.7	18.6	0.1	0.2	0.0	1.0	351.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.7	0.0	0.1	1.0	0.3	0.2	0.3	0.6	0.2	0.4	0.2	0.0	0.2	3.4	0.7	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.1	2.5	0.3	0.8	0.5	0.4	0.2	0.4	1.9	0.3	59.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	3.8	0.0	2.0	0.1	1.1	0.1	0.3	0.2	20.8	3.8	81.1	70.5	0.0	5.0	0.2	0.0	9.6	16.2	1.0	0.2	1.9	0.0	0.0	0.0	2.1	0.2	0.0	0.3	0.0	2.5	0.0	4.2	0.0	5.7	0.4	0.0	0.0	0.0	13.1	16.1	0.7	8.9	4.2	1.1	0.0	0.0	3.4	4.1	112.4	636.0	2.4	9.7	0.3	0.8	0.0	1.7	0.0	0.0	1.0	3.6	0.2	0.6	3.5	1.8	0.0	0.1	0.4	0.0	0.5	0.6	0.1	0.1	4.9	1.9	3.8	0.0	0.1	0.7	0.8	0.0	0.4	1.3	0.2	2.1	0.0	2.7	0.0	5.6	9.8	0.1	0.1
SLC18A3	VACHT	ENSG00000187714	"Solute carrier family 18 member A3"	Q16572	10	49610310-49612720	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 25.6"	"Cell type enriched"	"Detected in some"	4	"Fibroblasts: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 7.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 78.1"	CAB079011		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"CAB079011: "				"unprognostic (2.14e-4)"	"unprognostic (1.55e-1)"			"unprognostic (1.01e-1)"		"unprognostic (9.39e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-1)"		"unprognostic (5.85e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.16e-1)"		0.0	0.0	0.7	0.3	2.0	0.0	0.0	0.0	19.7	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	18.9	8.0	0.0	0.0	0.0	1.2	0.4	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	3.6	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	6.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	19.7	0.1	4.9	18.9	8.0	25.6	3.6	0.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446207	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"basal ganglia: 10.4"							NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	0.1	0.1	0.3	0.0	0.3	0.0	0.7	2.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.4	0.1	0.4	0.5	0.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.2	0.1	0.4	0.4	0.5	0.3	0.4	0.3	0.5	0.3	6.4	2.6	5.5	0.2	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.2	0.5	0.0	0.0	4.1	0.0	0.0	2.2	7.1	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.5	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	6.5	0.0	0.3	0.0	2.0	4.2	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.2	1.2	0.0	0.2	0.1	0.3	0.5	0.0	0.3	0.0	0.6	0.0	0.0	0.6
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922301-136925660	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.3"	"Cell type enriched"	"Detected in single"	9	"Ionocytes: 8.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 3.3;stomach cancer: 0.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 3.4;cerebral cortex: 1.5;hypothalamus: 5.2;midbrain: 2.1;thalamus: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 15.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 29.6;olfactory bulb: 8.5"	"Region enriched"	"Detected in many"	6	"basal ganglia: 20.1"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.0	0.9	0.4	0.0	3.4	0.2	0.0	0.0	1.5	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.4	0.0	0.3	2.1	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	15.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.4	0.0	1.5	0.0	5.2	0.3	2.1	0.2	0.2	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 149.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in some"	10	"pons: 149.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"SH-SY5Y: 489.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 13.8"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	0.9	21.7	0.1	0.0	0.1	0.0	0.8	0.0	0.2	2.4	0.0	0.2	0.1	5.4	0.2	0.2	0.5	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	3.8	14.6	0.1	0.0	0.5	0.0	12.6	149.4	0.2	0.3	0.0	1.9	0.6	0.0	13.3	0.2	0.8	0.1	0.0	0.1	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.7	489.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	3.8	14.6	149.4	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	10.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	11.5	0.3	0.0	0.4	5.6	0.0	0.0	0.0	0.1
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392794-1445440	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"brain: 60.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.3;Cardiomyocytes: 1.2;Smooth muscle cells: 1.4"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 25.7"	"Region enriched"	"Detected in some"	26	"midbrain: 60.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"midbrain: 80.6;thalamus: 29.0"	"Region enriched"	"Detected in some"	152	"midbrain: 302.6"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles		"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484"	"unprognostic (2.25e-4)"	"unprognostic (2.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-5)"	"unprognostic (9.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.40e-7)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.74e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.0	0.0	60.6	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2.3	0.1	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	60.6	0.3	0.0	2.3	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667046-69834978	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.5;skeletal muscle: 7.6;tongue: 11.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 10.1;Cardiomyocytes: 14.4;Enteroendocrine cells: 15.6;Excitatory neurons: 8.6;Inhibitory neurons: 30.1;monocytes: 21.2;Oligodendrocyte precursor cells: 26.2;Plasma cells: 14.3;Prostatic glandular cells: 11.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.5;NTERA-2: 3.7;RPMI-8226: 3.6;SCLC-21H: 3.9;U-266/70: 2.1"	"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory bulb: 6.7"	"Region enriched"	"Detected in some"	7	"olfactory bulb: 12.8"	HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.1	0.0	0.3	0.9	0.4	0.9	0.1	0.0	0.4	0.2	0.0	0.2	0.2	0.2	0.0	0.5	0.3	0.2	3.7	0.2	0.6	0.0	0.0	0.1	1.0	0.2	0.0	0.0	0.4	0.0	1.5	0.0	0.2	2.3	0.4	0.7	0.3	0.0	7.6	0.1	0.3	0.1	0.0	0.5	0.2	0.3	0.1	6.5	0.0	11.1	0.9	0.6	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	3.7	0.0	0.6	0.6	0.6	3.6	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	2.1	0.3	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.6	0.2	0.0	0.2	0.0	0.1	0.1	0.1	3.2	0.0	3.6	3.6	0.3	1.8	0.0	0.6	10.1	0.2	0.3	14.4	0.0	0.6	0.0	2.1	0.0	0.0	0.6	0.0	1.8	0.6	0.4	1.7	2.0	15.6	0.0	8.6	1.3	0.0	4.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	1.7	30.1	2.0	0.0	0.0	3.6	0.6	0.0	0.7	0.0	3.7	21.2	0.5	0.0	26.2	2.2	2.1	0.1	0.0	14.3	11.8	0.0	0.1	0.0	0.3	0.0	3.4	2.0	1.1	2.6	0.4	0.4	0.0	0.1	0.4	1.5	1.5
SMCO3	"C12orf69, LOC440087"	ENSG00000179256	"Single-pass membrane protein with coiled-coil domains 3"	A2RU48	12	14804650-14814182	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.4;kidney: 3.0"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 2.8;Collecting duct cells: 1.8;Distal tubular cells: 5.9;Erythroid cells: 2.7;Hepatic stellate cells: 4.6;Proximal tubular cells: 7.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"AN3-CA: 1.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"spinal cord: 3.6"	"HPA040574, HPA047804"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane, Cytosol"		"HPA040574: AB_2677026, HPA047804: AB_2680160"	"unprognostic (1.16e-1)"	"unprognostic (2.09e-4)"	"unprognostic (2.40e-4)"	"unprognostic (5.10e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.45e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.48e-8)"	"unprognostic (2.85e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-1)"	0.5	0.4	0.0	0.1	0.2	0.3	0.2	0.1	0.1	3.4	0.3	0.2	0.0	0.3	0.1	0.0	0.3	1.8	0.9	0.1	0.2	3.0	1.5	1.1	0.5	0.1	0.2	0.2	0.2	0.5	0.2	1.1	0.1	0.8	0.1	1.3	0.1	1.6	0.1	0.1	0.1	0.1	0.1	1.8	0.1	0.2	0.1	0.0	0.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	1.9	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.5	2.8	0.0	1.8	0.0	0.1	0.0	0.0	5.9	0.2	0.0	0.0	0.2	0.3	0.0	2.7	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.0	4.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	7.3	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
SMIM35	TMPRSS4-AS1	ENSG00000255274	"Small integral membrane protein 35"	A0A1B0GVV1	11	118003634-118088299	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;kidney: 1.1"	"Cell type enhanced"	"Detected in single"		"Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"Karpas-707: 10.9;RPMI-8226: 7.2"	"Group enriched"	"Detected in some"	5	"basal ganglia: 1.2;olfactory bulb: 3.5"	"Region enriched"	"Detected in some"	6	"basal ganglia: 7.9"							NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"					"unprognostic (8.83e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.64e-1)"		"unprognostic (1.58e-1)"		"unprognostic (3.04e-4)"		"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"			"unprognostic (1.64e-1)"			"unprognostic (1.88e-1)"	0.1	0.1	0.2	0.5	0.3	1.2	0.2	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.2	1.1	0.1	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.1	0.0	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.3	0.2	0.1	0.0	0.1	0.0	0.4	0.2	0.2	1.6	0.1	0.2	0.3	0.1	0.5	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNAI1	"SLUGH2, SNA, SNAH, SNAIL, SNAIL1"	ENSG00000124216	"Snail family transcriptional repressor 1"	O95863	20	49982980-49988886	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 191.3;Endothelial cells: 54.4;Extravillous trophoblasts: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 28.1;TIME: 39.3;WM-115: 25.1"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"spinal cord: 7.0"	"CAB005883, HPA056831, HPA069985, CAB078687"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB005883: AB_443967, CAB078687: AB_2665847, HPA056831: AB_2732606, HPA069985: AB_2732146"	"unprognostic (4.60e-2)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (4.76e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (3.34e-3)"	"unprognostic (9.85e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.63e-7)"	"unprognostic (3.75e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (8.82e-7)"	"unprognostic (1.88e-2)"	30.3	12.0	2.5	4.4	2.3	4.5	16.8	2.7	2.8	6.1	2.7	5.1	1.0	7.0	0.7	2.7	9.6	16.5	16.0	2.2	3.8	8.3	5.2	16.7	2.1	4.5	2.7	2.4	5.1	1.3	6.5	7.2	2.6	4.1	0.8	0.3	3.9	2.4	2.3	4.6	3.3	3.1	2.4	9.7	5.9	3.9	4.2	0.8	15.4	1.3	0.7	9.4	4.6	3.0	1.2	0.9	5.4	0.7	1.6	1.0	10.9	4.7	5.8	0.9	0.6	8.9	1.4	0.7	12.6	8.4	5.6	0.1	1.6	0.0	0.5	0.1	1.1	0.6	2.0	5.4	13.6	1.5	4.3	3.1	0.3	2.0	0.0	14.3	14.0	0.7	7.0	0.2	0.0	2.0	0.1	1.6	7.2	0.8	3.8	2.5	1.4	0.8	6.4	0.0	2.3	5.6	28.1	7.1	1.2	4.6	1.4	6.5	39.3	0.0	6.8	0.0	0.1	0.2	0.1	7.5	2.3	2.1	25.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.5	2.3	2.7	2.8	2.2	3.8	4.5	2.7	2.6	2.4	4.2	3.0	191.3	0.0	5.3	0.3	11.8	5.2	2.4	0.5	5.2	0.6	18.6	37.0	4.5	2.8	3.8	0.0	0.0	8.3	29.7	2.8	0.0	1.5	3.0	5.8	18.6	54.4	1.8	0.0	0.6	0.2	79.9	31.7	5.6	8.7	1.3	1.0	17.5	0.3	8.0	3.3	0.4	4.5	2.0	6.4	40.3	0.8	5.6	35.6	5.4	0.0	1.0	0.8	0.0	0.0	0.7	4.7	1.6	14.3	2.2	1.6	1.4	0.2	1.0	0.4	6.6	7.6	17.5	1.4	3.8	7.2	4.8	14.0	12.2	7.2	3.0	0.6
SOCS3	"CIS3, Cish3, SOCS-3, SSI-3"	ENSG00000184557	"Suppressor of cytokine signaling 3"	O14543	17	78356778-78360077	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 501.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 989.2;Endothelial cells: 635.9;Fibroblasts: 394.4;Langerhans cells: 381.5;Skeletal myocytes: 485.9;Smooth muscle cells: 381.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.5;T-cells: 3.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 154.2;HSkMC: 73.3;U-266/70: 76.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 9.8"	"CAB012220, HPA068569"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol	"Plasma membrane"	"CAB012220: AB_443287, HPA068569: AB_2686008"	"prognostic favorable (4.80e-4)"	"unprognostic (2.67e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.41e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (9.34e-9)"	"unprognostic (1.08e-2)"	"unprognostic (8.80e-2)"	"unprognostic (7.59e-3)"	"unprognostic (8.40e-2)"	501.5	50.3	19.1	99.0	20.2	126.4	114.1	18.8	27.5	35.1	21.7	119.0	19.4	53.4	1.9	72.7	306.5	190.4	76.8	16.8	21.2	72.1	84.2	234.8	46.9	43.1	22.1	55.5	46.2	23.6	55.7	77.5	24.6	61.8	27.2	4.2	36.3	17.1	26.1	55.3	64.2	125.2	23.7	52.0	123.9	5.9	32.2	115.9	54.1	37.1	11.8	187.9	31.6	19.6	6.4	10.2	7.3	3.8	2.8	44.3	19.1	31.4	28.3	32.1	13.6	6.6	4.4	0.2	6.7	7.5	20.4	2.0	1.5	3.1	12.7	154.2	0.9	5.8	24.1	1.4	14.5	0.1	2.7	73.3	2.6	24.9	9.3	19.4	14.0	0.5	17.4	58.2	15.1	3.3	3.3	1.0	5.2	1.2	12.8	0.2	36.9	1.1	51.4	6.3	0.3	4.6	9.5	2.5	1.3	26.8	2.9	1.4	8.4	62.7	17.6	22.2	18.4	76.0	46.9	0.1	51.6	0.8	4.1	0.0	1.0	0.2	0.8	0.1	1.9	0.0	2.1	0.9	1.1	0.0	3.1	0.6	9.5	0.3	0.0	1.0	1.3	0.5	19.1	20.2	18.8	27.5	16.8	21.2	43.1	22.1	24.6	23.7	32.2	19.6	989.2	48.1	125.6	0.7	64.7	164.3	120.7	75.0	125.2	1.0	176.3	136.4	23.1	18.6	51.7	38.6	2.1	14.9	42.1	20.5	5.9	44.4	0.8	106.7	207.6	635.9	33.0	11.6	0.0	38.6	46.0	394.4	125.4	166.8	36.0	5.8	307.3	20.2	94.6	0.0	0.1	25.0	30.5	78.4	381.5	1.7	78.3	231.0	85.4	1.0	33.6	7.7	1.0	0.0	1.0	43.0	28.1	2.2	115.5	72.0	24.3	11.5	38.1	2.7	13.1	485.9	381.7	0.4	1.0	36.3	133.0	62.1	88.7	5.3	41.0	90.5
SP8		ENSG00000164651	"Sp8 transcription factor"	Q8IXZ3	7	20782279-20786886	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.6;prostate: 6.6"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 3.5;Inhibitory neurons: 5.3;Paneth cells: 1.2;Prostatic glandular cells: 2.9;Spermatocytes: 1.1;Spermatogonia: 1.5;Urothelial cells: 1.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.3;HUVEC TERT2: 6.4;NTERA-2: 12.6;PC-3: 21.6"	"Group enriched"	"Detected in many"	11	"basal ganglia: 15.3;olfactory bulb: 54.5"	"Region enriched"	"Detected in some"	11	"olfactory bulb: 29.8"	HPA054006	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA054006: AB_2682340"		"unprognostic (1.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.90e-4)"		"unprognostic (3.46e-1)"	"unprognostic (5.49e-1)"	"unprognostic (1.73e-2)"		"unprognostic (2.42e-2)"		"unprognostic (3.38e-1)"	"unprognostic (7.44e-2)"			0.0	0.0	0.8	0.0	1.9	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.7	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.6	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	1.2	0.0	0.0	0.0	4.3	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	12.6	0.1	21.6	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.4	0.8	0.0	0.0	0.0	0.0	2.7	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.9	0.0	4.6	0.8	2.7	3.5	0.0	0.7	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	0.0	0.0	0.0	0.0	0.2	1.0
SPATC1	"MGC61633, SPATA15, SPERIOLIN"	ENSG00000186583	"Spermatogenesis and centriole associated 1"	Q76KD6	8	144012280-144047114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"testis: 37.5"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 358.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebellum: 1.2;medulla oblongata: 1.9;pons: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"U-937: 7.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 13.9"							NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.96e-1)"	"unprognostic (1.41e-3)"	"unprognostic (3.34e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.59e-3)"	"unprognostic (6.96e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.74e-1)"	0.2	0.1	0.2	1.8	0.2	8.4	0.1	1.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.0	0.3	0.3	0.8	0.6	1.9	0.2	0.0	0.1	0.0	0.0	0.2	1.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.1	0.0	2.0	0.2	37.5	0.3	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.2	1.2	0.4	0.2	0.0	1.9	0.2	1.7	0.0	0.3	0.2	0.0	0.0	0.5	5.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	358.1	2.5	0.5	0.0	0.0	4.3	0.0	0.0	1.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 140.7;salivary gland: 114.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 94.2;Breast myoepithelial cells: 61.1;Intestinal goblet cells: 315.1;Prostatic glandular cells: 72.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 388.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 288.4;OE19: 118.0;SK-BR-3: 192.2;T-47d: 154.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"midbrain: 2.9"	HPA055707			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.4	0.1	0.5	1.4	0.5	0.1	36.6	0.8	1.1	28.0	0.0	18.4	11.6	9.0	0.5	2.2	6.3	2.4	0.4	0.5	0.2	0.1	0.1	1.1	0.0	0.3	0.4	0.1	0.6	0.0	0.2	0.0	0.2	140.7	10.2	0.0	114.8	0.1	0.3	9.3	14.3	0.6	0.1	0.1	35.4	0.3	0.5	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	30.9	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.4	0.3	0.4	0.0	118.0	38.6	0.1	0.0	0.3	0.3	0.3	2.1	0.2	0.0	192.2	0.0	0.0	154.0	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.8	1.1	0.5	0.2	0.3	0.4	0.2	0.1	0.5	0.5	0.8	0.0	2.2	0.7	0.3	0.1	13.3	20.7	0.0	0.0	94.2	61.1	0.3	5.7	31.7	0.0	0.0	0.0	1.4	27.1	0.0	2.6	1.1	6.2	0.7	0.6	5.4	0.0	0.8	1.2	0.0	0.4	28.1	18.7	0.0	0.2	0.4	0.0	0.0	0.0	0.6	315.1	12.2	0.0	0.2	5.5	0.0	0.9	3.6	0.0	0.0	0.0	0.0	0.0	0.2	20.2	12.3	0.0	0.1	72.7	5.7	0.0	2.9	0.0	0.0	0.0	1.2	0.1	0.2	0.0	0.0	0.3	0.8	0.0	30.0	11.5
SPTBN5	"BSPECV, HUBSPECV, HUSPECV"	ENSG00000137877	"Spectrin beta, non-erythrocytic 5"	Q9NRC6	15	41848146-41894053	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 8.8;retina: 26.9"	"Group enriched"	"Detected in many"	22	"Cone photoreceptor cells: 210.6;Rod photoreceptor cells: 211.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"cerebellum: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.7;SCLC-21H: 5.1;TIME: 13.6;WM-115: 4.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"spinal cord: 3.6"	HPA055283	Approved					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA055283: "	"unprognostic (5.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.84e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.11e-2)"	1.0	0.3	0.4	0.7	1.3	0.4	1.1	8.8	1.4	0.6	0.1	0.5	0.3	0.4	0.8	1.7	0.5	0.9	2.0	0.6	0.1	1.7	1.6	1.2	0.6	0.8	0.3	0.6	1.1	0.5	1.9	0.2	1.0	1.6	0.2	26.9	2.7	0.3	0.4	1.7	0.5	0.2	0.1	0.5	1.0	0.8	0.1	0.0	2.1	0.4	0.1	2.6	0.7	0.8	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.6	0.0	0.8	0.0	1.5	0.4	0.0	0.2	0.0	0.8	0.1	0.0	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.4	0.0	0.3	0.0	0.3	1.4	5.1	0.1	0.2	0.4	0.1	0.4	0.8	0.0	13.6	0.0	1.3	0.3	1.7	1.5	2.3	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	8.8	1.4	0.6	0.1	0.8	0.3	1.0	0.1	0.1	0.8	1.9	0.0	2.4	2.9	0.2	0.8	0.9	0.4	1.2	7.9	1.8	2.0	4.0	0.0	1.5	0.0	210.6	0.1	0.8	0.7	0.0	0.5	1.1	1.1	0.3	3.7	0.0	0.0	2.3	0.2	0.3	0.6	2.0	3.8	1.3	1.0	0.4	0.5	2.0	3.3	0.5	0.5	0.0	0.0	0.6	0.9	0.0	1.0	1.8	0.0	0.8	9.6	1.0	6.0	0.5	1.0	1.4	0.0	0.9	0.2	0.2	0.6	0.8	211.8	0.0	0.2	0.3	0.5	0.5	3.9	1.3	0.0	0.5	0.2	0.6	1.0
SUMO1	"GMP1, OFC10, PIC1, SMT3C, SMT3H3, SUMO-1, UBL1"	ENSG00000116030	"Small ubiquitin like modifier 1"	P63165	2	202206182-202238599	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.6"	"CAB004269, HPA056956"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear membrane"	"Nucleoli, Nuclear bodies"	"CAB004269: AB_628300, HPA056956: AB_2683285"	"unprognostic (7.15e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (7.93e-4)"	"unprognostic (7.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.19e-1)"	77.5	99.1	79.4	62.7	84.9	133.7	83.6	89.0	99.9	68.9	84.4	82.7	72.0	65.1	86.3	71.6	65.7	71.7	79.8	85.6	85.3	118.1	174.1	66.5	86.4	79.9	80.1	54.5	55.8	91.6	56.7	75.6	81.1	75.3	82.8	80.2	66.8	61.9	107.5	57.1	80.5	71.5	78.9	68.1	73.8	54.7	81.4	112.1	102.3	103.3	95.4	77.9	54.9	86.6	164.1	82.4	291.4	155.8	159.3	168.5	129.7	171.0	214.6	209.0	274.6	178.1	203.7	111.6	153.5	199.0	193.5	117.1	242.2	237.9	325.0	104.8	185.7	207.6	159.0	211.2	114.9	237.2	188.5	130.9	225.2	164.0	123.9	195.1	197.3	219.0	194.2	176.0	226.4	141.1	298.3	391.6	351.7	168.5	172.2	190.9	163.2	197.9	255.5	134.3	201.7	219.3	140.3	133.6	236.4	313.9	120.0	223.2	139.9	152.5	153.0	141.4	152.8	151.7	322.9	285.8	170.2	165.4	137.2	242.2	220.0	284.2	169.2	226.5	179.6	276.3	206.8	200.0	223.6	231.6	193.8	202.3	256.5	246.5	239.7	187.8	329.0	394.7	79.4	84.9	89.0	99.9	85.6	85.3	79.9	80.1	81.1	78.9	81.4	86.6	182.7	112.2	61.1	10.7	143.1	422.1	204.4	448.6	177.6	99.6	196.8	170.2	58.1	130.1	215.3	189.4	64.6	259.4	162.3	136.6	481.3	250.4	91.3	148.3	115.1	170.7	142.4	140.1	31.4	173.3	297.8	161.8	89.7	115.2	92.6	114.7	142.8	202.1	205.3	87.5	27.8	156.4	319.4	140.7	330.2	28.0	129.8	137.7	211.7	15.9	241.3	182.3	176.1	16.6	21.2	208.1	191.1	127.9	130.5	258.5	272.2	534.4	185.5	87.8	111.7	92.5	221.9	212.0	141.5	183.9	424.5	209.7	174.5	134.9	157.5	254.1
SVEP1	"bA427L11.3, C9orf13, FLJ13529, POLYDOM"	ENSG00000165124	"Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1"	Q4LDE5	9	110365248-110579880	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 38.6;placenta: 61.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 92.8;Inhibitory neurons: 50.3;Leydig cells: 42.0;Oligodendrocytes: 140.5;Syncytiotrophoblasts: 67.3;Theca cells: 34.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"ASC diff: 147.1;ASC TERT1: 84.7;BJ hTERT+: 62.3;HHSteC: 53.8;HSkMC: 66.7"	"Region enhanced"	"Detected in some"		"cerebellum: 2.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 20.8"	"HPA020610, HPA021520"	Enhanced				"Intracellular and membrane"	NA	NA		160000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA020610: AB_2197021, HPA021520: AB_1855533"	"unprognostic (4.47e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (8.33e-4)"	"unprognostic (9.84e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-3)"	38.6	4.2	1.5	2.5	8.6	0.0	23.2	8.9	2.8	10.6	0.9	9.7	1.2	8.6	5.6	3.5	12.4	6.2	6.5	1.1	3.4	3.9	2.9	19.7	3.8	2.7	5.3	3.9	4.7	5.3	0.8	61.7	3.3	1.7	5.1	0.0	4.1	2.1	4.4	11.3	8.7	9.5	1.0	5.2	7.7	1.0	4.3	1.8	7.4	5.5	2.4	9.7	12.1	6.1	0.0	0.1	1.2	0.0	147.1	84.7	0.0	16.3	62.3	1.2	1.9	1.5	0.0	0.0	0.0	3.9	0.1	0.0	0.0	12.2	1.0	0.0	0.3	0.1	1.4	0.0	53.8	0.0	2.9	66.7	0.0	12.1	3.2	1.4	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.2	7.5	2.0	0.0	10.6	0.0	0.0	0.0	2.3	0.0	1.0	0.0	1.3	2.5	0.0	7.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	8.6	8.9	2.8	1.1	3.4	2.7	5.3	3.3	1.0	4.3	6.1	7.4	0.0	0.5	2.9	0.1	5.7	0.6	0.5	1.2	0.5	0.4	0.9	1.8	5.7	0.1	0.0	0.0	12.2	0.3	0.0	0.0	0.9	0.3	0.5	13.8	2.0	0.0	0.0	16.9	0.2	1.6	92.8	4.1	0.3	0.0	0.0	2.2	0.0	3.0	0.0	50.3	0.0	0.0	0.0	8.2	0.6	42.0	0.6	7.2	13.1	0.0	0.0	0.0	3.0	140.5	0.0	1.2	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	3.5	7.8	0.4	1.5	0.4	3.3	67.3	1.2	34.1	0.2	0.2
SYNDIG1L	"capucin, DSPC1, IFITMD4, TMEM90A"	ENSG00000183379	"Synapse differentiation inducing 1 like"	A6NDD5	14	74405894-74426210	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	42	"brain: 468.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.7;Bipolar cells: 10.9;Inhibitory neurons: 4.8"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Region enriched"	"Detected in all"	5	"basal ganglia: 468.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"basal ganglia: 280.7"	"Region enriched"	"Detected in many"	7	"basal ganglia: 125.1"	"HPA042594, HPA048487"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 56: Bipolar cells - Visual perception"			"HPA042594: AB_2678069, HPA048487: AB_2680416"	"unprognostic (5.75e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.25e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.08e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	0.5	0.1	42.9	0.0	468.2	0.0	0.3	1.2	65.4	0.3	0.5	0.4	0.0	0.3	11.0	0.1	0.2	0.2	0.2	3.4	30.8	0.3	0.1	1.4	0.1	16.7	50.9	0.2	0.2	0.0	0.7	0.0	12.9	0.3	0.2	4.6	0.2	0.2	0.2	0.4	0.5	0.3	19.6	0.2	0.2	0.2	100.2	0.0	0.3	0.0	0.0	0.2	0.3	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	468.2	1.2	65.4	3.4	30.8	16.7	50.9	12.9	19.6	100.2	7.5	0.1	0.0	2.7	1.0	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0
TAC1	"NKNA, NPK, TAC2"	ENSG00000006128	"Tachykinin precursor 1"	P20366	7	97732084-97740472	"Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 55.6;lymphoid tissue: 46.1"	"Cell type enriched"	"Detected in some"	7	"Inhibitory neurons: 99.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"U-266/70: 22.8"	"Region enhanced"	"Detected in all"		"basal ganglia: 560.0"	"Region enriched"	"Detected in all"	10	"basal ganglia: 388.8"	HPA014429	Enhanced				"Secreted to blood"	NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA014429: AB_1857722"	"unprognostic (9.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.92e-1)"					"unprognostic (2.08e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.86e-2)"	2.1	8.6	7.3	10.9	34.2	0.0	2.1	2.0	12.1	0.6	1.9	9.8	8.3	0.8	1.6	0.0	1.0	6.6	1.4	6.1	45.1	7.3	0.3	0.5	0.0	53.2	55.6	0.2	0.6	0.5	1.5	0.0	21.5	1.3	3.6	3.4	6.8	2.1	0.3	1.2	10.3	7.5	16.4	46.1	3.0	0.4	23.9	0.1	7.4	0.0	0.0	1.5	0.8	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	34.2	2.0	12.1	6.1	45.1	53.2	55.6	21.5	16.4	23.9	6.4	0.1	0.0	0.0	2.9	0.5	0.4	0.1	0.0	0.0	0.0	0.4	0.6	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	13.2	0.0	9.7	0.0	0.0	0.0	0.0	0.1	0.0	99.4	5.4	0.0	0.0	0.4	0.1	0.3	0.1	0.0	1.9	0.0	0.0	0.0	1.5	3.4	0.5	0.0	0.0	0.0	4.2	0.3	9.1	0.0	0.0	0.0	1.1	1.3	0.2	2.1	0.0	0.1	0.0	0.4	0.0	0.5	0.9
TBX21	"T-bet, TBLYM"	ENSG00000073861	"T-box transcription factor 21"	Q9UL17	17	47733236-47746122	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.1;lung: 3.3;lymphoid tissue: 11.7"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 92.8;NK-cells: 119.4;Plasma cells: 22.8;T-cells: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 15.7;NK-cell: 14.3"	"Group enriched"	"Detected in many"	7	"NK-cells: 14.3;T-cells: 15.7"	"Cell line enriched"	"Detected in single"	113	"HDLM-2: 16.3"	"Region enriched"	"Detected in single"	27	"olfactory bulb: 22.1"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 4.2"	"CAB009524, CAB030043"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB009524: AB_2200557, CAB030043: AB_1595503"	"unprognostic (3.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (5.35e-6)"	"unprognostic (3.93e-1)"	"unprognostic (2.56e-4)"	"unprognostic (5.86e-4)"	"unprognostic (6.90e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.26e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.04e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.67e-1)"	"unprognostic (9.19e-3)"	"unprognostic (4.43e-3)"	0.9	0.4	0.3	1.9	0.3	11.1	0.4	0.3	0.3	0.4	0.4	0.5	0.9	0.3	0.4	0.3	0.4	0.8	0.3	0.2	0.3	0.5	1.2	3.3	7.5	0.4	0.3	0.2	0.2	0.0	0.2	0.2	0.3	0.4	0.5	0.0	0.6	0.2	0.5	0.2	1.6	0.4	0.3	11.7	1.2	0.4	0.3	1.0	0.7	0.2	2.2	0.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	3.6	2.0	3.1	8.9	0.0	0.5	0.4	7.8	0.2	14.3	0.0	0.1	0.1	2.4	0.3	0.3	0.3	0.3	0.2	0.3	0.4	0.3	0.3	0.3	0.3	0.3	1.1	0.0	0.6	0.0	7.6	0.0	0.0	0.0	0.6	0.0	0.6	0.9	1.3	1.5	0.0	0.0	0.0	0.1	92.8	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	1.3	0.1	0.0	0.0	0.2	1.1	0.2	2.5	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	1.9	0.0	1.9	0.8	0.0	119.4	0.0	0.1	0.0	0.0	0.0	22.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.1	0.1	0.0	45.6	0.0	0.0	0.0
TFAP2D	TFAP2BL1	ENSG00000008197	"Transcription factor AP-2 delta"	Q7Z6R9	6	50713526-50773033	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"brain: 6.3"	"Cell type enhanced"	"Detected in single"		"Horizontal cells: 1.7"	"Cancer enriched"	"Detected in single"	10	"lung cancer: 0.5"	"Region enriched"	"Detected in some"	5	"midbrain: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Region enriched"	"Detected in many"	4	"midbrain: 11.8"	"Region enriched"	"Detected in some"	6	"midbrain: 9.4"	HPA048962			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA048962: AB_2680573"																		0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.3	0.2	0.0	0.0	6.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGM6	"dJ734P14.3, SCA35, TGM3L, TGY"	ENSG00000166948	"Transglutaminase 6"	O95932	20	2380901-2432753	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"cerebellum: 1.0"	HPA059196	Uncertain					NA	NA									"HPA059196: AB_2683943"						"unprognostic (1.18e-1)"						"unprognostic (2.84e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171815	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"adrenal gland: 196.6;brain: 270.9"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 9.0;Extravillous trophoblasts: 12.4;Leydig cells: 3.4;Syncytiotrophoblasts: 2.2"	"Cancer enriched"	"Detected in some"	5	"urothelial cancer: 4.0"	"Group enriched"	"Detected in many"	5	"midbrain: 192.4;pons: 270.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"PC-3: 60.8;SK-BR-3: 21.0"	"Region enhanced"	"Detected in many"		"olfactory bulb: 178.8"	"Region enriched"	"Detected in many"	20	"midbrain: 594.4"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374"	"unprognostic (1.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.75e-4)"	"unprognostic (8.82e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.39e-4)"	"unprognostic (4.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.18e-2)"	3.3	196.6	1.9	0.1	3.0	0.0	0.0	0.2	1.3	0.6	0.2	0.1	0.0	0.5	0.1	0.7	0.2	0.4	0.1	1.3	46.5	0.4	0.4	0.0	0.0	13.9	192.4	0.7	0.2	0.0	1.7	0.1	270.9	0.3	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.8	0.2	0.3	0.5	14.6	0.0	0.0	0.0	0.0	1.4	1.5	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.6	60.8	0.0	0.0	0.0	0.1	0.1	1.1	0.2	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.0	0.2	1.3	1.3	46.5	13.9	192.4	270.9	0.8	14.6	1.6	0.3	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.2	1.8	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.4	9.0	0.4	0.0	0.0	0.1	0.0	12.4	0.4	0.0	0.3	0.0	0.0	1.1	0.2	0.5	0.0	0.3	0.1	0.0	0.0	0.3	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	2.2	0.1	0.3	0.2	0.2
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Tissue remodeling, Unfolded protein response"	"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 216.7;heart muscle: 167.9;smooth muscle: 251.4;tongue: 214.6"	"Cell type enriched"	"Detected in many"	4	"Sertoli cells: 493.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	46	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	46	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"AF22: 3.1;THP-1: 7.0;U-2 OS: 2.8;U-266/70: 2.6"	"Region enriched"	"Detected in many"	8	"white matter: 85.7"	"Region enriched"	"Detected in many"	27	"spinal cord: 89.3"	"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		510000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB004597: AB_628352, HPA042426: AB_2677992"	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavorable (3.33e-4)"	216.7	1.2	15.4	5.2	19.6	10.6	26.8	13.8	13.0	2.1	5.0	58.1	2.2	26.8	1.6	6.0	2.5	10.4	167.9	12.2	24.5	0.7	0.3	1.3	1.1	22.3	25.3	4.1	22.8	35.7	14.3	0.2	19.9	9.0	8.7	7.5	46.5	5.7	77.2	2.9	3.3	251.4	21.7	0.3	8.6	8.7	28.0	3.6	27.0	214.6	4.0	3.5	5.8	20.0	0.1	0.0	3.1	0.2	0.2	1.3	0.3	0.1	0.1	0.9	0.3	0.1	0.4	0.1	0.1	0.2	0.8	0.1	0.1	0.4	0.8	0.1	0.4	0.3	0.0	0.2	1.7	0.0	0.0	0.9	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.2	0.5	0.0	0.0	2.4	0.0	0.0	0.0	0.9	0.0	0.2	0.0	2.5	0.7	0.0	0.0	0.2	1.3	0.0	7.0	0.0	0.0	2.8	0.2	0.2	2.6	0.1	0.4	1.1	2.2	0.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	19.6	13.8	13.0	12.2	24.5	22.3	25.3	19.9	21.7	28.0	20.0	57.0	0.0	1.1	37.2	0.7	0.3	0.1	0.2	2.2	1.3	0.8	1.8	9.1	0.0	0.7	3.7	56.3	0.1	0.5	0.0	0.0	0.2	40.8	0.3	0.8	9.4	9.0	0.0	9.7	0.0	0.0	84.2	0.5	0.3	0.0	5.9	0.4	0.2	0.1	1.7	12.7	0.0	0.0	0.0	0.3	7.2	0.9	2.7	1.8	6.5	0.0	2.2	0.0	60.3	24.0	0.0	0.0	43.6	0.3	1.0	0.0	0.8	0.2	1.9	493.0	78.9	116.9	14.5	2.1	0.6	1.0	0.0	2.1	1.2	0.0	0.0
THEM5	FLJ37964	ENSG00000196407	"Thioesterase superfamily member 5"	Q8N1Q8	1	151847101-151853712	"Enzymes, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"skin 1: 158.5"	"Cell type enriched"	"Detected in some"	18	"Suprabasal keratinocytes: 34.7"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 2.1;cerebral cortex: 4.0;hippocampal formation: 3.0;white matter: 1.0"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 57.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"basal ganglia: 13.8"							NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 28: Keratinocytes - Keratinization"				"unprognostic (2.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.58e-3)"	"unprognostic (9.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.86e-3)"	"unprognostic (3.07e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.62e-2)"	0.3	1.9	2.1	2.0	0.3	0.5	4.2	0.0	4.0	1.6	0.5	0.4	1.4	0.5	0.0	6.5	0.7	3.1	1.9	3.0	0.0	1.1	0.6	1.3	6.3	0.3	0.0	0.2	1.3	0.0	0.5	0.5	0.2	0.4	0.0	0.7	3.1	0.0	1.3	158.5	0.8	0.0	0.0	1.0	1.9	1.2	0.6	0.1	1.0	0.0	0.3	1.2	3.2	1.0	6.6	0.0	0.1	0.2	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	2.3	0.0	0.0	0.0	57.6	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	1.7	0.2	0.0	7.1	1.2	0.6	0.0	0.2	0.7	0.0	0.0	0.4	0.1	8.6	2.1	1.1	1.4	1.4	2.4	0.0	0.0	0.0	1.6	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	0.1	1.7	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.9	1.7	2.1	0.3	0.0	4.0	3.0	0.0	0.3	0.0	0.2	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.9	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.8	34.7	1.1	0.0	0.0	0.0	0.0
THSD4	"ADAMTSL6, FLJ13710, FVSY9334, PRO34005"	ENSG00000187720	"Thrombospondin type 1 domain containing 4"	Q6ZMP0	15	71096952-71783383	"Predicted membrane proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 103.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 106.4;Basal squamous epithelial cells: 449.0;Microglial cells: 247.3;Squamous epithelial cells: 141.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 45.3;BJ hTERT+: 53.0;T-47d: 43.3;TIME: 66.6;U-2197: 44.4"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.0"						"Secreted - unknown location"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"				"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.01e-3)"	4.8	8.4	9.8	1.6	7.8	0.0	14.7	6.1	8.6	103.7	9.5	7.0	7.9	22.2	7.8	60.3	37.0	10.9	41.6	8.5	7.2	14.2	7.0	10.3	0.9	7.8	9.1	3.1	6.4	0.7	9.7	3.6	7.6	34.0	6.9	1.2	11.4	15.0	3.0	8.5	8.7	10.3	7.0	1.9	12.0	3.1	15.9	1.6	8.8	2.5	2.5	13.3	38.5	5.9	6.0	45.3	0.8	13.0	6.7	40.2	0.2	22.0	53.0	11.2	5.8	0.3	8.7	0.0	17.7	7.8	38.5	17.0	1.8	9.1	6.8	2.0	2.0	0.0	4.4	0.0	4.3	0.0	0.0	3.0	6.7	6.7	26.6	30.5	20.7	0.0	0.0	0.5	9.2	9.1	0.0	0.1	3.9	0.1	7.8	0.0	0.7	0.8	29.5	6.0	0.7	5.5	8.8	10.9	0.0	5.0	43.3	0.1	66.6	0.2	1.0	44.4	11.8	0.0	0.3	0.0	10.4	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	7.8	6.1	8.6	8.5	7.2	7.8	9.1	7.6	7.0	15.9	5.9	1.1	19.2	9.0	6.5	0.0	13.9	106.4	11.3	449.0	3.0	48.7	43.9	60.1	58.6	7.5	5.5	6.2	0.4	0.8	16.2	1.9	18.3	7.5	19.3	13.2	9.8	3.0	0.0	17.1	1.8	0.4	12.5	2.6	31.8	0.0	0.3	6.1	12.3	0.2	0.0	19.1	6.1	0.0	0.0	2.1	16.9	17.4	1.6	8.8	247.3	0.0	0.3	0.0	8.5	6.7	13.6	11.0	74.4	1.2	94.6	29.3	0.5	11.0	0.9	0.0	16.8	6.6	0.9	1.7	141.5	10.9	0.8	3.1	42.2	13.2	29.7
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153068-12158912	"Plasma proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 177.7;breast: 119.6"	"Cell type enriched"	"Detected in many"	10	"Adipocytes: 363.9"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 212.9;ASC TERT1: 53.0;HSkMC: 91.9;NTERA-2: 50.7;U-87 MG: 53.6"	"Region enhanced"	"Detected in all"		"cerebellum: 106.1"	"Region enriched"	"Detected in all"	9	"cerebellum: 47.7"						"Secreted to extracellular matrix"	NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	177.7	8.3	7.7	3.9	8.4	0.6	119.6	49.6	7.2	9.3	3.9	12.1	1.4	8.1	1.0	2.9	6.8	4.4	31.0	6.8	8.8	2.8	1.1	6.6	0.6	13.7	8.6	3.8	4.0	1.4	12.3	9.9	11.7	5.5	4.3	1.0	8.9	2.3	16.7	7.7	11.0	4.4	11.3	3.4	9.2	0.7	7.1	2.0	23.1	30.1	0.1	9.8	8.7	11.6	0.7	24.2	0.7	0.0	212.9	53.0	26.4	0.8	8.9	1.0	1.3	0.5	0.1	0.0	2.2	0.9	0.8	0.9	0.0	0.8	0.4	1.0	0.0	0.0	12.7	0.9	33.2	0.0	0.1	91.9	2.2	5.8	0.2	1.6	0.0	0.0	0.5	17.3	0.2	0.6	0.0	0.0	50.7	0.0	6.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	5.0	0.0	0.0	6.1	0.0	0.0	1.0	0.1	0.0	0.6	0.9	0.0	0.1	0.0	53.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.4	49.6	7.2	6.8	8.8	13.7	8.6	11.7	11.3	7.1	11.6	363.9	0.0	0.0	0.0	0.4	0.1	1.3	0.3	0.6	0.4	12.4	2.8	7.0	0.0	0.2	0.0	0.0	0.4	1.4	1.3	0.0	0.6	1.6	0.2	2.1	33.6	6.6	5.3	0.1	2.6	2.7	15.7	0.0	0.0	0.0	0.2	22.5	0.0	3.4	0.0	0.2	2.8	0.0	1.2	0.3	7.5	12.2	0.8	3.6	0.0	0.0	0.7	0.0	9.0	0.1	4.6	4.8	2.6	0.0	4.2	2.7	0.5	5.5	0.0	32.9	3.1	29.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	2.0	2.2
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873237-166104457	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 20.0;placenta: 6.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 115.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 6.0;Karpas-707: 9.6;PC-3: 3.3"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 45.8"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		560000		"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA060767: AB_2684357"	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	3.1	0.5	0.7	1.0	5.9	0.0	2.7	20.0	8.9	1.8	0.0	1.2	0.6	1.1	0.3	0.7	1.3	2.4	0.7	9.9	5.4	1.6	0.1	1.2	1.0	3.5	6.9	0.3	2.3	0.8	0.9	6.4	4.4	0.9	0.9	1.8	0.8	0.8	0.4	1.4	1.8	1.4	0.0	0.0	0.7	0.4	3.0	0.3	1.4	0.4	0.8	1.6	1.5	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.3	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	1.3	0.0	0.9	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.9	0.0	3.3	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.9	20.0	8.9	9.9	5.4	3.5	6.9	4.4	0.0	3.0	1.1	10.2	0.0	0.6	0.0	0.0	1.8	0.3	1.3	0.6	14.1	0.2	0.1	7.1	1.5	1.8	0.0	0.0	4.4	0.0	0.0	0.0	1.5	0.1	0.0	2.0	18.9	0.0	0.0	24.9	2.0	1.4	2.4	0.0	0.1	0.0	0.0	2.5	0.0	0.3	8.4	8.0	0.1	0.0	0.0	1.0	0.0	3.1	0.1	1.8	10.3	0.0	0.1	0.0	115.1	0.5	0.1	0.0	4.5	0.0	1.1	4.0	1.1	0.8	0.7	0.0	0.2	0.3	0.1	0.2	0.1	1.7	1.9	0.8	0.0	0.6	0.2
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309248-171312139	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"brain: 9.0"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 7.7"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Group enriched"	"Detected in many"	6	"cerebellum: 9.0;medulla oblongata: 2.3;spinal cord: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 25.9"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.2"	"Region enriched"	"Detected in some"	8	"cerebellum: 15.5"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	2.3	0.6	1.0	5.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
TMEM266	"C15orf27, FLJ38190"	ENSG00000169758	"Transmembrane protein 266"	Q2M3C6	15	76059958-76229121	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 8.4;skeletal muscle: 5.8;tongue: 2.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 10.4;Cytotrophoblasts: 16.0;Early spermatids: 7.0;Late spermatids: 19.7;Rod photoreceptor cells: 9.1;Sertoli cells: 6.6;Spermatogonia: 6.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 8.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 58.7"	"Region enriched"	"Detected in many"	5	"cerebellum: 26.8"	"HPA041921, HPA049425"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane, Cytosol"		"HPA041921: AB_10796789, HPA049425: AB_2732552"	"unprognostic (8.63e-3)"	"unprognostic (6.11e-3)"	"unprognostic (3.44e-3)"	"unprognostic (9.17e-5)"	"unprognostic (4.67e-1)"	"unprognostic (2.61e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.86e-2)"	0.0	0.9	0.9	0.0	1.0	0.0	0.1	8.4	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.5	0.0	0.5	0.1	0.6	0.8	0.0	1.1	0.0	1.2	0.9	0.7	0.1	0.0	1.1	0.0	0.0	5.8	0.5	0.0	0.0	0.5	0.1	0.0	0.6	1.4	0.3	0.0	2.2	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	8.4	1.7	1.2	0.9	0.6	0.8	0.7	0.5	1.4	0.8	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.5	0.5	0.0	0.0	0.0	1.8	10.4	16.0	0.0	0.0	1.9	0.0	7.0	0.2	0.1	0.4	0.0	0.0	0.0	0.2	2.2	0.9	1.5	0.1	0.0	0.2	0.4	0.4	4.5	1.7	0.0	0.0	0.0	0.3	0.0	19.7	0.0	0.4	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.0	0.0	0.7	1.5	9.1	6.6	1.3	0.2	0.5	6.3	0.0	0.0	5.9	0.2	0.5	0.0	0.7
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151943-30161211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.8;kidney: 2.0;liver: 2.9"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 126.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HEL: 22.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 3.4"	HPA043325	Uncertain					NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.1	0.0	1.6	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	126.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.9	0.0	0.0	0.0	3.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0
TRIM29	"ATDC, FLJ36085"	ENSG00000137699	"Tripartite motif containing 29"	Q14134	11	120111286-120185529	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 600.1;skin 1: 551.2;vagina: 269.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 272.0;Basal squamous epithelial cells: 250.4;Late spermatids: 150.3;Squamous epithelial cells: 552.9;Suprabasal keratinocytes: 460.6;Urothelial cells: 159.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 93.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 399.9;HBEC3-KT: 107.5;hTCEpi: 476.0;RT4: 190.5;SiHa: 268.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"spinal cord: 4.0"	"HPA020053, HPA074841"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA020053: AB_1858280, HPA074841: "	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (9.79e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.46e-4)"	"unprognostic (9.37e-2)"	"unprognostic (4.29e-3)"	"prognostic favorable (4.93e-4)"	"unprognostic (2.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.15e-2)"	2.5	1.0	0.1	0.4	0.2	0.4	41.7	0.0	0.4	133.8	1.6	3.0	1.7	2.6	4.8	600.1	17.4	3.5	0.4	0.3	0.0	1.7	1.8	3.7	0.0	1.8	0.6	0.4	1.0	0.0	8.1	30.7	1.8	31.4	2.6	0.3	131.5	23.7	2.2	551.2	1.0	1.5	2.6	0.3	1.4	2.7	0.0	19.9	0.4	0.2	107.2	55.8	269.1	0.6	34.4	2.5	0.0	0.0	0.0	0.0	0.9	0.1	0.8	0.2	0.1	0.8	25.6	0.2	3.9	0.2	0.5	399.9	0.0	107.5	0.0	0.1	0.0	0.2	25.4	0.4	0.0	0.2	0.5	0.0	476.0	0.0	2.6	0.0	0.0	0.0	0.2	0.7	0.0	4.4	0.0	0.0	0.1	11.4	0.1	0.0	0.3	0.0	0.3	190.5	1.3	5.9	268.3	35.2	0.1	0.2	1.9	0.0	0.4	0.1	2.1	0.2	0.1	0.2	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.3	0.0	1.8	0.6	1.8	2.6	0.0	0.6	0.5	0.0	1.5	3.3	0.2	272.0	106.1	76.4	250.4	0.0	9.5	58.8	1.2	1.5	39.2	0.0	0.0	41.0	0.2	11.3	0.0	5.0	28.1	8.7	0.8	3.4	2.4	0.0	0.5	4.3	7.1	5.6	1.1	3.6	1.3	0.0	0.0	0.4	5.0	0.0	0.1	2.1	12.2	0.0	30.3	150.3	0.6	1.4	23.2	1.0	0.0	0.0	0.0	0.0	0.1	57.1	11.3	0.0	0.0	66.0	0.2	0.6	64.6	0.0	0.0	0.1	4.9	0.8	2.6	552.9	460.6	24.8	2.4	0.1	3.7	159.3
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 68.7;Extravillous trophoblasts: 105.1;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 96.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 213.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.1"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	25.4	12.9	11.0	7.1	12.1	0.6	25.0	96.6	13.5	29.6	9.7	18.0	7.9	32.3	11.5	15.4	23.2	35.2	128.8	6.9	12.6	45.8	54.8	35.8	5.4	12.3	13.0	35.3	13.1	28.1	8.6	58.7	14.5	27.6	6.2	14.8	18.0	24.4	16.8	27.9	12.3	23.6	8.6	20.6	13.4	5.1	17.1	19.1	18.4	12.4	7.1	18.4	22.3	7.6	1.5	12.7	20.1	16.1	19.2	15.5	48.3	26.7	82.3	20.1	26.1	30.6	11.6	0.8	23.9	14.6	19.7	3.1	9.5	9.6	11.8	5.0	9.3	36.3	8.5	20.6	42.2	0.2	3.0	17.7	7.4	40.4	16.9	50.4	55.7	1.1	1.0	1.1	17.6	16.7	0.0	0.8	25.5	7.8	7.4	9.9	213.0	3.1	61.7	7.4	36.8	22.6	18.8	36.6	16.4	45.9	13.7	0.2	27.2	8.5	28.8	14.8	25.7	0.2	0.6	0.3	20.3	0.5	10.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.2	11.0	12.1	96.6	13.5	6.9	12.6	12.3	13.0	14.5	8.6	17.1	7.6	60.1	0.0	4.1	10.4	0.8	19.2	13.3	22.4	13.1	68.7	19.8	9.0	50.1	11.5	6.5	12.9	2.1	53.1	0.2	1.7	5.9	21.1	3.0	2.3	24.9	43.1	6.0	5.3	16.8	9.1	105.1	22.2	2.0	5.7	0.0	13.0	41.0	36.7	6.2	33.7	45.5	2.3	2.0	3.2	3.5	4.1	17.4	7.1	12.4	30.9	0.8	4.0	0.0	9.0	2.0	9.9	0.6	17.3	1.4	13.8	2.4	22.4	2.5	4.7	19.7	1.4	20.9	1.3	3.4	9.7	11.9	80.7	1.5	6.4	2.5	10.5
TTC6	"C14orf25, NCRNA00291"	ENSG00000139865	"Tetratricopeptide repeat domain 6"	Q86TZ1	14	37595847-38041442	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 7.9;prostate: 17.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 13.8;Club cells: 11.1;Early spermatids: 39.1;Late spermatids: 18.1;Spermatocytes: 10.7"	"Group enriched"	"Detected in some"	7	"breast cancer: 2.2;prostate cancer: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 8.4;MCF7: 12.2;RT4: 8.4;T-47d: 22.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	7	"midbrain: 9.7"	HPA069293			Approved	Centrosome		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 35: Glandular cells - Unknown function"	Centrosome		"HPA069293: AB_2686110"	"unprognostic (7.92e-2)"	"unprognostic (6.95e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.98e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.60e-4)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-4)"	"unprognostic (5.60e-2)"	"unprognostic (8.91e-8)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.07e-3)"	0.0	0.0	0.5	0.2	0.8	0.0	7.9	0.1	0.8	0.1	1.1	1.0	0.6	0.0	0.0	0.4	0.3	0.7	0.0	0.7	1.0	0.0	3.5	1.1	0.0	2.5	5.0	0.0	0.0	0.0	0.3	0.0	1.3	17.5	0.5	0.0	2.7	0.1	0.0	0.7	0.7	0.0	3.9	0.0	3.6	5.8	3.9	0.0	0.0	0.0	0.1	1.4	0.3	1.0	0.7	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.4	0.0	0.0	2.4	1.3	0.2	0.0	0.0	3.4	0.0	1.2	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	12.2	0.0	0.0	0.0	1.7	4.5	0.0	0.0	0.0	1.0	8.4	2.4	0.0	0.0	4.5	0.0	0.0	22.8	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.8	0.7	1.0	2.5	5.0	1.3	3.9	3.9	1.0	0.2	0.0	8.4	0.3	0.1	0.0	2.8	1.5	6.2	0.0	13.8	6.9	0.8	1.5	11.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	39.1	0.0	0.0	0.4	7.7	0.0	6.4	0.0	0.0	0.4	7.1	0.1	0.0	0.0	0.0	2.5	0.0	0.0	1.0	0.7	0.0	0.0	0.0	18.1	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.8	0.4	0.0	4.9	0.0	0.0	7.5	0.0	0.0	0.2	0.4	10.7	1.9	2.3	0.0	0.0	0.3	0.0	1.1	3.1
TUFT1		ENSG00000143367	"Tuftelin 1"	Q9NNX1	1	151540305-151583583	"Predicted intracellular proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 111.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 69.2;Glandular and luminal cells: 76.8;Suprabasal keratinocytes: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.2;T-cells: 3.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 41.7"	"HPA028112, HPA054301"	Approved	Approved	Approved	Vesicles	"Secreted - unknown location"	NA	Yes			"Cluster 41: Basophils - Cellular respiration"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA028112: AB_10603224, HPA054301: AB_2682442"	"unprognostic (6.16e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.29e-3)"	"unprognostic (9.06e-2)"	"unprognostic (6.70e-3)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.82e-3)"	"unprognostic (4.53e-2)"	5.6	6.8	4.7	2.8	4.2	6.7	10.1	5.0	5.3	25.4	3.4	11.6	7.5	5.3	6.3	48.1	5.1	5.9	4.9	3.8	5.9	14.1	7.0	8.4	0.9	4.0	4.0	7.4	17.2	11.4	7.2	13.3	5.2	9.6	13.0	2.1	18.3	9.2	2.5	111.5	10.8	6.2	3.3	1.5	12.8	5.4	6.2	2.2	5.7	2.7	6.2	12.4	26.8	3.5	40.7	13.7	10.0	11.5	2.3	1.9	63.1	10.7	9.5	41.3	39.6	43.6	31.5	3.5	64.6	12.5	19.5	46.4	17.6	16.2	30.1	27.0	8.7	2.2	23.0	6.7	32.2	0.8	4.7	6.5	18.9	32.5	71.6	24.5	3.4	5.0	3.6	26.8	12.8	16.8	2.0	0.5	11.7	29.6	11.4	0.1	28.1	14.2	34.7	61.8	19.5	8.0	68.2	45.8	8.0	29.4	36.5	2.1	8.6	7.4	51.7	46.2	71.7	6.6	13.7	0.5	6.3	0.9	4.7	5.2	0.6	0.7	0.3	0.1	0.7	0.6	1.0	0.5	0.9	0.2	0.8	0.3	2.5	0.1	0.3	0.1	3.5	0.5	4.7	4.2	5.0	5.3	3.8	5.9	4.0	4.0	5.2	3.3	6.2	3.5	2.1	25.6	2.0	1.6	3.8	69.2	35.2	14.7	35.9	2.5	28.8	20.2	9.8	8.6	19.0	14.7	0.0	28.1	6.6	59.5	13.7	18.2	2.7	43.2	8.9	2.7	32.2	2.7	4.4	15.2	13.9	7.0	46.9	76.8	4.5	9.0	1.1	10.5	4.0	0.0	9.3	39.1	20.3	0.0	12.7	3.2	2.5	6.5	8.8	1.0	2.0	2.1	0.0	8.5	1.8	47.4	34.6	5.3	7.7	21.7	15.4	11.2	15.9	0.5	6.6	4.1	5.5	0.6	3.5	39.6	66.5	56.8	5.8	10.9	35.7	35.6
UNC13C	"DKFZp547H074, Munc13-3"	ENSG00000137766	"Unc-13 homolog C"	Q8NB66	15	53978201-54633414	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 103.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 73.1;Early spermatids: 184.4;Excitatory neurons: 130.3;Inhibitory neurons: 301.3;Late spermatids: 65.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Karpas-707: 73.7;U-266/70: 97.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 198.6"							NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (4.85e-2)"			"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.56e-1)"		"unprognostic (6.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.58e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.26e-1)"	0.1	0.2	10.5	0.1	11.2	0.1	0.1	103.6	25.6	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.2	19.0	26.4	0.9	0.0	0.1	0.3	29.5	38.4	0.8	0.0	0.0	1.1	0.0	34.9	0.0	0.1	19.1	0.1	0.0	3.5	0.1	0.1	0.0	6.2	0.1	0.1	8.7	16.9	0.0	0.6	0.0	0.3	0.0	0.0	11.7	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	97.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	11.2	103.6	25.6	19.0	26.4	29.5	38.4	34.9	6.2	16.9	11.7	0.1	0.0	0.0	8.5	0.1	0.4	0.4	0.0	0.0	73.1	0.1	0.3	0.8	1.5	0.0	3.7	6.2	1.0	1.3	0.0	0.0	0.0	184.4	0.0	0.0	0.4	0.0	0.0	130.3	0.0	0.1	0.4	0.0	0.1	0.0	0.5	0.7	0.0	0.1	0.0	301.3	0.0	0.0	0.0	0.6	65.9	2.1	0.3	0.0	3.7	0.0	3.2	0.0	4.5	3.2	0.0	0.0	0.4	0.0	0.3	0.0	0.4	0.0	33.8	0.0	2.2	0.7	1.2	1.2	0.0	0.1	0.3	0.1	0.5	0.0	0.5
UNCX	Uncx4.1	ENSG00000164853	"UNC homeobox"	A6NJT0	7	1232872-1237326	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 17.5"	"Cell type enriched"	"Detected in single"	10	"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"NB-4: 98.5"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.2"	"Region enriched"	"Detected in single"	8	"cerebellum: 7.5"	HPA063294			Approved	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 24: NB-4 - Immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA063294: AB_2684977"					"unprognostic (1.15e-1)"										"unprognostic (9.71e-2)"			0.0	0.0	0.7	0.0	0.1	0.0	0.0	17.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.4	0.0	0.0	0.0	2.2	3.0	0.0	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	17.5	0.5	0.0	2.8	2.2	3.0	3.2	0.6	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UTS2	"PRO1068, U-II, UCN2, UII"	ENSG00000049247	"Urotensin 2"	O95399	1	7843083-7853512	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 43.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 15.3;granulocytes: 41.2;monocytes: 17.9;NK-cells: 88.6;T-cells: 18.2"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"medulla oblongata: 43.0;pons: 27.0;white matter: 25.2"	"Immune cell enriched"	"Detected in many"	5	"T-reg: 45.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 45.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 22.6;HEL: 7.1;HMC-1: 5.7;THP-1: 26.2"	"Region enriched"	"Detected in single"	19	"pons and medulla: 6.1"	"Region enriched"	"Detected in some"	12	"spinal cord: 79.7"	HPA017000	Uncertain				"Secreted to blood"	NA	NA	2590000		"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA017000: AB_1858656"	"unprognostic (2.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.32e-5)"	"unprognostic (1.09e-4)"	"unprognostic (4.95e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.30e-3)"	0.5	3.7	0.1	0.5	0.1	2.9	0.1	1.5	0.5	0.3	0.0	0.7	0.6	0.1	0.0	0.1	0.4	0.5	0.0	0.2	4.6	0.3	0.1	0.5	1.8	43.0	6.2	0.3	0.0	0.0	0.0	0.0	27.0	1.4	1.2	0.9	0.0	0.0	0.3	0.3	0.5	1.2	4.0	1.1	0.2	0.0	0.9	0.9	0.1	0.0	0.3	0.2	0.1	25.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.1	0.0	0.2	0.0	0.0	5.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	8.5	0.1	0.6	5.0	0.0	6.7	0.0	4.4	4.5	0.8	0.0	0.4	1.3	0.1	6.1	0.0	0.0	45.2	1.7	0.1	0.1	1.5	0.5	0.2	4.6	43.0	6.2	27.0	4.0	0.9	25.2	0.1	0.0	1.9	0.0	5.1	1.5	0.1	0.1	1.8	3.2	0.0	0.0	0.1	0.0	0.7	1.8	0.0	0.0	15.3	2.7	0.0	0.0	0.0	0.0	0.1	0.3	1.2	1.7	0.4	0.0	0.0	0.6	1.1	0.1	41.2	0.0	0.0	0.0	0.1	5.0	0.5	3.7	0.0	0.0	1.3	0.0	0.0	5.5	0.0	1.0	17.9	0.8	88.6	0.5	0.2	0.1	4.7	0.0	4.3	1.2	3.0	0.6	0.0	1.2	0.0	0.2	0.3	0.0	0.0	0.8	0.4	0.1	18.2	0.0	8.0	0.0
UTS2B	"U2B, URP, UTS2D"	ENSG00000188958	"Urotensin 2B"	Q765I0	3	191267168-191330536	"Predicted secreted proteins"		Hormone		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 14.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;B-cells: 2.6;Early spermatids: 8.3;Late spermatids: 2.3;Oligodendrocyte precursor cells: 3.0;Spermatocytes: 2.6;Spermatogonia: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.8;naive B-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"PC-3: 3.3"	"Region enriched"	"Detected in some"	9	"pons and medulla: 11.3"	"Region enriched"	"Detected in single"	46	"spinal cord: 6.0"	HPA026992	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA026992: AB_1858703"	"unprognostic (1.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.10e-2)"	1.0	1.2	0.8	0.8	0.5	0.5	1.2	4.1	1.4	0.2	0.0	0.5	5.3	0.7	0.5	0.7	1.0	1.2	0.7	0.7	0.5	0.6	3.2	0.5	1.0	0.7	0.4	1.0	0.5	0.2	0.0	0.4	1.1	0.6	0.4	14.9	0.6	0.2	0.5	1.1	3.2	0.5	0.1	0.6	1.6	2.3	0.6	0.1	0.5	0.0	0.3	0.4	0.1	0.9	0.4	1.0	1.3	0.6	0.3	1.6	0.4	1.0	0.5	0.3	0.2	0.7	0.5	0.7	0.5	0.4	2.6	0.5	0.4	0.0	1.6	0.6	0.5	0.6	1.4	2.9	0.3	0.8	0.4	0.6	0.2	0.2	0.3	0.9	0.3	0.6	0.4	0.6	0.5	0.6	0.2	0.5	0.7	1.3	3.3	0.9	1.5	0.2	0.2	1.6	0.7	0.5	0.6	0.7	0.4	0.5	0.5	0.5	1.4	0.7	0.4	1.3	0.4	1.1	0.6	0.6	0.9	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.8	0.5	4.1	1.4	0.7	0.5	0.7	0.4	1.1	0.1	0.6	0.9	0.2	3.2	1.1	0.7	2.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	8.3	1.4	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.1	0.0	0.7	1.6	0.0	0.2	0.1	1.5	0.0	0.0	0.1	0.2	2.6	2.1	0.0	0.3	0.3	0.0	0.1	0.0	0.1
ZFP36	"G0S24, NUP475, RNF162A, TIS11, TTP"	ENSG00000128016	"ZFP36 ring finger protein"	P26651	19	39406847-39409412	"Predicted intracellular proteins"	"Host-virus interaction, mRNA transport, RNA-mediated gene silencing, Transport"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2759.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 313.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 154.7;hTCEpi: 179.0;Karpas-707: 167.0;U-266/84: 149.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"spinal cord: 151.4"	HPA006009	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Intermediate filaments"		"HPA006009: AB_1859030"	"unprognostic (2.30e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.26e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.59e-2)"	"unprognostic (5.20e-1)"	"unprognostic (3.61e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.20e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.92e-3)"	1520.5	341.7	46.9	258.1	49.9	745.3	716.3	55.6	74.0	517.1	71.2	582.4	168.3	316.1	17.0	645.5	1276.8	520.0	575.4	42.8	84.3	288.1	462.0	1135.1	175.1	130.5	63.1	480.5	160.6	124.5	311.5	120.9	68.5	342.3	175.6	39.2	329.7	143.6	322.8	828.9	322.5	426.0	78.8	282.1	554.4	49.4	86.3	269.6	510.2	281.6	73.1	523.2	712.5	79.6	27.5	16.5	4.3	1.5	108.8	154.7	7.7	20.8	26.7	11.2	8.7	12.8	28.3	16.8	6.2	32.7	12.1	13.2	1.0	35.0	3.5	21.1	1.6	7.2	12.1	8.0	70.2	7.4	41.6	56.7	179.0	8.0	66.3	14.6	6.6	18.7	10.2	167.0	19.4	21.5	13.2	17.7	1.6	83.4	2.6	18.9	2.3	35.9	14.9	43.6	1.2	4.2	10.1	23.6	6.1	6.3	16.8	39.8	11.4	15.3	6.1	28.2	6.3	116.5	149.7	19.5	15.4	15.1	6.4	121.8	72.2	68.8	38.8	69.9	32.8	47.8	33.4	39.5	69.0	45.5	38.0	37.0	313.6	17.4	95.5	50.9	41.9	44.3	46.9	49.9	55.6	74.0	42.8	84.3	130.5	63.1	68.5	78.8	86.3	79.6	2759.0	419.9	864.0	7.5	686.2	1160.4	1543.0	789.3	2108.6	0.4	819.5	566.2	514.9	351.8	426.9	80.9	4.2	70.3	962.4	628.2	31.3	234.2	6.1	528.1	797.5	1208.6	631.9	109.2	0.4	105.6	95.5	2072.6	881.3	1055.0	690.7	45.7	668.6	206.4	703.1	1.7	0.2	608.3	250.3	669.9	2332.1	17.4	557.7	1189.0	631.5	24.4	125.6	55.0	94.7	0.0	1.6	156.4	907.8	139.5	1540.1	823.3	1060.8	60.2	298.5	7.1	769.2	878.2	1346.7	2.9	5.4	1641.6	1585.6	154.2	1193.0	87.1	366.5	639.9
ZIC1	"ZIC, ZNF201"	ENSG00000152977	"Zic family member 1"	Q15915	3	147393422-147510293	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Craniosynostosis, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 616.8"	"Group enriched"	"Detected in some"	4	"Microglial cells: 25.3;Skeletal myocytes: 61.0"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 616.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 174.0;MCF7: 43.9;U-2197: 28.5"	"Region enhanced"	"Detected in all"		"cerebellum: 207.4"	"Region enriched"	"Detected in all"	8	"cerebellum: 638.1"	HPA004098	Supported		Supported	Nucleoplasm		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA004098: AB_1859065"	"unprognostic (1.33e-2)"			"unprognostic (1.82e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.19e-1)"		"unprognostic (5.01e-1)"	"unprognostic (2.61e-7)"	"unprognostic (2.95e-3)"	"unprognostic (1.67e-2)"		"unprognostic (3.01e-1)"	3.4	0.7	25.0	0.0	50.7	0.0	0.2	616.8	30.3	0.0	39.0	0.1	0.2	0.0	1.8	0.2	0.0	0.1	0.1	13.6	39.5	0.1	12.8	0.1	0.1	66.8	55.3	0.2	0.1	0.0	2.4	0.0	67.3	0.0	0.1	10.7	0.5	0.0	6.9	2.5	0.8	0.0	23.8	0.0	0.2	0.3	112.1	0.0	0.0	0.8	0.0	0.0	0.0	44.8	0.0	0.0	174.0	0.0	17.9	19.6	9.8	11.4	13.5	12.1	9.9	0.0	0.0	0.0	9.1	0.9	9.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.4	0.0	0.7	0.0	0.0	3.1	0.0	10.9	43.9	0.0	0.0	0.5	0.9	0.0	0.0	17.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	17.9	0.0	28.5	11.0	0.0	0.0	0.0	13.5	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	50.7	616.8	30.3	13.6	39.5	66.8	55.3	67.3	23.8	112.1	44.8	0.2	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.9	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.1	0.0	25.3	0.0	4.3	0.0	2.0	9.5	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	61.0	0.3	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ZIC2	HPE5	ENSG00000043355	"Zic family member 2"	O95409	13	99981784-99986765	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease variant, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"brain: 123.4;choroid plexus: 35.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 28.1;Cone photoreceptor cells: 6.2;Microglial cells: 29.0;Muller glia cells: 10.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 123.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 86.2;HDLM-2: 43.5;HEK 293: 66.1;NTERA-2: 80.5;SCLC-21H: 179.7"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 113.3"	HPA055031			Supported	"Nuclear bodies"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear bodies"		"HPA055031: AB_2682676"	"unprognostic (6.43e-6)"	"prognostic favorable (2.64e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.42e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.26e-1)"	"unprognostic (2.11e-1)"		"unprognostic (5.36e-3)"	0.0	0.2	17.0	0.0	19.0	0.0	0.0	123.4	16.2	0.0	35.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.0	10.4	0.1	0.0	0.0	0.0	20.9	14.8	0.0	0.0	0.0	1.2	0.0	22.5	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.5	4.9	86.2	5.5	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.5	5.8	0.0	7.3	0.0	4.6	0.1	3.9	0.0	0.0	43.5	66.1	6.4	4.0	4.4	0.0	0.0	4.3	0.0	6.2	0.0	3.9	0.4	0.0	2.2	6.5	0.0	0.0	2.9	0.4	34.3	80.5	0.0	2.0	19.8	3.3	0.1	0.4	2.2	179.7	0.0	2.8	0.5	0.0	3.3	4.2	33.5	0.0	20.2	0.0	3.6	5.8	0.6	0.0	0.0	4.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	19.0	123.4	16.2	16.0	10.4	20.9	14.8	22.5	8.8	27.1	11.3	0.2	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.6	0.3	0.2	0.3	0.7	0.0	0.0	1.8	6.2	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.0	0.0	10.3	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	1.5	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0
ZIC4		ENSG00000174963	"Zic family member 4"	Q8N9L1	3	147386046-147406809	"Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 68.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 5.0;Late spermatids: 13.5;Microglial cells: 6.5;Muller glia cells: 5.5;Oligodendrocytes: 6.9;Skeletal myocytes: 6.2"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Region enriched"	"Detected in all"	4	"cerebellum: 68.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 16.5;ASC diff: 4.7;BEWO: 3.5;MCF7: 4.7;SH-SY5Y: 4.9;U-2197: 3.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"cerebellum: 67.3"	HPA030194	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030194: AB_2673367"	"unprognostic (1.12e-1)"			"unprognostic (9.95e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.13e-2)"			"unprognostic (1.10e-10)"	"unprognostic (3.50e-2)"	"unprognostic (8.69e-2)"			0.6	0.0	1.9	0.0	6.6	0.0	0.0	68.5	4.7	0.0	5.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.7	5.5	0.0	0.3	0.0	0.0	10.6	5.8	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	4.8	0.0	0.0	1.3	1.2	0.1	0.0	2.7	0.0	0.0	0.5	10.5	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	16.5	0.0	4.7	1.9	3.5	1.8	0.4	0.2	0.5	0.0	0.0	0.0	2.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	4.9	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.1	0.0	3.9	1.8	0.0	0.0	0.0	1.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	6.6	68.5	4.7	1.7	5.5	10.6	5.8	9.0	2.7	10.5	15.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	6.5	0.0	5.5	0.0	0.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	6.2	0.1	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZIC5		ENSG00000139800	"Zic family member 5"	Q96T25	13	99962964-99971909	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.1;choroid plexus: 8.1"	"Group enriched"	"Detected in some"	7	"Astrocytes: 20.5;Microglial cells: 15.0;Spermatocytes: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 22.0;HEK 293: 12.7;NTERA-2: 15.1;SCLC-21H: 85.5"	"Group enriched"	"Detected in all"	5	"basal ganglia: 18.9;cerebellum: 18.4;thalamus: 5.3"	"Region enriched"	"Detected in all"	7	"cerebellum: 39.7"	HPA074045			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Vesicles"		"HPA074045: "	"unprognostic (2.78e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.38e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.87e-2)"		"unprognostic (1.13e-1)"	"unprognostic (3.12e-2)"		"unprognostic (4.94e-2)"	0.0	0.0	2.8	0.0	3.5	0.0	0.0	17.1	11.2	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.1	0.0	0.0	0.0	0.0	2.8	2.1	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.6	3.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	2.2	22.0	1.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	1.0	2.1	0.0	3.1	0.0	1.1	0.0	4.5	0.0	0.0	4.0	12.7	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.9	3.3	0.0	0.0	1.7	0.0	1.7	15.1	0.0	0.3	1.9	0.8	0.0	0.0	0.0	85.5	0.0	2.4	2.0	0.0	1.6	0.0	2.8	0.0	1.2	0.0	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.5	17.1	11.2	3.9	2.1	2.8	2.1	3.0	1.8	3.1	2.6	0.1	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.0	0.0	1.9	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF521	"EHZF, Evi3"	ENSG00000198795	"Zinc finger protein 521"	Q96K83	18	25061924-25352190	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 95.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 170.1;Microglial cells: 53.4;Oligodendrocyte precursor cells: 221.7;Oligodendrocytes: 104.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 95.9"	"Group enriched"	"Detected in some"	6	"basophil: 11.4;plasmacytoid DC: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 8.8;granulocytes: 11.4"	"Cell line enhanced"	"Detected in many"		"AF22: 67.6;fHDF/TERT166: 32.7;HUVEC TERT2: 46.9;THP-1: 38.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 49.7"	"HPA023056, HPA023849"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm		"HPA023056: AB_1859315, HPA023849: AB_1859316"	"unprognostic (8.80e-3)"	"unprognostic (9.68e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.52e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.52e-3)"	"unprognostic (7.82e-4)"	13.4	11.9	8.8	3.1	10.5	2.3	11.4	95.9	9.5	10.8	29.9	4.7	1.7	15.3	4.3	3.9	9.0	10.6	9.1	6.0	14.7	3.2	1.2	6.3	3.8	17.4	14.3	20.5	1.2	1.1	7.6	8.6	21.2	2.6	3.6	5.7	9.0	3.0	3.7	6.1	4.4	13.6	12.4	21.0	2.7	3.6	10.8	4.3	6.8	6.0	2.8	5.8	6.8	13.5	0.1	0.0	67.6	0.1	10.6	18.4	0.2	10.0	14.3	3.4	2.1	0.0	0.1	0.0	0.0	32.7	0.0	0.3	0.0	0.0	2.8	0.0	4.0	14.0	0.6	0.5	1.9	0.0	20.2	23.0	0.0	0.3	0.0	0.0	46.9	16.4	0.3	0.1	6.0	0.0	9.2	0.0	4.7	0.0	0.0	0.0	15.2	1.1	0.0	0.0	8.7	5.5	0.8	0.0	0.0	6.1	0.0	38.9	26.9	26.5	2.0	8.0	1.5	0.1	0.0	0.3	10.0	0.0	22.2	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	8.8	0.0	0.1	8.8	10.5	95.9	9.5	6.0	14.7	17.4	14.3	21.2	12.4	10.8	13.5	19.0	0.0	3.0	170.1	0.3	3.7	0.1	0.0	1.2	42.4	8.0	10.9	11.9	0.0	0.6	0.0	2.1	0.1	1.7	0.0	0.0	0.0	2.1	0.5	3.3	28.6	1.2	13.9	16.5	0.0	0.0	21.4	0.0	0.2	13.3	4.7	20.3	0.0	0.1	15.2	22.7	0.1	0.0	0.6	5.5	3.3	9.9	0.9	14.2	53.4	0.1	0.7	0.0	221.7	104.6	0.0	0.0	7.9	0.1	0.2	0.0	4.0	1.5	3.0	0.0	13.7	6.0	0.1	6.1	0.8	4.4	0.1	0.8	17.2	0.0	0.2